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Diastereoselective synthesis of 4-hydroxypiperidin-2-ones via Cu(I)-
catalysed reductive aldol cydlisation 
The development of a diastereoselective reductive aldol reaction and its application 
in the synthesis of a number of 4-hydroxypiperidin-2-ones is described. The 
reactions proceed in the presence of Cu(OAc)2 H20, a bis-phosphine ligand and 
TMDS (1,1,3,3-tetramethyldisiloxane). The scope of this process with respect to the 
ketone functionality is broad, encompassing a range of aliphatic, aromatic and 
heteroaromatic groups. Synthetic applications of the resulting J3—hydroxycarbonyl 
compounds, including the preparation of enantioenriched piperidines, are discussed. 
The use of chiral non-racemic bis-phosphine ligands enables the lactam products to 
be isolated in up to 65% ee. 
Ligand (5 rnol%( 	
0 
0 	0 	Cu(OAc)2.H20 (5 mot%) Mo...IL _PMP 
Ph N 	 TMDS, THE, rt Ph"L..._) 
	
PMP HO 
Representative racemic examples obtained using the achiral ligand DPPF 
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N
...)U._PMP Me,', ti N 
	 N 
_PMP Me, )L _PMP 
Me 
iB 
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Diastereoselective cobalt and nickel-catalysed reductive aldol cyclisations 
using diethyizinc as the stoichiometric reductant 
The development of a diastereoselective reductive aldol reaction and its application 
in the synthesis of substituted 4-hydroxypiperidin-2-ones and pyrrolidin-2-ones are 
described. The reactions proceed in the presence of either Co(acac)2 2H20 or 
Ni(acac)2 and diethylzinc. The scope of this process with respect to the 
a,f3—unsaturated component is broad, encompassing -a-  range of aliphatic and 	- - 
aromatic groups. Catalyst optimisation studies including the evaluation of a number 
of chiral, non-racemic ligands are discussed. 
iv 
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n=1,2 
Method A: Co(aca02 2H20 (5 mol%) 
Method B: CoCl2 (5 mot%), Cy2PPh (5.5 mol%) 
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III. Enantioselective synthesis of highly substituted pyrrolidinones via an aldol 
cyclisation mediated by a chiral non-racemic hydrogen bond donor 
catalyst 
Catalytic, enantioselective aldol cyclisations of substituted malonic esters tethered to 
a ketone through an amide linkage are described. The development of an effective 
catalyst system through the evaluation of Lewis acid catalysts and hydrogen bonding 
catalysts are discussed. The potential use of the developed methodology to the 
synthesis of complex natural products is presented. 
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1. The Reductive Aldol Reaction 
Regioselective enolate formation in the presence of multiple carbonyl groups is a 
particular challenge in synthetic chemistry (Scheme 1.1). 
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mixture of regiolsomeric products 
Scheme 1.1 
The Mukaiyama aldol reaction,' for example, is one possible solution to competitive 
enolate formation (eq 1) whereby, the latent enolate is trapped as a silyl enol ether 
which is then used in a subsequent coupling reaction with an aldehyde or ketone. 
0 








However, this methodology requires the pre-formation of highly reactive and 
relatively unstable intermediates which must be used immediately once synthesised. 
On the other hand, the reductive aldol reaction allows the mild and regioselective 
formation of the desired enolate in the presence of other carbonyl species. 
The reductive aldol reaction is the coupling of the ct-carbon of an (x,,8- unsaturated 
carbonyl species to an acceptor aldehyde or ketone in the presence of a 
substoichiometric amount of a metal promoter and a stoichiometric amount of a 
reducing agent (eq 2). The 8-hydroxy carbonyl products can be isolated either as the 
free hydroxyl compound or as the silyl ether if silanes are used as the reducing agent. 
In addition, the reductive aldol reaction can be carried out under mild conditions 
using commercially available materials with no pre-formation of an enolate required. 
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0 
0 OH 
Meta' Catalyst R1R 	
(2) 
Hydride Source 
1.1. Rhodium-catalysed intermolecular reductive aldol reactions 
The reductive aldol reaction has attracted a great deal of attention from some of 
world's largest research groups since its discovery in the late 1980's. This 
methodology was pioneered by Revis and Hilty who in 1987 demonstrated that a 
selection of ketones and aldehydes could be efficiently coupled to a variety of 





0 Me aIMS Me 	95 
,JY
MeO 	
RhCI,3H20 (10 mot%) MeO)&R 	
Et 91 
78 
Me 	Me3SiH 	 Me Me 	nEt 	nr 
Table 1.1 
In their work Revis and Hilty observed a small amount of silyl ketene acetal as a 




0 Me OTMS 	 OTMS 	I 
MeO 	 RhCL3 3H20 (10 mol%) MeO 
	Me 	MeOMe 	 (3) 
+ 
Me 	 Me3SiH 	 Me Me 	 Me 	I 
95% yield 
j 	5% yield 
They postulated that the rhodium catalyst promoted the formation of the silyl ketene 
acetal by the oxidative addition of the silane followed by acrylate insertion and 
reductive elimination. This acetal would then be free to couple with the electrophile 
in a Mukaiyama type coupling (eq 4). However, when the silylketene acetal was 
independently synthesised and subjected to the reaction conditions, no coupling 
between the acetal and electrophile was observed. 




0 Me OTMS 
) M Me 
MeO 	 Rhc13 3H 20 (10 mo(%) MeO Me 	
(4) 
Me 	 Me Me 
No reaction 
As a consequence, Revis surmised that the reductive aldol reaction was proceeding 
through a novel reaction mechanism. However, Revis was not successful in 
generating the products with any degree of diastereoselection. 
Several years after this seminal work by Revis and Hilty, Matsuda and co-workers 
reported the first example of a diastereoselective reductive aldol reaction (Table 
1.2). Using aR h4(CO)12 catalyst and PPh2Me as ligand, Matsuda illustrated that 
various enones could be coupled to a small selection of aldehydes in the presence of 
Et2MeSiH with modest diastereoselectivities of up to 4:1 in favour of the syn 
diastereomer. 
0 




Rh4(CO)8 (0.5 mol%( 
MePh2P (1.0 mot%) 
R1 	R Et2MeSiH 
R1 	R2 R3 	%YieId syn:anti 
H 	Me Ph 	 99 83:17 
H 	Me CH3(CH2)6 	80 68:32 
H 	Me c-C6H,, 	63 58:42 
H 	Ph Ph 	 88 55:45 
Me 	Me Ph 	 86 80:20 
Table 1.2 
In a similar fashion to Revis, Matsuda demonstrated that independently synthesised 
silylketene acetals were unreactive under the reaction conditions. Following 
mechanistic information discovered by Bergman and Heathcock in 1989, Matsuda 
postulated a tentative mechanistic rationale for the rhodium catalysed reductive aldol 
reaction, where an oxygen-bound rhodium enolate reacted directly with the aldehyde 
(Scheme 1.2). 
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R2 	 R2 
Scheme 1.2 
More recently, the group of Morken utilised high-throughput technology to rapidly 
develop a catalyst system for the diastereoselective reductive coupling of acrylates 
with aldehydes. By using a 96-well plate, Morken and co-workers were able to 
analyse and compare the efficiencies of 192 independent catalyst systems for the 
reductive aldol reaction between methyl acrylate and benzaldehyde (Table 1.3).' 
From these results, a number of interesting observations on reaction conditions and 
yield were made. Firstly, the use of catechol borane as the stoichiometric reductant 
tends to give reactions with the majority of catalysts, whereas, trichlorosilane is only 
effective when [(allyl)PdCI]2 is used in the presence of MOP ligand (4). 
Additionally, it was noted that the reaction characteristics are highly sensitive to the 
choice of ligand and silane. 
Metal salt Chiral ligand Reductant 
0 
Co(acac)2 'Pr-pybox (1) Cl2MeSiH 
0 
_Ji. 	HPh 	
0 	OH [(aUyl)PdCI]2  
f(COD)WO], 
'Bu-box (2) Et2MeSiI-1 
MeO 
Vary metal salt (4) 	
MeO Ph Ph-semicorn (3) PhSIH3 
Vary chiral ligand  (8) Me [(COD)RhCL]2 MOP (4) Ph2S1H5 
Vary reductant (6) 
BINAP (5) CL3SLI-1 
4 * 8 * 6 = 196 independent catalyst systems 




Of the catalyst systems examined, Morken opted for the combination of 
[Rh(COD)Cl]2 with Me-DuPhos (7) as the ligand and dichloromethylsilane as the 
stoichiometric reductant (Table 1.4). Using this system, acrylates were shown to 	- - - - - 
undergo reductive aldol coupling with a variety of aromatic and aliphatic aldehydes, 
producing the aldolate products in moderate to good yields with diastereoselectivities 
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up to 23:1 (syn:anti). However, little or no enantioselectivities were observed with 




R'O R1O R2 
Me-DuPhos (7) (5.5 mot%) 
[Rh(COD)C(12 (2.5 mot%( Me 
CL2MeSIH 
R' 	R2 %Yield syn:anti 	%ee syn 
Me 	Ph 69 23:1 0 
Et 	1-naphth 82 10:1 0 
Et 	'Bu 38 21:1 0 
Et 	'Pr 15 15:1 0 
Et 	PhCH=CH 41 '20:1 0 
Table 1.4 
In an effort to understand the reaction pathway, Morken used NMR spectroscopy to 
study the generation and reactivity of reaction intermediates .6  Initially, the Rh-
DuPhos-catalysed reaction between methyl acrylate and dichloromethylsilane was 
shown to produce a single stereoisomer of the intermediate silylketene acetal. 
Introduction of benzaldehyde led to rapid consumption of the silylketene acetal 
forming a single diastereomer of the reductive aldol product (Scheme 1.3). 
0 
0 	[Rh(COD)C(]2 (2.5 moL%) 	OSiCl2Me 	 0 	OSICI2Me 
MeO 	





C6D6 	 Me 	 Me 
Scheme 1.3 
In addition, itwas shown that vacuum-distilled silylketene acetal reacted with 
benzaldehyde in the absence of catalyst to provide the aldol adduct with high levels 
of stereoselection. It was concluded that the role of the Rh-DuPhos complex in the 
reductive aldol reaction is to catalyse the formation of the _silylketene acetal and _that-
the chiral catalyst is not involved in the aldol addition step. As a consequence, these 
results would seem to preclude the prospect of an enantioselective variant of this 
system. Nevertheless, this system represents a method of generating syn aldol 
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adducts with a large variety of aldehydes in excellent yields and selectivities superior 
to the previously mentioned single-sequence procedure (Table I 5)•5 
1. CLMeSiH 
o Me-DuPhos (7) (2.5 mot%) 0 	OH 
MeO" 	2 
[Rh(COD)Ct]2 (1.25 mot%) 
MeO R 0 
HR 
Me 
R %YieLd Syn:anti 
PhCHO 94 '60:1 
PhCH'CHCHO 	 95 13:1 
'PrCHO 89 9:1 
EtO2CCHO 84 >20:1 
Bn0CH2CH0 80 '20:1 
Table 1.5 
On the other hand, by modifying the catalyst system to incorporate excess (R)-
BINAP (6)as ligand and Et2MeSiH as the reductant, Morken was able to effect the 
reductive aldol reaction between acrylate esters and aldehydes to give the products 
with impressive levels of enantioselection. Indeed, this work constitutes the first 
reported example of a catalytic asymmetric reductive aldol reaction (Table 1.6). 
0 
,11 0 	OH 
PhO [Rh(COD)Ct]2 (2.5 mot%( PhO R 
BINAP (6) (6.5 mot%( Me 
Et2MeSIH 
R %Yietd 	syn:anti %ee syn(anti) 
Ph 72 	 3.4:1 87(34) 
Et 59 	 5.1:1 88(7) 
c-05H11  54 	 3.9:1 84(48) 
tBu 48 	 1.8:1 45(>99) 
1-naphth 82 	 3.8:1 80(13) 
PhCH=CH 0 	 - - 
Table 1.6 
He surmised that during the initial catalyst screening process equimolar quantities of 
ligand and metal salt resulted in incomplete complexation, resulting in very low 
enantioselection. However, by adding excess ligand with respect to the metal salt, 
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increased complexation resulted in increased enantioselectivity to a maximum of 
88% albeit with a greatly reduced diastereoselection of up to 5:1 (syn:anti)f rom the 
initial 23:1 (Table 1.4). 
Krische further extended the scope of the rhodium catalysed reductive aldol reaction 
by employing elemental hydrogen as the stoichiometric reductant (Table 1.7).' A 
variety of aromatic aldehydes could be efficiently coupled with phenyl vinyl ketone 
in the presence of Rh(COD)2OTf, PPh3, KOAc and hydrogen gas (1 atm) at room 
temperature to give the reductive aldol adducts in good yields but with only poor 






h Ph3P (12 mol%), H2 (1 atm) 
0 	OH 
Ph1 R 
Rh(COD)2OTf (5 mot%) Me 
KOAc (50 mot%) 
R %Yietd syn anti 
4-NO2PhCHO 92 1.8:1 
4-MeOPhCHO 75 1.7:1 
2-furytCHO 88 2.5:1 
2-naphth 61 2.3:1 
4FPh 65 2:1 
CH3(CH2(2 44 2:1 
Table 1.7 
It was found that competitive conjugate reduction of phenyl vinyl ketone was a 
prevalent side-reaction. However, by increasing the molar equivalents of phenyl 
vinyl ketone and reducing the catalyst loading of rhodium salt from 10 mol% to 5 
mol% the yield of aldol adducts could be maximised. 
Initial work by Nishiyama and co-workers into the rhodium-catalysed asymmetric 
conjugate reduction of a,/3-unsaturated esters identified a rhodium complex with 




variety of silanes as a highly efficient catalyst system.9 Application of this system to 
the reductive coupling of tert-butyl acrylate with a diverse selection of aromatic 
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aldehydes provided the aldol adducts in excellent yields with remarkable levels of 





(8) or (9) (1 moiX) 	BuO R 
Hydrosilane Me 
,OAc 
R %YieLd syn:anti %ee ant/ (syn) 
N 
F 	OF-/2 
OAc 4-MeOPh 98 6:94 94(42) 
2-Naphthyt 93 7:93 96(5) 
PhCH=CH 56 19:81 93(79) 
PhCH2OCH2 56 19:81 93(79) R = 'Pr: 	Rh(Phebox-ip) 	(8) 
c-C61111  70 13:87 93(12) R = Be: 	Rh(Phebox-bn) 	(9) 
4-CF3Ph 93 8:92 89(34) 
Table 1.8 
Notably, this catalyst system tolerates a large variety of silane reductants. Alkoxy, 
alkyl and aromatic silanes can be used with no loss in yield, diastereoselectivity or 
enantioselectivity. Indeed the robust nature of this methodology and remarkable 
levels of anti selectivity represent a complete contrast to the methodologies 
developed by Morken and Krische (vide supra). 
Nishiyama extended this strategy to encompass the reductive coupling of cinnamates 
with acetone in the presence of RliPhebox-ip (8) and MePh2SiH (Table 1.9).'0 









R Ar %YieLd %ee 
Me Ph 83 96 
Pr Ph 82 98 
Bn Ph 82 96 
'Bu Ph 36 97 
Ph Ph 28 
Et CF, 64 97 
Et Cl 62 97 
Et OMe 81 96 
Table 1.9 
The aldol products were produced in moderate to excellent yields and with 
enantioselectivities of up to 98%. By replacing acetone with an unsymmetrical 
ketone such as acetophenone the corresponding aldol adduct could be isolated in 
90% yield with a diastereoselectivity of 96:4 (anti:syn) and an enantioselectivity of 




0 H Me 




96:4 d:r (anti:syn) 
97% ee (anti) 
However, replacement of the cinnamate with the corresponding acrylate led to 
diminished yields and selectivities. 
Recently, Krische and co-workers have developed methodology to increase the 
substrate diversity in order to improve the chemical utility of the reductive products. 
It has been reported that the reductive coupling of divinyl ketones to a diverse range 
of aldehydes has been accomplished using cationic rhodium catalysts ligated by tri-2-
furyl phosphine in the presence of elemental hydrogen (Table 1.10). LI 










Ri> Rh(OOD(2sbF6 (5 mot%) R> Me 
(2-Fury 3P (12 mot%( 
Ri R2 %YieLd syn:anti 
Me 4-NO2Ph 82 13:1 
Me BnOCH2 80 9:1 
Me 2-NO2PhCH=CH 75 12:1 
4-NO2Ph 4-NO2Ph 93 10:1 
4-NO2Ph BnOCH2 90 10:1 
4-NO2Ph 2-NO2PhCH=CH 71 13:1 
Table 1.10 
By careful choice of anionic counterion, the system could be optimised to allow the 
efficient coupling of the less substituted vinyl moiety to the aldehydes in good yield 
and with excellent syn diastereoselection. Furthermore, the yield of the reductive 
aldol addition of styryl vinyl ketones to aromatic aldehydes is dependent on the 
electron releasing properties of the aromatic para- substituent of the styryl unit (Table 
1.11). Electron donating substituents, for example, dimethylamino led to increased 
product yield over electron withdrawing substituents like nitro. This trend can be 
attributed to the modulation of the HOMO in the rhodium enolate, where by the more 





H2 (1 atm), L12CO3 (10 mot%) MIM RRI Rh(COD(2SbF6 
0 	OH 
(5 mot%) 
(2-Furyl(3P (12 mot%) 
RI R2 	%YieLd syn:onti 
4-NO2Ph 4-NO2Ph 	44 16:1 
Ph 4-NO2Ph 	50 12:1 
4-MeOPh 4-NO2Ph 	64 11:1 
4-(Me2N(Ph 4-NO2Ph 	93 10:1 
Table 1.11 
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A further advancement from the Krische group has been the development of a 
hydrogen mediated reductive aldol coupling of vinyl ketones to enriched a-chiral 
aminoaldehydes (Table 1.12). 12  Incorporation of an internal hydrogen bond donor 
was observed to be essential for controlling selectivity as well as enhancing the 
reactivity of the aldehyde. 
0 
H)(R 
0 0 	OH Zimmerman-Traxter-like 
NHBoc Transition State "R 
Me'' 	H, (1 atm), Li,CO3 (10 mol%) 	Me Me r Rh(COD),OTf (5 mot%) Me 	NHBoc BocN-H 
(2-Furyl),P (12 moiX) 
I H 
R 	%Yietd syn:anti [ 	
14 Me 	
j 
Me 	78 12:1 anti-Felkin-Ahn 
Addition via H-Bond 
Ph 	81 >20:1 Chelation Control 
'Pr 55 10:1 
CH,Ph 	84 >20:1 
Table 1.12 
The syn-aldol, anti-Felkin-Ahn selectivity can be accounted for by invoking a 
Zirnrnerrnan-Traxler'3  transition state involving hydrogen-bond control for the 
substrates containing a free N-I-I bond. Aldehydes derived from amino acids 
incorporating either aromatic or aliphatic side-chains undergo reductive aldol 
coupling to give the syn-aldol products in excellent yield with diastereoselectivities 
of up to >20: 1. The introduction of an additional hydrogen bond donor in the form of 
tert-amyl alcohol leads to an erosion in the diastereoselectivity, providing further 
evidence to support asymmetric induction through intramolecular hydrogen bonding. 
To date, the majority of rhodium-catalysed intermolecular reductive aldol reactions 
incorporate stoichiometric quantities of silanes or molecular hydrogen as the 
reductant. Despite the obvious merits of these systems there are some remaining 
limitations to their usefulness. For example, reaction efficiency can be reduced by 
- competing reaction - pathways such as C=O and C=C bond reduction-and---the 
formation of silyl enol ethers. In effort to avoid these limitations Willis and co-
workers reported a novel rhodium-catalysed reductive aldol system where /3-methyl 
Chapter 1-The Reductive Aldol Reaction 	 12 





H)(R2 0 R' 
R1  NC R' NC 
[Rh(dppe)]C104 (10 m(Il%) 	
*M R2 SR 
MeS 	 EtS 	 EtS 
O 	 O> Me 
NC.yJ 	 NCLMe 	NCy Me 
Me 	 Me 	 M e 
SMe 	 SEt 	 Me 	SEt 
88% yield 	 88% yieLd 	 93% yield 
2.3:1 d.r 6.6:3.6:1 d.r 1.4:1 d.r 
0 O SEt 





A diverse variety of /3-methyl sulfide-substituted aldehydes are tolerated in the 
reductive coupling with acrylonitrile. The reaction also tolerates variations in the ci,/3 
-unsaturated carbonyl species as acrylonitrile can be readily exchanged for phenyl 
vinyl ketone and phenyl acrylate with no loss in reactivity. In general, the reductive 
aldol adducts are generated in yields approaching 93% albeit with poor levels of 
diastereoselection. 
Two mechanisms are proposed in the report with both being initiated by the 
oxidative insertion of aRh(I ) species into the aldehyde C-H bond generating the 
chelated acyl rhodium hydride species 10. Path A then involves the hydroacylation of 
phenyl vinyl ketone to generate the ketone ha followed by the Tischenko-type15 
reduction of the ketone with another molecule of acyl rhodium hydride generating 
the product 13. Path B involves conjugate addition of the rhodium hydride species 
onto phenyl vinyl ketone. The intermediate rhodium enolate lib then reacts with the 
starting aldehyde to generate the aldol adduct 12. Regeneration of the active catalyst 
species and liberation of the product 13 occurs following the reductive elimination of 
the rhodium species (Scheme 1.5). 
	




H R nh- S\ 
10 Me 
Path/' 	0 "\ th B 
0 
lk~ 	
0 nRh—, a SMe 
Ph 
Ph 	 Me 
Me 	 Me 
ha 	 lib 
on 	
0 SMe 
10 Me 	 0 
 
OSMe 	0 
Ph SMe 	 Ph SMe 
Me 	 Me 
13 12 
Scheme 1.5 
1.2. Rhodium-catalysed intramolecular reductive aldol reactions 
The first example of a rhodium-catalysed intramolecular reductive aldol reaction was 
reported by Krische and co-workers in 2002. It was shown that under hydrogenative 
conditions, aldehydes tethered to enones via an all carbon linkage underwent 
efficient reductive aldol cyclisation giving the desired six membered carbocycles 
(Table L13).8 
0 	 0 	(4-CF3-Ph)3P (24 rnot%) 	0 	OH 
Rh(COD)2OTf (10 mot%) 
12 (1 atm), KOAc (30 mot%) 
R %Yietd syn:anti 
Ph 89 10:1 
4-MeOPh 74 5:1 
2-furyt 70 6:1 
2-naphthyl 90 10:1 
2-thiophenyt 76 19:1 
Me 65 1:5 
Table 1.13 
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Initially, competitive conjugate reduction of the enone led to attenuated yields of the 
desired cyclised product. However, through a combination of modulating the ligand 
electronic effects and the use of potassium acetate as an additive, the levels of 
conjugate reduction could be minimised. Using the optimised conditions, a number 
of aromatic, heteroaromatic and alkyl enones perform well in the reductive 
cyclisation to give the products in yields of up to 90% and with diastereoselectivities 
ranging between 5:1 and 19:1. Moreover, Krische reported a plausible catalytic cycle 
























Oxidative addition of LnRh(I) into elemental hydrogen produces rhodium hydride 
species 14. This is followed by hydrometallation of enone 15 to give rhodium enolate 
16. Aldol addition to the internal aldehyde moiety gives rhodium aldolate 17. Finally, 
an oxygen-hydrogen reductive elimination releasesthe product 18 and the catalyst 
LnRh(I). However, a competing reaction pathway exists which involves the 
conjugate reduction of rhodium enolate 16 to furnish the reduced by-product 19. 
-- 
	
	- - - - 
-- This workwasiater extended in afollow-up paper in wtvich ketones were employed- 
as 
 
the internal electrophile allowing the construction of a variety of five- and six-
membered carbocycles (Scheme 1.7). 16 
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0 	 0 
Ph3P (24 mol%) OH 
R 	Rh(COD)20T1 (10 mot%) 
0 
H2 (1 atm), K2CO3  (80 mot%) 	Me 





OH Ph 	 OH( q
H Me 	 OH (;:. e
84% yield 	 86% yield 	 73% yield 	 65% yield 
'95:5 dr '95:5 dr '95:5 dr '95:5 dr 
Scheme 1.7 
Through the use of diketone electrophiles, products containing three stereogenic 
centres, two of which are contiguous quaternary stereocentres could be synthesised 
in excellent yields and with remarkable control of the relative stereochemistry (d.r. 
>95:5). These levels of diastereoselection were consistent for all cyclisations 
reported. 
In addition to this methodology, alternative reductants were investigated by 
Krische.'7  To this end a combination of [Rh(COD)C1]2 and borane reductants such as 
pinacolborane proved to be effective in the reductive aldol cyclisation of enones 
tethered to ketones through an all carbon linkage (eq 6 and 7). Six-membered rings 
are readily formed in high yields as single diastereomers (eq 6); however, under the 
same conditions, the formation five-membered rings proved to be inefficient (eq 7). 
0 	0 HO 
Me 	
[Rh(COD)CI], (8 mol%) 
Me 	
(6) 
BINAP (6) (8.8 mo(%) 




BINAP (6) (8.8 moL%) 	 0 HO Me 
DY 0 	Me 	[Rh(COD)C[]2 (8 moL%) Pinacotborane (1.2 eq) I I U 
32% yield 
Alternatively, catecholborane was shown to efficiently mediate the reductive aldol 
cyclisation of enones tethered to ketones through an all carbon linkage. Using 
stoichiometric quantities of catecholborane, Krische demonstrated that a variety of 
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six-membered carbocycles could be readily synthesised in excellent yields as a single 
diastereomer (Scheme 1.8)17 
0 	0 	 0 HO Me 
R1'1JMe 	
Catecholborane (1.2 eq) 
THF 
0 H 	Me 	0 OHOMe Jc6e 
	
Me 
91% yield 	 83% yield 	 86% yield 	 80% yield 
Scheme 1.8 
In asim ilar fashion to Krische, Motherwell has also reported the reductive aldol 
cyclisation of aldehydes tethered to enones via an all-carbon linkage to produce a 















EtJ CO2Et  
61% yield 	 29% yield 
Scheme 1.9 
The combination of substoichiometric quantities of a rhodium salt and triethylsilane 
allows the product to be obtained in up to 81% yield and with a diastereoselectivity 
of up to 3.3:1. Motherwell observed that olefin geometry did not influence the 
stereochemical outcome of the cyclisation, with both (E)an d (Z)isorn ers giving the 
same product distribution. However, the nature of the rhodium catalyst has a 
- 	dramatic_effectofthedistereose1ectiY1tyf the process (Table 1.1 4).— -  







6 c:7.0O Et,SiH 
CO2Me syn anti 
Catalyst %Yield 	syn:Qnti 
RhCI(PPh3)3  76 	3:1 
[RhCL(COD)2]2 - DIPHOS 78 	3.3:1 
RhH(PPh 3)4 81 	1:2 
Table 1.14 
The use of Wilkinson's catalyst RhC1(PPh3)3 gives the silylated cyclopentanol 
product in 76% yield in favour of the syn diastereomer (3:1), whereas the use of the 
hydridotetrakis (triphenyiphosphine) rhodium(I) salt RhH(PPh3)4 not only proves to 
be the most active catalyst but also leads to a reversal of selectivity with predominant 
formation of the anti diastereomer (1:2). 
1.3. Copper-catalysed intermolecular reductive aldol reactions 
Copper salts have been used to great effect in the enantioselective conjugate 
reduction of various a,/3-unsaturated carbonyl compounds since 1999.19  Despite this 
the use of copper salts in reductive aldol chemistry has only recently been explored. 
To this end, the first example of an enantioselective copper catalysed intermolecular 
reductive aldol reaction was reported by Shibasaki and co-workers in 2006. 
Optimised conditions include a combination of CuF2-3PPh3  and a chiral non-racemic 
ligand such as (R)-tol-BINAP (20) in the presence of (EtO)3SiH as the stoichiometric 
reductant. Using these conditions, substituted methyl acrylates couple with 
symmetrical ketones to give the corresponding aldol adducts in good yield and with 
20 
moderate to good levels of enantio selection (Table 1.15) .  





El MeO 	 R (R)-to(-BINAP (20) (5 moL%) MeO 
	 Et 	
M) 
CuF2 2EtOH (2.5 niot%) P~a 2 
(EtO)3SiH 
R 	%YteLd 	% ee 	 I 	(L 
Me 	93 	71 \ 	Me,/2 
Et 	96 	76 	 (R).to-BINAP (20) 
Ph 	52 	80 
Table 1.15 
Allenic esters were further shown to be potent nucleophiles, giving a mixture of aldol 
products (eq 8).20 
0 
0 	OH 	 Me OH I 
Eto) 	 OH Me 	Ph 	
EtO Ph + EtO2C 	 + P Ph I 	(8) 
	
(R)-to(-8l NAP (20) (5 mot%) 	 Me 
CuP2 2EtOH (2.5 mot%) Me 	CO2Et 
Pinacolborane 
38 % yield, 	 20 % yield 24 % yield, I 
21:79 d:r I 
Interestingly, the aldol products were formed in low to moderate yields but with 
excellent levels of enantioselection when pinacolborane was used as the reductant. In 
addition, Shibasaki further explored the effect of copper salt and ligand additive on 
the enantioselectivity of the asymmetric reductive aldol addition of allenic esters to 
ketones. 21 A combination of pinacolborane as the stoichiometric reductant and (R)-
DTBM-SEGPHOS (21) as the chiral non-racemic ligand were chosen and a variety 
of copper(I) salts and mono-phosphine additives were screened for efficiency. 
Consequently it was found that the use of CuOAc and PCy3 proved to be an 
extremely effective combination for a large variety of ketones, giving predominately 
the 7-cis-selective reductive aldol adducts in excellent yields and with excellent 
levels of enantioselection (Table 1.16). 
R %Yietd %ee 
Ph 96 99 
4-CIPh 93 98 
PhCHCH 97 84 
'Pr 80 98 
(R)-DTBM-SEGPHOS 
(21) 
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0 
Me'R 	
Me OH 	 / Bu 
( 
(R)-DTBM-SEGPHOS (21) (5 mot%) 	 0 	
OM DO
Pinacotborane (slow addition) c02Et 
CuOAc (2.5 mot%) 
PCy, (5rnol%) 	
- 	 I / 
Table 1.16 
The a-selective aldol adducts could also be obtained by further changes to the 
catalyst system. By using CuF3PPh3 as the catalyst in combination with TaniaPhos-
type ligand 22, the a-selective aldol products are generated in high yields, with 
moderate diastereoselectivity and with high levels of asymmetric induction for a 
large variety of ketones (Table 1.17). 
0 





Taniaphos 22 (5 mol%) 
Pinacotborane (slow addition) 
CuF3PPh3 (2.5 mol%) 
R 	%Yie)d 	syn:anti 	%ee 	 Fe ~PAJ  
Ph 	 90 	10:1 	84 
4-CIPh 	 89 	8:1 	83 	 Ar = 3,5-xylyt 
PhCH=CH 	87 	9:1 	67 	
Taniaphos-type 
22 
4-IPh 	 86 	7:1 	84 
Table 1.17 
This powerful methodology developed by Shibasaki and co-workers allows the 
selective formation of enantiomerically enriched a-linked or '-linked aldol adducts 
by simply changing the metal/ligand combination. 
Independently from Shibaski, Riant and co-workers also reported the copper - - - 	 - 
catalysed reductive aldol reaction of methyl acrylate with a variety of aldehydes .22 
Using a combination of {CuF(PPh3)3], bisphosphine ligand and PhSiH3 as the 
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stoichiometric reductant the reductive aldol products could be obtained in excellent 
yields and with high levels of asymmetric induction when Taniaphos-type ligands, 






MeO R 	 Me Me 
Ta aphos 23 (1 mot%) 	 - 	 N 	
PPh2 
Me 
CuF3PPh3 (1 MOM - 
PhSiH3, -50°C 
R 	 %Conversion 	syn:anti 	%ee syn(anti( 	
Fe PPh2 
Pr 	 99 	 64:36 	73(26) 
Ph 	 99 	41:58 	nd(72) 	
Taniaphos-type 
23 
4CLPh 	 99 	44:56 	85(69) 
4-MeOPh 	 99 	60:40 	68(72) 
Table 118 
Although the catalyst system was noted to be highly active with a turnover frequency 
(TOF) estimated at 40,000 If 1  the levels of diastereoselection were poor in the 
majority of cases. The poor levels of diastereoselection maybe improved for a 
selection of aldehyde electrophiles when the reactions are allowed to run at -50 °C. 
1.4. Copper-mediated intramolecular reductive aldol reactions 
The first example of a copper mediated intramolecular reductive aldol reaction was 
reported by Chiu and co-workers in 1998, during her studies towards the total 
synthesis of pseudolaric acid A (24) (eq 9)•23 The key step in the synthesis involves 
the use of a stoichiometric amount of Stryker's reagent ([Ph3PCuH]6) at low 
temperature to promote the reductive aldol cyclisation. The desired 5,7-bicyclic ring 
system is produced in a yield of 66% and with a diastereoselectivity of 3:1. However, 
the major diastereomer was later confirmed by X-ray crystallography to be the 
undesired cis-fused ring system. 
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CO Et o 	 pOEt






30 mins 	0 
me 	 Me 	 Me 




ocDi.  Me 
H OA c: 
Me 
Pseudolaric Acid A 
(24) 
By further extending the scope of this methodology, Chiu and co-workers were able 
to demonstrate that a number of five- and six-membered carbocycles could be 
formed in one-pot with diastereoselectivities of up to 95:5 in the majority of cases 
(Scheme 1.10).24 
0 
0 R1 [Ph3PCuH]s 	
R:' -40°C 	HO 
-, 	 0 	 n=1,2 R' L_ ) 
Me0 	 Me 
Me OH  
Me 
Me 
80% yield 	 72% yield 	 89% yield 	 66% yield 
Scheme 1.10 
In addition, it was shown that the reaction temperature is critical in controlling the 
diastereoselectivity and yield of cyclisations where fused ring systems are formed 
(Table 1.19). At temperatures of -10 °C a mixture of cis- and trans-fused ring 
systems are formed with the more thermodynamically stable trans-product 
dominating. However, on cooling to -40 °C the cis-fused kinetic product could be 
exclusively obtained in 93% yield.  
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0 	 0 
cis 	trans 
	




CO2Et 	 C 	
T(°C) 	t(h) 	%Y,e(d 
00 	 _
-40 	1 	93 	0 
O2Et 
Me Temperature 
-25 	0.5 	79 	3 
-10 	0.25 	12 	58 
Os 	 trans 
Table 1.19 
Subsequently, Chiu and co-workers improved upon this methodology by developing 
a catalytic variant, which uses polymethyihydrosiloxane (PMHS) as the 
stoichiometric reductant in the presence of a substoichiometric amount of Stryker's 
reagent (Scheme 1.11).25 
0 	 0 
0 
[Ph5PCuH]6  (10 mo(%) 	




Me 	 n1,2 L 	_J 
Major product 	Over reduced 
by-product 
Me 
OHMe 	 OHMe 
	0 
OH 	
Me OH IJ 
Me 	 a,_ M e 
CO2Et 	 CO2Et 	 Me 
54% yield 65% yield 	 56% yield 	 62% yield 
Scheme 1.11 
A number of diketone substrates efficiently cyclised to give the products in moderate 
to good yields and with very high diastereoselectivities. In the case of bicycle 
formation the cis-fused ring systems were the sole or major product in all systems 
examined. Side-product formation due to over-reduction occurs with the majority of 
substrates and accounts for 6-39% of the mass balance. Nevertheless this 
methodology represents the first example of a non-radical based copper-catalysed 
reductive aldol reaction. 26 
The scope of the intramolecular copper-catalysed reductive aldol methodology was 
extended by Lam and co-workers to the synthesis of five- and six-membered /3- 
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hydroxylactones.27 Using a combination of Cu(OAc)2 H20, DPPF (25) and 
tetramethyldihydrosiloxane (TMDS) as the stoichiometric reductant, various a,/3-
unsaturated carbonyl compounds tethered to ketones through an ester linkage 
underwent reductive aldol cyclisation to provide the reductive aldol products in 
moderate yield and with excellent levels of diastereoselectivity (Scheme 1. 12). 
0 	p2 	DPPF (25) (5 mol%) 	
R2 	0 	 —PPh2 
R1 _( 
if 	





PPh2 TMDS, TNt, it 





HO 	 HO 	 HO 	 HO 
73% yield 	 62% yield 	 72% yield 60% yield 
95:5 d.r 95:5 d.r 95:5 d.r 	 95:5 d.r 
Scheme 1.12 
Moreover, the process could be rendered enantioselective by the replacement of (25) 
with an appropriate chiral, non-racemic bis-phosphine ligand. Consequently, a 
variety of five- and six-membered /3-hydroxylactones could be obtained with 
enantioselectivities of up to 83% (Scheme 1.13). 
0 	R 2 Cu(OAc)2 H20 (5 moL%) 
(k)-3,5-xyLyl-MeO-BIPHEP (26) (5 mot%) 
IkAP3 Fl 	0 	 TMDS, THF, It 
0 n=1,2 
0 	 0 	 0 
Ph 
Ph
O 4-CIPhMe O 
Me Me--~t  
HO 	 HO 	 HO 
69% yield 	 71% yield 61% yield 
70% ee 83% ee 	 80% ee 
p2 0 
'Me 
MeO 0 P 	Me)2 
R1' 
HO 




51% yield 	(R)-3,5-xytyl-MeO-BIPHEP 
49% ee (26) 
Scheme 1.13 
This process developed by Lam and co-workers was the first reported example of the 
formation of heterocyclic ring systems via a reductive aldol methodology and to date 
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is the only example of an enantioselective copper-catalysed intramolecular reductive 
aldol reaction. 
1.5. Iridium-catalysed intermolecular reductive aldol reactions 
An additional interesting result from Morken's high throughput screening of catalyst 
systems was that a combination of [Ir(COD)Cl]2 and Indane-pybox (27) was able to 
effect the enantioselective reductive aldol reaction. This metal-ligand combination 
appeared very attractive due to the ease of which these ligands maybe accessed from 
commercially available materials. To this end a variety of pybox ligands were 
investigated and found to catalyse the reductive aldol reaction of methyl acrylate 




MeO Indane.pybox (27) (7.5 mot%) 	MeO R 
[Ir(COD)U]2 (2.5 mot%) Me 
Et2MeSIH 
R %Yied 	 syn:anti %ee syn 
Ph 68 	 6.6:1 94 
BnOC112 49 	 9.9:1 96 
TBSOCI42 47 	 8.2:1 96 
BnO(CH2 )2 65 	 2.7:1 82 
Et 5 - 





It was found that bulkier pybox-type ligands gave the reductive aldol products with 
greater levels of enantioselection; however, changing the steric bulk had little effect 
on the diastereoselectivity. Aromatic and c-hydroxy aldehydes are the most reactive 
electrophilic coupling partners whereas simple aliphatic aldehydes prove to be 
relatively unreactive. Moreover, it was reported that pre-existing substrate chirality 
had a dramatic effect on the selectivity on the reaction. Reductive aldol coupling 
with aldehydes bearing a - /3-hydroxy substituent -gave the correspondingaldoI - 
products in moderate yields and with excellent selectivity, regardless of which 
enantiomer of aldehyde was employed. Conversely, aldehydes bearing an a-hydroxy 
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substituent led to significant double stereo-differentiation corresponding to good 




Indane-pybox (27) (7.5 moL%) 





Atdehyde Product %YieId 	syn:anti 
O 0 	OH 
MeO<'( 
50 	>95:5 







O 	OBn 0 	OH 	OBn 
89:11 HMe MeO 	 Me65 
Me 
O 	OBn 0 	OH 	OBn 
'Me 57 	88:12 HMe MeO 
Me 
Table 121 
Morken further demonstrated the usefulness of his catalyst system when he used an 
iridium-indane-pybox catalysed reductive aldol reaction in the first step of the 
enantioselective total synthesis of Borrelidin (28) (eq 10).29 
Me Me Me 
0 
0 	 0 OH 
MeO 	 Ir.Indane-pybox (1 mo%) 	MeO 1 (1 	--- 




1.6. Indium-mediated intermolecular reductive aldol reactions 
The use of indium salts in the reductive aldol reaction has been pioneered by Akio 
Baba and co-workers. 30 Following his work into the reduction of aldehydes and acid 
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chlorides using a combination of indium(III) halides and n-Bu3SnH,31 Baba further 
extended this system to include the reductive aldol reaction between enones and 
substituted benzaldehydes (Table 1.22). 
0 
o 0 	OH 	 0 	OH 
Ph t Me + Ph Bu3SnH (1.2equiv) Ph R 	 R 
In 	(1.2 equiv) . 
Solvent Me 	 Me 
syn 	 anti 
R Solvent %Yield 	syn:anti 
4-MeOPh THF 86 	4:96 
4-MeOPh MeOH 69 	99:1 
4-MeOPh THF 89 	4:96 
4-MeOPh THF/I-120 (9/1) 77 	95:5 
4-CLPh THF 83 	7:97 
4-CIPh MeOH 68 90:10 
Table 1.22 
The reductive aldol adducts are obtained in moderate to good yield and with 
excellent diastereoselectivities of up to >99:1 (syn:anti) when MeOH or aqueous 
THF are used as solvents. Interestingly, the anti diastereomer can be readily obtained 
in excellent yields and with selectivities of up to 4:96 (syn:anti) when anhydrous 
THF is used as solvent. In addition, Baba further proposed a tentative mechanism for 
this diastereoselective reductive aldol methodology in an effort to account for the 
remarkable solvent effects (Scheme 1.14). 
Chapter I-The Reductive AIM Reaction 27 
Ph 	 Me 
HInBr2 29 
InBr2 _.. InBr 










Me 	 d 
Me 
0 	OInBr2 0 	OInBr2 
R R 
syn 31aMe anti 3lb 	Me 
0 	OH 0 	OH 
Ph R Ph(R 
syn 32aMe anti 32b 	Me 
CMeOH or  THF/H20D CTHF anhy 
Scheme 1.14 
The conjugate addition of indium hydride 29 occurs to generate initially the (Z)-
enolate 30a which reacts with the aldehyde via a Zimmerman-Traxler-type transition 
state 13  to give the syn aldol adduct 31a which is rapidly protonated in MeOH or 
THF/H20. When anhydrous THF is used as solvent, retro aldol from the syn aldolate 
31a to the anti aldolate 31b occurs under thermodynamic control which is then 
trapped by hydrolysis on reaction work-up. 
Despite _the _excellent results, this system requires stoichiometric quantities of indium 
salt and employs highly toxic tin hydride as the reductant. As a result, Baba has 
recently developed a catalytic approach using InBr3 (10 mol%) and triethylsilane as 
32 the stoichiometric reductant (Table 1.23) 





Ph Me InBr3 (10 mot%) 
Et3SjH 
Me 
R %YieLd Syn:anti 
4-MeOPh 75 90:10 
4-NOPh 59 >99:1 
Ph 78 92:8 
Be 40 >99:1 
tBu 73 >99:1 
Table 1.23 
A variety of enone starting materials can be efficiently coupled with a range of 
aromatic and aliphatic aldehydes to give the corresponding aldol adducts in good 
yield and with diastereoselectivities of up to 99:1 (syn:anti). A plausible catalytic 
cycle was proposed which is similar to that previously discussed (Scheme 1 .1 5). 
InBr3 + Et3SIH 
	
0 OTES 	 it 	0 
Ph R Ph 	 Me 
34 
37 	Me MInBr2 33 
EL3SiH  
Et3SIBr 
0 	OInBr2 	 -InBr2 
PhY R 	




[ Hph 1 
Me 	j 	 HR 
Scheme 1.15 
The conjugate addition of indium hydride 33 into enone 34 occurs to generate the 
(Z-eno!ate 35 which reacts with the aldehyde ijiä a Zithitftian-Traxier-type 	- - 
transition state'3 to give the syn aldol adduct as the indium alkoxide 36. Silylation 
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with another molecule of reductant gives the product as the silyl ether 37 and 
liberates the active catalyst to initiate another cycle. 
1.7. Cobalt-catalysed intermolecular reductive aldol reactions 
Following the pioneering work of Revis and Hilty,2 Mukaiyama endeavored to 
uncover the potential of other transition metals to catalyse the reductive aldol 
coupling of various a,/3-unsaturated nitriles(eq 11 and 12), esters (eq 13 and 14) and 
amides (eq 15 and 16) to aldehydes. Consequently, Mukaiyama and co-workers 








Co(dpm)2 (5 niol%) 	 Ph 
PhSiH3, DCE 
R = H 	93% yield; 1:1 d.r 	(11) 





MeO 	 Co(dpm) (5 mol%) 	
MeO R 
PhSiH3, DCE Me 
R = PhCH=CH 	80% yield; 1:1 d.r 	(13) 
R = Ph(CH2) 62% yield; 1:1 d.r (14) 
0 
O 	 HR 	
0 OH 
Me2N 	 Co(dpm)2 (5 mol%) 	
Me2N R 
PhSiH3, DCE Me 
R = PhCH=CH 	96% yield; 72:28 d.r 	(15) 
R = Ph(Cl-42 )2 90% yield; 70:30 d.r (16) 
Mukaiyama demonstrated that c,/3-unsaturated esters and nitriles couple efficiently 
to benzaldehyde and hydrocinnamaldehyde respectively in moderate to good yields 
but with no stereocontrol. On the other hand, a,/3-unsaturated amides couple with a 
variety of aldehydes in excellent yields and with moderate levels of 
diastereoselection. Although no mechanistic rational was reported, Mukaiyama 
postulated that a carbon-bound cobalt enolate would result from the hydrometallation 
of the a,/3-unsaturated component by a cobalt-hydride species. This would be 
Chapter 1 -The Reductive Aldol Reaction 	 30 
followed by reductive aldol coupling to the corresponding aldehyde aided by phenyl 
silane to liberate the ,8-siloxy aldol adducts which are hydrolysed during work-up to 
give the desired ,B-hydroxy carbonyl species. 
12. 	Cobalt-catalysed intramolecular reductive aldol reactions 
Using identical conditions to those discovered by Mukaiyama, Krische and co-
workers were able to effect the highly diastereoselective reductive aldol cyclisation 
of a variety of ct,/3-unsaturated ketones tethered to an aldehyde through an all—carbon 
34 linkage (Table 1 
R)J'H 
R %Yield syn:anti 
Ph 87 '99:1 
4-CF3Ph 72 '99:1 
2-naphthyt 68 '99:1 
Me 38 '99:1 
2-furyt 75 '99:1 
2-thtophene 73 '99:1 
Table 1.24 
Krische demonstrated that a variety of aromatic enones are tolerated under 
Mukaiyama's conditions33  to produce the corresponding six-membered carbocycles 
in moderate to good yields and with exceptionally high levels of diastereoselection. 
In addition, Krische proposed a plausible mechanistic rational for the process 
(Scheme 1.16) 


























The combination of Co(dprn)2 and phenyl silane produces cobalt-hydride species 38 
which, upon hydrometallation of the enone 39, produces a chelated cobalt enolate 40. 
Subsequent aldol cyclisation results in the formation of cobalt alkoxide 41. a-Bond 
metathesis of 41 with afu rther molecule of reductant liberates the silylated aldol 
14,11 
product 42 and regenerates the cobalt-hydride catalyst 38. 
1.9. Nickel-catalysed intermolecular reductive aldol reactions 
The first example of a nickel-catalysed reductive aldol process was reported by 
Montgomery and co-workers in 2007.36  Montgomery elegantly demonstrated that 
substoichiometric quantities of Ni(COD)2  in combination with stoichiometric 
amounts of triethylborane (Et3B) and phenyl iodide (PhI) allowed tert-butyl acrylate 
to couple with a variety of aldehydes, producing the reductive aldol products in good 
yield and with good diastereoselectivities (Table 1.25). 








R %Yield syn:anti 
Ph 87 88:12 
4-MeOPh 88 87:13 
2-furyt 91 88:12 
4-NCPh 86 90:10 
CFI3(CH2 )5 80 86:14 
(CH3CHZ )2CH 68 96:4 
Table 1.25 
It was observed that the presence of Pill was essential for reaction efficacy and that 
in its absence the reaction failed to initiate. This type of effect has been noted in a 
related study by Cheng and co-workers describing the initiating effect of organic 
iodide species in palladium-catalysed silaboration of allenes.37 In their work Cheng 
and co-workers suggested that the organic iodide species participates in the 
formation of a boron-containing side-product which then initiates the catalytic cycle. 
On the other hand, Montgomery and co-workers proposed that the presence of PhI in 
the reaction mixture results in a catalyst modification which then proceeds to initiate 
the reaction. As a result of experimental observation Montgomery proposed the 
following mechanism involving a novel catalyst activation sequence (Scheme 1 .17). 
[ Et 	Et 1 
I 	I' I O 	Ni(0) 	B I 	I 	. 1 	I 




Phi, Et3B 0 	El.. 




BuO\. 'Ph ] 45 46 









RCHO 	 Bu 
1 
0 / ' 
B 	
0 	OH 
Et , 	I BuOR 
H Bu0 	'H 
Ni I 
50 	 ] 	
Ph - 	 L 	 47 - 	 ---- - -449 	-- 	 48-- 8 
Scheme 1.17 
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Initially, oxidative insertion of Ni(0) to phenyl iodide followed by coordination of 
acrylate 43 and triethylborane will give intermediate species 44. Rearrangement of 
44 to an ethyl(iodo)nickel species 45 and boron enolate 46 may well proceed through 
sequential migratory insertion and transmetalation. Triethylborane acts both as a 
Lewis acid and a Lewis base by activating the enone and nickel centre 
simultaneously. 38  The aldol addition of boron enolate 46 with the aldehyde generates 
product 47. The ethyl(iodo)nickel species 45 complexes with the acrylate 43 and a 
further molecule of triethylborane with the subsequent loss of ethylene to generate 
nickel hydride 48. Rearrangemnet of 48 results in the formation of boron enolate 49 
and regenerated ethyl(iodo)nickel species 45. The aldol addition of 49 with the 
aldehyde affords product 50, the major product of the reaction. 
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2. Nickel-Mediated Reductive Coupling Reactions 
Nickel-catalysed reductive coupling and cyclisation reactions have emerged as 
important methodologies in the construction of various polyfunctionalised 
compounds. The reductive coupling of unsaturated species such as: alkynes, 1,3-
dienes, 1,3-enynes and allenes with a variety of electrophiles including aldehydes, 
ketones, imines and epoxides can be accomplished under mild conditions using 
substoichiometric quantities of an appropriate nickel salt and stoichiometric 
quantities of a reductants such as, diethylzinc, triethylborane or silanes. Through the 
use of chiral non-racemic ligands as additives in the reductive coupling reactions the 
products can often be generated with high levels of diastereo- and enantiocontrol. 
2.1. Intramolecular nickel-mediated reductive coupling reactions 
Nickel-catalysed reductive cyclisation reactions were pioneered by Montgomery and 
co-workers in 1996. Following the observation by MacKenzie and co-workers that 
nickel(0)-species undergo oxidative addition reactions to enals in the presence of a 
Lewis-acid additive, 40  Montgomery demonstrated that this fundamental process 
could be efficiently utilized in the nickel-catalysed alkylative cyclisation of alkynyl 
enones (Table 2. 
0 
Ni(COD) (5 mot%) 
R22Zn I R2ZriCI 
R1 	 R2 %Yied 
H 	Me 	 82 
H 	Bu 	 51 
H 	Ph 	 61 
H 	CH=CH2 	 59 
Ph 	Bu 	 68 
Bu 	Ph 	 38 
Table 2.1 
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A variety of alkyl-, alkenyl- and aryl-substituted organozinc reagents, including 
those bearing /3-hydrogens, were shown to promote efficient cyclisations, producing 
the corresponding /3-alkenyl ketones in moderate to good yield and with complete 
control of olefin geometry. In addition to alkylative cyclisations, Montgomery and 
co-workers demonstrated that reductive cyclisations could be obtained through the 
pre-treatment of Ni(COD)2 with 5 equivalents of triphenyiphosphine in combination 
with dibutyizinc as the reductant (Table 2.2). 
R 	%Yie(d 
0 	 PPh, (25 rno(%) 
H 	92 N(COD) (5 mol%) 
Bu2Zn / BuZnCL 	 Ph 	47 
Bu 	58 
Table 2.2 
Similar to the results detailed in (Table 2.1), the cyclisations occur in moderate to 
good yield with complete control of the olefin geometry, delivering the hydride cis to 
the ketone in all cases. Notably, when alternative organozinc reagents were used 
such as, dimethyizinc or diphenyizinc, only alkylative cyclisation is observed even in 
the presence of 5 equivalents of triphenyiphosphine. As a consequence, Montgomery 
proposed that when using dibutylzinc as the reductant the reaction can proceed 
through a competitive /3-hydride elimination pathway promoted by the presence of 
triphenyiphosphine. In an effort to confirm the involvement of a /3-hydride 
elimination pathway in the reductive cyclisation reactions, several deuterium 
labelling experiments were conducted (eq 17-19). 
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Ph)1j H R
2Zn / Ni(COD)2 I PPh3 
	
with Et2Zn-d10 in THF, then H20 quench: 68% D incorporation 	(17) 
with Bu2Zn in TI-IF, then AcOD quench: 12% D incorporation 	(18) 
with Et2Zn in THF-d8, then H20 quench: 	0% D incorporation 	(19) 
From these results it was reasoned that two reaction pathways are operative. The 
major pathway involves /3-hydride elimination whereas the minor pathway involves 
the protonation of a zinc-alkenyl-species on work-up. As a result of these findings 




R1 ' 1 
	
R2 	
Ni)COD) (5 mol%) 	
BuZnO 	LnN1 
H 
BuZn / BuZnCL 
51 	 el  
52 
with 	 without PPh3 







It was suggested that in the absence of triphenyiphosphine intermediate 52 could 
coordinate with unreacted enone starting material 51 and through the formation of an 
electron-deficient Ni(II) it-complex,4 ' promote the reductive elimination affording 
the alkylative cyclisation products 53 (Table 2.1). However, in the presence of 
- - 	- triphenyiphosphine thea!kyl(a!kenyl)nickel intermediate-54-would be- -more-electron- 
rich at nickel and therefore, facilitating /3-hydride elimination to produce the 
42 reductive cyclisation products 55 (Table 2.2) 
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Montgomery and co-workers further extended their methodology to include the 
cyclisation of bis-enones (eq 20 and 21). 43 
0 	 0 	 COR 	 COR 





Ni(COD) (3 mot%) 
C!r 
R = Ph 	 65% 	 0% 	 (20) 
R=Me 58% 12% (21) 
In this example, the cyclisation reaction proceeds through a mechanism involving 
sequential conjugate addition reactions. This reaction pathway is in stark contrast to 
that of the cyclisation of alkynyl-enone substrates where conjugate addition was not 
39 observed 
In addition, it was demonstrated by Montgomery and co-workers that allylic alcohols 
could be efficiently synthesised through the application of their nickel-catalysed 
alkylative coupling methodology to the cyclisation of ynals (Table 
0 	 R1  Ni(COD(2(5moL%( 
H0?7R1 
X RI R2 %YieLd 
CH2 H CI-13 70 
CH2 H Ph 72 
CH2 H n-Bu 62 
CH2 CH3 Ph 64 
CH2 CH3 n-Bu 76 
CH2 Ph CH3 73 
CH2 Ph Et 67 
NCOPt, H CH3 72 
Table 2.3 
- - 	The combination of substoichiornetric quantities of Ni(COD)2  and stoichiometric 	- - - 
quantities of a variety of dialkylzinc reagents results in the alkylative cyclisation of 
an array of ynals giving the products in moderate yields and with complete control of 
the olefin geometry. Alternatively, by the replacement of dialkylzinc reagents with 
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silane reductants and by the addition of a phosphine additive, Montgomery illustrated 
that protected allylic alcohols could be readily synthesised through the application of 
their nickel-catalysed reductive coupling methodology (Table 2.4) .45  
R 
Ni(COD)2 (5 mot%) 
	
CiCHO 	
PBu3 (20 mot%( 	 R 
Et3SiH QYOSiEt3  
H 	 H 
R 	T(°C) 	dr 	%YieLd 
Ph 	 45 	90:10 	85 
Ph 	 23 	98:2 	90 
Ph 	 0 	'97:3 	89 
SMe3 	45 	98:2 	93 
n-C6H13 	45 	99:1 	83 
H 	 45 	95:5 	81 
Table 2.4 
As previously illustrated (Scheme 2. 1), the addition of phosphine additives results in 
the formation of the reductively coupled products. In this case a variey of ynals 
cyclised efficiently giving the silylated allylic alcohols in excellent yield and with 
excellent levels of diastereoselectivity. 
Through their extensive research in the area Montgomery and co-workers proposed a 
detailed mechanism for both the reductive and alkylative cyclisation reactions 
46 (Scheme 2.2).  
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o 	 r 	 0 
: 
ii j OZnR 	 OZflR 	 II 
/ R2 Zn RZnCI 	
+ 
Ni(COD) 	 CI 	RZn  
X - CR,NO 	 56 	 57 	 58 	 59 
Y = CR, CR2, N, 0 
Ni(COD)2 	 ,/R2 Zn 
r 	L 	 R 0 RZnO 	 RZnO 












i 	 1 
rRZnO 	 RZnO 	
El 	




x [ x vj 
64 
Scheme 2.2 
They speculate that two general mechanistic pathways lead to common intermediate 
61. The first pathway is analogous to the studies carried out by MacKenzie4° which 
involves the oxidative addition of a low valent nickel catalyst to an organozinc-
activated electron-deficient alkene to produce nickel it-allyl complex 56. If the 
organozinc species rapidly transmetalates to nickel or if the coordinated olefin is 
sufficiently deactivated then 7t-allyl complex 56 may undergo a 
transmetalation/reductive elimination sequence to produce enolate 57, resulting in 
conjugate addition products 58 or 59. Alternatively, cyclisation of species 56 would 
afford intermediate 61. The second pathway is analogous to the mechanism of 
zirococene-catalysed cyclomagnesiations of dienes,47 involving the oxidative 
cyclisation to produce metallacycle 60. However, additional mechanistic studies 
carried out by Montgomery and co-workers indicate that metallacycle 60 forms via a 
[3 + 2] cycloaddition with Ni(0).48 Subsequent transmetalation of metallacycle 60 
with a further molecule of organozinc reagent would afford intermediate 61. With 
substrates containing tethered enone or aldehyde moieties, intermediate 61 would be 
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liable to undergo ligand displacement by reaction with the organozinc reagent to 
generate intermediate 62 which is then hydrolysed to reductive cyclisation product 
63 on work-up. With substrates tethered to alkynes, intermediate 61 undergoes a 
reductive elimination in the absence of a phosphine ligand to produce the alkylative 
cyclisation product 64. In the presence of a phosphine ligand, /3-hydride elimination 
occurs instead to produce the reductive cyclisation product 63. 
Since then, Tamaru and co-workers have extended the scope of nickel-catalysed 
reductive cyclisation reactions to encompass intramolecular homoallylation of a 
variety of w-dienyl aldehydes. 49 Through a combination of Ni(acac)2 and either 
diethyizinc or triethylborane as the stoichiometric reductant, an array of substrates 
cyclised in moderate to good yield (Table 2.5). 
R 
Me 	Ni(acac)2 (10 mol%) 	
Me 
CHO 	
Et2 Zn or Et3B 	
<rO H 
R Reductar,t Time (h( %Yietd 
CO2Me EtZn 0,25 72 
CO2Me Et3B 34 67 
CI-l2OBn Et2Zn 0.25 64 
CHOBn Et3B 24 80 
CH2OBz Et2Zn 0.5 66 
CH2OBz Et3B 24 27 
'Competitive ethyl addition into aldehyde 
Table 2.5 
It was observed that diethylzinc was the most effective reductant in terms of the 
reaction rate compared to triethylborane. However, in some cases the use of 
diethyizinc resulted in the competitive ethyl addition to the pendant aldehyde 
producing the corresponding secondary alcohol, for example (eq 22). 













0.5 h, 57% yield 	 16% yield 	OH 
Another research group working extensively in the area of nickel-catalysed reductive 
cyclisation reactions is that of Miwako Mon. Mori and co-workers have published 
many articles concerning developments of stereoselective nickel-catalysed 
cyclisations of 1,3-dienes with tethered carbonyl groups for the synthesis of five- to 
seven-membered carbocycles,50 heterocycles 51 and bicyclic heterocycles. 51,51 In 2002 
Mori and co-workers reported the development of an asymmetric cyclisation of 0o-
formyl-1,3-dienes mediated by substoichiometric quantities of Ni(COD)7 and a chiral 
non-racemic mono-dentate phosphine ligand 65 in the presence of silanes as the 
53 reductant (Table 
Me 
P—Ph 
MeO2C,'CHO 	 Me 	65 (20 mol%) 
Me02C 
, OSiR3
>{l' 	 + MeO2C>ì 
MeO2C 	 Ni(COD)2 (10 mol%( MeO2C MeO2C 	,,, 
R3SIH (5 equiv) 'Me 
THE, 0 oC 
66 67 
R3SIH 	 %Yield 66:67 ee% 66(67) 
Et3SIH 	 84 4.3:1 2(47) 
tBuMe SIll 83 50:1 	16(-) 
(EtO)3S1H 60 12:1 	 46(33) 
Ph3SIH 80 1.7:1 	 47(53) 
Ph2MeSIH 83 1.2:1 	 27(78) 
PhMe2SII-1 82 1.9:1 	 21(72) 
Ph2MeS1H 73 1:1.2 	 44(86)° 
DMF I -20 °C 
Table 2.6 
The reaction is effectively mediated by a large variety of silanes, giving the products 
iwupto 84% yie1dHôwever, double bond isomerisation pres-e—nts problem with 
geometric isomers 66 and 67 being produced in almost equal amounts when aryl 
Me 
(23) 
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silanes ared used as the reductant. Nevertheless, the use of Ph2MeSiH allows the 
synthesis of 67 to be accomplished in an excellent 86% enantiomeric excess. 
More recently Jamison and co-workers have demonstrated the broad synthetic utility 
of stereoselective nickel-catalysed reductive cyclisation methodology by applying it 
to the synthesis of the l8-mernbered macrocycle in the natural product amphidinolide 
Ph 
TI (68) (eq 23). 
Me Me 
MeTh 	( 
PBu3 (40 mo(%) 	HO 	
Ph 





44% yield 	 Aniphidinoude Ti 
>10:1 d.r (68) 
Using substoichiometric quantities of Ni(COD)2 and tributylphosphine in the 
presence of triethylborane as the reductant enabled the construction of the 18-
membered ring in an impressive 44% yield and with good diastereoselectivity 
(>10:1). 
In addition, Montgomery and co-workers have reported that by using N-heterocyclic 
carbene ligands in place of mono-dentate phosphines such as tributyiphosphine; 
macrocycles of up to 22-membered rings can be constructed using nickel-catalysis 
(Table 
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X 	 69 (20 mo(%) 	 X 
Ni(COD)2 (20 moL%( 
KOtBu (20 rno(%) 	TESO 
Et3SiH 
CIO 




- 	 I N N 
Me 	;~Me Me 	 Me 
69 
H2 CH2 1 3 11 50 
H2 CH2 1 6 14 62 
o 0 7 3 15 69 
o 0 7 5 19 70 
o 0 7 8 22 67 
Table 2.7 
It was demonstrated that large macrocyclic ring systems could be synthesised in 
moderate yield with only the endocyclic product being observed. 
2.2. Intermolecular nickel-mediated reductive coupling reactions 
Tamaru and co-workers demonstrated in 1998 that the combination of 
substoichiometric quantities of Ni(acac)2 and triethylborane as the reductant, 
efficiently mediates the homoallylation of benzaldehyde in high yields and 
selectivities (Table 2.8).56 
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Diene 
0 	 OH 
Ni(acac)2 (10 mol%) 
Ph 	H 	Et,B, THF 	Ph 
Diene 	 Time (h) 	 Products 	 syn:anti 	XYleM 
OH 
21 na 	 77 
Ph 
Me 	 OH Me 
35 	 1:15 	90 
Me 	 OH Me 
41 	 Ph( 	
N .D 	86 
Me 	 Me 
Me 	 OH Me 
23 	 Ph'-" 	
8:1 	 94 
Me 	 Me 
Me 	 OH Me 






The reaction tolerates a wide variety of diene coupling partners, generating the 
products in up to 95% and with excellent levels of 1,2-stereoselection. Furthermore, 
reduced amounts of nickel catalyst can be readily tolerated, with 1 mol% of 
Ni(acac)2  resulting in similar levels of conversion and selectivity in the majority of 
cases. Subsequent to these results, Tamaru and co-workers reported the extension of 
their nickel-catalysed homoallylation methodology of benzaldehyde56 to include a 
number of diverse aldehydes and ketones, utilising diethylzinc as the stoichiometric 
reductant (Table 2.9).' 58 
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0 
_L1 R2 OHMe 
R' 	R2 
Ni(acac) 	(10 mot%) 
Et2Zn, THF 
R2 	syn:anti %Yield 
Ph 	 H 	1:15 63 
2-furyl 	H 	1:3 66 
PhCH=CH 	H 	- 0 
PHCH 2CH2 	H 	1:15 73 
'Bu 	 H 	1:15 66 
Me 	 Me 	5.3:1 69 
°Regioisonieric mixture (4-Me) and (5-Me) 
Table 2.9 
A variety of aldehydes were shown to be competent coupling partners giving the 
corresponding homoallyl products in moderate yield and with excellent levels of 1,3-
anti-selectivity in the majority of cases. On the other hand, the use of acetone as the 
coupling partner gave the corresponding product as a mixture of regioisomers. 
Notably, the use of diethylzinc in place of triethylborane led to increased reaction 
rates with complete conversion of starting materials after 1 hour in most cases. 
Using a combination of Ni(0)-PPh3  (synthesised from a BuLi addition into a solution 
of NiCl2(PPh3)2) and 'Bu2Al-acac Mori and co-workers were able to couple a range 
of aryl and aliphatic aldehydes to a substituted 1,3-diene (Table 2.1O). 
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0 
MOMO'~a~," 	
H AR MO MO 
Nl(0)-PPh3(20 mot%) 	
O JR 






'Pr 	 57 
'Pr 	 26 
Table 2.10 
The coupling reaction gave the products in moderate yields and with complete 
control of the olefin geometry (E-isomer). However, the yields were reduced 





Moreover, Mori proposed the following outline mechanism to account for the 
experimental observations (Scheme 2.3). 





R1 	 R2 
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H N1 
	ON I 	 OH I  
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linear product 73 L  
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+ 	 AL=At(Bu)(acac) 
Nt(0)-PPh3 
R1  
r R2  
s—Ni 	I 	 [ 	1 
71 I 
1' 




R2 	 L R2 	
OAI 	 branched product 75 
74 ] 
,t-aLlyL 	 Me 
Scheme 2.3 
Linear adduct 73 would be produced via nickelacycle 70. Transmetallation of 
nickelacycle 70 with 'Bu2 AI-acac followed by fl-hydride elimination with 
concominant evolution of isobutene, would give nickel-hydride species 72. 
Reductive elimination followed by reaction work-up would give linear product 73. 
The branched adduct 75 would be formed via nickelacycle 71 in a similar fashion to 
that described for the linear product 73. 
Further developments in the area of nickel-catalysed additions of dienes to aldehydes 
have emerged from the laboratory of Zhou and co-workers. In 2007 they described 
the hornoallylic coupling of a substituted diene to a variety of aromatic aldehydes, 
generating the corresponding products in excellent yields and with remarkable levels 
of both diastereo- and enantioselectivity (Table 2.11).60 







Ni(acac)2 (5 mol%) 
o 76 (6 mol%) OH Ph 
Et2Zn 
Ar syn:anti 	%Yietd %ee L.,< 	0 P—NR2 
Ph '1:99 	99 96 
2-MeOPh '1:99 	98 91 
Ph 
4-MeOPh '1:99 	94 96 R = Morphotine 
76 
4-CtPh >1:99 	92 90 
2-naphthy >1:99 	96 86 
2-fury >1:99 	96 92 
Table 2.11 
More recently, Jamison andco -workers described the first example of a highly 
enantioselective method for the nickel-catalysed reductive coupling of alkynes to 
aldehydes (Table 2.12).61 
0 
OH 
Ph 	- R' 
H' 	R2 
Ph' 	R2 (+(-NMDPP (77) (20 mol%( 
Ni(COD)2  (10 mol%( R' 
Et3B 
Ri R2 	%Yietd %ee 
Me 'Pr 	 95 90 
Me c-C6H11 	97 90 
Me 'Pr 	 82 65 
S1Me3 'Pr 	 43 92 
CH2NHBoc Or 	 60 96 







Using a combination of Ni(COD)2 and the mono-dentate phosphine ligand (+)-
NMDPP (77) in the presence of triethylborane a variety of substituted alkynes gave 
the corresponding allylic alcohol products in moderate to excellent yields and with 
generally excel lent-levels ofenantioselectivity. Most -notablyinalleasesexamined 
only the cis-olefin geometry was obtained. Moreover, Jamison and co-workers 
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utilized this methodology to great effect in the key-step in the synthesis of the natural 






Me 	 Ni(COD)2 (10 mo%) 







Me 	 Me \ Me / 
diastereoselectivity = 2:1 










HO Me Me 0H 
(-)-Terpestacin 
(79) 
In addition, Jamison and co-workers extended their methodology to include the 
enantioselective nickel-catalysed alkylative coupling of an aliphatic alkyne to a 





"  Pr 	- "Pr 
Ni(COD)2 (SmoL%( "PI R 
80 (5 mol%( "Pr 
Et3B 
R %Yietd %ee 
Ph 85 89 
2-MePh 74 85 
4-MeOPh 75 82 
4-CF3Ph 91 85 






--By - using triethylborane —in combination with substoichiometric quantities of - - 
Ni(COD)2  and a P-chiral ferrocenyl phosphine ligand 80, this three-component 
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coupling reaction smoothly provided the allylic amine products in moderate to 
excellent yield and with good enantioselectivity. 
Moreover, Jamison and co-workers demonstrated that other electrophilic species 
could be effective coupling partners in their nickel-catalysed reductive coupling 
methodology. For example, a variety aliphatic epoxides were shown to couple with 
an aryl alkyne in moderate yield and with complete control of olefin geometry (eq 
2527).65 
Ph 	- Me 	Ni(COD) (10 mol%) 	
Ph 
PBu3(ZOmoL%) Me OH 
Et3B 
R = Me; 71% yield 	 (25) 
R = n-Hex; 68% yield 	 (26) 
R = Ph; 50% yield 	 (27) 
The contruction of five-membered rings is an important goal in synthetic chemistry. 
In this regard, Montgomery and co-workers recently reported a nickel-catalysed [3 + 
2] reductive cycloaddition methodology of enal-alkyne systems that readily provided 
cyclopentanols in moderate yields and with good diastereoselectivities (Scheme 
2.4) 66 
0 	 HO 
H 	Ph 	Me 	 Ph 
R 	 Ni(COD)2 00 mol%) 
o R1 
R3 	P8u3 (20 moL%) 	R20~Me 
MeOHTHF 
Et3B 
HO 	 HO 	 HO 	 HO 




Me 	 Me 
Ph 	
C. 
56% yield 	 80% yield 	 57% yield 	 68% yield 
81:19 d.r 90:10 d.r 81:11:8 d.r 87:13 d.r 
Scheme 2.4 
Conversely, by using enone compounds as coupling partners instead of enals, the 
reaction proceded through an intermolecular reductive coupling pathway producing 
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the corresponding y,-unsaturated carbonyl compounds in good yield and with 
excellent diastereoselectivities (>95:5) (Scheme 2.5)67 
0 
R1 	Ph 	- Me 0 	R2 
Ni(COD) 	(10 mot%) Rl Ph 
R2 





Me" 	 Ph 	Me Ph 
0 0 	n-hex 
Ph 	Ph Ph t Ph 
0 	'OH 
Me Me 	Me Me Me 
85% yield 80% yield 65% yield 84% yield 
Scheme 2.5 
Montgomery describes the divergent reactivity of enones compared with enals within 
the same mechanistic pathway as catalytic [3 + 2] reductive cycloadditions (Scheme 
2.6). 
0 	 ® 
BEt2OMe 	 GBEL2OMe 
R1 Q 
R1 	Ph - Me 	
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Initial oxidative cyclisation of the enone and alkyne with Ni(0) would produce 
metallacycle 81 or alternatively the borane adduct 82.6869  Protonation of intermediate 
81 or 82 would afford intermediate 83. From this intermediate if using an enal (R1 = 
H), vinyl nickel addition to the tethered aldehyde would occur giving boron alkoxide 
84, which following reaction work-up produces the cyclopentenol products as 
described (Scheme 2.4). On the other hand, if using an enone (R' = aryl or alkyl) 
then carbonyl addition is sterically impeded resulting in the ethyl transfer from boron 
to nickel producing 85. This is followed by /3-hydride elimination to 86 and 
subsequent reductive elimination generates the reductive coupling products as 
described (Scheme 2.5). 
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3. Copper-Catalysed Reductive Aldol Cyclisations 
The abundance of heterocyclic structures in many biologically significant natural 
products and pharmaceutical agents, such as salinosporamide A (87) 0 and morphine 
(88), makes the pursuit of an efficient and stereoselective synthesis of heterocyclic 
targets an immensely important goal in synthetic chemistry (Figure 3.1). 
HO 
0 	 .Me 
CI H 
0I 	iH OH 
HO 
Satinosporamide A 	 Morphine 
(87) 	 (88) 
Figure 3.1 
In this regard the Lam group has previously demonstrated the application of 
reductive aldol chemistry in the enantioselective synthesis of a number of five- and 
six- membered /3-hydroxylactones (Scheme 1.13) 
.27  Through the extension of this 
methodology we surmised that a variety of a,/3-unsaturated carbonyl compounds 
tethered to ketones through an amide linkage would lead to the stereoselective 
synthesis of five- and six-membered /-hydroxylactams. If successful, this 
methodology could form the basis of a novel and highly efficient total synthesis of 





R20 	 N PMP 
Me") 	...R' 
HO R 
R' R1  
-> R20_)LNMe 
Reductive atdot 	 PMP 0 
cyctisatiOn 
Scheme 3.1 
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3.1. Results and Discussion 
12 
As previously described (Chapter 1.4) initial work within the Lam group had 
identified an effective catalyst system for the reductive aldol cyclisation of a,/3-
unsaturated carbonyl compounds tethered to ketones through ester linkages (eq 28).27 
The catalyst system based on Buchwald sl9a methodology for the conjugate reduction 
of enones offered an excellent foundation for further exploration of reaction 
conditions. 
R2 0 
0 	R2 	bisphosphine (5 mot%) 
Cu(OAc)2 H0 (5 mot%) R
O 	 (25) 
n 
TMDS, THF, rt 	
R"f 1,2 0 	 HO 
For our initial studies, we looked at the synthesis of 4-hydroxypiperidin-2-ones with 
variations in the choice of copper(1I) salt, silane reductant and solvent (eq 29). In 
order to increase the synthetic versatility of the products we opted to examine 
substrates containing removable nitrogen protecting groups such as PMP (p-






R 	tN 	 (29) 
silane, so'vent, rt 
0 	Ar 
Ar = PMP or OMP 
1" n=1,2 	 R 	fl 
HO 
At the commencement of this program of research we were aware that N-alkyl-N-
arylamides such as 89 are known to exist predominately as the E-amide rotamer 
(Scheme 	75 As a consequence it was unknown as to whether this rotamer 
distribution would have any impact on the reactivity of these substrates. 
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R' 	 N 	R2 
N 	 R2 
amide 
rotation 
E-89 	OMe 	 Z-89 	
R1 
17~2' 





Cu 	 I 	 NAr \ -  
RN 	 HO 
"Ar 	 90 
Scheme 3.2 
Nevertheless, using the conditions previously developed within the group ,27 substrate 
89a underwent cyclisation to form 4-hydroxypiperdin-2-one 90a in 69% yield and 
with a diastereoselectivity of >95:5 (eq 30). 
0 
0 	 0 	DPPF (25) (5 mot%) 	
Me 	Li N 
Ph NiL, 	
1 "— 
Cu(OAc)2 H20 (5 MOM) 
'' 	 (30) 





89a 	 90a 
69 % yield 
>95:5 d.r 
Alternative copper(II) salts76 were examined for efficacy; however, none proved to 
be as effective as Cu(OAc)2 H20 in terms of reactivity. Furthermore, silane structure 
has been noted to have significant effects on both the reactivity and selectivity of 
reductive aldol reactions.5 To this end, we explored a number of structurally diverse 
silanes (Table 3.1). 
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0 
0 	 0 	DPPF (25) (5 moi%) 
Cu(OAc)2 H20 (5 moi%) 
_PMP 
N 
I 	 silane, THF, rt, Ph 
PMP 	 24 hours HO 
89a 90a 
Siiane 	Equivalents 	%Conversiort" 
TMDS 	 1.2 '95 
(EtO)2MeSiIf 	1.2 >95 
(Et0)3SiH 	 1.2 >95 
PMHS 	 4.0 —70 
PhSiH3 	 2.0 <5 
PhMe2SiH 	 2.0 <5 
Et3SiH 	 2.0 <5 
"Determined by 	ii NMR analysis of the uispurilicd reaction 
mixtures 
Table 3.1 
It was observed that alkoxy silanes ((EtO)2MeSiH and (EtO)3SiH) and siloxanes 
(TMDS and PMHS) were efficient reductants. However, alkyl (Et3SiH) and aromatic 
(PhMe2SiH and PhSiH3) silanes proved to be ineffective. The use of TMDS as the 
reductant was considered to be more favourable in terms of its availability and cost. 
In addition, it has been noted in a variety of reported reductive aldol reactions that 
the structure of the complexing ligand plays a pivotal role in the efficiency of the 
reaction. Therefore, to explore these effects in our system we investigated a number 
of bidentate phosphine ligands (Table 3.2). 
Ligand 	%Conversion°  
0 
0 	 0 	 Lfgand (5 moi%) 
Ph N 	
Cu(OAC)2 H20 (5 mot%) Me 1 	_PMP 	
DPPF (25) 	>95 
rac-BINAP 	>95 
I TMDS, THF, , 	Ph" 
DPPE 	 <5 PMP 	 24 hours 
89a 	
HO 90a 
DPPB 	 <5 
'Determined by 'El NMR analysts of 
Site unpurified reaction mixtures 
Table 3.2 
	
Of the ligands tested rccBiNAP and DPPF (25) performed with siit 	ffira.cy, 	-- - 
with poor conversion being observed for DPPE and DPPB. As a result, DPPF (25) 
was chosen for subsequent experiments based on its availability and cost. Moreover, 
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reactions in alternative solvents such as toluene, dichioromethane or acetonitrile were 
observed to be sluggish. Therefore, with optimised conditions in hand a range of 
substrates 89a-k underwent cyclisation to form 4-hydroxypiperidin-2-ones 90a-k 
(Table 3.3). 
DPPF (25) (5 mot%) 
R1 N R2 	
Cu(OAc)2 H20 (5 mol%) 







Entry Substrate Product Time(h) %YieId 
1 R=Ph 89a 90a 21 69 
2 o 	o R = 
Et 89b 0 90b 5.5 61 
3 II )L... R = 'Bu 89c Me.___.JL.. PMP 90c 24 64 
R 	N R =Me 89d I 	t 
R 
90d 2.5 66 
5 PMP R = 4-MePh 89e 	HO 90e 24 64 









90g 22 55 
R 













R=Me 89j Et....Jt.N _ oMP 	90j 24 70 
R 	N 	Me R= Ph 89k 90k 23 650 
OMP 
HO 
(EtO)2MeSiH (2.0 mmot) was employed in place of TMDS 
Table 3.3 
The reaction tolerated wide variations in the ketone component with alkyl (entries 2-
4 and 7-10), aromatic (entries 1, 5 and 11) and heteroaromatic (entry 6) ketones 
reacting readily. However, the reaction was far less tolerant of substitution in the 
cc,/3-unsaturated carbonyl component. Acryloyl amides proved to be the most 
reactive substrates, giving the reductive aldol products in all cases examined. Even 
though crontonyl amides underwent cyclisation, reaction rates and conversions were 
lower, in the majority of cases. In general, as the steric bulk of the substituent on the 
(t,/3-unsaturated carbonyl component increases, the formation of uncyclised side 
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products resulting from both ketone reduction and conjugate reduction becomes 
problematic (eq 31). 
0 	 0 DPPF (25) (5 mol%) 
Cu(OAc)2 H20 (5 mot%) 
_PMP 
OH 	0  




891 77% conversion 
HO 
901 91 
34% yield By-product 
66% yield 
For example, the reductive aldol cyclisation of cinnamic derivative 891 was observed 
to be very inefficient, giving only 77% conversion after 24 hrs. Analysis of the 
product distribution by proton NMR spectroscopy indicated that the major product 
formed was the uncyclised, doubly reduced starting material 91. In cases where 
reaction turnover was observed to be problematic, alternative silanes could be used to 
good effect. For example, the reductive aldol cyclisation of substrate 89k in the 
presence of TMDS proved sluggish. Nevertheless by changing the silane for 
(EtO)2MeSiH allowed the product to form in 65% yield over 23 hrs. Proton NMR 
spectroscopy of the crude product material indicates that all reactions proceed with 
high levels of diastereoselection (>95:5). 
3.1.1. Proposed Mechanism 
The proposed mechanism for this transformation bears similarities to the previously 
reported mechanistic details for the rhodium-catalysed reductive aldol reaction 
8 (Scheme 33) 





~tN 	 DPPF 














Z-enoLate 93 E-er,otate 94 
Leds to syn products 	Leds to anti products 
AldoL cycLisation 
Scheme 3.3 
Treatment of Cu(OAc)2-H20 with TMDS in the presence of DPPF results in the 
formation of a copper(I) hydride species 92. Hydrometallation of substrate 89 with 
92 generates a chelated copper enolate 93. The enolate generation is most likely to be 
highly Z-selective, owing to the exclusive formation of the syn aldol products. 
Enolate 93 then undergoes aldol cyclisation to give the copper alkoxide 95 which is 
followed by a cr-bond metathesis with another molecule of reductant to liberate the 
silated product 96 and regenerate the copper hydride catalyst 92. 
The relative configurations of products (90a, 90d and 90g) were confirmed by X-ray 
crystallography and reflected those of the lactone products previously reported from 
27 the Lam group (Figure 3.2) 
P\ 'P 	 P\ 1P 
Cu _ Cu o\o 0 \O 
R 12  
NAr 	R1 NA 
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MeJ tJ  
HO 90g 
Figure 3.2 
We postulated that the high levels of diastereoselectivity observed were due to both 
selective Z-enolate formation and chelation control in the six-membered 
Zimmerman-Traxier-like transition state. 
13  To investigate the effect of pre-existing 
stereocentres on the diastereoselectivity of the process, a number of complex 
substrate molecules were synthesised (97a-d). Substrates 97b-d were constructed in 
enantiomerically enriched form via an L-proline-catalysed asymmetric Mannich 
reaction as detailed in the experimental (Section 3.3). In addition, acrylamide 
substituted substrates were chosen due to their previously observed greater reactivity 
under our standard reaction conditions (Table 3.4). 
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0 
0 	R3 	0 	 DPPF(25) (5 mol%) 	
_PMP 
Cu(OAc)2 H50 (5 mot%) N 
TMIDS, THE, it 
	
R2 PMP 	 HO R 
R2 
97a'd 	 98a-d 
Entry 	Substrate Product 	 di" 	%Yield 
0 
0 
0Me  _PMP Ph 	 N Ph' 	 8:1 	78 






 P P 
2 	





97b 85% ee 98b 
O 	CO2EtO 
0 
Me .) j(  PMP 







Me 	 PMP 
HO 	 5:1 	66 
PMP 
97d '99% ee 98d 
'Determined by 'I-I NMR analysis of the unpurified reaction mixtures 
Table 3.4 
Substrate 97a (entry 1) containing an a-methyl substituent cyclised to give an 8:1 
mixture of diastereomers, from which the major product 98a was isolated in 78% 
yield. Cyclisation of substrates 97b-d (entries 2-4) gave piperidinones 98b-d in good 
yield and with moderate to good diastereoselectivities. Moreover, the observed levels 
of 1,2- and 1,3-asymmetric induction in these cyclisations may be rationalised by 
considering the chelated chairlike transition states (Figure 3.3) with substituents 
preferring to adopt a pseudoequatorial conformation. The relatively poor levels of 
diastereoselection obtained for 98d is most likely due to the a-su5fitiiiñi being - 
forced into an energetically unfavourable pseudoaxial position in the transition state 
D. 
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P\ ,P 	 P\ ,P P\ ,P 
Cu Cu 
Ph \ 	Me1\ 
Cu 
0\O 




A 	 B R=Ph 
C 	R=CO2Et 
Figure 3.3 
The benzylic proton in piperidinone 98b was found to reside in a pseudoaxial 
position on the basis of the large axial-axial coupling constant of 11.3 Hz. Therefore, 
the phenyl substituent occupies a pseudoequatorial position. The relative 
stereochemistries of the remaining piperidinones were confirmed by X-ray 
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N 	 Me 
Ph PMP 	 HO 
Ph 
98b 	 98b 
Figure 3.4 
In addition, it is vitally important that the piperidinone products could be further 
elaborated to gain access to more synthetically desirable materials. To this end, the 
synthetic utility of the piperinidone products was examined. Reductive removal of 
the carbonyl group would allow access to the piperidine ring system which is an 
important structural feature of many natural products and biologically important 
compounds.77  For example, exposure of 90a to borane at reflux provided 99 in good 
yield. Oxidative removal of the PMP protecting group using PhI(OAc)274 followed 
by in situ treatment of the resulting amine with Boc20 gave 100 in moderate yield 
over the two steps (Scheme 3.4). 




8H3 THF 	Me 	PMP 1. Phl(OAc)2, MeOH 	Me 	_Boc 
-----  ------ rN' 	 N 
Ph 	 THF, reflux 	




86% yield Na2CO3 (ml 
HO HO 49% yield 	HO 
90a 	 99 	 100 
Me 	PMP 
Me 	_PMP 	 HO 	 OH 
Me-", 	'OH 
HO 
101 	 102 
75% yield from 98c 	 64% yield from 98d 
(96% ee) 	 (>99% ee) 
Scheme 3.4 
Furthermore, reduction of piperidinones 98c and 98d with borane was accompanied 
by reduction of the esters to give PMP protected piperidines 101 and 102, 
respectively. Polyhydroxylated piperidine moieties are of substantial biological 
importance due to their reported potential to act as glycosidase inhibitors. 78 
Enantioselective carbon—carbon bond forming reactions are invaluable tools in 
organic synthesis. Therefore, a number of chiral non-racemic ligands were 
investigated in order to probe a possible asymmetric variant of this methodology 
(Table 3.5). 
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0 
0 	 0 	 Ligand (5 mot%) 	 PMP 
Cu(OAc)2 -H 20 (5 mot%) 
):t 
I 	 TMDS, THE, rt 
MP P 
HO 





<O 	 PPh2(OIf.PA12 
P P h 
2 	
j1PAr2 	0 .._PPh2 	eO 
0 	 10:a 
(S)-BINAP(103) (R)-tol-BINAP (20) 	(S)-SEGPHOS (104) 	(S(-DTBM-SEGPFIOS (21) 
20% ee 	 -14% ee 	 51% ee 	 nr 
MeO PAr2Me0 2 	 —NMe2 
Oj1 	
MeOXPAr2 MeO-j7PAr2 
(S)-DM-SEGPHOS (105) 	(R)-3,5-xylyl-Me0BIPIIEP 	(R)-35-iPr-Me0BIPHEP 	
(R)-MONOPHOS (107) 
Ar = 35-Me-Ph 	 (26) 	 (106) 	
-5%ee 
65% ee 	 -55% ee -20% ee 
Ph2P 












CyPPhCHNMe2-T-PCY2 	(R)-(S)-Ph2 PPhCHNMe2-T-PPh2 
(109) 	 (110) 
nr 41% ee 
Et ", Et 
	 o 
Et &NH HN h2 Ph2 
(R,R)-Et-DUPh0S (111) 	 Trost Ugand (112) 
nr 	 nr 
Table 3.5 
Of the ligands examined, those based on a biaryl structural motif proved to be the 
most effective in terms of reactivity, giving product 90a in the majority of cases. 
Although the use BINAP-type ligands (103) and (20) led to efficient cyclisation, the 
maximum enantiomeric excess of 20% was disappointing. Alternative biaryl-type 
ligands.for example, SEGlHQSWPe (104) and (105) and BIPHEP-type (26) and 	- 
(106) ligands were shown to provide greater levels of stereocontrol, giving the 
products with enhanced enantiomeric excesses. In the case of (5)-SEGPHOS (104), 
product 90a was obtained in 51% ee after 24 hrs. Increasing the bulk of the steric 
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environment around the phosphines by replacing the phenyl groups with 3,5-xylyl 
groups (105) led to a further increase in selectivity, giving the product 90a in 65% 
ee. It was envisioned that further increases in the steric bulk of the complexing ligand 
would lead to further enhancements in the enantiomeric excesses of the observed 
products. Hence, (S)-DTBM-SEGPHOS (21) would appear to offer the necessary 
steric bulk in order to further increase the selectivity of the cyclisation. Unfortunately 
(21) proved to be completely ineffective under these conditions giving only 
unreacted starting material 89a after 48 hrs. DPPF (25)w as previously shown to be 
an effective ligand in the non-asymmetric reactions (Table 3.3 and Table 3.4). 
However, application of chiral non-racemic ferrocene ligands gave only a maximum 
of 41% ee when (R)-(5)-Ph2PPhCHNMe2-T-PPh2 (110) was used as the complexing 
ligand. Electron-rich phosphine ligands such as: (R,R)-Et-DuPhos (111), Trost ligand 
(112)an d Cy2PPhCHNMe2-T-PCy2  (109)wer e observed to be catalytically inactive 
for this process. 
Although the initial programme of research centred on the synthesis of 
hydroxypiperidin-2-ones, we were interested in applying our optimised methodology 
to the synthesis of substituted pyrrolidin-2-ones. This y-lactam motif is prevalent in a 
number of biologically important natural products, for example, salinosporamide A 
(87) (Figure 3.1). We envisioned that on exposure to our conditions substrates 113a-
c would undergo reductive aldol cyclisation to produce the requisite pyrrolidin-2-
ones 114a-c (eqs 32-34). 
DPPF (25) (5 moL%) 









R=H, 114a 	(32) 
R=Me, 113b R=Me, 114b (33) 
R= Ph, 113c R= Ph, 114c 	(34) 
However, according to Baldwin's rules this type of 5-(enolendo)-exo-trig ring 
closure is -formally difavdd.79 Neverthelessprevious-work WflhtffthLamgroUp 
has demonstrated that these disfavoured cyclisations occur readily in moderate to 
27 good yields in the case of five-membered f3-hydroxylactone formation (Table 3.6).  
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0 
DPPF (25) (5 mo%) 
Cu(OAc)2 H20 (5 rnot%) R 	 o 
TMDS, THF, It  
P:)~ 
0 	 HO 
R XYleM dr 
H 69 >95:5 
Me 72 >95:5 
'Bu 65 >95:5 
PhCH,CHZ 60 '95:5 
Table 3.6 
Unfortunately, on exposing substrates 113a-c to our conditions complex mixtures 
were obtained from which the products of ketone reduction could be observed. An 
investigation into alternative ligands, silanes and copper salts failed to improve 
reaction efficiency. Although five-membered /3-hydroxylactone formation is facile 
under these conditions, a,-unsaturated amide functionalities are less electrophilic 
compared to the corresponding esters. This may lend itself to slow 1,4-addition of the 
copper hydride species and therefore, making alternative reaction pathways such as 
ketone reduction more competitive. 
3.2. Conclusions and Future Work 
We 	have developed methodology whereby 4 -hydroxypiperidin-2- ones can be 
constructed in moderate yields and with excellent levels of diastereoselection. 
However, the synthesis of pyrrolidin-2-ones using this methodology has to date 
failed to yield any promising results. Furthermore, moderate levels of 
enantioselection (up to 65% ee) may be achieved by using chiral non-racemic 
bisphosphine ligands such as (S)-DM-SEGPHOS (105) in place of DPPF (25)i n the 
synthesis of 4-hydroxypiperidin-2-ones. Finally, by use of L-proline catalysed 
asymmetric Mannich reactions a selection of highly substituted 4-hydroxypiperidin-
2-ones can be synthesised in enantiomerically enriched form from easily attainable 
- - 	
- 	 of these products-allows-entry into-the an 
piperidine ring system which is a ubiquitous structural feature in many natural 
77 products.  
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3.3. Experimental 
All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-
dried apparatus. CH2Cl2 was distilled from CaH2. THF was distilled from sodium 
benzophenone ketyl. 'Petrol' refers to that fraction of light petroleum ether boiling in 
the range 40-60 °C. Crotonoyl chloride was distilled from CaH2. All other 
commercially available reagents were used as received. Thin layer chromatography 
(TLC) was performed on Merck DF-Alufoilien 60F254  0.2 mm precoated plates. 
Product spots were visualised by UV light at 254 nm, and subsequently developed 
using potassium permanganate or ceric ammonium molybdate solution as 
appropriate. Flash column chromatography was carried out using silica gel (Fisher 
Scientific 60A particle size 35-70 micron) employing the method of Still and co-
workers.80  Melting points were recorded on a Gallenkamp melting point apparatus 
and are uncorrected. Infra-red spectra were recorded on a Jasco FT/IR-460 Plus 
instrument as a thin film on sodium chloride plates or as a dilute solution in CHC13. 
111 NMR spectra were recorded on a Bruker DPX360 (360 MHz) spectrometer or a 
Bruker ARX250 (250 MHz) spectrometer. Chemical shifts (8) are quoted in parts per 
million (ppm) downfield of tetramethylsilane, using residual protonated solvent as 
internal standard (CDC13 at 7.27 ppm, C2D2C4 at 5.94 ppm, CD30D at 3.35 ppm). 
Abbreviations used in the description of resonances are: s (singlet), d (doublet), t 
(triplet), q, (quartet), app (apparent), hr (broad). Coupling constants (J) are quoted to 
the nearest 0.1 Hz. Proton-decoupled '3C NMR spectra were recorded on a Bruker 
DPX360 (90.6 MHz) spectrometer or a Bruker ARX250 (62.9 MHz) spectrometer. 
Chemical shifts (6) are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using deuterated solvent as internal standard (CDC13 at 77.0 ppm, 
C2132CL at 74.2 ppm, CD30D at 49.0 ppm). Assignments were made using the DEPT 
sequence with secondary pulses at 90° and 135°. High resolution mass spectra were 
recorded on a Finnigan MAT 900 XLT spectrometer using the electrospray (ES) 
positive ion mode at the EPSRC National Mass Spectrometry Service Centre, 
-U-ni-versity-of Kratos MS50TC spectrometer using the fast 
atom bombardment (FAB) technique in the mass spectrometry laboratory at the 
School of Chemistry, University of Edinburgh. Stated calculated mass values refer to 
that of the ion (i.e. the actual species being detected), not that of the neutral parent 
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compound. Chiral HPLC analysis was performed on an Agilent 1100 instrument. 
Optical rotations were performed on an Optical Activity POLAAR 20 polarimeter. 
Preparation of/3-Dimethylaminoketone Hydrochlorides: General Procedure A 
0 	 0 conc. HCI 
II + CH20 + MeNH2'HCI 
Me 	
DOH, A 	HcIMe2N R 
A mixture of the appropriate methyl ketone (1.0 equiv), dimethylamine 
hydrochloride (1.1 equiv), paraformaldehyde (1.4 equiv), and conc. HCl (5 tL/rnmo1 
of methyl ketone) in ethanol (2.0 M with respect to methyl ketone) was heated at 
reflux until TLC analysis showed the reaction to be complete. The reaction was 
cooled to room temperature and the ethanol was removed in vacuo. EtOAc was 
added, and the suspension was stirred for 15 min before the solid product was 
collected by filtration, washed with EtOAc (x 2) and dried under vacuum to leave the 
fI-dimethylaminoketone hydrochloride. 
0 	 1Dimethylamino5-methylhexan-3-ofle-hYdrOChtOride 
HCI'M N -B 	 81 e2 	 I U (115). The title compound was prepared according to general 
procedure A from 4-methylpentan-2-one (1.25 mL, 10.0 mmol), dimethylamine 
hydrochloride (906 mg, 11.0 mmol), paraformaldehyde (443 mg, 14.0 mmol) and 
conc. HC1 (50 jtL) for a reaction time of 20 h to give a white crystalline solid (700 
mg, 36%) which displayed identical spectroscopic data to those previously reported. 
3-Dimethylamino- 1-(4-methylphenyl)propan-1 -one- 
HCI Me2N 	 hydrochloride (116). The title compound was prepared 
Me  according to general procedure A from 4'-
methylacetophenone (5.6 mL, 40 mmol), dimethylamine hydrochloride (3,62 g, 44.0 
mmol), paraformaldehyde (1.77 g, 56.0 mmol) and conc. HCI(0.2 mL) for a reaction 
time of 36 h to give a white solid (8.03 g, 88%). m.p. 158-160 °C; 1H NMR (360 
WHzCDOD)8799-(-2Tf, d, J z-&3Hz; ArH),-7-3-7 	 --- 
3.59 (4H, in, CH2CH2N), 3.01 (6H, s, N(CH3)2), 2.45 (3H, s, CH3C6H4); 13C NMR 
(62.9 MHz, CD30D) 5 197.8 (C), 146.1 (C), 134.7 (C), 130.5 (2 x CH), 129.4 (2 x 
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CH), 54.3 (CH2), 43.8 (2 x Cl3), 34.2 (CH2), 21.7 (CH3); HRMS (ES) Exact mass 
calcd for C12H18N0 [M-Cl]: 192.1383, found: 192.1385. 
° 	 3-Dimethylamino-1-(furan-2-yI)propafl-1-Ofle- 
HCIMe2Nc 	hydrochloride (117). The title compound was prepared 
according to general procedure A from 2-furyl methyl ketone 
(2.22 g, 20.0 mmol), dimethylamine hydrochloride (1.81 g, 22.0 mmol), 
paraformaldehyde (885 mg, 28.0 mmol) and conc. HC1 (0.1 mL) for a reaction time 
of 20 h to give an off-white crystalline solid (3.00 g, 74%). m.p. 180-182 °C; 1 H 
NMR (360 MHz, CD30D) 6 7.89 (lH, dd, J= 1.7, 0.7 Hz, CH), 7.52 (1H, dd, J= 
3.7, 0.7 Hz, CH), 7.34 (1H, dd, J= 3.7, 1.7 Hz, CH), 3.61-3.57 (2H, m, CH2N), 
3.53-3.49 (2H, m, CH2CH2N); '3C NMR (62.9 MHz, CD30D) 8 186.6 (C), 153.0 
(C), 149.2 (CI), 120.0 (CH), 113.8 (CH), 53.7 (CH2), 43.9 (2 x CH3), 33.8 (CH2); 
HRMS (ES) Exact mass calcd for C9H14NO2 [M-Cl]: 168.1019, found: 168.1018. 
Preparation of/3-Arylaminoketones: General Procedure B 
MeO 
THF,E 	 ii I 	II 
NH2 + 	 PMPHN R 1  
A solution of the appropriate alkyl vinyl ketone (1.2 equiv) and p-anisidine (1.0 
equiv) in THF (1.0 M with respect top-anisidine) was heated at reflux for 24 h. The 
mixture was cooled to room temperature and washed with brine. The aqueous layer 
was extracted with EtOAc (x 2), and the combined organic layers were dried 
(MgSO4) and concentrated in vacuo. Purification of the residue by column 
chromatography (EtOAc/petrol) afforded the -aminoketone. 
4-(4-Methoxyphenylamino)butan-2-one (118). The title 
PMPHN 	Me 
compound was prepared according to general procedure B from 
methyl vinyUcn (7.0nik, 85 mmol) and p-anisidine (8.86 g,7L2 mmol) for a 
reaction time of 24 h and purified by column chromatography (30% 
EtOAc/petrol-*50% EtOAc/petrol) to give an orange/brown oil (13.6 g, 99%), which 
was judged to be ca. 90% pure by 1H NMR spectroscopy. IR (film) 3379 (NH), 
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2935, 1711 (C=0), 1513, 1465, 1361, 1237, 1169, 1036, 822 cm 1 ; 1 H NMR (250 
MHz, CDC13) 6 6.78 (211, d, J= 9.0 Hz, ArH), 6.58 (211, d, J= 9.0 Hz, ArH), 3.74 
(3H, s, OCH3), 3.53 (111, bs, NET), 3.34 (2H, t, J= 6.2 Hz, CH2N), 2.71 (2H, t, 1= 
6.2 Hz, CH2CH2N), 2.15 (3H, s, CH3C=0); '3C NMR (62.9 MHz, CDC13)  ö 208.2 
(C), 152.1 (C), 141.7 (C), 114.7(2 x CH), 114.4(2 x CH), 55.6 (CH3), 42.5 (CH2), 
39.3 (CH2), 30.2 (CH3); LRMS (ES) Mass calculated for C11 H,6NO2 [M+H]: 194. 1, 
found: 194.0. 
0 4-(4-Methoxyphenylamino)pentan-3-one (119). The title 
PMPHN 	Et  compound was prepared according to general procedure B from 
ethyl vinyl ketone (1.47 mL, 14.3 mmol) and p-anisidine (1.48 g, 11.9 mmol) for a 
reaction time of 24 h and purified by column chromatography (30% 
Et0Ac/petrol-50% EtOAc/petrol) to give a dark orange solid (1.84 g, 75%) that 
displayed identical spectroscopic data to those previously reported .82 
Preparation of fl-Arylaminoketones: General Procedure C 
A solution of the appropriate 3-dimethylaminoketone hydrochloride (1.0 equiv) and 
the appropriate aniline (1.0 equiv) in 1:1 EtOH/H20 (1.0 M) was heated at reflux for 
24 h. After the mixture was cooled to room temperature, the precipitated solid was 
collected by filtration, washed with 1120 (x 2) and EtOH (x 2), and dried under 
vacuum to afford the 3-aminoketone. 
0 	1-(4-Methoxyphenylamino)-5-methylhex-3-one (120). The title 
PMPHN 	 i-Bu 
compound was prepared according to general procedure C from the 
dimethylamine hydrochloride 115 (697 mg, 3.60 mmol) and p-anisidine (448 mg, 
3.60 mmol) to give an orange solid (495 mg, 56%). m.p. 45-47 °C; JR (CHC13) 3385 
(NH), 2956, 1707 (C=0), 1514, 1465, 1367, 1236, 1178, 1038, 820cm
1 ; 'H NMR 
(360 MHz, CDC13) 3 6.78 (2H, d, J= 9.0 Hz, AnT), 6.59 (2H, d, J= 9.0 Hz, ArH), 
3.753Hs0QH3),334 (2H,t,J = 6.1 Hz, CH2N), 2RJ,L6LHz, 
CH2CH2N), 2.29 (2H, d,J 6.9 Hz, CHCH2), 2.19-2.08(111, in, CHCH2), 0.91 (611, 
d, J = 6.6 Hz, (CH3)2CH); 13C NMR (90.6 MHz, CDC13) 8 210.1 (C), 152.1 (C), 
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141.8 (C), 114.7(2 x CH), 114.4(2 x CH), 55.5 (CH3), 51.9 (CH2), 42.0 (CH2), 39.4 
(CH2), 24.4 (CH), 22.4 (2 x Cl3); HRMS (ES) Exact mass calcd for C14H22NO2 
[M+H]: 236.1645, found: 236.1644. 
3-(4-Methoxyphenylamino)- 1-phenylpropan-1-one (121). The 
PMPHN 	 '' title compound was prepared according to general procedure C from 
commercially available 3-(dimethylamino)propiophenone hydrochloride (4.32 g, 
20.0 mmol) and p-anisidine (2.49 g, 20.0 mmol) to give a light yellow/green 
crystalline solid (4.80 g, 94%), which displayed identical spectroscopic data to those 
previously reported. 83 
3-(4-Methoxyphenylamino)-1-(4-methyiphenyl) propan- 1- 
PMPHN J1j 	one (121). The title compound was prepared according to 
Me  general procedure C from the demethylamine hydrochloride 
116 (4.55 g, 20.0 rnmol) and p-anisidine (2.49 g, 20.0 mmol) to give a yellow/grey 
crystalline solid (4.13 g, 77%). m.p. 120-121 °C; IR (CHC13) 3377 (NH), 2856, 1672 
(C=O), 1516, 1382, 1288, 1037, 908, 818, 732 cm-1; H NMR (360 MHz, CDC13) 6 
7.86 (2H, d, J= 8.5 Hz, ArH), 7.26 (2H, d, J= 8.5 Hz, ArH), 6.81 (2H, d, J= 8.8 
Hz, ArH), 6.64 (2H, d, J= 8.8 Hz, ArH), 3.75 (4H, br s, OCH3 and NH), 3.55 (2H, t, 
J= 6.2 Hz, CH2N), 3.23 (2H, t, J= 6.2 Hz, CH2CH2N), 2.42 (3H, s, CH3C6H4); 13C 
NMR (62.9 MHz, CDC13) 6 198.9 (C), 152.1 (C), 144.0 (C), 141.9 (C), 134.1 (C), 
129.1 (2 x CH), 128.0(2 x CH), 114.8 (2 x CH), 114.4(2 x CH), 55.6 (Cl3), 39.8 
(Cl2), 37.4 (CH), 21.5 (CH3); HRMS (ES) Exact mass calcd for C17H19NO2 
[M+H]: 270.1489, found: 270.1487. 
° 	 3-(40methoxyphenylamino)-1-(furan-2-yl)propan- 1-one 
PMPHN') (123). The title compound was prepared according to general 
procedure C from the dimethylamine hydrochloride 117 (2.44 g, 12.0 mmol) and p-
anisidine (1.49 g, 12.0 mmol) to give a yellow/brown solid (1.10 g, 37%). m.p. 
78-7-9 °C-TR(CHC13)-3380 (NH), 2832, 1670 (C=O), 1568, 1514, L467, 1395, 1238, 
1034, 822 cm'; 11  NMR (360 MHz, CDC13) 6 7.58 (11, dd, J = 1.7, 0.6 Hz, CH), 
7.18 (1H, dd, J = 3.6, 0.6 Hz, CH), 6.79 (2H, d, J= 8.9 Hz, ArH), 6.62 (2H, d, J= 
	
Chapter 3—Copper-Catalysed Reductive Aldol Cyclisations 	 73 
8.9 Hz, ArH), 6.53 (1H, dd, J= 3.6, 1.7 Hz, CH), 3.82 (1H, br s, NH), 3.75 (3H, s, 
OCH3), 3.53 (2H, t, J= 6.2 Hz, CH2N), 3.12 (2H, t, J= 6.2 Hz, CH2CH2N); 13C 
NMR (90.6 MHz, CDC13) 6 188.3 (C), 152.6 (C),152.3 (C), 146.5 (CH), 141.8 (C), 
117.3 (CH), 114.9 (2 x CH), 114.5 (2 x CH), 112.3 (CH), 55.7 (CH3), 39.8 (CH2), 
37.6 (CH2); HRMS (ES) Exact mass calcd for C14H16NO3 [M+H]: 246.1125, found: 
246.1126. 
o 	3-(4-Methoxyphenylamino)-1 -fu ran-2-ylpropan-1-one 	(124). 
OMPHN 	 Ph The title compound was prepared according to general procedure C 
from commercially available 3-(dimethylamino)propiophenone hydrochloride (2.44 
g, 12.0 mmol) and o-anisidine (1.49 g, 12.0 mmol) to give a yellow/brown solid 
(1.10 g, 37%). m.p. 78-79 °C; JR (CHC13) 3380 (NH), 2832, 1670 (C0), 1568, 
1514, 1467, 1395, 1238, 1034, 822 cm'; 'H NMR (360 MHz, CDC13) 6 7.58 (1H, 
dd, J= 1.7, 0.6 Hz, CH), 7.18 (1H, dd, J= 3.6, 0.6 Hz, CH), 6.79 (2H, d, J= 8.9 Hz, 
ArH), 6.62 (2H, d, J= 8.9 Hz, ArH), 6.53 (1 H, dd, J= 3.6, 1.7 Hz, CH), 3.82 (1H, br 
s, NH), 3.75 (3H, s, OCH3), 3.53 (2H, t, J= 6.2 Hz, CH2N), 3.12 (2H, t, .J= 6.2 Hz, 
CH2CH2N); '3C NMR (90.6 MHz, CDC13) 6 188.3 (C), 152.6 (C), 152.3 (C), 146.5 
(CH), 141.8 (C), 117.3 (CH), 114.9 (2 x CH), 114.5 (2 x CH), 112.3 (CH), 55.7 
(CH3), 39.8 (CH2), 37.6 (CH2); HRMS (ES) Exact mass calcd for C14H,6NO3 
[M+H]: 246.1125, found: 246.1126. 
4-(2-Methoxyphenylamino)butan-2-one (125) 
0Me 	 a 	 o 
+ 	
La(OTf)3 xH20 	 II 
Me 	CH2Ci2, RT 	OMPHN Me 
A solution of methyl vinyl ketone (4.3 mL, 52 mmol), o-anisidine (5.6 mL, 50 mmol) 
and La(OT03 xH20 (1.47 g, 2.50 mmol) in CH202 (50 mL) was stirred at room 
temperature for 48 h. The mixture was washed with saturated aqueous NaHCO3 
so1ntiom(2OmL),ancLthe aqueous -layer was extracted with CH2Ch(2xOmL)Jhe 
combined organic layers were dried (MgSO4) and concentrated in vacuo. Purification 
of the residue by column chromatography (30% EtOAc/petrol—*60% EtOAc/petrol) 
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afforded the title compound as a pale pink crystalline solid (5.65 g, 57%). m.p. 40-42 
°C; IR (CHC13) 3408 (NH), 2939, 1713 (C=O), 1602, 1514, 1457, 1247, 1223, 1128, 
1028 cm'; 'H NMR (360 MHz, CDC13) 3 6.93 (IH, m, ArH), 6.81-6.76 (IH, m, 
ArH), 6.75-6.68 (IH, m, ArH), 6.66-6.63 (IH, m, ArH), 4.45 (IH, br s, NH), 3.84 
(3H, s, OCH3), 3.44 (2H, t, J= 6.4 Hz, CH2N), 2.76 (2H, t, J= 6.4 Hz, CH2CH2N), 
2.16 (3H, s, CH3C=O); '3C NMR (90.6 MHz, CDC13) 3 207.5 (C), 146.8 (C), 137.4 
(C), 121.0 (CH), 116.4 (CH), 109.5 (CH), 109.3 (CH), 55.1 (CH3), 42.5 (CH2), 37.8 
(CH2), 29.9 (CH3); HRMS (ES) Exact mass calcd for C,,H,6NO2 [M+H]: 194.1176, 
found: 194.1177. 
1-(4-Methoxyphenyl)aminopropanone (126) 
CV ' J( 	 PMPHN Me PMPNH2,E t3N 	 f( Me 
THF, 
0 	 0 
A solution of p-anisidine (5.00 g, 40.6 mmol), chioroacetone (3.56 mL, 44.7 mmol) 
and Et3N (11.3 mL, 81.2 mmol) in THF (100 mL) was heated at reflux for 24 h. The 
reaction mixture was cooled to room temperature before the addition of brine (25 
mL) and water (25 mL). The aqueous layer was separated and extracted with EtOAc 
(2 x 30 mL), and the combined organic layers were dried (MgSO4) and concentrated 
in vacuo. Purification of the residue by column chromatography (40% 
EtOAc/petrol—)-50% EtOAc/petrol) gave the am inoketone 126 as a yellow/orange 
crystalline solid (4.60 g, 68%). m.p. 70-71 °C; IR (CHCI3) 3397 (NH), 2961, 2839, 
1715 (C=O), 1511, 1436, 1345, 1254, 1036, 821 cm'; 'H NMR (360 MHz, CDC13) 6 
6.79 (2H, dm, J= 9.0 Hz, ArH), 6.56 (2H, dm, J = 9.0 Hz, ArH), 4.31 (1H, bs, NH), 
3.95 (2H, s, CH2N), 3.74 (3H, s, OCH3), 2.23 (3H, s, CH3C=O); '3C NMR 
(62.9 MHz, CDC13) 6204.5 (C), 152.2 (C), 141.2 (C), 114.9(2 x CH), 113.9 (2 x 
CH), 55.7 (CH3), 55.1 (CH2), 27.3 (CH3); HRMS (FAB) Exact mass calcd for 
C21H24NO3 [M+H]E:  180.1020, found: 180.1032. 
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PMPHN ( 	Na2CO3(q) 	
PMP 0 CH2Cl2, RT 
The appropriate a,/3-unsaturated acid chloride (1.5 equiv) was added dropwise to a 
vigorously stirred mixture of the appropriate /3-arylaminoketone (1.0 equiv) in 
CH2C12 0  mL/mmol of 3-arylaminoketone) and saturated aqueous Na2CO3 solution 
(1 mL/mmol of 3-arylaminoketone). The mixture was stirred at room temperature 
until TLC analysis showed the reaction to be complete. The reaction was partitioned 
between saturated aqueous NaHCO3 solution and CH2C12. The aqueous layer was 
separated and extracted with CH202 (x 3), and the combined organic layers were 
dried (MgSO4) and concentrated in vacuo. Purification of the residue by column 
chromatography (EtOAc/petrol) afforded the cyclization substrate. 
o 	o 	N-(4-Methoxyphenyl)-N-(3-oxo-3-phenylpropyl) 
Ph propenamide (89a). The title compound was prepared according 
PM P 
to general procedure D from the amine 121 (5.00 g, 19.6 mmol) 
and acryloyl chloride (2.60 mL, 30.7 mmol) for a reaction time of 20 h and purified 
by column chromatography (30% EtOAc/petrol) to give an off-white solid (5.76 g, 
95%). m.p. 51-53 °C; JR (CHC13) 2933, 1681 (C0), 1655 (C0), 1614, 1510, 1446, 
1411, 1249, 1210, 1180 cm-'; 'H NMR (360 MHz, CDC13) 6 7.96-7.93 (2H, in, 
ArH), 7.57 (1H, in, ArH), 7.46-7.42 (2H, in, ArH), 7.11-7.06 (2H, in, ArH), 6.93-
6.89 (2H, in, ArH), 6.36 (1H, dd, .1= 16.8, 2.0 Hz, =CH), 6.03 (1H, dd, .1= 16.8, 
10.3 Hz, CH), 5.52 (1H, dd, J= 10.3, 2.0 Hz, CH), 4.14 (2H, t, J= 7.5 Hz, 
CH2N), 3.81 (3H, s, OCH3), 3.34 (2H, t, J= 7.5 Hz, CH2CH2N); '3C NMR (62.9 
MHz, CDC13) 6 198.4 (C), 165.9 (C), 159.0 (C), 136.5 (C), 134.5 (C), 133.2 (CH), 
129.1 (2 x CH), 128.5 (3 x CH), 128.0 (2 x CH), 127.4 (CH2), 114.7 (2 x CH), 55.4 
(CH3), 46.1 (CH2), 36.6 (CH2); HRMS (FAB) Exact mass calcd for C19H20NO3 
[M+H]: 310.1438, found: 310.1442. 
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o 	a N-(4-Methoxyphenyl)-N-(3-oxopentyl) propenamide (89b). 
FJ 	Et The title compound was prepared according to general procedure 
P MP 
D from the amine 119 (500 mg, 2.41 mmol) and acryloyl chloride 
(305 iL, 3.60 mmol) for a reaction time of 20 h and purified by column 
chromatography (EtOAc) to give an orange/brown solid (620 mg, 98%). m.p. 43-44 
°C; IR (CHC13) 2938, 1712 (C=O), 1654 (C=O), 1615, 1510, 1412, 1249, 1182, 
1031, 795 cm-1 ; 'H NMR (360 MHz, CDC13) 67.06(211, d, J= 9.0 Hz, ArH), 6.91 
(2H, d, J= 9.0 Hz, ArH), 6.33 (1H, dd, J= 16.8, 2.0 Hz, CH), 5.99 (1H, dd, J 
16.8, 10.3 Hz, CH), 5.50 (1H, dd, J= 10.3, 2.0 Hz, =CH), 4.00 (2H, t, J= 7.5 Hz, 
CH2N), 3.83 (311, s, 0C113), 2.74 (2H, t, J= 7.5 Hz, CH2CH2N), 2.43 (2H, q, 1= 7.3 
Hz, CH2CH3), 1.02 (3H, t, J = 7.3 Hz, CH2CH3); 13C NMR (62.9 MHz, CDC13) 6 
209.7 (C), 165.8 (C), 159.0 (C), 134.3 (C), 129.2 (2 x CH), 128.5 (CH), 127.4 (CH2), 
114.7(2 x CH), 55.5 (CH3), 45.2 (CH2), 40.1 (CH2), 36.0 (CH2), 7.6 (CH3); HRMS 
(ES) Exact mass calcd for C15H20NO3 [M+H]+: 262.1438, found: 262.1441. 
a 	a 	N-(4-Methoxyphenyl)-N-(5-methyl-3-oxohexyl) propenamide 
(89c). The title compound was prepared according to general 
PMP 
procedure D from the amine 120 (500 mg, 2.12 mmol) and 
acryloyl chloride (260 iL, 3.07 mmol) for a reaction time of 20 h and purified by 
column chromatography (30% EtOAc/petrol) to give an orange oil (400 mg, 65%). 
IR (film) 2956, 1710 (C0), 1657 (C0), 1616, 1511, 1411, 1249, 1181, 1032, 839 
cm- 1; 111 NMR (360 MHz, CDC13) 6 7.05 (211, d, J = 8.9 Hz, ArH), 6.91 (2H, d, J = 
8.9 Hz, ArH), 6.38 (1H, dd, J = 16.8, 2.0 Hz, =CH), 5.98 (iH, dd, J = 16.8, 10.3 Hz, 
=CH), 5.49 (1H, dd, J = 10.3, 2.0 Hz, =CH), 3.98 (2H, t, J = 7.5 Hz, CH2N), 2.72 
(2H, d, J = 6.9 Hz, (CH3)2CHCH2), 2.15-2.03 (1H, in, (CH3)2CH), 0.88 (6H, d, J = 
6.6 Hz, (CH3)2CH); 13C NMR (62.9 MHz, CDC13) 6 208.9 (C), 165.7 (C), 158.9 
(C), 134.3 (C), 129.2 (2 x CH), 128.5 (CH), 127.3 (CH2), 114.7 (2 x CH), 55.4 
(CH3), 51.8 (CH2), 45.0 (CH2), 40.8 (CH2), 24.3 (CH), 22.5 (2 x CH3); HRMS 
(ES) Exact mass calcd for C17H24NO3 [M+H]+: 290.175 1, found: 290.1752. 
0 	0 	N-(4-Methoxyphenyl)-N-(3-oxobutyl) propenamide (89d). The 
title compound was prepared according to general procedure D 
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from the amine 118 (1.46 g, 7.56 mmol) and acryloyl chloride (950 VtL, 11.2 mmol) 
for a reaction time of 1.5 h and purified by column chromatography (50% 
EtOAc/petrol) to give a light brown oil (970 mg, 52%). IR (film) 2956, 1713 (C=O), 
1656 (C=O), 1618, 1512, 1412, 1249, 1169, 1030, 838 cm'; 'H NMR (360 MHz, 
CDC13) 6 7.02 (2H, d, J= 8.9 Hz, ArH), 6.87 (2H, d, J= 8.9 Hz, ArH), 6.27 (1 H, dd, 
J= 16.8, 2.0 Hz, =CH), 5.94 (1H, dd, J= 16.8, 10.3 Hz, =CH), 5.44 (1 H, dd, J 
10.3, 2.0 Hz, =CH), 3.94 (2H, t, J= 7.4 Hz, CH2N), 3.78 (3H, s, OCH3), 2.71 (3H, t, 
J = 7.4 Hz, CH2CH2N), 2.08 (3H, s, CH3C=O); '3C NMR (90.6 MHz, CDCI3) 6 
206.8 (C), 165.6 (C), 158.9 (C), 134.1 (C), 129.1 (2 x CH), 128.4 (CH), 127.3 (CH2), 
114.6 (2 x CH), 55.3 (CH3), 44.9 (CH2), 41.2 (CH2), 29.8 (CH3); HRMS (FAB) 
Exact mass calcd for C14H18NO3 [M+H]: 248.1281, found: 248.1288. 
° 	 N-(4-Methoxyphenyl)-N-(3-oxo-3-phenylpropyl) 
NaPMP 	 Me 
 propenamide (89e). The title compound was prepared 
according to general procedure D from the amine 122 (5.00 
g, 19.6 mmol) and acryloyl chloride (2.60 mL, 30.7 mmol) for a reaction time of 20 h 
and purified by column chromatography (30% EtOAc/petrol) to give an off-white 
solid (5.76 g, 95%). m.p. 51-53 °C; IR (CHC13) 2933, 1681 (C0), 1655 (C=O), 
1614, 1510, 1446, 1411, 1249, 1210, 1180 cm 1; 1 H. NMR (360 MHz, CDC13)6 7.96-
7.93 (2H, m, Am), 7.57 (111, in, ArH), 7.46-7.42 (2H, in, ArH), 7.11-7.06 (2H, in, 
ArH), 6.93-6.89 (2H, in, ArH), 6.36 (1 H, dd, J = 16.8, 2.0 Hz, =CH),  6.03 (1H, dd, 
J= 16.8, 10.3 Hz, =CH), 5.52 (1 H, dd, J = 10.3, 2.0 Hz, =CH), 4.14 (2H, t, J = 7.5 
Hz, CH2N), 3.81 (3H, s, OCH3), 3.34 (2H, t, J= 7.5 Hz, CH2CH2N); '3C NMR (62.9 
MHz, CDCI3) 6 198.4 (C), 165.9 (C), 159.0 (C), 136.5 (C), 134.5 (C), 133.2 (CH), 
129.1 (2 x CH), 128.5 (3 x CH), 128.0 (2 x CH), 127.4 (CH2), 114.7 (2 x CH), 55.4 
(CH3), 46.1 (CH2), 36.6 (CH2); HRMS (FAB) Exact mass calcd for C19H20NO3 
[M+H]: 310.1438, found: 310.1442. 
° 	° 	 N-(4-Methoxyphenyl)-N-[3-(furan-2-yl)-3-0xOPrOPYI] 
N  
t 	propenamide (89t. The title compoundwaprepared 
PMP 
according to general procedure D from the amine 123 (1.00 g, 4.08 mmol) and 
acryloyl chloride (509 tL, 6.02 mmol) for a reaction time of 20 h and purified by 
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column chromatography (30% EtOAc/petrol) to give a white solid. m.p. 93-94 °C; 
JR (CHC13) 2937, 1656 (C=O), 1614, 1569, 1510, 1469, 1411, 1249, 1182, 1029cm 
'H NMR (360 MHz, CDC13) 6 7.57 (1 H, dd, J= 1.7, 0.7 Hz, CH), 7.25 (1H, dd, J 
= 3.6, 0.7 Hz, CH), 7.07 (1 H, d, J= 9.0 Hz, ArH), 6.90 (1H, d, J= 9.0 Hz, ArH), 
6.52 (1H, dd, J= 3.6, 1.7 Hz, CH), 6.34 (1H, dd, J= 16.8, 2.0 Hz, =CH), 6.01 (1H, 
dd, J= 16.8, 10.3 Hz, =CH), 5.50 (1H, dd, J= 10. 3, 2.0 Hz, CH), 4.12 (2H, t, J 
7.5 Hz, CH2N), 3.82 (3H, s, OCH3), 3.18 (2H, t, J= 7.5 Hz, CH2CH2N); '3C NMR 
(62.9 MHz, CDC13) 6 187.1 (C), 165.9 (C), 159.0 (C), 152.3 (C), 146.5 (CH), 134.4 
(C), 129.2 (2 x CH), 128.5 (CH), 127.5 (CH2), 117.7 (CH), 114.7 (2 x CH), 112.2 
(CH), 55.5 (CH3), 45.9 (CH), 36.6 (CH2); HRMS (ES) Exact mass calcd for 
C17H18N04 [M+H]: 300.1230, found: 300.1229. 
N-(4-Methoxyphenyl)-N-(3-oxobutyl)-(E)-but-2-enamidc 
Me 	 Me  (89g). The title compound was prepared according to genera] 
PMP 
procedure D from the amine 118 (970 mg, 5.02 mmol) and crotonoyl chloride (718 
[LL, 7.50 mmol) for a reaction time of 2 h and purified by column chromatography 
(50% EtOAc/petrol) to give a light brown oil (1.01 g, 77%). JR (film) 2936, 1713 
(C0), 1664 (C0), 1627, 1511, 1444, 1292, 1249, 1168, 1031 cm 1 ; 'H NMR (360 
MHz, CDC13)  6 7.06 (2H, d, J= 9.0 Hz, ArH), 6.94-6.84 (1H, in, =CH), 6.92 (2H, d, 
J= 9.0 Hz, ArH), 5.66 (1H, dq, J= 15.1, 1.7 Hz, =CH), 3.98 (2H, t, J= 7.4 Hz, 
CH2N), 3.85 (3H, s, OCH3), 2.14 (3H, s, CH3C=O), 1.73 (3H, dd, J=6.9, 1.7 Hz, 
CH3CH=); '3C NMR (62.9 MHz, CDC13) 6 207.0 (C), 166.1 (C), 158.8 (C), 141.2 
(CH), 134.5 (C), 129.2 (2 x CH), 122.6 (CH), 114.6 (2 x CH), 55.4 (CH3), 44.9 
(CH2), 41.5 (CH2), 29.9 (CH3), 17.8 (CH3); HRMS (ES) Exact mass calcd for 






I 	 (89h). The title compound was prepared according to general 
PMP 
procedure D from the amine 119 (500 mg, 2.41 mmol) and crotonoyl chloride (345 
L360YrnmoJ)fora reacttowiiinief20hand purified bycoliimwchmnratography 
(EtOAc) to give an orange oil (645 mg, 97%). JR (film) 2938, 1712 (C=O), 1665 
(C=O), 1627, 1510, 1445, 1292, 1249, 1182, 1032 cm'; 'H NMR (360 MHz, CDC13) 
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6 7.05 (2H, d, J= 9.0 Hz, ArH), 6.91 (2H, d, J= 9.0 Hz, ArH), 6.91-6.83 (1H, m, 
=CH), 5.65 (1 H, dq, J= 15.1, 1.6 Hz, =CH), 3.96 (2H, t, J= 7.4 Hz, CH2N), 3.83 
(3H, s, OCH3), 2.72 (2H, t, J= 7.5 Hz, CH2CH2N), 2.41 (2H, q, J = 7.3 Hz, 
CH2CH3), 1.71 (3H, dd, J = 6.9, 1.6 Hz, CH3CH=), 1.01 (3H, t, J = 7.3 Hz, 
CH2CH3); '3C NMR (62.9 MHz, CDC13) 6 209.8 (C), 166.2 (C), 158.8 (C), 141.3 
(CH), 134.7 (C), 129.3 (2 x CH), 122.7 (CH), 114.6 (2 x CH), 55.5 (CH3), 45.1 
(CH2), 40.2 (CH2), 36.0 (CH2), 17.9 (CH3), 7.6 (CH3); HRMS (ES) Exact mass calcd 
for C15H22NO3 [M+H]: 276.1594, found: 276.1594. 
N-(2-Methoxyphenyl)-N-(3-oxobutyl)propenamide (89i). The 
N 	 Me 
OMP 	 title compound was prepared according to general procedure D 
from the amine 125 (483 mg, 2.50 mmol) and acryloyl chloride (317[LL, 3.75 mmol) 
for a reaction time of 20 h and purified by column chromatography (50% 
EtOAc/petrol-+EtOAc) to give a light orange oil (610 mg, 99%). JR (film) 2944, 
1713 (C=O), 1657 (C=O), 1618, 1595, 1500, 1415, 1267, 1024, 756 cm'; 1 H NMR 
(3 60 MHz, CDC13) 6 7.29-7.24 (1H, m, ArH), 7.02 (1H, dd, J= 8.0, 1.8 Hz, ArH), 
6.92-6.88 (2H, m, ArH), 6.24 (1 H, dd, J= 16.8, 2.1 Hz, =CH), 5.85 (1 H, dd, J= 
16.8, 10.3 Hz, =CH), 5.38 (1H, dd, J= 10.3, 2.1 Hz, =CH), 3.99-3.91 (lH, m, 
CH2N), 3.82-3.74 (1H, m, CH2N), 3.72 (3H, s, OCH3), 2.71 (2H, t, J = 7.4 Hz, 
CH2CH2N), 2.04 (3H, s, CH3C=O); '3C NMR (62.9 MHz, CDC13) 6207.1(C), 166.0 
(C), 155.1 (C), 130.0 (C), 129.8 (CH), 129.5 (CH), 128.2 (CH), 127.0 (CH2), 120.8 
(CH), 111.7 (CH), 55.3 (CH3), 43.9 (CH2), 41.3 (CH2), 29.8 (CH3); HRMS (ES) 
Exact mass calcd for C 4H18NO3 [M+H]: 248.1281, found: 248.1281. 
o 	o 	N-(2-Methoxyphenyl)-N-(3-oxobutyl)-(E)-but-2-enamide 
Me )(1Me (89j). The title compound was prepared according to general 
OMP 
procedure D from the amine 125 (483 mg, 2.50 mmol) and 
crotonoyl chloride (360 jtL, 3.76 mmol) for a reaction time of 20 h and purified by 
column chromatography (50% EtOAc/petrol—EtOAc) to give a yellow oil (653 mg, 
>99%). JR (film) 2942, 1713 (C=O), 1666 (C=O), 1629 1500, [443—,1398—,1369, 
1291, 1244 cni'; 'H NMR (360 MHz, CDC13) 6 7.36-7.31 (1H, m, ArH), 7.08-7.05 
(1H, m, ArH), 6.98-6.94 (2H, m, ArH), 6.90-6.82 (lH, m, =CH), 5.61-5.56 (lH, m, 
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=CH), 4.07-3.99 (1H, m, CH2N), 3.79 (3H, s, OCH3), 2.84-2.69 (2H, m, CH2CH2N), 
2.10 (3H, s, CH3C=O), 1.68 (3H, app ddd, J= 6.9, 1.7, 0.9 Hz, CH3CH=); '3C NMR 
(62.9 MHz, CDC13) 6 207.3 (C), 166.3 (C), 155.2 (C), 140.8 (CH), 130.3 (C), 130.0 
(CH), 129.3 (CH), 122.3 (CH), 120.7 (CH), 111.8 (CH), 55.3 (CH3), 43.8 (CH2), 
41.5 (CH2), 29.9 (CH3), 17.7 (CH3); HRMS (ES) Exact mass calcd for C,51120NO3 
[M+H]: 262.1438, found: 262.1437. 
N(2MethoxyphenyI)-N-(3-oxo-3-pheny1prOPYI)-(E)-bUt- 
Me N Ph 
I 	 2-enamide (89k). The title compound was prepared 
OMP 
according to general procedure D from the amine 124 (1.03 g, 4.03 mmol) and 
crotonoyl chloride (575 iL, 6.00 mmol) for a reaction time of 20 h and purified by 
column chromatography (50% EtOAc/petrol) to give an off-white solid (830 mg, 
64%). m.p. 118-119 °C; JR (CHC13) 2940, 1682 (C=O), 1666 (C=O), 1627, 1596, 
1499, 1447, 1397, 1243, 1024 cnf'; 'H NMR (360 MHz, CDC13) 6 7.98-7.96 (2H, in, 
ArH), 7.56-7.52 (111, m, ArH), 7.47-7.42 (2H, m, ArH), 7.36-7.31 (111, in, ArH), 
7.13-7.10 (1H, in, ArH), 7.00-6.88 (311, in, ArH and =CH), 5.67-5.62 (1H, in, =CH), 
4.18-4.10 (lH, m, CH2N), 4.05-3.97 (lH, in, CH2N), 3.75 (311, s, OCH3), 3.47-3.39 
(lH, in, CH2CH2N), 3.36-3.27 (1H, in, CH2CH2N), 1.72 (3H, dd, J= 6.9, 1.7 Hz, 
CH3CH=); '3C NMR (62.9 MHz, CDC13) 6 198.8 (C), 166.6 (C), 155.3 (C), 141.0 
(CH), 136.7 (C), 133.0 (CH), 130.8 (C), 130.0 (CH), 129.4 (CH), 128.5 (2 x CH), 
128.1 (2 x CH), 122.5 (CH), 120.8 (CH), 111.8 (CH), 55.4 (CH3), 45.1 (CH2), 37.0 
(CH2), 17.9 (CH3); HRMS (ES) Exact mass calcd for C20H22NO3 [M+H: 324.1594, 
found: 324.1594. 
N(4-Methoxypheny1)-N-(3-oxobuty1)-(E)-3- 
Ph-'( Me phenylpropenoate (891). The title compound was prepared 
PMP 	 according to General Procedure D from the amine 118 (2.00 g, 
10.3 mmol) and cinnamoyl chloride (2.10 g, 12.4 mmol) for a reaction time of 24 h 
and purified by column chromatography (30% EtOAc/petrol-40% EtOAc/petrol) 
- - 
	f5iI 	 to give a colorless crystaHine solid- 
(1.84 g, 55%). m.p. 85-86 °C; JR (CHCI3) 2955, 1713 (C=O), 1654 (C=O), 1615, 
1510, 1394, 1249, 1183, 1030, 765 cm'; 'H NMR (360 MHz, CDC13) 67.63 (1H, d, 
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J= 15.6 Hz, PhCH=), 7.29-7.26 (5H, in, ArH), 7.11 (2H, dm, J= 8.9 Hz, ArH), 6.93 
(2H, dm, J= 8.9 Hz, Aril), 6.26 (111, d, J= 15.6 Hz, PhCHCH), 4.03 (2H, t, J 
7.4 Hz, CH2N), 3.84 (3H, s, OCH3), 2.78 (2H, t, J= 7.4 Hz, CH2CH2N), 2.14 (3H, s, 
CH3C=O); '3C NMR (69.2 MHz, CDCI3) 6 207.0 (C), 166.2 (C), 158.9 (C), 141.8 
(CH), 135.1 (C), 134.5 (C), 129.5 (CH), 129.3 (2 x CH), 128.6 (2 x CH), 127.8 (2 x 
CH), 118.7 (CH), 114.8(2 xCH), 55.5 (CH), 45.2 (CH2), 41.5 (CH2), 30.0 (CH3); 
HRMS (FAB) Exact mass calcd for C20H22NO3 [M+H]: 324.1595, found: 324.1599. 
N-(4-MethoxypheflYl)-N- [2-methyl-3-oxo-3-phenyIPrOPYI] propenamide (97a) 
	
0 	
0 0 	0 
Ph NHPMP 	 Ph 
Me 	
NazCO,q> 	 Me PMP 
127 
CH,CL2, rt 97a 
The title compound was prepared according to general procedure D from the amine 
12783 (808 mg, 3.00 mmol) for a reaction time of 16 h and purified by column 
chromatography (20 % EtOAc/petrol) to give a colorless oil (807 mg, 83 %). JR 
(film) 2934, 1681 (C=O), 1658 (C=O), 1617, 1510, 1446, 1409, 1248, 1031, 973 crn 
'; 'H NMR (360 MHz, CDC13) 6 7.92-7.90 (211, in, ArH), 7.56-7.52 (1H, m, ArH), 
7.46-7.41 (2H, in, ArH), 6.93 (2H, d, .J = 8.7 Hz, ArH), 6.82 (2H, d, J = 8.7 Hz, 
ArH), 6.34 (1H, dd, J = 16.8, 2.0 Hz, =CH), 5.98 (1H, dd, J= 16.8, 10.3 Hz, =CH), 
5.48 (1H, dd, .J = 10.3, 2.0 Hz, =CH), 4.17-3.95 (3H, in, CHCH2N), 3.79 (3H, s, 
OCH3), 1.22 (3H, d, J = 6.9 Hz, CH3CH); '3C NMR (62.9 MHz, CDCI3) 6 202.6 (C), 
166.4 (C), 158.7 (C), 136.3 (C), 135.1 (C), 133.1 (CH), 129.0 (2 x CH), 128.7 (CH), 
128.6 (2 x CH), 128.3 (2 x CH), 127.4 (CH2), 114.5 (2 x CH), 55.4 (Cl3), 53.4 
(CH2), 39.6 (CH), 16.0 (Cl3); HRMS (ES) Exact mass calcd for CHNO [M+H]: 
found. 
N-(4-Methoxyphenyl)-N- [S)3-oxo1-phenyLbutY11 propenamide (97b) 
0 	
0 Pb 0 
0 NHPMPCII 	
Me N 
Me 	Ph Na2C0)(q 	
97b PMP 128 	CI1,C12, rt 
85% ee 
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The title compound was prepared according to general procedure D from the amine 
128 (350 mg, 1.30 mmol, prepared in 85% ee according to a literature procedure)84 
and acryloyl chloride (165 iL, 1.95 mmol) for a reaction time of 5 h and purified by 
column chromatography (30% EtOAc/petrol) to give a colourless viscous oil (390 
mg, 93%). [a] 22 +20.9 (c 1.05, CHC13); JR (film) 2959, 1715 (C0), 1653 (C=O), 
1614, 1510, 1406, 1252, 1171, 1031, 834 cm-1; 'H NMR (360 MHz, CDC13) 67.26-
7.24 (3H, in, ArH), 7.20-7.17 (2H, in, ArH), 6.77 (4H, br s, ArH), 6.50 (1 H, dd, J= 
9.1, 6.4 Hz, CHN), 6.35 (1 H, dd, J= 16.8, 2.0 Hz, =CH), 5.81 (1H, dd, J= 16.8, 
10.3 Hz, =CH), 5.46 (1 H, dd, J= 10.3, 2.0 Hz, =CH), 3.79 (3H, s, 0CH3), 3.16 (1 H, 
dd, J = 15.7, 9.1 Hz, CH2CI-IN), 2.96 (1H, dd, J= 15.7, 6.4 Hz, CH2CHN), 2.24 (3H, 
s, CH3C=O); '3C NMR (62.9 MHz, CDC13) 6 205.8 (C), 165.6 (C), 159.0 (C), 138.8 
(C), 131.1 (2 x CH), 130.5 (C), 128.8 (CH), 128.1 (2 x CH), 128.0 (2 x CH), 127.6 
(CH), 127.4 (CH2), 113.9(2 x CH), 55.1 (CH), 54.5 (CH3), 45.3 (Cl-I2), 29.7 (CH3); 
HRMS (ES) Exact mass calcd for C20H22NO3  [M+H]: 324.1594, found: 324.1590. 





Me 1 	CO2Et Na2CO31q> 	
97c PMP 129 	 CH2Ct2, rt 
96% ee 
The title compound was prepared according to general procedure D from the amine 
129 (950 mg, 3.58 mmol, prepared in 96% ee according to a literature procedure)84 
and acryloyl chloride (457 LL, 5.40 mmol) for a reaction time of 1 h and purified by 
column chromatography (30% EtOAc/petrol-50% EtOAc/petrol) to give a yellow 
solid (762 mg, 66%). m.p. 74-76 °C; [a]
12 -41.9 (c 1.05, CHC13); JR (CHC13) 2981, 
1739 (C0), 1721 (C0), 1659 (C0), 1619, 1511, 1411, 1249, 1030, 841 cm 1 ; 1 H 
NMR (360 MHz, CDC13) 6 7.19 (2H, d, J = 9.0 Hz, Aril), 6.90 (2H, d, J=  9.0 Hz, 
ArH), 6.33 (1H, dd, J= 16.8, 2.0 Hz, =CH), 5.96 (1H, dd, 1= 16.8, 10.3 Hz, =CH), 
5.5 F 	 496 (1 H, app t, J =6.5 Hz, CHCO2E),A26 
4.16 (2H, In, CO2CH2CH3), 3.83 (3H, s, OCH3), 3.51 (1H, dd, J= 17.7, 6.9 Hz, 
CH2CHCO2Et), 2.87 (1H, dd, J = 17.7, 6.1 Hz, CH2CHCO2Et), 2.16 (3H, s, 
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CH3C=O), 1.27 (3H, t, J = 7.1 Hz, CO2CH2CH3); 13C NMR (62.9 MHz, CDC13) 
205.3 (C), 170.1 (C), 165.9 (C), 159.2 (C), 134.0 (C), 129.6 (2 x CH), 128.1 (CH), 
128.0 (CH2), 114.5 (2 xCII), 61.5 (CH2), 58.8 (CH), 55.4 (CH3), 43.2 (CH2), 30.1 




0 NHPMP 0 	 0 C0Et0 
CO Ft 	 N 
N a2 CO3  q) P M P 
130 	 CH2Cl2, RT 7d 
'99% ee 
The title compound was prepared according to general procedure D from the amine 
130 (1.07 g, 3.50 mmol, prepared in >99% ee according to a literature procedure)84 
and acryloyl chloride (444 iL, 5.25 mmol) for a reaction time of 2 h and purified by 
column chromatography (30% EtOAc/petrol) to give an off-white solid (1.21 g, 
96%). m.p. 132-134 °C; [a] 21  —187 (c 1.00, CHCI3); IR (CHCI3) 2939, 1741 (C=O), 
1712 (C=O), 1659 (C=O), 1619, 1510, 1411, 1250, 1182, 1030 cm'; 'H NMR (360 
MHz, CDC13) ö 7.19 (2H, br s, ArH), 6.90 (2II, d, J= 9.1 Hz, ArH), 6.34 (1 H, dd, J 
= 16.8, 2.0 Hz, =CH), 6.01 (1 H, dd, J= 16,8, 10.3 Hz, =CH), 5.53 (1H, dd, J= 10.3, 
2.0 Hz, =CH), 4.84 (1H, d, J = 6.9 Hz, CHCO2Et), 4.18 (2H, q, J = 7.1 Hz, 
CO2CH2CH3), 3.83 (3H, s, OCH3), 3.60 (1H, ddd, J = 14.0, 9.6, 5.4 Hz, 
CIICHCO2Et), 2.57-2.37 (2H, m, (CH2)4),2.24-2.11 (2H, m, (CH2)4),1.95-1.92 (lH, 
in, (CH2)4), 1.84-1.57 (2H, m, (CH2)4), 1.49-1.39 (lH, m, (CH2)4), 1.25 (3H, t, J= 
7.1 Hz, CO2CH2CH3); '3C NMR (62.9 MHz, CDC13) 8 211.2 (C), 169.7 (C), 166.2 
(C), 159.0 (C), 135.1 (C), 129.2(2 xCH), 128.2 (CH2), 127.9 (CH), 114.6(2 xCH), 
62.3 (CH), 61.2 (CH2), 55.4 (CH3), 49.9 (CH), 42.3 (CH2), 31.7 (CH2), 28.7 (CII2), 
25.3 (CH2), 14.0 (CH3); HRMS (ES) Exact mass calcd for C20H26N05 [M+II]: 
360.1805, found: 360.1805. 
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0 	 N-(4-Methoxyphenyl)-N-(2-oxopropyl)propeflamide (113a). The 
N 	
Me 
title compound was prepared according to general procedure D 
IMP 0 
from the amine 126 (1.07 g, 6.00 mmol) and acryloyl chloride (762 
.iL, 9.00 mmol) for a reaction time of 2.5 h and purified by column chromatography 
(30% EtOAc/petrol—+60% EtOAc/petrol) to give a beige solid (1.21 g, 87%). m.p. 
48-51 °C; IR (CHC13) 2960, 1732 (C=O), 1652 (C0), 1618, 1512, 1427, 1250, 
1172, 1030, 843 cm'; 'H NMR (360 MHz, CDC13) 6 7.21 (2H, dm, J = 8.9 Hz, 
ArH), 6.88 (2H, dm, J = 8.9 Hz, ArH), 6.35 (111, dd, J = 16.8, 2.0 Hz, CH2 ), 6.10 
(1H, dd, J= 16.8, 10.3 Hz, CH2=CH), 5.54 (1 H, dd, J = 10.3, 2.0 Hz, CH2=), 4.47 
(2H, s, CH2N), 3.81 (311, s, OCH3), 2.18 (3H, s, CH3C=O); '3C NMR (62.9 MHz, 
CDC13) 6 202.3 (C), 165.9 (C), 159.1 (C), 135.0 (C), 129.2 (2 x CH), 128.1 (CH2), 
127.7 (CH), 114.6 (2 x CH), 59.7 (CH2), 55.4 (CH3), 27.2 (CH3); HRMS (ES) Exact 
mass calcd for C13H16NO3 [M+H]: 234.1125, found: 234.1125. 
° 	 N(4Methoxypheny1)-N-(2-oxopropy1)-(E)-but-2-eflamide 
M 	 N 
PMP 	
(113b). The title compound was prepared according to General 
Procedure D from the amine 126 (1.05 g, 5.80 mrnol) and crotonoyl chloride (834 
1.iL, 8.70 mmol) for a reaction time of 18 h and purified by column chromatography 
(30% EtOAc/petrol) to give a yellow oil (921 mg, 64%). IR (film) 2915, 1731 
(C=O), 1665 (C=O), 1628, 1513, 1250, 1030, 967, 842, 686 cm'; 'H NMR (360 
MHz, CDC13) 6 7.18 (211, d, J = 9.0 Hz, ArH), 6.92 (111, app q, J = 6.9 Hz, 
CH3CH=), 6.87 (2H, d, J= 9.0 Hz, ArlI), 5.77 (1 H, dq, J= 15.1, 1.7 Hz, CHCO), 
4.43 (211, s, CH2N), 3.80 (3H, s, OCH3), 2.15 (311, s, CH3C=O), 1.72 (3H, dd, J= 
6.9, 1.7 Hz, CH3CH=); '3C NMR (69.2 MHz, CDC13) 6 202.6 (C), 166.2 (C), 158.9 
(C), 142.0 (CH), 135.3 (C), 129.2 (2 xCII), 121.8 (CH), 114.5 (2 x CH), 59.6 (CH2), 
55.4 (CH3), 27.1 (CH3), 17.9 (CH3); HRMS (ES) Exact mass calcd for C14H18NO3 
[M+H]: 248.1281, found: 248.1279. 
0 	 N-(4-Methoxyphenyl)-N-(2-oxoprOpyl)-(E)-3- 
Pt The titlecOmpouiidwas prered 
according to General Procedure D from the amine 126 (1.07 g, 6.00 mmol) and 
cinnamoyl chloride (1.50 g, 9.00 mmol) for a reaction time of 2.5 h and purified by 
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column chromatography (30% EtOAc/petrol—+60% EtOAc/petrol) followed by 
recrystallization (EtOAc/petrol) to give a beige solid (590 mg, 32%). m.p. 115-117 
°C; IR (dC13) 2918, 1731 (C0), 1654 (C0), 1616, 1511, 1378, 1250, 1214, 
1171, 1030 cm4 ; 'H NMR (360 MHz, CDC13) ö 7.67 (1H, d, J = 15.6 Hz, PhCH=), 
7.67-7.29 (7H, m, ArH), 6.92 (2H, dm, J = 8.8 Hz, ArH), 6.39 (1H, d, J= 15.6 Hz, 
PhCHCH), 4.52 (2H, s, CH2N), 3.34 (3H, s, OCH3), 2.20 (3H, s, CH3C=O); 13C 
NMR (62.9 MHz, CDCI3) 6 202.5 (C), 159.0 (C), 142.4 (CH), 135.1 (C), 135.0 (C), 
129.5 (CH), 129.2 (2 x CH), 128.6 (2 x CH), 127.8 (2 x CH), 117.8 (CH), 114.6 (2 x 
CH), 59.8 (CH2), 55.4 (CH3), 27.2 (CH3); HRMS (FAB) Exact mass calcd for 
C,9H20NO3 [M+H]: 310.1438, found: 310.1437. 
Copper-Catalysed Reductive Aldol Cyclisations 
General Procedure E: (1 mmol Scale) 
A solution of Cu(OAc)2 H20 (10.0 mg, 0.05 mmol) and DPPF (25) (28.6 mg, 0.05 
mmol) in THF (2 mL) was stirred for 15 min before TMDS (182 1iL, 1.00 mmol) 
was added. The initially green solution was stirred until it became yellow (Ca. 5 mm), 
after which a solution of the substrate (1.00 mmol) in THF (2 mL + 1 mL rinse) was 
then added rapidly via cannula. The reaction was stirred at room temperature until 
complete consumption of the starting material as observed by TLC analysis. The 
reaction was quenched by the addition of 1 M HC1 (1 mL), and the mixture was 
stirred for 1 h before being diluted with saturated aqueous NH4C1 solution (20 mL). 
The mixture was extracted with CH202  (3 x 15 mL) and the combined organic layers 
were dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (EtOAc/petrol) afforded the cyclised product. 
General Procedure F: (0.2 mmol Scale) 
so1utin_af_Cu(OAc)2 Hzft(2.Omg, 0.01 mmol) and DPPF (25) (5.7 mg, 0.01 
mmol) in THF (1 mL) was stirred for 15 min before TMDS (36 iL, 0.20 mmol) was 
added. The initially green solution was stirred until it became yellow (ca. 5 mm), 
after which a solution of the substrate (0.20 mmol) in THF (0.5 mL + 0.5 mL rinse) 
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was then added rapidly via cannula. The reaction was stirred at room temperature 
until complete consumption of the starting material as observed by TLC analysis. 
The reaction was quenched by the addition of 1 M HC1 (0.5 mL), and the mixture 
was stirred for 1 h before being diluted with saturated aqueous NH4CI solution (10 
mL). The mixture was extracted with CH202 (3 x 10 mL) and the combined organic 
layers were dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (EtOAc/petrol) afforded the cyclised product. 
Me 
Ph 	
phenylpiperidifl-2-one (90a). The title compound was prepared 
HO 	 according to general procedure F from 89a (62 mg, 0.20 mmol) for a 
reaction time of 21 h and purified by column chromatography (80% EtOAc/petrol) to 
give a white solid (43 mg, 69%). Slow evaporation of a CDCI3 solution of 90a was 
found to give colourless crystals suitable for X-ray diffraction. m.p. 159-161 °C; JR 
(CHC13) 3389 (OH), 2940, 1629 (C=O), 1605, 1511, 1444, 1335, 1299, 1245,1034 
cm'; 'H NMR (360 MHz, CDCI3) ö 7.49-7.46 (211, in, ArH), 7.43-7.39 (2H, in, 
ArH), 7.33-7.29 (1 H, in, ArH), 7.19 (2H, d, 1=8.5 Hz, ArH), 6.91 (2H, d, J= 8.5 
Hz, ArH), 4.06-3.98 (1 H, in, CH2N), 3.80 (3H, s, OCH3), 3.48-3.44 (1H, In, CH2N), 
3.02 (1H, q, J = 7.1 Hz, CH3CH), 2.48-2.39 (111, in, CH2CH2N), 2.30 (lH, br s, 
OH), 2.12-2.08 (1H, in, CH2CH2N), 1.12 (3H, d, J= 7.1 Hz, CH3CH); '3C NMR 
(62.9 MHz, CDC13) 8 172.0 (C), 158.0 (C), 145.8 (C), 136,2 (C), 128.5 (2 x CH), 
127.4(2 x CH), 127.2 (CH), 124.5 (2 x CH), 114.3 (2 x CH), 74.6 (C), 55.4 (CH3), 
47.6 (CH2), 46.5 (CH), 36.7 (CH2), 10.0 (CH3); HRMS (FAB) Exact mass calcd for 







-. methylpiperidin-2-one (90b). The title compound was prepared 
HO 
according to general procedure E from 89b (261 mg, 1.00 mmol) for 
a reaction time of 5.5 h and purified by column chromatography (80% 
a white solid (161 mg, 61%)p-.---1-32-134-C_TR 
(CHC13) 3410 (OH), 2962, 1631 (C=O), 1604, 1511, 1331, 1297, 1244, 1034, 830 
cm'; 'H NMR (360 MHz, CDCI3) 6 7.15 (2H, d, J= 9.0 Hz, ArH), 6.90 (211, d, J= 
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9.0 Hz, ArH), 3.86 (1H, ddd, J= 12.0, 8.3, 6.7 Hz, CH2N), 3.80 (3H, s, OCH3), 3.46 
(1H, ddd, J= 12.0, 10.2, 5.2 Hz, CH2N), 2.54 (1H, q, J= 7.2 Hz, CH3CH), 2.00-1.96 
(2H, in, CH2CH2N), 1.70-1.61 (3H, in, CH3CH2 and OH), 1.29 (3H, d, J= 7.2 Hz, 
CH3CH), 0.97 (3H, t, J= 7.5 Hz, CH3CH2); '3C NMR (62.9 MHz, CDC13) 6 172.3 
(C), 157.9 (C), 136.3 (C), 127.3 (2 x CH), 114.3 (2 x CH), 72.3 (C), 55.4 (CH3), 
47.1 (CH2), 44.9 (CH), 33.1 (CH2), 31.7 (CH2), 9.8 (CH3), 8.0 (CH3); HRMS (ES) 
Exact mass calcd for C15H22NO3 [M+H]: 264.1594, found: 264.1591. 
0 
Me 	PMP 	(±)-(3R,4R)-4-Hyd roxy-4-zso-butyl-1-(4-methoxyphenyl)-3- 
N 
i-Bu . methylpiperidin-2-one (90c). The title compound was prepared 
HO 
according to general procedure E from 89c (289 mg, 1.00 rnmol) for 
a reaction time of 24 h and purified by column chromatography (30% 
EtOAc/petrol—>50% EtOAc/petrol) to give a white solid (186 mg, 64%). m.p. 120-
121 °C; JR (CHC13) 3417 (OH), 2952, 1632 (C0), 1606, 1511, 1334, 1298, 1245, 
1034, 829 cm-1 ; 1 H NMR (360 MHz, CDC13) 6 7.15 (2H, d, J= 8.6 Hz, ArH), 6.90 
(2H, d, J= 8.6 Hz, ArH), 3.87 (IH, ddd, J= 12.0, 9.9, 5,1 Hz, CH2N), 3.80 (3H, s, 
OCH3), 3.46 (1H, ddd, J = 12.0, 5.7, 4.4 Hz, CH2N), 2.52 (1H, q, J= 7.2 Hz, 
CHCO), 2.13-2.07 (1H, in, CH2CH2N), 2.04-1.96 (IH, m, CH2CH2N), 1.89-1.79 
(111, in, (CH3)2CH), 1.60-1.49 (2H, in, (CH3)2CHCH2), 1.31 (3H, d, J = 7.2 Hz, 
CH3CHC=O), 1.04 (3H, d, J = 6.6 Hz, (CH3)2CH), 1.00 (3H, d, ,J = 6.6 Hz, 
(CH3)2CH); '3C NMR (62.9 MHz, CDC13) 6 172.2 (C), 158.0 (C), 136.3 (C), 127.3 
(2 x CH), 114.3 (2 x CH), 72.6 (C), 55,4 (CH3), 49.3 (CH2), 47.1 (CH2), 46.5 (CH), 
32.4 (CH2), 25.0 (CH3), 24.4 (CH3), 24.0 (CH), 10.2 (CH3); HRMS (ES) Exact mass 
calcd for C17H26NO3 [M+H]: 292.1907, found: 292.1910. 
Me, 	N 
 PMP 	 (±)-(3R,4R)-4-Hydroxy-1-(4-mcthoxyphenyl)-3,4- 
MeLJ 	dimethylpiperidin-2-one (90d). The title compound was prepared 
HO 
according to general procedure E from 89d (247 mg, 1.00 mmol) for 
a reaction time of 2.5 h and purified by column chromatography (80% EtOAc/petrol) 
to vwwhiteso1id(i6mg,66%) Slow evaporation of a CDC13-solution of-90d- -- f-90d-- --_______-- 
was  found to give colourless crystals suitable for X-ray diffraction. m.p. 121-123 °C; 
JR (CHC13) 3410 (OH), 2942, 1631 (C=O), 1605, 1512, 1335, 1245, 1035, 830 cm; 
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'H NMR (250 MHz, CDC13) 6 7.15 (2H, d, J= 8.9 Hz, ArH), 6.90 (2H, d, J= 8.9 
Hz, ArH), 3.90 (1H, ddd, J= 12.1, 8.8, 6.7 Hz, CH2N), 3.81 (3H, s, OCH3), 3.50-
3.41 (1H, in, CH2N), 2.49 (IH, q, J = 7.2 Hz, CH3CH), 2.06-2.01 (2H, in, 
CH2CH2N), 1.77 (1H, br s, OH), 1.40 (3H, s, CH3COH), 1.34 (3H, d, J= 7.2 Hz, 
CH3CH); '3C NMR (62.9 MHz, CDC13) 6 171.9 (C), 158.0 (C), 136.3 (C), 127.4 (2 x 
CH), 114.3 (2 x CH), 70.2 (C), 55.4 (CH3), 47.2 (CH2), 47.0 (CH), 35.6 (CH2), 28.4 
(CH3), 10.1 (CH3); HRMS (FAB) Exact mass calcd for C14H20NO3 [M+H]: 
250.1438, found: 250.1447. 
Me ° PMP 
(±)-(3R,4R)-4-Hydroxy-1-(4-methoyptiy1)-3-methiy1-4- 
N 	
(4-methylphenyl)piperidin-2-one (90e). The title compound 
was prepared according to general procedure E from 89e (323 
mg, 1.00 mmol) for a reaction time of 24 h and purified by column chromatography 
(30% EtOAc/CHC13) to give a white solid (207 mg, 64%). m.p. 173-174 °C; lR 
(CHC13) 3395 (OH), 2941, 1629 (C=O), 1605, 1510, 1335, 1299, 1244, 1034, 817 
cm'; 'H NMR (360 MHz, CDC13) 6 7.36 (2H, d, J= 8.1 Hz, ArH), 7.22 (2H, d, J= 
8.1 Hz, ArH), 7.19 (2H, d, J = 8.9 Hz, ArH), 6.92 (2H, d, J= 8.9 Hz, ArH), 4.02 
(I H, ddd, J= 11. 7, 11.7, 4.6 Hz, CH2N), 3.81 (3H, s, OCH3), 3.47 (1 H, ddd, J= 
11.7, 5.7, 2.8 Hz, CH2N), 3.02 (1H, q, J= 7.2 Hz, CH3CH), 2.46-2.38 (IH, in, 
CH2CH2N), 2.38 (3H, s, CH3C6H4), 2.26 (IH, s, OH), 2.10 (1H, ddd, J= 13.9, 4.6, 
2.8 Hz, CH2CH2N), 1.14 (3H, d, J= 7.2 Hz, CH3CH);' 3  C NMR (62.9 MHz, CDC13) 
6 172.0 (C), 158.0 (C), 142.8 (C), 136.9 (C), 136.2 (C), 129.3 (2 x CH), 127.4 (2 x 
CH), 124.4 (2 x CH), 114.3 (2 x CH), 74.6 (C), 55.4 (CH3), 47.6 (CH2), 46.4 (CH), 
36.8 (CH2), 20.9 (CH3), 10.1 (CH3); HRMS (ES) Exact mass calcd for C20H24NO3 
[M+H]: 326.1751, found: 326.1749. 
° 	(±)-(3R,4R)-4-Furan-2-yl-4-hydroxy- 1-(4-methoxyphenyl)-3- 
Me 	..PMP 
N 	methylpiperidin-2-one (90fl. The title compound was prepared 
HO 	according to general procedure E from 89f (299 mg, 1.00 mmol) 
fctrwreaeticn timeof24hand purified - by —column chromatography—(30°Ai-
EtOAc/petrol) to give an off-white solid (160 mg, 53%). m.p. 178-180 °C; JR 
(CHC13) 3375 (OH), 2938, 1631 (C=O), 1605, 1510, 1335, 1299, 1245, 1153, 1034 
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cm'; 'H NMR (3 60 MHz, CDC13) 6 7.42-7.41 (1H, m, CH), 7.15 (2H, d, J= 8.5 Hz, 
ArH), 6.91 (2H, d, J= 8.5 Hz, ArH), 6.39-6.38 (1H, m, CH), 6.34-6.33 (IH, in, CH), 
3.93 (1H, ddd, J= 12.0, 9.8, 4.9 Hz, CH2N), 3.81 (3H, s, OCH3), 3.43 (1 H, app dt, .1 
= 12.0, 5.5 Hz, CH2N), 3.06 (1 H, q, J= 7.2 Hz, CH3CH), 2.47 (1H, ddd, J = 13.8, 
9.8, 5.5 Hz, CH2CH2N), 2.36 (1H, hr s, OH), 2.25 (1H, app dt, J = 13.8, 4.9 Hz, 
CH2CH2N), 1.28 (3H, d, J= 7.2 Hz, CH3CH); '3C NMR (62.9 MHz, CDC13) 6 171.5 
(C), 158.0 (C), 157.5 (C), 142.0 (CH), 136.0 (C), 127.3 (2 x CH), 114.3 (2 x CH), 
110.3 (CH), 105.4 (CH), 71.9 (C), 55.4 (CH3), 47.0 (CH2), 45.1 (CH), 33.8 (CH2), 




PMP 	 (±)-(3R,4R)-4-Ethyl-4-hydroxy-1-(4-meth6xyphenyl)-3- 
Me.....methylpiperidin-2-one (90g). The title compound was prepared 
HO 	
according to general procedure F from 89g (52 mg, 0.20 mrnol) for a 
reaction time of 22 h and purified by column chromatography (80% EtOAc/petrol) to 
give a white solid (29 mg, 55%). Slow diffusion of petrol into a dichioromethane 
solution of 90g was found to give colourless crystals suitable for X-ray diffraction. 
m.p. 109-111 °C; JR (CHC13) 3412 (OH), 2963, 1633 (C=O), 1605, 1512, 1296, 
1246, 1155, 1033, 832 cm'; 'H NMR (360 MHz, CDC13) 6 7.14 (2H, d, J= 8.9 Hz, 
ArH), 6.90 (2H, d, J= 8.9 Hz, ArH), 3.82-3.75 (1H, in, CH2N), 3.80 (3H, s, OCH3), 
3.47 (1H, ddd, 1= 12.2, 6.1, 6.1 Hz, CH2N), 2.25 (1H, dd, J= 7.2, 4.1 Hz, CH2CH), 
2.10-2.02 (1H, m, CH2CH2N), 1.97-1.76 (4H, m, CH3CH2, CH2CH2N and OH), 1.41 
(311, s, CH3COH), 1.17 (3H, t, J= 7.4 Hz, CH3CH2); '3C NMR (62.9 MHz, CDC13) 
6 172.1 (C), 158.0 (C), 136.1 (C), 127.4 (2 x CH), 114.4 (2 x CH), 70.9 (C), 55.4 
(CH3) 54.4 (CH), 47.4 (CH2), 35.1 (CH2), 28.5 (CH3), 20.2 (CH2), 14.6 (CH3); 
HRMS (FAB) Exact mass calcd for C15H22NO3 [M+H]: 264.1594, found: 264.1597. 
Et 	
N 
PMP 	 (±)-(3R,4R)-3,4-Diethyl-4-hydroxy-1-(4-methoxyphenyl) 
piperidin-2-one (90h). The title compound was prepared according 
--- --------to-general-procedure E from 89h (275 mg; LOO mmo1)-for-areactirnt---
time of 24 h and purified by column chromatography (80% EtOAc/petrol—EtOAc) 
to give a fluffy white solid (144 mg, 52%). m.p. 110-112 °C; JR (CHC13) 3419 (OH), 
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2963, 1634 (C=O), 1606, 1511, 1442, 1296, 1246, 1032, 832 cm 1 ; 'H NMR (360 
MHz, CDC13) 6 7.14 (2H, d, J= 9.0 Hz, ArH), 6.90 (2H, d, J= 9.0 Hz, ArH), 3.80 
(3H, s, OCH3), 3.78-3.71 (1H, in, CH2N), 3.50-3.44 (1H, in, CH2N), 2.32 (1H, dd, J 
= 7.7, 3.5 Hz, CH2CH), 2,05-1.64 (7H, CH2CH2N, 2 x CH3CH2 and OH), 1.17 (3H, 
t, J = 7.4 Hz, CH3CH2), 0.99 (3H, t, J = 7.5 Hz, CH3CH2); '3C NMR (62.9 MHz, 
CDC13) 6 172.4 (C), 157.9 (C), 136.0 (C), 127.3 (2 x CH), 114.3 (2 x CH), 73.0 (C), 
55.4 (CH3), 52.7 (CH), 47.3 (CH2), 32.9 (CH2), 31.4 (CH2), 20.1 (CH2), 14.4 (CH3), 
7.8 (CH3); HRMS (ES) Exact mass calcd for C,6H24NO3 [M+H]: 278.175 1, found: 
278.1748. 
Me 	NOMP 	
(±)-(3R,4R)-4-Hyd roxy- 1-(2-methoxyphenyl)-3,4-dimethyl 
Me, •• 	 piperidin-2-one (90i). The title compound was prepared according 
HO 
to general procedure E from 89i (247 mg, 1.00 mmol) for a reaction 
time of 4 h and purified by column chromatography (80% EtOAc/petrol—.EtOAc) to 
give an off-white solid (175 mg, 70%). m.p. 139-140 °C; JR (CHC13) 3418 (OH), 
2973, 1633 (C=O), 1595, 1503, 1462, 1437, 1334, 1265, 1025 cm 1 ; 'H NMR (360 
MHz, CDC13) 6 7.31-7.26 (1H, in, ArH), 7.16 (1H, dd, J= 7.6, 1.7 Hz, ArH), 7.00-
6.95 (2H, in, ArH), 3.82 (3H, s, OCH3), 3.71-3.62 (I H, in, CH2N), 3.52-3.43 (1 H, in, 
CH2N), 2.51 (1H, q, .1=7.2 Hz, CH3CH), 2.12-2.05 (3H, in, CH2CH2N and OH), 
1.38 (3H, s, CH3COH), 1.33 (3H, d, .1=7.2 Hz, CH3CH); '3C NMR (90.6 MHz, 
C2D2C4, 353 K) 6 172.0 (C), 155.1 (C), 132.5 (C), 129.4 (CH), 128.8 (CH), 121.4 
(CH), 112.9 (CH), 70.6 (C), 56.2 (CH3), 47.6 (CH), 46.4 (CH2), 35.8 (CH2), 28.0 






methylpiperidin-2-one (90j). The title compound was prepared 
HO according to general procedure E from 89j (261 mg, 1.00 mmol) for a 
reaction time of 24 h and purified by column chromatography (80% EtOAc/petrol) to 
-- 	give a whtt 	Itd(t85n1g7 70%)tmp. l44t46°C; JR HCIfr3408(OH);2964, 
1636 (C=O), 1596, 1502, 1460, 1436, 1315, 1266, 1026 cm-1 ; 'H NMR (360 MHz, 
CDC13) 8 7.31-7.26 (1H, m, ArH), 7.15-7.13 (1H, in, ArH), 7.00-6.95 (2H, in, ArH), 
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3.82 (3H, s, OCH3), 3.62-3.44 (2H, hr in, CH2N), 2.28 (1H, t, J= 5.8 Hz, CH2CH), 
2.20-2.06 (2H, in, CH2CH2N), 1.97-1.70 (3H, in, CH3CH2 and OH), 1.42 (3H, s, 
CH3COH), 1.15 (3H, t, J= 7.4 Hz, CH3CH2); '3C NMR (90.6 MHz, C2D2C14, 353 K) 
6 171.8 (C), 155.2 (C), 132.4 (C), 129.4 (CH), 128.8 (CH), 121.4 (CH), 112.9 (CH), 
71.4 (C), 56.2 (CH3), 55.1 (CH), 46.5 (CH2), 35.5 (CH2), 28.3 (CH3), 20.4 (CH2), 






Ph......phenypiperidin-2-one (90k). The title compound was prepared 
HO 	according to general procedure E from 89k (323 mg, 1.00 mmol) but 
using (EtO)2MeSiH (330 j.iL, 2.00 mmol) in place of TMDS for a reaction time of 23 
h and purified by column chromatography (30% EtOAc/CHC13) to give an off-white 
solid (212 mg, 65%). m.p. 180-182 °C; JR (CHCI3) 3388 (OH), 2931, 1631 (C=O), 
1595, 1502, 1436, 1332, 1266, 1027, 752 cm'; 'H NMR (360 MHz, CDC13) 6 7.54 
(2H, d, J= 7.5 Hz, ArH) 7.44-7.40 (2H, m, ArH), 7.34-7.30 (211, in, ArH), 7.22 (1H, 
d, J= 7.1 Hz, ArH), 7.03-6.98 (2H, in, ArH), 3.87 (3H, s, OCH3), 3.82-3.75 (1H, m, 
CH2N), 3.53-3.50 (IH, in, CH2N), 2.85-2.84 (IH, m, CH2CH), 2.48-2.40 (2H, br in, 
CH2CH2N and OH), 2.18-2.12 (1H, in, CH2CH2N), 1.89-1.77 (1H, in, CH3CH2), 
1.49-1.44 (111, in, CH3CH2), 1.00 (311, t, J = 7.3 Hz, CH3CH2); '3C NMR (62.9 
MHz, CDC13) 6 172.1 (C), 154.4 (C), 145.8 (C), 131.6 (C), 128.9 (CH), 128.7 (CH), 
128.3 (2 x CH), 126.9 (CH), 124.7 (2 x CH), 121.1 (CH), 112.0 (CII), 75.4 (C), 55.7 
(CH3), 53.2 (CH), 46.4 (CH2), 37.1 (CII2), 19.8 (CH2), 14.5 (CH3); HRMS (ES) 
Exact mass calcd for C20H24NO3  [M+H]: 326.175 1, found: 326.1753. 
Me 	N - PMP 	(d)-(3R,4R,5R)-4-Hyd roxy-1-(4-methoxyphenyl)-3,5-dimethYI4 
Ph-
, 
...phenylpiperidin-2-one (98a). The title compound was prepared 
HO 
Me 	according to general procedure F from 97a (65 mg, 0.20 mmol) for a 
reaction time of 16 h and purified by column chromatography (50% EtOAc/petrol) to 
give a flf ofcWliit solid (5tmg, 78%). Slow evaporation ofamethanoi/hexane - 
solution of 98a was found to give colourless crystals suitable for X-ray diffraction. 
m.p. 204-206 °C; IR(CHC13) 3452 (OH), 1626 (C=O), 1511, 1342, 1250, 1030, 980, 
Chapter 3-Copper-Catalysed Reductive Aldol Qyclisations 	 92 
913, 839, 752 cm'; 'H NMR (360 MHz, CDC13) 6 7.44-7.37 (4H, in, ArH), 7.32-
7.27 (1H, in, ArH), 7.23 (211, d, J= 8.8 Hz, ArH), 6.93 (2H, d, J = 8.8 Hz, ArH), 
3.82 (3H, s, 0CH3), 3.78 (1H, t, J= 11.8 Hz, CH2N), 3.48 (1H, dd, J= 11.8, 5.5 Hz, 
CH2N), 3.00 (1 H, q, J= 7.2 Hz, CHCO), 2.65-2.55 (1H, in, CHCH2N), 2.07 (1H, 
hr s, OH), 1.04 (3H, d, J = 7.2 Hz, CH3CHC=O), 0.66 (3H, d, J = 6.7 Hz, 
CH3CHCH2N);'3C NMR (62.9 MHz, CDC13) 6 171.6 (C), 158.0 (C), 143.9 (C), 
136.1 (C), 128.5 (2 xCH), 127.4(2 x CH), 126.9 (CH), 124.8(2 xCH), 114.4(2 x 
CH), 77.1 (C), 55.4 (CH3), 54.6 (CH2), 47.5 (CH), 38.4 (CH), 12.4 (CH3), 9.8 (CH3); 
HRMS (ES) Exact mass calcd for C20H24NO3 [M+H]+: 326.175 1, found: 326.1747. 
PMP 
	
Me'L...)..., 	phenylpiperidin-2-one (98b). The title compound was prepared 
HO 	
Ph 
according to general procedure F from 97b (65 mg, 0.20 mmol) for a 
reaction time of 2 h and purified by column chromatography (30% 
EtOAc/petrol—*50% EtOAc/petrol) to give a fluffs,' off-white solid (38 mg, 58%). 
m.p. 84-86 °C; [c] 22 -81.5 (c 1.01, CHCI3); IR (CHC13) 3410 (OH), 2944, 1633 
(C=O), 1606, 1510, 1331, 1295, 1248, 1041, 910 cm'; 'H NMR (360 MHz, CDC13) 
6 7.23-7.12 (5H, m, ArH), 6.92 (2H, d, J= 9.0 Hz, Aril), 6.68 (2H, d, J= 9.0 Hz, 
ArH), 5.08 (111, dd, .1= 11.3, 5.3 Hz, CI1Ph), 3.67 (3H, s, OCH3), 2.68 (111, q, J 
7.1 Hz, CH3CII), 2.31 (1H, dd, J = 14,1, 11.3 Hz, CH2CHPh), 2.25 (1 H, dd, J= 
14.1, 5.3 Hz, CH2CHPh), 1.79 (111, brs, OH), 1.38 (3H, s, CH3COH), 1.36 (3H, d,J 
= 7.1 Hz, CH3CH); '3C NMR (62.9 MHz, CDC13) 6 173.0 (C), 157.5 (C), 141.5 (C), 
134.6 (C), 128.9 (2 x CH), 128.4 (2 x CH), 127.4 (3 x CH), 113.8 (2 x CH), 70.3 (C), 
61.5 (CH), 55.2 (CH3), 46.6 (CH), 28.3 (CH3), 9.2 (CH3); HRMS (ES) Exact mass 




,. 	6oxopiperidine-2-carboxYIate (98c). The title compound was 
HO 
CO2Et 
prepared according to general procedure F from 97c (64 mg, 0.20 
mmol) for a reaction time of 24 h and purified by column chromatography(311% 
EtOAc/petrol) to give a white solid (44 mg, 68%). Slow diffusion of pentane into a 
dichioromethane solution of 98c was found to give colourless crystals suitable for X- 
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ray diffraction. m.p. 170-172 °C; [a] -44.4 (c 0.90, CHC13); JR (CHC13) 3247 
(OH), 2930, 1746 (C=O), 1640 (C=O), 1607, 1511, 1295, 1246, 1186, 1032 cm-1 ; 1 H 
NMR (360 MHz, CDC13) 6 7.15 (211, d, J= 9.0 Hz, ArH), 6.87 (2H, d, J= 9.0 Hz, 
ArH), 4.72 (1H, dd, J= 10.3, 5.9 Hz, CHCO2Et), 4.05-3.99 (2H, m, CO2CH2CH3), 
3.79 (3H, s, 0CH3), 2.55 (1H, q, J= 7.1 Hz, CH3CH), 2.33 (1H, dd, J13.7, 5.9 Hz, 
CH2CHCO2Et), 2.14 (IH, dd, J= 13.7, 10.3 Hz, CH2CHCO2Et), 1.79 (1H, br s, 
OH), 1.39 (3H, s, CH3COH), 1.29 (3H, d, J = 7.1 Hz, CH3CH), 1.10 (3H, t, J= 7.1 
Hz, CO2CH2CH3); '3C NMR (62.9 MHz, CDC13) 6 171.9 (C), 171.6 (C), 158.3 (C), 
134.3 (C), 128.6 (2 x CH), 114.1 (2 x CH), 70.4 (C), 61.3 (CH2), 60.2 (CH), 55.4 
(CH3), 46.4 (CH), 39.8 (CH2), 28.3 (CH3), 13.9 (CH3), 9.0 (CH3); HRMS (ES) Exact 
mass calcd for C17H24N05  [M+H]: 322.1649, found: 322.1652. 
° 	(1S,2S,5R,6R)2Carbethoxy-6-hYdrOXY3-(4-meth0XY phenyl)-5- 
Me 	_PMP 
HO methyl-3-azabicyclo[4.4.0]deCafl-4-Ofle (98d). The title compound 
"CO2Et 
H 	was prepared according to general procedure F from 97d (72 mg, 
0.20 mmol) for a reaction time of 24 h and purified by column chromatography (30% 
EtOAc/petrol—*40% EtOAc/petrol) to give an off-white solid (48 mg, 66%). Slow 
diffusion of petrol into a dichloromethane solution of 98dwa s found to give 
colourless crystals suitable for X-ray diffraction. m.p. 141-143 °C; [a] 22  +2.5 (0.80, 
CH2C12); IR (CHC13) 3425 (OH), 2939, 1750 (C=O), 1642 (C0), 1607, 1510, 1294, 
1245, 1187, 1029 cm-1 ; 1 H NMR (3 60 MHz, CDC13) 67.15 (2H, d, J= 8.9 Hz, ArH), 
6.85 (2H, d, J= 8.9 Hz, ArH), 5.14 (1H, d, J= 5.7 Hz, CHCO2Et), 4.03-3.94 (2H, in, 
CO2CH2CH3), 3.77 (3H, s, OCH3), 2.94 (1H, q, J= 7.1 Hz, CH3CH), 2.24-2.17 (11-1, 
in, CHCHCO2Et), 2.05-1.99 (2H, in, (CH2)4 and OH), 1.86-1.84 (1H, in, (CH2)4), 
1.73-1.61 (3H, in, (CH2)4), 1.55-1.51 (1H, in, (CH2)4), 1.41-1.29 (2H, in, (CH2)4), 
1.22 (3H, d, J= 7.1 Hz, CH3CH), 1.09 (3H, t, J= 7.1 Hz, CO2CH2CH3); 13C NMR 
(62.9 MHz, CDC13) 6 172.7 (C), 170.1 (C), 157.9 (C), 135.0 (C), 128.5 (2 x CH), 
113.8 (2 x CH), 73.1 (C), 63.0 (CH), 60.8 (CH2), 55.3 (CH3), 44.0 (CH), 37.8 (CH), 
3-75-(GH2)-2-5.3-(CH2),-250_(CH2), 22.9 (CH2), 14.0 (CH3), 8.0 (CH3); HRMS (ES) - 
Exact mass calcd for C20H28NO5  [M+H]: 362.1962, found: 392.1966. 
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(±)(3S,4R)-4-Hydroxy-1-(4-methoxyphenyI)-3-methy1-4-pheflyLpiperidifle (99) 
0 
Me.)'. _PMP 	 Me 
BF-13 THF 
Ph 	 THF, A 	Ph, L , ) 
HO 90a 	 HO 99 
BH3 THF (1 M in THF, 1.6 mL, 1.6 mmol) was added to the piperidinone 90a (125 
mg, 0.4 mmol) and the resulting solution was heated at reflux for 4 h. The reaction 
was cooled to room temperature and quenched with H20 0  mL) followed by I M 
NaOH (3 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined 
organic layers were dried (MgSO4) and concentrated in vacuo. Purification of the 
residue by column chromatography (25% EtOAc/petrol) gave the piperidine 92 (102 
mg, 86%) as an off-white solid. m.p. 114-115 °C; JR (CHC13) 3501 (OH), 2959, 
1511, 1464, 1388, 1284, 1245, 1200, 1036, 825 cm; 1 H NMR (360 MHz, CDC13) 
7.52-7.49 (2H, in, ArlI), 7.41-7.36 (211, in, ArH), 7.30-7.25 (1H, in, ArH), 7.01 (211, 
d, .1= 9.0 Hz, ArH), 6.88 (211, d, J= 9.0 Hz, ArH), 3.80 (3H, s, OCH3), 3.46-3.40 
(I H, in, CH2N), 3.35 (1H, ddd, J= 11. 8, 4.2, 1.7 Hz, CH2N), 2.85 (1 H, app t, J= 
11.6 Hz, CH2N), 2.49-2.39 (1 H, in, CH3CH), 2.31 (1 H, ddd, J= 13.4, 13.4, 4.7 Hz, 
CH2CH2N), 1.82 (1H, app dt, .1= 14.0, 2.5 Hz, CH2CH2N), 1.70 (IH, br s, OH), 0.71 
(3H, d, J= 6.9 Hz, CH3CH); '3C NMR (62.9 MHz, CDC13) 5  154.7 (C), 147.0 (C), 
145.9 (C), 128.2 (2 x CH), 126.6 (CH), 124.7 (2 x CH), 118.7 (2 x CH), 114.4 (2 x 
CH), 73.8 (C), 55.5 (CH3), 54.3 (CH2), 47.2 (CH2), 40.5 (CH2), 39.1 (CH), 12.1 
(CH3); HRMS (ES) Exact mass calcd for C19H24NO2 [M+H]: 298.1802, found: 
298.1806. 
(100) 
Me 	PMP 	 Me 	Boc 
PhJIIIIIIIJ 	
1. PhI(OAc)2, MeOH 
2. Boc2O, CI-I202 	Ph - rj 
HO 99 Na2CO3 	 HO 100 
To a stirred solution of PhI(OAc)2 (131 mg, 0.40 mmol) in MeOH (1.5 mL) was 
added a solution of the piperidine 99 (30 mg, 0.10 mmol) in MeOH (1.5 mL) 
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dropwise over 2 mm. The solution immediately became dark red. After 30 mm, 1 M 
HCl (1 mL) was added and the mixture was stirred for 1.5 h. The mixture was 
washed with CH2Cl2 (3 x 1 mL) and the combined organic layers were back-
extracted with 1 M HC1 (1 mL). To the combined aqueous layers were added CH2C12 
(3 mL) followed by Boc2O (89 mg, 0.40 mmol). The aqueous layer was made basic 
(pH 	10) by the addition of saturated aqueous Na2CO3 and the mixture was left to 
stir for 16 h. The aqueous layer was separated and extracted with CH2C12 (3 x 5 mL), 
and the combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification of the residue by column chromatography (20% EtOAc/petrol) gave the 
carbainate 100 (14.4 mg, 49%) as a beige solid. m.p. 152-154 °C; IR (film) 3453 
(OH), 2976, 1669 (C=O), 1429, 1366, 1251, 1168, 1004, 816, 701 cm'; 'H NMR 
(360 MHz, C2132C4, 353K) 8 7.40-7.38 (2H, in ArH), 7.35-7.30 (2H, in, ArH), 7.24-
7.20 (111, in, ArH), 4.01-3.96 (1 H, in, CH2N), 3.92 (1H, dd, J= 13.8, 3.8 Hz, CH2N), 
3.15 (1H, ddd, J = 13.0, 13.0, 2.9 Hz, CH2N), 2.84 (1H, app t, J 12.4 Hz, CH2N), 
2.13-2.03 (1H, in, CH3CH), 1.96 (111, ddd, J= 13.5, 13.5, 5.0 Hz, CH2CH2N), 1.64 
(1H, app dt, J= 14.0, 2.5 Hz, CH2CH2N), 1.60 (1H, br s, OH), 1.47 (9H, s, C(CH3)3), 
0.62 (3H, d, J= 6.8 Hz, CH3CH); '3C NMR (90.6 MHz, C2132C4, 353K) 6 155.0 (C), 
147.1 (C), 128.5 (2 x CH), 127.0 (CH), 79.6 (C), 74.5 (C), 46.7 (CH2), 40.6 (CH2), 
40.4 (CH2), 39.3 (CH), 28.8 (3 x CH3), 12.0 (CH3); HRMS (FAB) Exact mass calcd 









HO 98c 	 HO 101 
BH3 THF (1 M in THF, 1.84 mL, 1.84 mmol) was added to the piperidinone 98c (74 
0.23 mmol) and the resulting solution was heated at reflux for 48 h. The reaction 
was cooled to room temperature and quenched with H20 (1 mL) followed by 1 M 
NaOH (3 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined 
organic layers were dried (MgSO4) and concentrated in vacuo. Purification of the 
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residue by column chromatography (80% EtOAc/petrol) gave the piperidine 101 (46 
mg, 75%) as an off-white solid. m.p. 115-116 °C; [c] 22  +11.4 (c 0.70, CHC13); JR 
(CHC13) 3391 (OH), 2963, 2834, 1508, 1462, 1291, 1245, 1208, 1037, 835 cm'; 1 H 
NMR (3 60 MHz, CDC13) 6 7.18 (211, d, J= 8.9 Hz, ArH), 6.86 (2H, d, .J= 8.9 Hz, 
ArH), 3.79 (3H, s, OCH3), 3.47 (1 H, dd, J= 11. 3, 3.8 Hz), 3.27-3.22 (2H, m), 2.80 
(111, app q, J= 11.5 Hz), 2.73 (111, dd, J= 11.5, 4.4 Hz), 2.05 (1H, br s, OH), 1.96-
1.89 (111, in, CH2CHN), 1.85-1.73 (211, in, CH2CHN and CH3CH), 1.40 (111, br s, 
OH), 1.28 (311, s, CH3COH), 0.86 (3H, d, .1 = 6.8 Hz, CH3CH); '3C NMR (62.9 
MHz, CDC13) 6 157.1 (C), 144.0 (C), 126.3(2 x CH), 114.4(2 x CH), 69.8 (C), 63.2 
(CH2), 59.8 (CH2), 56.5 (CH), 55.4 (CH3), 42.4 (CH2), 39.6 (CH), 28.3 (CH3), 11.5 





Me 	 PMP 	 Me 	_PMP 




98d 	 102 
BH3 THF (1 M in THF, 1.84 mL, 1.84 mmol) was added to the piperidine 98d (72 
mg, 0.20 mmol) and the resulting solution was heated at reflux for 36 h. The reaction 
was cooled to room temperature and quenched with 1120 (1 mL) followed by 1 M 
NaOH (3 mL). The mixture was extracted with EtOAc (3 x 5 mL) and the combined 
organic layers were dried (MgSO4) and concentrated in vacuo. Purification of the 
residue by column chromatography (80% EtOAc/petrol) gave the piperidine 102 (39 
mg, 64%) as an off white solid. m.p. 48-50 °C; [ct]12 -84.8 (c 0.83, CHC13); JR 
(CHC13) 3366 (OH), 2936, 1507, 1450, 1243, 1039, 836, 761 cm'; 'H NMR (360 
6.85 (2-11, d,-J- 
OCH3), 3.49-3.73 (3H, m), 2.99 (111, app t, J= 11.3 Hz), 2.68 (111, br d), 2.38 (111, 
br s, OH), 2.07 (2.04 (111, m), 1.90-1,79 (2H, m), 1.69-1.61 (311, m), 1.46-1.20 (511, 
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M); '
3C NMR (62.9 MHz, CDC13) 8  157.2 (C), 144.6 (C), 126.9 (2 x CH), 114.4 (2 x 
CH), 71.9 (C), 63.8 (CH2), 60.7 (CH), 59.3 (CH2), 55.4 (CH3), 47.6 (CH), 37.5 
(CH2), 30.9 (CH), 25.8 (CH2), 22.9 (CH2), 22.7 (CH2), 10.9 (CH3); HRMS (ES) 
Exact mass calcd for C18H28NO3 [M+H]: 306.2064, found: 306.2066. 
General Procedure G: Enantioselective Cyclisations 
A solution of Cu(OAc)2 H20 (2.0 mg, 0.01 mmol) and the chiral ligand (0.01 mmol) 
in THF (1 mL) was stirred for 15 min before TMDS (35 iL, 0.20 mmol) was added. 
The solution was stirred for 5 mm, after which a solution of the substrate (0.20 
mmol) in THF (0.5 + 0.5 mL rinse) was then added rapidly via cannula. The reaction 
was stirred at room temperature until complete consumption of the starting material 
as observed by TLC analysis. The reaction was quenched by the addition of I M HCI 
(0.5 mL), and the mixture was stirred for I h before being diluted with saturated 
aqueous NH4C1 solution (10 mL). The mixture was extracted with CH202 (3 x 10 
mL) and the combined organic layers were dried (MgSO4) and concentrated in 
vacuo. Purification of the residue by column chromatography (EtOAc/petrol) 
afforded the cyclised product. 
Me 	N PMP 	 (3R,4R)-4-Hydroxy- 1-(4-methoxyphenyl)-3-methyl-4- 
Ph 	 phenylpiperidin-2-one (90a). The title compound was prepared 
HO 
according to general procedure G using 89a (62 mg, 0.20 mmol) and 
(S)-DM-SEGPHOS (105) (9.2 mg, 0.01 mmol) for a reaction time of 24 h and 
purified by column chromatography (80% EtOAc/petrol) to give the enantioenriched 
product 90a as a white solid (41 mg, 65%). Enantiomeric excess was determined by 
HPLC with a Chiralpak AD-H column (90:10 hexanes:isopropanol, 0.8 mL/min, 210 
nm, 25 °C); tr (minor) = 30.9 mm, tr  (major) = 43.2 mm; 65% ee. 
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4. Cobalt-Catalysed Reductive Aldol Cyclisations 
The copper-mediated cyclisation of a,/3-unsaturated carbonyl components tethered to 
a variety of ketones through an amide linkage allows the efficient synthesis of 4-
hydroxypiperidine-2-ones in moderate yields. Although the products were obtained 
with generally high levels of diastereoselectivity the process suffered from a number 
of limitations. Firstly, due to competing side reactions such as ketone reduction 
product yield was limited to a modest 60-70% in the best cases .72 Secondly, the 
reduced electrophilicity of a,/3-unsaturated amides compared with the corresponding 
esters27 meant that productive cyclisations were restricted to those amide substrates 
were R2 = H or Me (Table 3.3). In order to overcome the limitations of the 
previously described copper-mediated methodology, a search for improved reaction 
conditions was initiated. To this end, a number of alternative reductants and metal 
salts were investigated for reaction efficacy. Following the identification of an active 
catalyst system, a variety of 4-hydroxypiperidine-2-ones and pyrrolidin-2-ones were 
to be synthesised in order to gauge the robustness of the newly developed 
methodology. 
4.1. Results and Discussion" 
Initially, the cyclisation of cinnamic amide substrate (891) was investigated (Table 
4.1). 
Chapter 4—Cobalt-Catalysed Reductive Aldol Cyclisations 	 99 
0 
0 	 0 	 Ligand (5 mol%) OH 	0 
Metal salt (5 mol%) 	 _PMP 
I 	 reductant, solvent 	Me 
PMP 	
N 	
Me 	 N 	 Ph 
PMP 
HO 
891 	 901 	 91 
Entry 	Reagents 	Solvent T(°C( %Conversion° 901/91 
1 Cu(OAc)2 H20, DPPF, THF rt 77 34:66 
TMDS (1 equiv( 
2 Cu(OAc)2 H2O, rae- THF rt 87 39:61 
BINAP, TMDS (1 equiv( 
3 Cu(OAc)2 I-120, DPPF, THF rt <5 - 
PhSiH3 (1 equiv) 
4 Co(dpm)5 , CH2Cl2 b b 
PhSiH3 (1 equiv) 
5 Co(dpm)21  DCE 1 to 50 
b 
PhSiH3 0  equiv) 
6 Co(acac)2 2H201  THF/ 0 tort <5 - 
Et3B (2 equiv) hexane 
7 Co(acac)5 2H2O, THF/ 0 tort <95 '95:5 
Et2 Zn (2 equiv) hexane 
8 Cod 2 , PhCy2P1  TI-IF/ 0 tort >95 '95:5 
Et2Zn (2 equiv) hexane 
"Determined by 'H NMR analysis of Else uispurilied reaction mixtures; "A complex mixture 
containing unidentified side-products was obtained 
Table 4.1 
As described previously (Chapter 3), the application of the copper conditions proved 
ineffective giving mostly uncyclised doubly reduced starting material 91 (entry 1). 
The formation of 91 can be attributed to a slow rate of aldol cyclisation, allowing 
competitive conjugate reduction to become more prevalent. Replacement of DPPF 
(25)w ith rac-BINAP led to a similar result (entry 2), whereas the use of alternative 
silanes such as PhSiH3 in place of TMDS resulted in negligible reactivity (entry 3). 
Consequently, alternative metal salts were considered as potential replacements for 
the copper-based catalyst system previously employed. In this regard, the use of an 
appropriate chiral ligand in conjunction with CoC12 and sodium borohydride 
(NaBH4) has proven useful for the asymmetric conjugate reduction of ct,J3-
unsaturated amides. 86  Predictably, conditions employing NaBH4 led to rapid ketone 
reduction of 891, even at reduced temperatures. Likewise, conditions utilising a 
combination of cobalt dipivoloylmethane (Co(dpm)2) and PhSiH3, which were 
developed for intermolecular reductive aldol reactions by Mukaiyama33 and 
subsequently extended to reductive aldol cyclisations by Krische34 also proved 
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ineffective, giving complex reaction mixtures (entries 4 and 5). Recently however, 
organornetallic reagents with fl-hydrogen-containing alkyl substituents have been 
utilised as the stoichiometric reductant in a number of transition metal catalysed 
reductive couplings and cyclisations. Therefore, we explored the effectiveness of 
triethylborane (Et3B) and diethylzinc (Et2Zn) in the reaction. In the presence of 5 
mol% of Co(acac)2 2H20, the use of Et3B resulted in minimal reaction (entry 6), 
whereas the more reactive Et2Zn led to the formation of 901 in 89% yield with no 
apparent formation of the side product 91 (entry 7). In addition, it was found that the 
combination of 5 mol% anhydrous CoCl2 and the electron rich phosphine Cy2 PPh led 
to augmented reaction rates giving similar levels of conversion and product 
distribution compared to those obtained when Co(acac)2 is used as the catalyst (entry 
8). 
Following the development of effective conditions, the scope of the process was next 
investigated (Table 4.2). 
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0 °Ctort 	 HO 
Method A: Co(acac)2 (5 mol%) 
Method B: CoCl2 (5 mol%),C y2PPh (5.5 mol%) 
Entry 	Substrate Method 	Product dr°  %Yield 
1 R= Ph 891 A 	 0 901 12:1 89 
O 	0 
2 _Jj R = 2-furyl 131a A 	 'k 	PMP 132a >19:1 90 R 	N 




4 R'H 131c A 	 0 132c 9:1 
O 	0 
R='Pr 	131d A 	 Bn 132d >19:1 ,99b 
6 Me I R=Phl3le 
A 
RJjjN 
132e '19:1 975 




8 R=Mel3lg A 	 - Bn 1329 '19:1 
945 










CO2Et) R = H 1311 B 	 PMP 
N 
1321 9:1 56' 
11 R R 'Me 13 8 132j >19:1 80' 
12 PMP RPh 131k B 132k '19:1 88'  
CO2EI 
13 R=H113a A 114b 9:1 47 0 
14 0 R=Phll3c A 114c 56 8:1 
15 Me R = 2-MeOPh 1311 
PMP 
B 	R 
A 	MN  
1321 14:1 74 
16 R = 2-furyl 131m 132m 14:1 55 
17 
0 	PMP 
R= 4-CIPh 131n A 	HO 132n 5:1 41 
'Determined by 1  H NMR analysis of the anpuritied reaction mixtures; 'Results taken from Pekku Joenssu;'Results taken from Euan Fordyce 
Table 4.2 
Substrates containing a wide range of substitution at both the a,/3-unsaturated amide 
and the ketone underwent cyclisation to give the corresponding 4-hydroxypiperidin-
2-one products in moderate to excellent yields and with high diastereoselectivities 
(entries 1-12). Notably, the copper conditions previously described (Table 4.1, entry 
1) proved ineffective in the majority of these cyclisations. Furthermore, the choice of 
nitrogen protecting greatly influenced the isolated yield of the products. Generally, 
the use of benzyl protection (entries 5-10) tends to result in increased yields of the 
----cyclisation-products-compar-ed-to- those -obtained when PMP-is-used-asAlie-protecting-- 
group (entries 1-3). 
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The reaction could also be applied to the synthesis of pyrrolidin-2-ones (entries 13-
17), giving the products in moderate to good yield and with generally good levels of 
diastereoselectivity. Most notably, in the case of pyrrolidin-2-one formation the 
electronics of the a,/3-unsaturated amide component have a crucial role to play in the 
yield and selectivity of the cyclisation reaction. For example, electron rich systems 
gave rise to the most efficient, high yielding reactions where the 
diastereoselectivities were particularly high (entries 7 and 8). On the other hand, 
electron deficient systems resulted in the least efficient, low yielding reactions where 
the diastereoselectivities were very poor (entry 9). The relative stereochemistry of 
pyrrolidin-2-one 114c was confirmed by X-ray crystallography (Figure 4.1) and 
reflected those of the 4-hydroxypiperidin-2-one products previously described .72 
0 
PMP 





A number of complications were encountered when substrates 133a,b containing 
phenyl ketones were utilised; in contrast to methyl ketones 113a,c and 1321-n (Table 
4.2, entries 13-17), the desired pyrrolidin-2-one products were obtained in <20% 
yield with an assortment of other unidentified side-products. This is most likely due 
to the decreased electrophilicity of phenyl ketones compared to alkyl ketones. 
Nevertheless, replacement of Et2Zn with Et3Al allowed the corresponding pyrrolidin-
2-ones 134a,b to be isolated in moderate yield with good to excellent levels of 
diastereoselection (eqs 35 and 26). 
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0 
EtAl (2 equiv) 
Ph 	 Co(acac)2 2H20 (5 mol%) 	Me N _R  
n 	 THF, hexane 	 Ph' '  
0 °Ctort HO 
	
133a R = PMP 	 134a (57% yield, >19:1 dr)> 	(35) 
133b R = PMB 	 134b (53% yield, 8:1 dr)> 	(36) 
Results taken from Oscar Pricto Congest, Post-Doctoral report 2006 
However, analogues of 133a,b containing substituted a,f3-unsaturated amides did not 
react under any conditions examined. 
Although 5 mol% of the cobalt source was used for convenience, the reaction is 
tolerant of far lower catalyst loadings. For example, on a 5 mmol scale, substrate 891 
underwent cyclisation using 0.5 mol% of Co(acac)2 2H20 to provide 901 in 79% 
yield and with no loss of diastereoselection (eqs 37 and 38). 
Et2Zn (2 equiv) 	 0 
me 	 Ph 	
(cat.) Ph NPMP 
THE, hexane 	 Me12 
PMP 	 0°Ctort HO 
891 Co(acac(2 2H20 (0.5 mo)%) 	 90) 79% yield, 9:1 dr 	
(37) 
891 Co)aca02 '2H20 (0.0 mo)%) 	 901 nr 	 (38) 
In the absence of Co(acac)2 2H20 the reaction failed to initiate, indicating that cobalt 
is essential for mediating the cyclisation reaction (eq 38). 
As detailed previously (Chapter 1 and 3) our copper-catalysed methodology could be 
used to great effect in the reductive aldol cyclisation of a variety of ketones tethered 
to ct,/3-unsaturated components through an ester-linkage. 27  However, the application 
of our cobalt-mediated conditions to the synthesis of /3-hydroxylactones 136 proved 
to be ineffective, resulting in a mixture of unidentifiable products (eq 39). 
0 	R2 Et2Zn (2 equiv) 
R2 	0 
R1 	n 	 R3 
Co(acac)2.2H20 (5 mol%) RO 	 (39) 
II THE, hexane  
--.—— 	 - O---- ---- 0 °C tort HO 
135 136 
Poor reactivity 
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The construction of all-carbon quaternary stereogenic centres remains an important 
goal for organic chemists. In particular the synthesis of heterocyclic ring systems 
bearing vicinal quaternary centres offers a significant challenge. Hence, we 
envisioned that our newly developed cobalt catalysed reductive aldol methodology 
could be extended to the synthesis of 4-hydroxypiperidin-2-ones containing an all-
carbon quaternary centre in the 3-position of the heterocyclic ring. Unfortunately, 
when substrates 137a,b were exposed to our standard conditions the products of 
cyclisation 138a,b were not observed. Instead, amides 139a,b were obtained in 
—80% yield resulting from conjugate elimination of the substrates (eqs 40 and 41). 
o 	o Et2Ln (2 equiv) 
Co(acac)2 2H20 (5 mot%) 
0 
Me  U 	.PMP 
R "N + 
THF, hexane M H  
PMP Me O°Ctort HO 
e M 
137a R = H 138a Not observed 139a 100% convserion 	(40) 
137b R = Me 138b Not observed 139b 100% conversion 	(41) 
Since enantioselective carbon-carbon bond forming reactions are invaluable tools in 
organic synthesis. A number of chiral non-racemic ligands were investigated in order 
to probe a possible asymmetric variant of this methodology (Table 4.3). 
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0 
Ligand (5 mol%) 	Ph 
0 	0 	 CoX2 (5 rnol%) _PMP 
N 
I 	 THF, hexane 
PMP 	
Me 
0°Ctort 	 HO 



















0 Q eF Ph2 Ph2P- 






NH N 	 Mef' Me 
R 	 R 	 OH 	
OH 
Semicorrin (143) Ephedrine (144) 	Pseudoephedrine (145) 
0% ee 	 0% ee 	 0% ee 
Table 4.3 
Unfortunately, in the presence of substoichiometric quantities of a variety of chiral 
ligands only racemic products were obtained (Table 4.3). Alternative cobalt salts 
such as CoC12 and CoBr2(PPh3)2 also gave rise to similar results. 
4.1.1. Proposed Mechanism 
At this stage, lacking any literature presedent, only speculative mechanisms for the 
cobalt-catalysed reductive aldol cyclisation can be proposed. For example, a 
plausible mechanism which involves the intervention of discrete enolate 
intermediates is detailed below (Scheme 4.1). 























R'  150  
EtZnO 	
El 
153 	 N 	R3 
Zn --- Et 







Treatment of Co(acac)2-2H20 or CoC12 with Et2Zn results in the formation of low 
valent cobalt species 146, presumably through sequential transmetalationlreductive 
elimination. A combination of Co(0) and diethylzinc may lead to the bimetallic 
intermediate 147 containing a three-centre-two-electron bridging interaction. The 
coordination of 147 with substrate 148 would provide structure 149, which would 
undergo a ,B-hydride elimination to produce cobalt hydride 150. Rearrangement of 
150 can then occur to give zinc enolate 151, which would undergo a reductive aldol 
cyclisation to produce the zinc alkoxide 153 and regenerate Co(0). In this case the 
observed stereochemical outcome can be rationalised by invoking a chelated 
Zimmerman-Traxler-type transition state 
13  152 and preferential Z-enolate formation. 
Even though this type of bridging interaction has not been disclosed for a cobalt-
catalysed reaction, it has been proposed for a number of associated Ni(0)-catalysed 
alkylative couplings to account for the accelerating effect of organozinc reagents. 69"1' 
Moreover, it has been observed by X-ray crystallography for cobalt 
69a  and nickel 
complexes with Grignard and organoaluminium reagents. Alternative mechanistic 
possibilities are comparable to those proposed for catalytic variants of the 
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Reformatsky reaction utilising a-bromocarbonyl compounds and dialkyizinc 
reagents mediated by rhodium87a  and nickel .87b  
Another mechanistic pathway initially considered, involves the Et2Zn-assisted 
oxidative cyclisation of a low-valent cobalt species with substrate 142 to form the 
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156 
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Oxidative cyclisation of the Co(0) species 154 with the alkene and ketone of 
substrate 148 would result in the oxacobaltacycle 155. Cleavage of the 
oxacobaltacycle 155 by transmetalation would furnish cobalt-ethyl species 156, 
which following /3-hydride elimination would generate cobalt-hydride species 157. 
Reductive elimination of 157 would produce the product as the zinc alkoxide 153 
(protonated upon work-up), ethylene and Co(0) 154, which re-enters the catalytic - - 
cycle. The observed relative stereochemistry of the cyclised products is related to the 
formation of the bicyclic intermediate preferring to adopt an energetically more 
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favourable cis-ring junction as apposed to the higher energy trans-ring junction. The 
formation of metallacycles as reaction intermediates has been reported in a number 
of cobalt-69 and nickel-catalysed 46,19,6' reductive couplings. Nonetheless, several 
observations led to the conclusion that this particular reaction pathway is not active. 
As illustrated previously, the addition of substoichiometric quantities of a variety of 
chiral ligands led only to racemic products (Table 4.3), indicating that cobalt is not 
involved in the stereochemical-determining step. 
In an effort to identify which mechanism is in operation, we examined the reaction of 
ct,/3-unsaturated amide 158 in the absence of the pendant ketone il-system to our 
standard conditions (eq 42; results taken from Pekka Joensuu). Theoretically, 
mechanism A (Scheme 4.1) does not require the presence of a second electrophilic it-
component until after the zinc enolate is formed, however, in mechanism B the 
ketone 31-component is an essential prerequisite for oxidative cyclisation to form the 
proposed oxacobaltacycle (Scheme 4.2). Consequently, if mechanism A is in 
operation one would expect to observe the product of conjugate reduction. In the 
event, exposure of 158 to our standard conditions provided the desired reduced 
amide 159 in 73% yield. Although, this observation suggests that Mechanism A is 







Ph THF, hexane Ph NBn2 
158 O°Ctort 159 
73% yield 
Given that the preceding experiment indicated that the reaction is proceding through 
mechanism A (Scheme 4. 1), we next conducted the cyclisation of deuterium labelled 
substrate 160 (Scheme 4.3). In principle, if mechanism A is operative via the 
proposed zinc enolate 161, we should theoretically expect to observe the cyclised 
- product as a cafrtmixtureofdiastereomers 163a and 163k-This-wou-ld-be-dtieto- ---- 
the 	diastereomeric Zimmerman-Traxler-type transition states 
13  162a and 162b 
possessing near identical energies. On the other hand, if mechanism B is operative, 
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the concerted nature of the oxidative cyclisation would be expected to provide 
metallacycle 164 with the relative stereochemistry illustrated. Subsequent reductive 
elimination of cobalt hydride 165 that proceeds with retention of configuration would 
be expected to produce a single diastereomer of cyclised product 163a. 
0 	 0 




_Bn Bn 	 \ Et—Co 	





160 	 161 
Ph,, D H 
a 	 at 	 Et 
Bn 	 p 
	
Zn Z1 11
0,  Hc JN 	
D H 	
Bn Bn 
EtZ Me 165 	
or 
Me 	 Ph Me 
162a 162b 
DH 0 	 DH 0 	 H0 0 
H U - 
Ph 	N Ph 	
Bn 	 Bn 
Ph 	N 
Me' )..) 	 Me- - 	
- 	Me' 
HO 	163a 	 HO 163a HO 	163b 
Scheme 4.3 
In the event, the cobalt-catalysed reductive cyclisation of 160 afforded a 2.6:1 
inseparable mixture of diastereomers 163a and 163b as determined of NMR 
spectroscopy of the unpurified reaction mixture (eq 43; results taken from Pekka 
Joensuu). 
a 	0 	D 	 Et2Zn (2 equiv) 
Co(acac)2 2I-l5O (5 mot%) 
Me 	N 	Ph 	THF/hexane 




+ 	P 1 N _ 0fl  
163a 	 16Th 
Relative stereochemistroes of major 
and minor isomers not assigned 
(43( 
From this result several possible explanations maybe invoked to rationalise the 
observed diastereomeric ratio. Firstly, both mechanism A and B are operative as 
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competing reaction pathways. Secondly, mechanism B is operative, but one or more 
steps in the pathway are not stereospecific. This may in part be due to the 
conformational lability of a carbon—cobalt bond allowing epimerisation. Thirdly, if 
mechanism A is operative, initial precoordination of either cobalt or zinc with both 
carbonyl groups could facilitate a degree of facial selectivity during the reduction of 
the a,/3-unsaturated system. This is probable as the chelate effect will favour the 
substrate acting as a bidenate ligand and the coordination of oxygen will activate the 
cc,/3-unsaturated system to reduction. Although on the available evidence, mechanism 
B cannot be completely discounted at this stage, we presently favour a variation of 
mechanism A as the probable reaction pathway based on the results from the 
deuterium-labelling studies. 
4.2. Conclusions and Future Work 
We have developed a noval synthetic methodology where a large variety of 4-
hydroxypiperidin-2--ones and pyrrolidin-2-ones can be efficiently synthesised in 
excellent yields and diastereoselectivities. The reaction tolerates a wide variety of 
substrate substitution. The catalyst system is highly active with a catalyst loading of 
0.5 mol% of Co(acac)2 facilitating the cyclisation of 891 in 79% yield over 4 hours. 
However, the combination of a variety of chiral non-racemic ligands has yet to yield 
any enantioselectivities, suggesting that the cobalt catalyst is not involved in the 
stereochemical determining step. Deuterium labelling studies have indicated that the 
mechanism most likely procedes through discrete enolate intermediates (Mechanism 
A); however, lacking further study the alternative reaction pathways cannot be 
discounted at this stage. 
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4.3. Experimental 
All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-
dried apparatus. CH2C12 and THF were dried and purified by passage through 
activated alumina columns using a solvent purification system from 
www.glasscontour.crn 'Petrol' refers to that fraction of light petroleum ether boiling 
in the range 40-60 'C. Crotonoyl chloride was distilled from CaH2. Commercially 
available CoC12  was dried by heating under vacuum until it turned from purple to 
blue. All other commercially available reagents were used as received. Thin layer 
chromatography (TLC) was performed on Merck DF-Alufoilien 60F254 0.2 mm 
precoated plates. Product spots were visualized by UV light at 254 rim, and 
subsequently developed using potassium permanganate or ceric ammonium 
molybdate solution as appropriate. Flash column chromatography was carried out 
using silica gel (Fisher Scientific 60A particle size 35-70 micron) employing the 
method of Still and co-workers .80 Melting points were recorded on a Gallenkamp 
melting point apparatus and are uncorrected. Infra-red spectra were recorded on a 
Jasco FT/IR-460 Plus instrument as a thin film on sodium chloride plates or as a 
dilute solution in CHC13. 'H NMR spectra were recorded on a Bruker DPX360 (360 
MHz) spectrometer or a Bruker ARX250 (250 MHz) spectrometer. Chemical shifts 
(ö) are quoted in parts per million (ppm) downfield of tetramethylsilane, using 
residual protonated solvent as internal standard (CDC13 at 7.27 ppm). Abbreviations 
used in the description of resonances are: s (singlet), d (doublet), t (triplet), q, 
(quartet), app (apparent), br (broad). Coupling constants (J) are quoted to the nearest 
0.1 Hz. Proton-decoupled '3C NMR spectra were recorded on a Bruker DPX360 
(90.6 MHz) spectrometer or a Bruker ARX250 (62.9 MHz) spectrometer. Chemical 
shifts () are quoted in parts per million (ppm) downfield of tetramethylsilane, using 
deuterated solvent as internal standard (CDC13 at 77.0 ppm). Assignments were made 
using the DEPT sequence with secondary pulses at 90° and 135°. High resolution 
mass spectra were recorded on a Finnigan MAT 900 XLT spectrometer using the 
-eiectrospra-y_(ES)_posithieJoit-mode- at the EPSjC National Mass Spectrometry 
Service Centre, University of Wales Swansea, or on a Kratos MS50TC spectrometer 
using the fast atom bombardment (FAB) technique in the mass spectrometry 
laboratory at the School of Chemistry, University of Edinburgh. Stated calculated 
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mass values refer to that of the ion (i.e. the actual species being detected), not that of 
the neutral parent compound. Optical rotations were performed on an Optical 
Activity POLAAR 20 polarimeter. 
Preparation of Aminoketones 
	
4-(4-Methoxyphenylamino)butan-2-one 	(118). 	Prepared 
PMPHN 	Me 
according to a previously reported procedure (Chapter 3.3). 
° 	5-(4-Methoxyphenylamino)pentan-3-one 	(119). 	Prepared 
PMPHN 	Et 
according to a previously reported procedure (Chapter 3.3). 
PMPHNj( Me 1-(4-Methoxyphenyl)aminopropanone (126). Prepared according to 
a previously reported procedure (Chapter 3.3). 




)~> CH201 p-anisidlnePMPHN+'\ 
KOH, EtOH, H20 
—2OC 	 166 
A solution of p-anisidine (4.73 g, 38.4 mmol) and aqueous formaldehyde solution 
(37% wt in H20, 2.88 mL, 38.4 mmol) in EtOH (200 mL) was stirred at room 
temperature for 10 mm. Ethyl 2-oxocyclopentanecarboxylate (4.00 g, 25.6 mmol) 
was added in one portion, the resulting mixture was cooled to —20 °C, and KOH 
(4.31 g, 76.8 mmol) was then added portionwise over 5 mm. The reaction mixture 
was stirred at —20 °C for 30 min and then poured into saturated aqueous NH4C1 
solution (200 mL). The mixture was extracted with CH2C12 (3 x 150 mL), and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo. Purification 
- of-the residue. by-column-chromatogr-aph-y (20% EtOAc/petroi)-gave-the-arninoketone 
166 (7.01 g, 94%) as a pale brown oil. IR (film) 3388 (NH), 2959, 1747 (C=O), 1719 
(C=O), 1514, 1465, 1234, 1176, 1036, 822 cm-'; 'H NMR (250 MHz, CDC13) 66.76 
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(2H, dm, J= 9.0 Hz, ArH), 6.60 (2H, d, J= 9.0 Hz, ArH), 4.16 (2H, qd, 1 = 7. 1, 1.2 
Hz, OCH2CH3), 3.73 (3H, s, OCH3), 3.48 (1 H, d,J= 13.1 Hz, C112N), 3.42 (1H, d,J 
= 13.1 Hz, CH2N), 2.56-2.41 (2H, in, CH2CH2CH2), 2.34-1.93 (5H, in, CH2CH2CH2 
and NH), 1.23 (3H, t, J= 7.1 Hz, OCH2CH3); 3C NMR (62.9 MHz, CDC13) 8 214.7 
(C), 170.9 (C), 152.3 (C), 142.2 (C), 114.7 (2 x CH), 114.5 (2 x CH), 61.5 (CH2), 
61.0 (C), 55.6 (CH3), 47.7 (CH2), 38.1 (CH2), 32.0 (CH2), 19.6 (CH2), 13.9 (CH3). 
2-(4-Methoxyphenyl)aminoacetophenone (167) 
Brf( 
Ph 	PMPNH2, Et3N 	 Ph 
THE, 	
PMPHN( 
0 	 0 
167 
A solution of 2-bromoacetophenone (3.98 g, 20.0 mmol), p-anisidine (2.23 g, 18.1 
mmol) and Et3N (5.05 mL, 36.2 mmol) in THF (100 mL) was heated at reflux for 24 
h. The reaction mixture was cooled to room temperature and washed with brine (100 
mL). The aqueous layer was separated and extracted with EtOAc (2 x 50 mL) and 
the combined organic layers were dried (MgSO4) and concentrated in vacuo. The 
residue was purified by recrystallization (EtOAc/petrol) to give the aminoketone 167 
as a dark orange solid (1.80 g, 40%) that displayed identical spectroscopic data to 
those reported previously. 
2-(4-Methoxybenzyl)aminoacetophenone hydrochloride (168) 
Ph 	PMBNH2, EtO, o c 	 Ph 
Br"—"r 
2. HCL(aq) 	 0 
168 
To a solution of p-methoxybenzylamine (5.20 mL, 40.0 mmol) in Et20 (20 mL) at 0 
°C was added a solution of 2-bromoacetophenone (3.90 g, 20.0 mmol) in Et20 (20 
mL) over 5 mm. The mixture was stirred at 0 °C for 12 h, and the resulting white 
precipitate was removed by filtration. The precipitate was washed with Et20 (2 x 20 
mL), and the combined filtrate and washings were cooled to 0 °C. 38% Aqueous HC1 
solution (2.5 mL) was added dropwise over 1 min to give a brown precipitate, which 
was filtered, washed with acetone (2 x 5 mL) and recrystallized from EtOHIEt2O to 
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give the aminoketone hydrochloride 168 as a white solid (1.40 g, 24%) that displayed 
identical spectroscopic data to those reported previously. 
Preparation of aJ3-Unsaturated Acid Chlorides: General Procedure H 
0 	 0 
(COd)2, DMF 
OH 	CH2C, RT 	R - CI 
Oxalyl chloride (1.21 equiv) was added dropwise over 2 min to a solution of the 
appropriate u.,,6-unsaturated carboxylic acid (1.10 equiv) and DMF (0.25 equiv) in 
CH2C12 (0.55 M with respect to carboxylic acid) at 0 °C. The mixture was stirred at 0 
°C until no more effervescence was observed (ca. I h) to give a solution of a,,6-
unsaturated acid chloride which was used directly in the next step. 
Preparation of Cyclization Precursors: General Procedure D 
0 
0 R2 R2 	
R CI R 
PMPHN ( 	Na2CO3ieq> 	
N 	ir 
MP 0 CH2Cl2, RT 
The appropriate a,/3-unsaturated acid chloride (neat in the case of commercially 
available acid chlorides, or as a solution in CH2C12 prepared according to General 
Procedure H, 1.5 equiv) was added dropwise or portionwise to a vigorously stirred 
mixture of the appropriate aminoketone (1.0 equiv) in CH2C12 (1 mL/mmol of 
aminoketone) and saturated aqueous Na2CO3 solution (1 mL/mmol of aminoketone). 
The mixture was stirred at room temperature until TLC analysis showed the reaction 
to be complete. The reaction was partitioned between saturated aqueous NaHCO3 
solution and CH2Cl2. The aqueous layer was separated and extracted with CH2C12 (x 
3), and the combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification of the residue by column chromatography afforded the cyclization 
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Preparation of Cyclization Precursors: General Procedure I 
0 
0 	 0 
RN Me 
BnNH2 	 R C! II 
BnHN-Me CH2C)2, RT 	 Na2CO3 ag) 
CH2Cl2 , RT 	 Bn 
A solution of benzylamine (1.0 equiv) and methyl vinyl ketone (1.1 equiv) in CH2Cl2 
(2.5 mL/mmol of benzylamine) was stirred at 0 °C for 18 h. Saturated aqueous 
Na2CO3 solution (2.5 mL/mmol of benzylamine) followed by the appropriate acid 
chloride (neat in the case of commercially available acid chlorides, or as a solution in 
CH2Cl2 prepared according to General Procedure H, 1.21 equiv) were then added 
dropwise or portionwise and the mixture was stirred at room temperature until TLC 
analysis showed the reaction to be complete. The reaction was partitioned between 
saturated aqueous NaHCO3 solution and CH2Cl2. The aqueous layer was separated 
and extracted with CH2Cl2 (x 3), and the combined organic layers were washed with 
10% HCI solution (x 1), dried (MgSO4) and concentrated in vacuo. Purification of 
the residue by column chromatography afforded the cyclization substrate. 
Preparation of Cyclization Precursors: General Procedure J 
	









0 	 0 
NPh Na 2CO3 ag) 
CH2CL2, RT 	 Bn 
Benzylamine (1.0 equiv) was added over I min to a solution of 3-
chloropropiophenone (1.1 equiv) and Et3N (3.3 equiv) in THF (2.5 mL/mmol of 
benzylamine) at room temperature and the mixture was stirred for 18 h. The reaction 
was partitioned between saturated aqueous NaHCO3 solution and EtOAc. The 
aqueous layer was separated and extracted with EtOAc (x 2), and the combined 
organic layers were dried (MgSO4) and concentrated in vacuo. The resulting amine 
169-was useddirectlyin the-next-step without further purification. 
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The appropriate a,/3-unsaturated acid chloride (neat in the case of commercially 
available acid chlorides, or as a solution in CH2Cl2 prepared according to General 
Procedure H, 1.5 equiv) was added dropwise or portionwise to a vigorously stirred 
mixture of the unpurified amine 169 (1.0 equiv) in CH2C12 0  mL/mmol of 169) and 
saturated aqueous Na2CO3 solution (1 mL/rnmol of 169). The mixture was stirred at 
room temperature until TLC analysis showed the reaction to be complete. The 
reaction was partitioned between saturated aqueous NaHCO3 solution and CH2C12 . 
The aqueous layer was separated and extracted with CH202 (x 3), and the combined 
organic layers were dried (MgSO4) and concentrated in vacuo. Purification of the 




'iMP 	 phenylpropenoate (891). Prepared according to a previously 
reported procedure (Chapter 3.3) 
° 	 N(4Methoxyphenyl)-N-(3-oxobuty1)-(L)-3-fUran-2- 
Me 	
MP 	
/ ylpropenamide (131a). The title compound was prepared 
according to General Procedure D from the amine 118 (1.00 g, 5.20 mmol) and the 
acid chloride (prepared according to General Procedure A) derived from 3-(2-
furyl)acrylic acid (1.10 g, 7.80 mmol) for a reaction time of 24 h and purified by 
column chromatography (30% EtOAc/petrol->50% EtOAc/petrol) to give a 
yellow/orange solid (1.01 g, 61%). m.p. 94-95 °C; JR (CHC13) 2934, 1713 (C0), 
1664 (C=O), 1614, 1511, 1392, 1250, 1017, 840, 748 cm'; 'H NMR (360 MHz, 
CDC13) 6 7.39 (1H, d, J = 15.3 Hz, CHCHCO), 7.31 (1H, d, J= 1.6 Hz, CH), 7.09 
(2H, d, J = 8.9 Hz, ArH), 6.93 (2H, d, J= 8.9 Hz, ArH), 6.47 (111, d, J= 3.3 Hz, 
CH), 6.36 (1H, dd, J = 3.3, 1.6 Hz, CH), 6.14 (1 H, d, J= 15.3 Hz, CHC=O), 4.02 
(2H, t, J= 7.4 Hz, CH2N), 3.84 (3H, s, OCH3), 2.77 (211, t, J = 7.4 Hz, CH2CH2N), 
2.13 (3H, s, CH3); 13C NMR (69.2 MHz, CDC13) 6 207.0 (C), 168.2 (C), 158.9 (C), 
151.5 (C), 143.8 (CH), 134.4 (C), 129.3 (2 x CH), 128.5 (CH), 116.3 (CH), 114.8(2 
x CH)-, -H-3-.7-(CH), 1-1-27.-O-(CH), 55 .4(CH45 2-(CH2)-4-LH2 -3Q.0-(GI43); 
HRMS (ES) Mass calcd for C,8H20N04  [M+H]: 314.1387, found: 314.1386. 
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o 	o 	N-(4-Methoxyphenyl)-N-(3-oxobutyl)-(E)-4-methylpeflt- 
Me1 	
2-enamide (131b). The title compound was prepared 
Me 	PMP 
according to General Procedure D from the amine 118 (1.00 
g, 5.20 mmol) and the acid chloride (prepared according to General Procedure A) 
derived from 4-methyl-2-pentenoic acid (890 mg, 7.80 mmol) for a reaction time of 
24 h and purified by column chromatography (30% EtOAc/petrol—+50% 
EtOAc/petrol) to give a yellow/orange solid (1.10 g, 73%). m.p. 95-96 °C; IR 
(CHC13) 2961, 1713 (C=O), 1661 (C=O), 1627, 1511, 1394, 1250, 1031, 838, 736 
cm'; 'H NMR (360 MHz, CDC13)  6 7.05 (2H, d, J= 8.9 Hz, ArH), 6.90 (2H, d, J= 
8.9 Hz, ArH), 6.81 (1H, dd, J= 15.2, 7.0 Hz, NCH=CH), 5.58 (1H, d, J= 15.2 Hz, 
NCH=CH), 3.96 (2H, t, J= 7.5 Hz, CH2N), 3.83 (3H, s, OCH3), 2.74 (2H, t, J= 7.5 
Hz, CH2CH2N), 2.27 (1H, heptet, J = 7.0 Hz, CH(CH3)2), 2.12 (3H, s, CH3), 0.91 
(611, d, J = 7.0 Hz, CH(CH3)2); '3C NMR (69.2 MHz, CDC13) 6 207.1 (C), 166.5 
(C), 158.8 (C), 152.4 (CH), 134.7 (C), 129.3(2 x CH), 118.7 (CH), 114.6(2 x CH), 
55.4 (CH), 45.1 (CH2), 41.6 (CH2), 31.0 (CH), 30.0 (CH3), 21.5 (2 x CH3); HRMS 
(ES) Mass calcd for C17H23NO3 [M+H]: 289.1673, found: 289.1674. 
N-Benzyl-N-(3-oxobutyl)propenamide (131c). The title 
Me
Bn   compound was prepared according to General Procedure D from 
methyl vinyl ketone (0.94 mL, 11.0 mmol), benzylamine (2.18 mL, 20.0 mmol) and 
acryloyl chloride (1.02 mL, 12.1 mmol) for a reaction time of 3 h. The product was 
purified by column chromatography (50% EtOAc/petrol) to give a colorless oil (1.08 
g, 47%) as a 2:1 mixture of rotamers. IR (film) 3063, 1714 (C=O), 1648 (C=C), 
1613, 1471, 1447, 1371, 978, 732, 699 cm'; 'H NMR (360 MHz, CDC13) (Major 
rotamer) 6 7.39-7.28 (411, in, ArH), 7.20-7.18 (1H, in, ArH), 6.56 (1H, dd, 1= 16.7, 
10.2 Hz, CH2 CH), 6.41 (111, dd, J= 16.7, 2.1 Hz, CH2=CH), 5.70 (1 H, dd, J= 
10.2, 2.1 Hz, CH2 CH), 4.70 (2H, s, CH2Ph), 3.65 (2H, t, J= 6.7 Hz, CH2CH2N), 
2.85 (211, t, J= 6.7 Hz, CH2CH2N), 2.14 (3H, s, CH3C=O); (Minor rotamer) 6 7.39-
7.28 (411, in, ArH), 7.20-7.18 (1H, m, ArH), 6.68 (1H, dd, J = 16.7, 10.3 Hz 
CH2 CH), 6.48 (1H, dd, J= 16 7, 1.9 Hz, C112=CH), 	ITTddJF03L9H 
CH2=CH), 4.68 (2H, s, CH2Ph), 3.63 (2H, t, J= 7.0 Hz, CH2CH2N), 2.66 (2H, t, J= 
7.0 Hz, CH2CH2N), 2.09 (3H, s, CH3C=O); 
13C NMR (62.9 MHz, CDC13) (Mixture 
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of rotamers - not fully assigned) 6 206.9 (C), 205.6 (C), 166.5 (C), 165.9 (C), 137.2 
(C), 136.6 (C), 128.5 (CH), 128.4 (CH), 128.2 (CH), 128.1 (CH2), 127.6 (CH), 127.3 
(CH), 127.1 (CH), 126.0 (CH), 51.8 (CH2), 48.9 (CH2), 42.3 (CH2), 42.0 (CH2), 41.5 
(CH2), 41.4 (CH2), 29.8 (Cl3), 29.6 (CH3); HRMS (ES) Exact mass calcd for 
C14H18NO2 [M+H: 232.1332, found: 232.1332. 
0 	0 	N-Benzyl-N-(3-oxobutyl)-(E)-4-methylpent-2-enamide 
Me N Me (131d). The title compound was prepared according to 
Me 	Bn 
General Procedure I from methyl vinyl ketone (1.88 mL, 
22.0 mmol), benzylamine (2.18 mL, 20.0 mmol) and the acid chloride (prepared 
according General Procedure A) derived from 4-methyl-2-pentenoic acid (2.76g, 
24.2 mmol) for a reaction time of 16 h. The product was purified by column 
chromatography (40% EtOAc/petrol) to give a white solid (2.36 g, 43%) as a 2:1 
mixture of rotamers. m.p. 59-61 °C; IR (CIIC13) 2923, 1713 (C0), 1650 (C=C), 
1423, 1214, 1161, 1016, 815, 732, 698 cm'; 'HNMR (360 MHz, CDC13) (Major 
rotamer) 6 7.35-7.23 (4H, in, ArH), 7.17-7.15 (1H, in, ArH), 6.90 (III, dd, J= 15.1, 
7.0 Hz, CHCH=), 6.12 (1H, dd, J= 15.1, 1.0 Hz, CICHCH), 4.64 (2H, s, CH2Ph), 
3.59 (21, t, J= 6.8 Hz, CH2CH2N), 2.80 (2H, t, J= 6.8 Hz, CH2CH2N), 2.43-2.34 
(11, in, (CH3)2CH), 2.10 (3H, s, CH3CO), 0.99 (61, J = 6.8 Hz, (CH3)2CH); 
(Minor rotamer) 6 7.35-7.23 (4H, in, ArH), 7.17-7.15 (11, in, ArH), 6.97 (1H, dd, J 
= 15.1, 7.0 Hz, CICH), 6.21 (lH, d, J = 15.1 Hz, CHCH=CH), 4.64 (2H, s, 
CH2Ar), 3.59 (2H, t, J = 7.1 Hz, CH2CH2N), 2.62 (2H, t, J = 7.1 Hz, CH2CH2N), 
2.51-2.43 (1H, in, (CH3)2CH), 2.06 (3H, s, CH3CO), 1.07 (6H, d, J = 6.7 Hz, 
(CH3)2CH); '3C NMR (62.9 MHz, CDC13) (Mixture of rotamers - not fully assigned) 
6 207.5 (C), 206.1 (C), 167.4 (C), 166.8 (C), 153.9 (CH), 153.4 (CH), 137.7 (C), 
137.2 (C), 128.7 (CH), 128.5 (CH), 128.0 (CH), 127.4 (CH), 127.2 (CH), 126.4 
(CH), 117.3 (CH), 116.9 (Cl), 52.2 (CH2), 49.3 (CH2), 42.8 (CH2), 42.3 (CH2), 41.9 
(CH2), 41.7 (CH2), 31.1 (CH), 30.2 (Cl3), 30.0 (CH3), 21.5 (Cl3); HRMS (ES) 




The title compound was prepared according to General 
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Procedure I from methyl vinyl ketone (1.88 mL, 22.0 mmol), benzylamine (2.18 mL, 
20.0 mmol) and cinnamoyl chloride (4.03 g, 24.2 mmol) for a reaction time of 3 h. 
The product was purified by column chromatography (30% EtOAc/petrol) to give a 
yellow solid (2.10 g, 34%) as a 2:1 mixture of rotamers. m.p. 71-73 °C; JR (CHC13) 
3027, 1713 (C=O), 1648 (C=C), 1426, 1203, 1161, 1028, 978, 764, 700 cm 1 ; 
'H NMR (360 MHz, CDC13) (Major rotamer) 6 7.79 (1H, d, J = 15.4 Hz, PhCH=), 
7.61-7.26 (10H, in, ArH), 6.86 (IH, d, J = 15.4 Hz, PhCH=CH), 4.80 (2H, s, 
CH2Ph), 3.73 (2H, t, J = 6.7 Hz, CH2CH2N), 2.90 (2H, t, J = 6.7 Hz, CH2CH2N), 
2.17 (3H, s, CH3C=O); (Minor rotamer) 6 7.85 (111, d, J= 15.3 Hz, PhCH=), 7.61-
7.26 (1 OH, in, ArH), 7.01 (1H, d, J= 15.3 Hz, PhCH=CH), 4.76 (211, s, CH2Ph), 
3.76 (2H, t, J= 7.1 Hz, CH2CH2N), 2.74 (2H, t, J= 7.1 Hz, CH2CH2N), 2.13 (3H, s, 
CH3C=O); '3C NMR (62.9 MHz, CDC13) (Mixture of rotamers - not fully assigned) 
6 207.4 (C), 206.0 (C), 167.0 (C), 166.4 (C), 143.5 (CH), 143.1 (CH), 137.5 (C), 
137.0 (C), 135.0 (C), 129.6 (CH), 128.8 (CH), 128.6 (CH), 128.5 (CH), 127.9 (CH), 
127.7 (CH), 127.6 (CH), 127.3 (CH), 126.4 (CH), 117.1 (CH), 116.9 (CH), 52.3 
(CH2), 49.5 (CH2), 42.9 (CH2), 42.6 (CH2), 41.8 (2 x CH2), 30.2 (CH3), 30.0 (CH3); 
HRMS (ES) Exact mass calcd for C20H21NO2 [M+Na]: 330.1465, found: 330.1465. 
° 	° 	N-benzyl-N-(3-oxobutyl)-(1l)-3-furan-2-yjpropenamide 
N 	M e 
(1310. The title compound was prepared according to Bn 
General Procedure I from methyl vinyl ketone (0.94 mL, 11.0 mmol), benzylamine 
(1.09 mL, 10.0 mmol) and the acid chloride (prepared according General Procedure 
A) derived from (2-furyl)acrylic acid (1.67 g, 12.1 mmol) for a reaction time of 14 h. 
The product was purified by column chromatography (40% EtOAc/petrol) to give an 
orange/red oil (1.56 g, 53%) as a 2:1 mixture of rotamers. JR (film) 2923, 1713 
(C=O), 1650 (C=C), 1423, 1214, 1161, 1016, 815, 732, 698 cm'; 'H NMR (360 
MHz, CDC13) (Major rotamer) 6 7.55 (1 H, d, J= 15.1 Hz, CH=CHC=O), 7.50-7.24 
(6H, in, ArH and CH), 6.78 (111, d, J= 15.1 Hz, CH=CHC=O), 6.58 (111, bs, CH), 
6.46-6.45 (1H, in, CH), 4.77 (211, s, CH2Ph), 3.69 (2H, t, J= 6.4 Hz, CH2CH2N), 
28-7-(HJ=-&4Hz-eHCHN) --27i 5 (3H, sCH3CO)(Minor rotamer) 6 1.61 
(I H, d, J= 15.2 Hz, CH=CHC=O), 7.50-7.24 (611, in, ArH and CH), 6.84 (1 H, d, J= 
15.2 Hz, CH=CHC=O), 6.62-6.58 (111, in, CH), 6.50-6.49 (1H, in, CH), 4.74 (211, s, 
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CH2Ar), 3.71 (2H, t, J= 6.9 Hz, CH2CH2N), 2.74 (2H, t, J= 6.9 Hz, CH2CH2N), 
2,13 (3H, s, CH3C=O); '3C NMR (62.9 MHz, CDC13) (Mixture of rotamers - not 
fully assigned) 6 207.5 (C), 206.1 (C), 166.9 (C), 166.3 (C), 151.5 (C), 143.9 (CH), 
137.6 (C), 137.1 (C), 130.3 (CH), 129.9 (CH), 128.8 (CH), 128.6 (CH), 128.0 (CH), 
127.6 (CH), 127.4 (CH), 126.6 (CH), 114.6 (CH), 114.3 (CH), 114.2 (CH), 114.0 
(CH), 112.1 (CH) 52.2 (CH2), 49.6 (CH2), 43.1 (CH2), 42.5 (CH2), 41.9 (CH2), 30.2 
(CH3), 30.0 (CH3); HRMS (ES) Exact mass calcd for C18H20NO3 [M+H: 298.1438, 
found: 298.1441. 
° 	° 	N-Benzyl-N-(3-oxo-3-phenylpropyl)-(E)-but-2-enamide 
Me 	N 	Ph 
(131g). The title compound was prepared according to 
General Procedure J from 3-chioropropiophenone (927 mg, 5.50 mmol), 
benzylamine (0.55 mL, 5.0 mmol) and crotonoyl chloride (0.72 mL, 7.5 mmol) for a 
reaction time of 5 h. The product was purified by column chromatography (20% 
EtOAc/CHC13) to give a colorless gum (1.27 g, 86%) as a 2:1 mixture of rotamers. 
IR (CHC13) 2914, 1713 (C=O), 1660 (C=C), 1449, 1369, 1160, 963, 815, 732, 698 
cm'; 'H NMR (360 MHz, CDC13) (Major rotamer) 6 7.96 (2H, d, J= 6.7 Hz, ArH), 
7.60-7.53 (IH, in, ArH), 7.47-7.43 (2H, m, ArH), 7.38-7.20 (5H, m, ArH), 7.11-6,95 
(1H, m, CH3CH=), 6.24 (1 H, dq, J = 14.9, 1.4 Hz, CH3CH=CH), 4.72 (2H, s, 
CH2Ph), 3.79 (2H, t, J= 6.8 Hz, CH2CH2N), 3.37 (2H, t, J= 6.8 Hz, CH2CH2N), 
1.82 (3H, dd, J = 6.8, 1.4 Hz, CH3CH=); (Minor rotamer) 6 7.85 (2H, d, J= 6.7 Hz, 
ArH), 7.60-7.53 (1H, m, ArH), 7.47-7.43 (2H, m, ArH), 7.38-7.20 (5H, m, ArH), 
7.11-6.95 (1H, m, CH3CH=), 6.36 (1H, d, J= 14.6 Hz, CH3CHCH), 4.71 (2H, s, 
CH2Ph), 3.79 (2H, t, J = 7.4 Hz, CH2CH2N), 3.17 (2H, t, J= 6.8 Hz, CH2CH2N), 
1.91 (3H, d, J= 6.5, 1.4 Hz, CH3CH=); '3C NMR (62.9 MHz, CDC13) (Mixture of 
rotamers - not fully assigned) 6 198.9 (C), 197.7 (C), 167.3 (C), 166.5 (C), 143.0 
(CH), 142.4 (CH), 137.7 (C), 137.2 (C), 136.5 (C), 136.2 (C), 133.5 (CH), 133.1 
(CH), 128.8 (CH), 128.6 (CH), 128.5 (CH), 128.1 (CH), 127.9 (CH), 127.5 (CH), 
127.3 (CH), 126.4 (CH), 121.6 (CH), 121.2 (CH), 52.3 (CH2), 49.3 (CH2), 43.2 
- 
	
	(CH2), 42.5 (CH2), 38.0 (CH2), 37.2 (CH3), 18.1 CH3), JR (CHC12914, 1713 
(C=O), 1660 (C=C), 1449, 1369, 1160, 963, 815, 732, 698 cm'; HRMS (ES) Exact 
mass calcd for C20H22NO2 [M+H]+: 308.1645, found: 308.1643. 
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Me 	0 	 a 	N-benzyl-N-(3-oxo-3-phenylpropyl)-(E)-5-methylhex- 
Me 	 Ph 2-enamide (131h). The title compound was prepared 
Bn 
according to General Procedure J from 3-
chioropropiophenone (1.85 mg, 11.0 mmol), benzylamine (1.10 mL, 10.0 mmol) and 
the acid chloride (prepared according to General Procedure A) derived from (E)-5-
methylhex-2-enoic acid (1.92 g, 15.0 mmol) for a reaction time of 15 h. The product 
was purified by column chromatography (15% EtOAc/CHC13) to give a yellow oil 
(1.62 g, 46%) as a 2:1 mixture of rotamers. JR (CHC13) 2955, 1680 (C=O), 1656 
(C=C), 1447, 1368, 1211, 1028, 980, 844, 742 cm'; 1 HNMR (360 MHz, CDC13) 
(Major rotamer) 6 8.02-8.00 (2H, in, ArH), 7.62-7.58 (lH, in, ArH), 7.51-7.46 (2H, 
in, ArH), 7.41-7.24 (SH, in, ArH), 7.01 (111, dt, J = 15.0, 7.5 Hz, CH2CH=), 6.24 
(1H, d, J = 15.0 Hz, CH2CH=CH), 4.76 (2H, s, CH2Ph), 3.83 (2H, t, .1 = 6.8 Hz, 
CH2CH2N), 3.41 (2H, t, J= 6.8 Hz, CH2CH2N), 2.10-2.06 (2H, in, CH2CH=), 1.86-
1.68 (1H, in, (CH3)2CH), 0.92 (6H, d, J = 6.8 Hz, (CH3)2CH); (Minor rotamer) 6 
7.88 (2H, d, J = 15.0 Hz, ArH), 7.64-7.58 (1H, in, ArH), 7.51-7.46 (2H, in, ArH), 
7.41-7.24 (511, in, ArH), 7.08 (1H, dt, J= 14.9, 7.4 Hz, CH2CH=), 6.35 (111, d, J= 
14.9 Hz, CH2CH=CH), 4.75 (2H, s, CH2Ph), 3.83 (2H, t, J = 7.4 Hz, CH2CH2N), 
3.21 (211, t, J= 7.4 Hz, CH2CH2N), 2.18-2.14 (2H, in, CH2CH=), 1.86-1.68 (1 H, in, 
(CH3)2CH), 0.97 (6H, d, .1= 6.6 Hz, (CH3)2CH); '3C NMR (62.9 MHz, CDC13) 
(Mixture of rotamers - not fully assigned) 6 198.9 (C), 197.6 (C), 167.3 (C), 166.5 
(C), 146.8 (CH), 146.1 (CH), 137.7 (C), 137.2 (C), 136.5 (C), 136.2 (C), 133.4 (CH), 
133.1 (CH), 128.7 (CH), 128.5 (CH), 128.0 (CH), 127.8 (CH), 127.4 (CH), 127,3 
(CH), 126.4 (CH), 121.1 (CH), 120.7 (CH), 52.3 (CH2), 49.3 (CH2), 43.3 (CH2), 42.5 
(CH2), 41.7 (CH2), 41.6 (CH2), 38.0 (CH2), 37.2 (CH2), 27.8 (CH), 22.2 (CH3); 
HRMS (ES) Exact mass calcd for C23H28NO2 [M+H]+: 350.2115, found: 350.2114. 
Co Et 	
1-[N-Acryloyl-N-(4-methoxyphenyl)aminomethyl]-2- 
oxocyclopentanecarboxylic acid ethyl ester (131i). The title 
PMP 
0 	 compound was prepared by General Procedure D from the amine 
r66(23800 mmol) diet34öyTThlOride (1-.02fflL71-270ThmoI) fotatttn 
time of 65 h and purified by column chromatography (40% EtOAc/petrol) to give a 
pale brown oil (1.78 g, 64%). JR (film) 2977, 1751 (C0), 1721 (C=O), 1659 (C=O), 
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1618, 1511, 1408, 1249, 1173, 1030 cm; 'H NMR (360 MHz, CDC13) 6 710 (2H, 
d, J= 8.5 Hz, ArH), 6.88-6.87 (2H, in, ArH), 6.30 (111, dd, J= 16.8, 2.0 Hz, CH2=), 
5.97 (1H, dd, J= 16.8, 10.3 Hz, CH2=CH), 5.50 (1 H, dd, .1= 10. 3, 2.0 Hz, CH2=), 
4.30 (2H, d, J= 5.2 Hz, CH2N), 3.86-3.78 (1H, in, OCH2CH3), 3.81 (3H, s, OCH3), 
3.72-3.63 (1H, in, OCH2CH3), 2.54-2.27 (3H, in, CH2CH2CH2), 2.19-1.97 (3H, in, 
CH2CH2CH2), 1.01 (3H t, J= 7.1 Hz, OCH2CH3); '3C NMR (62.9 MHz, CDC13) 6 
212.3 (C), 169.6 (C), 166.7 (C), 159.0 (C), 134.0 (C), 129.5 (2 x CH), 128.0 (CH and 
CH2), 114.4(2 x CH), 61.5 (CH2), 60.7 (C), 55.4 (CH3), 50.9 (CH2), 38.1 (CH2), 31.6 
(CH2), 19.5 (CH2), 13.7 (CH3); HRMS (FAB) Exact mass calcd for C19H24N05 
[M+H]: 346.1650, found: 346.1644. 
COEI 
1-[N-(E)-But-2-enoyl-N-(4-methoxyphenyl)aminomethyl]-2- 
Me 	 oxocyclopentanecarboxylic acid ethyl ester (131j). The title 
mi;~D 
compound was prepared by General Procedure D from the 
amine 166 (295 mg, 1.00 mmol) and crotonoyl chloride (143 tL, 1.50 mrnol) for a 
reaction time of 24 h and purified by column chromatography (30% EtOAc/petrol) to 
give a pale brown oil (307 mg, 84%). IR (film) 2965, 1750 (C=O), 1719 (C=O), 
1666 (C=O), 1629, 1510, 1445, 1289, 1249, 1029 cm-1 ; 'H NMR (360 MHz, CDC13) 
6 7.09 (2H, d, J= 8.4 Hz, ArH), 6.92-6.82 (3H, in, ArH and CH3CH=), 5.65 (1H, dq, 
.1= 15.1, 1.7 Hz, CH3CH=CH), 4.33 (1H, d, J= 13.9 Hz, CH2N), 4.25 (1H, d, J 
=13.9 Hz, CH2N), 3.87-3.78 (1H, in, OCH2CH3), 3.83 (3H, s, OCH3), 3.72-3.63 (1H, 
in, OCH2CH3), 2.55-1.97 (6H, in, CH2CH2CH2), 1.71 (3H, dd, .J= 6.9, 1.7 Hz, 
CH3CH), 1.01 (3H, t, J = 7.1 Hz, OCH2CH3); '3C NMR (62.9 MHz, CDC13) 6 
212.4 (C), 169.6 (C), 167.0 (C), 158.9 (C), 142.0 (CH), 134.3 (C), 129.5 (2 x CH), 
122.2 (CH), 114.3 (2 x CH), 61.4 (CH2), 60.8 (C), 55.4 (CH3), 50.8 (CH2), 38.1 
(CH2), 31.5 (CH2), 19.5 (CH2), 18.0 (CH3), 13.7 (CH3); HRMS (FAB) Exact mass 
calcd for C20H26N05 [M+H]: 360.1806, found: 360.1809. 
1-[N-(4-Methoxyphenyl)-N-((E)-3- 
	
2-oxocydo1Jentanecarboxylic 	 - 
acid ethyl ester (131k). The title compound was prepared by 
General Procedure D from the amine 166 (2.33 g, 8.00 mmol) and cinnamoyl 
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chloride (2.04 g, 12.0 mmol) for a reaction time of 65 h and purified by column 
chromatography (10% EtOAc/petrol—+30% EtOAc/petrol) to give a pale brown gum 
(2.19 g, 65%). JR (film) 2961, 1750 (C=O), 1720 (C=O), 1655 (C=O), 1616, 1510, 
1249, 1029, 839, 806 cm'; 'H NMR (360 MHz, CDC13) 6 7.62 (1 H, d, J= 15.6 Hz, 
PhCH=), 7.29 (511, br s, ArH), 7,16 (2H, app d, J= 7.8 Hz, ArH), 6.92 (2H, d, J 
9.1 Hz, ArH), 6.27 (1 H, d, J = 15.6 Hz, PhCH=CH), 4.40 (1 H, d, J = 13.9 Hz, 
CH2N), 4.34 (1H, d, J= 13.9 Hz, CH2N), 3.90-3.81 (1H, in, OCH2CH3), 3.85 (3H, s, 
OCH3), 3.77- 3.67 (111, m, OCH2CH3), 2.58-2.30 (3H, in, CH2CH2CH2), 2.24-2.13 
(2H, in, CH2CH2CH2), 2.09-1.98 (1 H, in, CH2CH2CH2), 1.04 (3H, t, J= 7.1 Hz, 
OCH2CH3); '3C NMR (90.6 MHz, CDC13) 6 212.5 (C), 169.6 (C), 167.1 (C), 159.0 
(C), 142.5 (CH), 135.0 (C), 134.1 (C), 129.6 (2 x CH), 128.6 (2 x CH), 127.9 (2 x 
CH), 118.1 (CH), 114.4 (2 x CH), 61.5 (CH2), 60.9 (C), 55.5 (CH3), 51.0 (CH2), 38.2 
(CH2), 31.6 (CH2), 19.6 (CH2), 13.7 (CH3); LRMS (ES) Mass calcd for C25H28N05 
[M+H]: 422.2, found: 422.0. 
N-(4-Methoxyphenyl)-N-(2-oxopropyl)propenamide 	(1 13a). 




phenyipropenamide (113c). Prepared according to a previously 
PMP 0 	reported procedure (Chapter 3.3). 
OMe 	0 	
N-(4-Methoxyphenyl)-N-(2-oxopropyl)-(E)-3-(2- 
N'Y Me methoxyphenyl)propenamide (1311). The title compound 
PMP 0 	was prepared according to General Procedure D from the 
amine 126 (537 mg, 3.00 mmol) and the acid chloride (prepared according to 
General Procedure A) derived from 2-methoxycinnamic acid (801 mg, 4.30 mmol) 
for a reaction time of 24 h and purified by column chromatography (30% 
EtOAcipetro]5O°LEtQAcLpetroI)Iogivea_beige solid (6L7mg, 	._m.p.11t_ 
112 °C; JR (CHC13) 2935, 1733 (C0), 1652 (C0), 1613, 1510, 1376, 1248, 1070, 
1028, 755 cm'; 'H NMR (360 MHz, CDC13)  8 7.97 (1H, d, J= 15.7 Hz, ArCH=), 
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7.30-7.24 (4H, in, ArH), 6.93 (2H, dd, J = 8.9 Hz, ArH), 6.88-6.83 (2H, m, Aril), 
6.52 (111, d, J = 15.7 Hz, ArCH=CH), 4.53 (2H, s, CH2N), 3.85 (3H, s, OCH3), 3.76 
(3H, s, 0CH3), 2.22 (3H, s, CH3C=O); '3C NMR (62.9 MHz, CDC13) 6 202.7 (C), 
166.8 (C), 158.9 (C), 158.1 (C), 137.8 (CH), 135,9 (C), 130.7 (CH), 129.2 (2 x CH), 
128.7 (CH), 124.0 (C), 120.4 (CH), 118.5 (CH), 114.5 (2 x CH), 110.9 (CH), 59.7 
(CH2), 55.4 (CH3), 55.2 (CH3), 27.2 (CH3); HRMS (FAB) Exact mass calcd for 
C20H22N04 [M+H]: 340.1544, found: 340.1549. 
° 	 N-(4-Methoxyphenyl)-N-(2-oxopropyl)-(E)-3-furan-2- 
	
PI MP 0 	y1propenamide (131m). The title compound was prepared 
according to General Procedure D from the amine 126 (1.07 g, 6.00 mmol) and the 
acid chloride (prepared according to General Procedure A) derived from 3-(2-
furyl)acrylic acid (1.24 mg, 9.00 mmol) for a reaction time of 24 hand purified by 
recrystallisation (30% EtOAc/petrol) to give brown needles (590 mg, 33%). m.p. 
103-104 °C; JR (CHC13) 2918, 1733 (C0), 1655 (C0), 1615, 1511, 1374, 1250, 
1171, 1017, 840 cm-1; 'H NMR (360 MHz, CDC13) 6 7.46 (IH, d, J = 15.3 Hz, 
ArCH=CH), 7.37 (1 H, d, J= 1.7 Hz, ArH), 7.28 (2H, d, J= 8.9 Hz, ArH), 6.95 (2H, 
d,J= 8.9 Hz, ArH), 6.53 (1 H, d,J= 3.4 Hz, ArCH=CH), 6.31 (1H, d,,J= 15.3 Hz, 
ArCH=CH), 4.54 (2H, s, CH2N), 3.87 (3H, s, OCH3), 2.23 (3H, s, CH3C=O); '3C 
NMR (62.9 MHz, CDC13) 6 202.5 (C), 166.3 (C), 159.0 (C), 151.5 (C), 144.0 (CH), 
135.2 (C), 129.1 (2 x CH), 115.4 (CH), 114.7(2 x CH), 114.0 (CH), 112.0 (CH), 
59.9 (CH), 55.4 (CH3), 27.2 (CH3); HRMS (FAB) Exact mass calcd for C17H17N04 




chlorophenyl)propenamide (131n). The title compound 
was prepared according to General Procedure D from the 
amine 126 (1.07 g, 6.00 mmol) and the acid chloride (prepared according to General 
Procedure A) derived from 4-chiorocinammic acid (1.64 mg, 9.00 mmol) for a 
—reaction-time-of-2 	 recrystallisation-(EtGH)-to-give-a beige-micro 
crystalline solid (756 mg, 37%). m.p. 119-120 °C; IR (CHC13) 2924, 1732 (C=O), 
1654 (C=O), 1616, 1511, 1491, 1378, 1250,980cm 1 ; 'H NMR (36O MHz, CDC13)6 
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7.63 (1H, d, J= 15.6 Hz, ArCH=CH), 7.28 (2H, d, J= 9.0 Hz, ArH), 6.95 (2H, d, J= 
9.0 Hz, ArH), 6.38 (III, d, J = 15.6 Hz, ArCH=CH), 4.55 (2H, s, CH2N), 3.87 (3H, 
s, OCH3), 2.23 (3H, s, CH3C=O); '3C NMR (62.9 MHz, CDC13) 5 202.4 (C), 166.1 
(C), 159.1 (C), 141.1 (C), 135.4 (CH), 135.4 (C), 135.1 (C), 133.5 (C), 129.2 (2 x 
CH), 129.1 (CH), 128.9 (CH), 118.3 (CH), 114.7(2 x CH), 59.9 (CH2), 55.5 (CH), 
27.2 (CH3); HRMS (FAB) Exact mass calcd for C19H18C1NO3 [M+H]: 344.1048, 
found: 344.1049. 
N-(4-Methoxyphenyl)-N-(2-oxo-2-phenylethyl)propenaflhide 
Ph (133a). The title compound was prepared according to general 
PMP 0 	procedure D from the amine 167 (1.00 g, 4.12 mmol) and acryloyl 
chloride (500 iL, 6.10 mmol) for a reaction time of 20 h and purified by column 
chromatography (40% EtOAc/petrol) to give a yellow solid (790 mg, 65%). m.p. 78-
80 °C; IR (CHC13) 2925, 1699 (C=O), 1655 (C=C), 1509, 1421, 1248, 1221, 979, 
754 cm'; 'H NMR (360 MHz, CDC13) 5 8.00-7.97 (2H, in, ArH), 7.61-7.57 (1 H, in, 
ArH), 7.50-7.45 (2H, in, ArH), 7.33 (211, dm, J = 8.9 Hz, ArH), 6.93 (211, dm, J = 
9.0 Hz, ArH), 6.42 (1H, dd,J = 16.8, 2.1 Hz, CH2=), 6.21 (1H, dd, J= 16.8, 10.3 Hz, 
CH2=CH), 5.60 (1H, dd, J= 10.3, 2.1 Hz, CH2 ), 5.18 (2H, s, CH2N), 3.83 (311, s, 
OCH3); '3C NMR (62.9 MHz, CDC13) 6  193.4 (C), 166.0 (C), 159.0 (C), 135.1 (C), 
135.0 (C), 133.4 (2 x CH), 129.4 (2 x CH), 128.6 (2 x CH2), 128.0 (CH), 127.9 (2 x 
CH), 127.8 (CH), 114.5 (2 x CH), 56.4 (CH2), 55.4 (CH3); HRMS (FAB) Exact mass 
calcd for C18H18NO3 [M+H]: 296.1282, found: 296.1286. 
° 	 N-(4-Methoxybenzyl)-N-(2-oxo-2-phenylethyl)PrOPeflamide 
PMB g 	(133b). The title compound was prepared according to general 
procedure D from the amine hydrochloride 168 (870 mg, 3.00 mmol) and acryloyl 
chloride (360 giL, 4.48 mmol) for a reaction time of 20 h and purified by column 
chromatography (40% EtOAc/petrol) to give a pale yellow solid (650 mg, 46%) as a 
3:1 mixture of rotamers. m.p. 78-80 °C; JR (CIICI3) 2930, 1698 (C=O), 1650 (C=C), 
1512, 1448, 1247, 1031, 754 cmH NMR (360 MHz, CD(Mdtamer6 
7.95-7.93 (211, in, ArH), 7.62-7.56 (111, in, ArH), 7.50-7.43 (211, in, ArH), 7.16-7.14 
(211, m, ArH), 6.90-6.88 (2H in, ArH), 6.72 (111, dd, J = 16.7, 10.4 Hz, CH2CH), 
Chapter 4—Cobalt-Catalysed Reductive Aldol Cyclisations 	 126 
6.45 (1H, dd, J = 16.7, 1.9 Hz, CH2=), 5.77 (1H, dd, J= 10.4, 1.9 Hz, CH2=), 4.81 
(2H, s, NCH2C=O), 4.68 (2H, s, CH2Ar), 3.80 (3H, s, OCH3); (Minor rotamer) 6 
7.89-7.86 (2H, in, ArH), 7.62-7.60 (1H, in, ArH), 7.50-7.43 (2H, in, ArH), 7.21-7.13 
(2H, in, ArH), 6.86-6.83 (2H, in, ArH), 6.40 (1H, dd, J= 16.7, 2.2 Hz, CH2=), 6.29 
(1H, dd, J= 16.7, 10.1 Hz, CH2=CH), 5.66 (1 H, dd, J= 10. 1, 2.2 Hz, CH2=), 4.81 
(2H, s, NCH2C=O), 4.69 (2H, s, CH2Ar), 3.78 (3H, s, OCH3); '3C NMR (62.9 MHz, 
CDC13) (Mixture of rotamers - not fully assigned) 6 194.1 (C), 193.5 (C), 167.4 (C), 
167.2 (C), 159.3 (C), 159.1 (C), 135.2 (C), 134.6 (C), 134.0 (C), 133.5 (CH), 129.9 
(CH), 129.2 (CH2), 128.9 (CH), 128.8 (CH), 128.6 (CH), 128.4 (CH2), 128.1 (CH), 
127.9 (CH), 127.8 (CH), 127.6 (CH), 114.3 (CH), 114.3 (CH), 55.3 (CH3), 52.5 
(CH3), 51.5 (CH2), 49.4 (CH2); HRMS (ES) Exact mass calcd for C19H20NO3 





(137a). The title compound was prepared according to General 
Procedure D from the amine 118 (1.00 g, 5.20 mmol) and methacryloyl chloride (755 
iL, 7.80 mmol) for a reaction time of 18 h and purified by column chromatography 
(30% EtOAc/petrol—+50% EtOAc/petrol) to give an orange/brown solid (976 mg, 
72%). m.p. 64-65 °C; JR (CHC13) 2954, 1713 (C=O), 1651 (C0), 1626, 1512, 1371, 
1249, 1182, 1031, 836 cm'; 'H NMR (360 MHz, CDC13) 67.01 (2H, d, J= 8.8 Hz, 
ArH), 6.83 (2H, d, J= 8.8 Hz, ArH), 5.00 (1H, s, CH=), 4.97 (1H, s, CH=), 3.96 
(2H, t, J= 7.4 Hz, CH2N), 3.79 (3H, s, UCH3), 2.72 (2H, t, J= 7.4 Hz, CH2CH2N), 
2.11 (3H, s, CH3C=U), 1.69 (3H, s, =CCH3); '3C NMR (69.2 MHz, CDC13) 6 207.0 
(C), 172.0 (C), 158.5 (C), 140.7 (C), 135.4 (C), 128.6 (2 x CH), 119.3 (CH2), 114.4 
(2 x CH), 55.4 (CH3), 45.2 (CH2), 41.2 (CH2), 30.0 (CH3), 20.2 (CH3); HRMS (ES) 
Exact mass calcd for C15H20NO3 [M+H]: 262.1438, found: 262.1438. 
o 	a 	N-(4-Methoxyphenyl)-N-(3-oxobutyl)-(Il)-2-methylbut-2- 
Me Me enamide (137b). The title compound was prepared according 
Me PMP 
tGenera[Peduié Dfr6th thëiiñë 118 (965 mg, 500 
mmol) and the acid chloride (prepared according to General Procedure A) from tiglic 
acid (613 mg, 6.00 mmol) for a reaction time of 18 h and purified by column 
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chromatography (30% EtOAc/petrol) to give an orange/brown oil (500 mg, 36%). IR 
(CHC13) 3489 (OH), 2961, 1732 (C=O), 1660 (C=O), 1513, 1380, 1251, 1171, 841, 
606 cm'; 'H NMR (360 MHz, CDC13) 8 6.98 (2H, d, J= 9.0 Hz, ArH), 6.82 (2H, d, 
J= 9.0 Hz, ArH), 5.77-5.70 (1H, m, CH3CH=C), 3.95 (2H, t, J= 7.4 Hz, CH2N), 
3.79 (3H, s, OCH3), 2.72 (2H, t, J= 7.4 Hz, CH2CH2N), 2.11 (3H, s, J= 6.8 Hz, 
CH3C=O), 1.48 (3H, s, =C(CH)3C=O), 1.49-1.45 (3H, m, CH3CH=); '3C NMR 
(69.2 MHz, CDCI3) 6 207.1 (C), 173.3 (C), 158.1 (C), 135.8 (C), 132.7 (C), 130.4 
(CH), 128.5 (2 x CH), 114.3 (2 x CH), 55.3 (CH3), 45.4 (CH), 41.3 (CH2), 30.0 
(CH3), 13.9 (CH3), 13.2 (CH3). 
Cobalt-Catalyzed Reductive Aldol Cyclizations 
Co (5 mol%) 	 0 
ligand (5.5 mol%) 
RI X(R 	
reductant (2 equiv) 	R1 
  THF/hexane 	 R2 ) fl  
0 	 OCtoRT HO 
Using Co(acac)2/Et2Zn: General Procedure K 
A solution of the substrate (0.20 mmol) and Co(acac)2 2H20 (2.6 mg, 0.01 mmol) in 
THF (1.5 mL) was stirred at room temperature for 15 mm. The mixture was cooled 
to 0 °C and Et2Zn (1 M solution in hexane, 0.40 mL, 0.40 rnmol) was then added 
dropwise over 1 mm. The reaction was stirred at 0 °C for 1 h and then at room 
temperature until complete consumption of starting material as observed by TLC 
analysis. Workup was carried out according to one of the procedures described 
below. 
Using CoC12/Cy2PPh/Et2Zn: General Procedure L 
A solution of the substrate (0.20 mmol), CoC12 (1.3 mg, 0.01 mmol) and Cy2PPh (3.0 
mg, 0.011 mmol) in THF (1.5 mL) was stirred at room temperature for 30 mm. The 
mixture was cooled to 0 °C and Et2Zn (1 M solution in hexane, 0.40 mL, 0.40 mmol) 
was then added dropwise over 1 mm. The reaction was stirred at 0 °C for 1 h and 
then at room temperature until complete consumption of starting material as 
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observed by TLC analysis. Workup was carried out according to one of the 
procedures described below. 
Using Co(acac)2/Et3A1: General Procedure M 
A solution of the substrate (0.20 mmol) and Co(acac)2-2H20 (2.6 mg, 0.01 mmol) in 
THF (3 mL) was stirred at room temperature for 15 mm. The mixture was cooled 0 
°C and Et3A1 (1 M solution in hexane, 0.40 mL, 0.40 mmol) was added dropwise 
over 5 mm. The reaction was stirred at 00  C for 1 h and then at room temperature 
until complete consumption of the starting material as observed by TLC analysis. 
The reaction was quenched carefully by the addition of I M HC1 (5 mL). The mixture 
was extracted with CH2C12 (3 x 10 mL) and the combined organic layers were dried 
(MgSO4) and concentrated in vacuo. Purification of the residue by column 
chromatography afforded the cyclized product. 
Workup A 
The reaction mixture was filtered through a short plug of Si02 (ca. 4 cm high x 2 cm 
diameter) using EtOAc as eluent (Ca. 50 mL) and the filtrate was concentrated in 
vacuo. Purification of the residue by column chromatography afforded the cyclized 
product. 
Workup B 
The reaction was quenched carefully with saturated aqueous NI-L1C1 solution (10 mL) 
and the mixture was then extracted with CH2C12 (3 x 10 mL). The combined organic 
layers were dried (MgSO4) and concentrated in vacuo. Purification of the residue by 
column chromatography (EtOAc/petrol) afforded the cyclized product. 
P M P 
(±)-(31R)nzy1yoxy-1-(4-methoxyphy14 
Me 	 methylpiperidin-2-one (901). On a 0.20 mniofliJe: The title 
HO compound was prepared according to General Procedure K from 
891 (65 mg, 0.20 mmol) for a reaction time of 4 h followed by Workup A and 
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purification by column chromatography (30% EtOAc/CHC13) to give a white solid 
(58 mg, 89%). 
On a 5.00 mmol scale. A solution of 891 (1.62 g, 5.00 mmol) and Co(acac)2 2H20 
(6.4 mg, 0.025 mmol) in THF (10 mL) was stirred at room temperature for 15 mm. 
The mixture was cooled to 0 °C and Et2Zn (1 M solution in hexane, 10.0 mL, 10.0 
mmol) was then added dropwise over 5 mm. The mixture was stirred at 0 °C for 1 h 
and then at room temperature for 2.5 h. The reaction was filtered through a short pad 
Of Si02 (Ca. 5 cm high x 3 cm diameter) using EtOAc (200 mL) as eluent and the 
filtrate was concentrated invacu ,o. Purification of the residue by column 
chromatography (30% EtOAc/CHC13) gave the lactan1 901 (1.28 g, 79%) as a white 
solid. 
m.p. 156-157 °C; JR (CHC13) 3409, 2935, 1630 (C0), 1605, 1511, 1442, 1334, 
1245, 1141, 1033 cm'; 1 H NMR (360 MHz, CDCI3) ö 7.38 (2H, d, J = 7.3 Hz, 
ArH), 7.27 (2H, t,J= 7.5 Hz, ArH), 7.18 (1H, d,J= 7.3 Hz, ArH), 7.15 (2H, d, J= 
9.0 Hz, ArH), 6.90 (2H, dm, J = 9.0 Hz, ArH), 3.82 (1H, ddd, J= 12.1, 7.4, 7.4 Hz, 
CH2CH2N), 3.84 (3H, s, OCH3), 3.41 (1 H, ddd, J= 10.5, 5.3, 5.3 Hz, CH2CH2N), 
3.34 (111, dd, J= 14.5, 5.3 Hz, CH2CH), 3.14 (1 H, dd, J= 14.5, 5.3 Hz, CH2CH), 
2.72 (1 H, t, J= 5.3 Hz, CH2CH), 1.95 (2H, app dd, .1=7.4, 5.3 Hz, CH2CH2N), 1.79 
(111, s, OH), 1.34 (3H, s, CH3COH); '3C NMR (62.9 MHz, CDC13) 6  171.4 (C), 
158.0 (C), 142.1 (C), 136.2 (C), 129.2 (2 x CH), 128,4 (2 x CH), 127.4 (2 x CH), 
125.9 (CH), 114.4 (2 x CH), 71.1 (C), 55.4 (CH3), 54.6 (CH), 47.3 (CH2), 36.1 
(CH2), 32.3 (CH2), 29.0 (CH3); HRMS (ES) Exact mass calcd for C20H23NO3Na 
[M+Na]: 348.1570, found: 348.1571. 
/y'-' N PMP 	
(±)-(3R,4R)-3-Furan-2-ylmethyl-4-hydroxy- 1-(4- 
methoxyphenyl)-4-methylpiperidin-2-one (132a). The title 
HO 	
compound was prepared according to General Procedure K from 
13i(63mg,0.20—mmol) for areaction time ofi6hfollowed_by_Woflcup_A_and 
purification by column chromatography (30% EtOAc/CHC13) to give a white solid 
(57 mg, 90%). m.p. 150-152 °C; JR (film) 3410, 2934, 1631 (C=O), 1604, 1511, 
Chapter 4—Cobalt-Catalysed Reductive Aldol Cyclisations 	 130 
1442, 1297, 1244, 1145, 1033 cm'; 'H NMR (360 MHz, CDC13) 6 7.33 (1H, dd, J= 
1.9, 0.8 Hz, CH), 7.14 (2H, dm, J = 9.0 Hz, ArH), 6.90 (2H, dm, J = 9.0 Hz, ArH), 
6.31 (1H, dd, J= 3.2, 1.9 Hz, CH), 6.16 (1H, dd, J = 3.2, 0.8 Hz, CH), 3.84 (1 H, 
ddd, J= 12.2, 100, 5.2 Hz, CH2CH2N), 3.80 (3H, s, OCR1), 3.45-3.39 (1H, in, 
CH2CH2N), 3.37 (1H, dd, J= 15.6, 5.0 Hz, CH2CH), 3.25 (1H, dd, J= 15.6, 6.2 Hz, 
CH2CH), 2.79 (1H, dd, J= 6.2, 5.0 Hz, CH2CH), 2.18 (1H, s, OH), 2.02-1.94 (1H, 
in, CH2CH2N), 1.88 (1H, dt, J= 13.7, 4.9 Hz, CH2CH2N), 1.32 (3H, s, CH3COH); 
'3C NMR (62.9 MHz, CDC13) 6 170.5 (C), 158.0 (C), 154.5 (C), 140.6 (CH), 136.2 
(C), 127.3 (2 x CH), 114.4 (2 x CH), 110.9 (CH), 107.0 (CH), 70.3 (C), 55.4 (CH3), 
51.8 (CH), 47.2 (CH2), 36.2 (CH2), 28.6 (CH3), 24.8 (CH2); HRMS (FAB) Exact 





Me 	 methoxyphenyl)-4-methylpiperidin-2-one (132b). The title 
HO 
compound was prepared according to General Procedure K from 
131b (58 mg, 0.20 mmol) for a reaction time of 16 h followed by Workup A and 
purification by column chromatography (20% EtOAc/CHC13) to give a white solid 
(45 mg, 78%). m.p. 120 °C; JR (film) 3416, 2954, 1631 (C=O), 1605, 1512, 1442, 
1297, 1244, 1143, 1034 cm'; 'H NMR (360 MHz, CDC13) 6 7.14 (1H, d, J= 9.0 Hz, 
ArH), 6.90 (2H, d, .1 = 9.0 Hz, ArH), 3.83 (lH, ddd, J = 12.1, 8.5, 5.6 Hz, 
CH2CH2N), 3.80 (3H, s, OCH3), 3.47 (1H, dt, J = 8.3, 2.6 CH2CH2N), 2.10-1.94 
(lH, in, CH2CH2N), 1.82 (IH, ddd, J = 13.4, 8.3, 4.7 Hz), 1.39 (3H, s, CH3COH), 
0.97 (3H, d, J = 6.7 Hz CH(CH3)2), 0.95 (3H, d, J = 6.7 Hz CH(CH3)2); '3C NMR 
(62.9 MHz, CDC13) 6 172.6 (C), 158.0 (C), 136.2 (C), 127.4 (2 x CH), 114.4 (2 x 
CH), 70.9 (C), 55.5 (CH), 50.4 (CH), 47.3 (CH2), 35.9 (CH2), 35.3 (CH), 28.5 
(CH3), 27.8 (CH), 23.5 (CH3), 21.6 (CH3); HRMS (ES) Exact mass calcd for 
C17H25NO3 [M+H]: 292.1907, found: 292.1905. 
(±)-(3R,4R)-1.-Benzyl-4-hydroxy-3,4-dimethylpiperidin-2-one 
- .Me. 	-- -- 	...an. 	 ... 
N 	 132c). The title compound was prepared according to General 
Me.... 
HO 	 Procedure K from 131c (46 mg, 0.20 mmol) for a reaction time of 8 h 
followed by Workup A and purification by column chromatography (80% 
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EtOAc/petrol) to give a white solid (41 mg, 88%). m.p.155-157 °C; IR (CHC13) 3335 
(OH), 2980, 1605 (C=O), 1496, 1509, 1360, 1236, 1196, 927, 735 cm-1; 'H NMR 
(360 MHz, CDC13) 6 7.33-7.22 (5H, m, ArH), 4.76 (lH, d, J = 14.8 Hz, CH2Ph), 
4.40(111, d,J= 14.8 Hz, CH2Ph), 3.44(IH, ddd, J= 12.1, 10.2, 5.3 Hz, CH2CH2N), 
3.09 (1H, ddd, J= 12.1, 6.1, 3.9 Hz, CH2CH2N), 2.38 (1H, q, J= 7.3 Hz, CH3CH), 
1.99(111, brs, OH), 1.90(IH, ddd, J= 13.6, 5.3, 3.9 Hz, CH2CH2N), 1.79 (1H, ddd, 
J = 13.6, 10.2, 6.1 Hz, CH2CH2N), 1.33 (3H, d, J = 7.3 Hz, CH3CH), 1.31 (3H, s, 
CH3COH); '3C NMR (62.9 MHz, CDC13) 6 171.7 (C), 137.2 (C), 128.5 (2 x CH), 
127.8 (2 x CH), 127.2 (CH), 69.9 (C), 50.2 (Cl2), 46.7 (CH), 42.9 (CH2), 34.8 
(CH2), 28.3 (CH3), 10.4 (CH3); HRMS (ES) Exact mass calcd for C14H,9NO2 
[M+H]: 234.1489, found: 234.1491, 
i-Pr 	 N Bn 
	
(±)-(3R,41?)-1-Benzy1-3-o--4-hydr0xy-4-methy1piperi 
Me.....2-one (132d). The title compound was prepared according to 
HO General Procedure K from 131d (55 mg, 0.20 mmol) for a reaction 
time of 8 h using Workup A and purified by column chromatography (50% 
EtOAc/petrol) to give a white solid (55 mg, >99%). m.p. 113-115 °C; JR (CHC13) 
3407 (OH), 2954, 1620 (C=O), 1495, 1452, 1267, 1150, 1116, 732, 700 cm
1 ; 
'H NMR (360 MHz, CDC13) 6 7.37-7.27 (5H, m, ArH), 4.72 (111, d, J= 14.7 Hz, 
CH2Ph), 4.49 (1H, d, J = 14.8 Hz, CH2Ph), 3.41 (1 H, ddd, J = 12.3, 7.9, 5.8 Hz, 
CH2CH2N), 3.15-3.08 (1H, m, CH2CH2N), 2.32 (1H, dd, J= 8.2, 2.8 Hz, CH2CH), 
2.11-1.93 (2H, m), 1.84-1.71 (3H, m) and 1.46 (1H, ddd, J= 13.6, 9.2, 3.0 Hz, 
CH2CH2N, (CH3)2CHCH2 and OH), 1.32 (3H, s, CH3COH), 1.03 (3H, d, J= 6.7 
Hz, (CH3)2CH), 0.99 (3H, d, J= 6.7 Hz, (CH3)2CH); '3C NMR (62.9 MHz, CDC13) 6 
172.3 (C), 137.3 (C), 128.5 (2 x CH), 127.9 (2 x CH), 127.2 (CH), 127.9 (2 x Cl), 
127.2 (Cl), 70.6 (C), 50.2 (CH), 50.0 (CH2), 43.0 (CH2), 36.4 (CH2), 34.2 (CH2), 
28.2 (CH3), 27.7 (CH), 23.5 (CH3), 21.7 (CH3); HRMS (ES) Exact mass calcd for 
C17H26NO2 [M+H]: 276.1958, found: 276.1960. 
PV' 11 ,N
IBn 
 (132e). The title compound was prepared according to General y  
HO 	Procedure K from 131e (61 mg, 0.20 mmol) for a reaction time of 8 h 
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followed by Workup A and purification by column chromatography (60% 
EtOAc/petrol) to give a white solid (60 mg, 97%). m.p. 137-139 °C; IR (CHC13) 
3399 (OH), 2928, 1617 (C=O), 1495, 1452, 1353, 1267, 1030, 740, 700 cm 1 ; 
'H NMR (360 MHz, CDC13) 6 7.44-7.41 (2H, in, ArH), 7.39-7.28 (7H, in, ArH), 
7.26-7.21 (1H, in, ArH), 4.76 (1H, d, J= 14.7 Hz, NCH2Ph), 4.58 (1H, d, J = 14.7 
Hz, NCH2Ph), 3.47 (1 H, ddd, J= 12.2, 9.1, 5.6 Hz, CH2CH2N), 3.37 (111, dd, J= 
14.4, 5.4 Hz, CH2CH), 3.23 (1H, dd, J= 14.4, 5.4 Hz, CH2CH), 3.16-3.09 (1H, in, 
CH2CH2N), 2.73 (111, t, J= 5.4 Hz, CH2CH), 1.92-1.78 (311, in, CH2CH2N and OH), 
1.31 (3H, s, CH3); '3C NMR (62.9 MHz, CDC13) 6 171.1 (C), 141.9 (C), 137.1 (CH), 
129.2 (2 x CH), 128.5 (2 x CH), 128.4 (2 x CH), 127.9 (2 x CH), 127.2 (C), 126.0 
(C), 71.0 (C), 54.2 (CH), 50.4 (CH2), 43.0 (CH2), 35.2 (CH2), 32.8 (CH2), 28.9 




OMe' 	 methylpiperidin-2-one (132!). The title compound was prepared 
HO 
according to General Procedure K from 131f (59 mg, 0.20 mmol) 
for a reaction time of 8 h followed by Workup A and purification by column 
chromatography (50% EtOAc/petrol) to give a white solid (59 mg, >99%). m.p. 120-
122 °C; JR (CHCI3) 3409 (OH), 2925, 1620 (C=O), 1496, 1452, 1270, 1146, 1008, 
731, 705 cm'; 'H NMR (360 MHz, CDC13) 6 7.37-7.26 (6H, in, ArH and CH), 6.36-
6.34 (111, in, CH), 6.20-6.19 (111, in, CH), 4.72 (lH, d, J= 14.7 Hz, NCH2Ar), 4.57 
(111, d,J = 14.7 Hz, NCH2Ar), 3.46(111, ddd,J = 12.1, 9.1, 5.9 Hz, CH2CH2N), 3.40 
(1H, dd, J= 15.5, 4.9 Hz, CH2CH), 3.32 (1H, dd, J= 15.5, 6.2 Hz, CH2CH), 3.14-
3.08 (1H, in, CH2CH2N), 2.76 (111, app t, J = 5.6 Hz, CH2CH), 2.11(1H, br s, OH), 
1.87-1.76 (211, in, CH2CH2N), 1.29 (3H, s, CH3); '3C NMR (62.9 MHz, CDC13) 6 
170.1 (C), 154.5 (C), 140.7 (CH), 137.1 (C), 128.5 (2 x CH), 127.8 (2 x CH), 127,2 
(CH), 110.8 (CH), 106.9 (CH), 70.2 (C), 51.5 (CH), 50.4 (CH2), 42.9 (CH2), 35.5 
(CH2), 28.4 (CH2), 25.0 (CH3); HRMS (ES) Exact mass calcd for C18H22NO3  
{M+H]: 300.1594, found: 300.1593. - 
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a 	 (±)-(3R,4R)- 1-Benzyl-3-ethyl-4-hydroxy-4-phenylpiperidin-2-Ofle 
Et _Bn 
N (132g). The title compound was prepared according to General 
Ph 
HO 	 Procedure K from 131g (61 mg, 0.20 mmol) for a reaction time of 8 h 
followed by Workup A and purification by column chromatography (50% 
EtOAc/petrol) to give a white solid (58 mg, 94%). m.p. 199-201 °C; JR (CHCI3) 
3384 (OH), 2948, 1604 (C=O), 1491, 1445, 1238, 1146, 755, 705, 682 cm-1 ; 
1 H NMR (360 MHz, CDC13) 5 7.50-7.28 (1 OH, m, ArH), 4.77 (1 H, d, J = 14.7 Hz, 
CH2Ph), 4.61 (1 H, d, J= 14.7 Hz, CH2Ph), 3.57 (1H, ddd, J= 12.1, 10.5, 5.2 Hz, 
CH2CH2N), 3.16 (111, ddd, J= 12.15 6.2, 3.5 Hz, CH2CH2N), 2.74 (111, dd, J= 7.3, 
3.4 Hz, CH2CH), 2.26 (111, ddd, J= 14.0, 10.5, 6.2 Hz, CH2CH2N), 2.01 (111, ddd, J 
= 14.0, 5.2, 3.5 Hz, CH2CH2N), 1.98 (lH, br s, OH), 1.92-1.80 (111, m, CH3CH2), 
1.59-1.48 (111, in, CH3CH2), 1.07 (311, t, J = 7.4 Hz, CH3CH2); '3C NMR (62.9 
MHz, CDC13) 6  171.8 (C), 145.9 (C), 137.3 (C), 128.6 (4 x CH), 127.9 (2 x CH), 
127.3 (2 x CH), 124.5 (2 x CH), 75.6 (C), 52.7 (CH), 50.2 (CH2), 43.3 (CH2), 36.6 
(CH2), 20.2 (CH2), 14.9 (CH3); HRMS (ES) Exact mass calcd for C20H24NO2 




Me 	 N Ph".. 
h 	 phenylpiperidin-2-one (132h). The title compound was 
HO prepared according to General Procedure K from 131h (70 mg, 
0.20 mmol) for a reaction time of 8 h followed by Workup A and purification by 
column chromatography (50% EtOAc/petrol) to give a white solid (66 mg, 94%). 
m.p. 134-136 °C; JR (CHC13) 3399 (OH), 2952, 1617 (C=O), 1494, 1451, 1353, 
1242, 758, 733, 700 cm'; 'H NMR (360 MHz, CDC13) 5 7.49-7.28 (1011, in, ArH), 
4.80 (111, d, J= 14.7 Hz, CH2Ph), 4.56 (111, d, J= 14.7 Hz, CH2Ph), 3.57 (111, ddd, 
J= 12.1, 10.6, 5.2 Hz, CH2CH2N), 3.16(111, ddd, J= 12.1, 6.2, 3.5 Hz, CH2CH2N), 
2.78 (1 H, dd, J = 7.4, 3.1 Hz, CHCO), 2.27 (111, ddd, J = 14.0, 10.6, 6.2 Hz, 
CH2CH2N), 2.10 (1H, br s, OH), 2.02 (1H, ddd, J = 14.0, 5.2, 3.5 Hz, CH2CH2N), 
1.87-1.77 (111, m), 1.68-1.58 (1H, m), 1.48-1.38 (211, m) and 1.15-1.05 (111, m, 
çC11j)CHCIICW)Y0.78 (3H, d,J 6.0 Hz, 
(CH3)2CH); '3C NMR (62.9 MHz, CDC13) 6 171.9 (C), 145.8 (C), 137.2 (C), 128.5 
(4 x CH), 127.9 (2 x CH), 127.2 (2 x CH), 124.6 (2 x CH), 75.4 (C), 51.5 (CH), 50.2 
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43.3 (Cl2), 39.4 (CH), 36,3 (CH2), 28.1 (CH), 24.6 (CH2), 22.4 (CH3), 22.2 
(CH3); HRMS (FAB) Exact mass calcd for C23H30NO2 [M+H]: 352.2272, found: 
352.2272. 
Me..)L PMP 
H 	 methyl-3-azabicyclol4.3.0jnonan-4-one (1321). The title compound O
ZCO2Et was prepared according to General Procedure L from 131i (69 mg, 
0.20 mmol) for a reaction time of 3 h followed by Workup B and purification by 
column chromatography (50% EtOAc/petrol-60% EtOAc/petrol) to give a white 
solid (39 mg, 56%). m.p. 111-112 °C; JR (CHCI3) 3434 (OH), 2941, 1724 (C=O), 
1666 (C0), 1512, 1465, 1443, 1246, 1033, 832 cm-1 ; 'H NMR (360 MHz, CDC13) 6 
7.20(2H, din, .J= 9.0 Hz, ArH), 6.87 (2H, din, J=9.0 Hz, ArH), 4.14 (1H, d,J 
13.5 Hz, CH2N), 4.15-4.09 (2H, In, OCH2CH3), 3.79 (3H, s, OCH3), 3.6 (1H, d, J 
13.5 Hz, CH2N), 3.21 (IH, s, 011), 2.68 (1H, q, J= 6.9 Hz, CH3CH), 2.43-2.33 (1H, 
in, CH2CH2CH2), 2.16-2.09 (1 H, in, CH2CH2CH2), 2.00-1.89 (2H, in, CH2CH2CH2), 
1.74-1.62 (2H, in, CH2CH2CH2), 1.33 (3H, d, J= 6.9 Hz, CH3CH), 1.11 (3H, t, J= 
7.1 Hz, OCH2CH3); '3C NMR (62.9 MHz, CDC13) 8 174.8 (C), 171.6 (C), 157.4 (C), 
135.7 (C), 126.4 (2 x CH), 113.8 (2 x CH), 85.5 (C), 61.5 (CH2), 57.4 (C), 55.4 
54.6 (CH2), 44.7 (CH), 40.8 (CH2), 36.3 (CH2), 23.1 (CH2), 13.9 (CH3), 9.4 




HO 	 methoxyphenyl)-3-azabicyclo[4.3.0]nonan-4-one (132j). The title 
CO2EI compound was prepared according to General Procedure L from 131j 
(72 mg, 0.20 mmol) for a reaction time of 1 h followed by Workup B and 
purification by column chromatography (40% EtOAc/petrol-50% EtOAc/petrol) to 
give a colorless oil (58 mg, 80%). JR (film) 3431 (OH), 2965, 1725 (C=O), 1666 
(C=O), 1512, 1288, 1247, 1101, 1033, 836 cm'; 'H NMR (360 MHz, CDC13)6 7.20 
	
dm, J = 9.1 Hz, ArH4Tt6 Hd±13T6 	- 
Hz, CH2N), 4.10 (2H, q, J= 7.2 Hz, OCH2CH3), 3.79 (3H, s, OCH3), 3.61 (1 H, d, J 
= 13.6 Hz, CH)N), 3.27 (lH, br s, OH), 2.42-2.34 (2H, m), 2.17-2.03 (2H, m), 2.00- 
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1.91 (2H, in) and 1.78-1.62 (3H, in, CH3CH2CH and CH2CH2CH2), 1.10 (3H, t, J 
7.2 Hz, OCH2CH3), 1.08 (3H, t, J = 7.4 Hz, CH3CH2CH); '3C NMR (62.9 MHz, 
CDC13) 6 174.6 (C), 170.9 (C), 157.4 (C), 135.7 (C), 126.3 (2 x CH), 113.8 (2 x CH), 
85.8 (C), 61.4 (CH2), 57.8 (C), 55.4 (CH3), 54.6 (CH2), 53.2 (CH), 41.8 (CH2), 36.6 
(CH2), 23.5 (CH2), 18.3 (CH2), 14.1 (CH3), 13.9 (CH3); HRMS (FAB) Exact mass 
calcd for C20H28N05 [M+H]: 362.1963, found: 348.1962. 
0 
PMP 	 (±)-(1R,5R,6S)-5-Benzyl-1-carbethoxy-6-hyd roxy-3-(4- Ph HO 
	 methoxyphenyl)-3-azabicyclo [4.3.0] nonan-4-one (132k). 	The 
CO2Et 
title compound was prepared by General Procedure L from 131k 
(84 mg, 0.20 nimol) for a reaction time of 1 h followed by Workup B and 
purification by column chromatography (40% EtOAc/petrol) to give a colorless oil 
(75 mg, 88%). JR (film) 3438 (OH), 2962, 1724 (C=O), 1671 (C=O), 1512, 1465, 
1287, 1247, 1115, 832 cm-1; 'H NMR (360 MHz, CDC13)  6 7.39-7.36 (2H, in, ArH), 
7.29-7.24 (2H, m, ArH), 7.21-7.15 (1 H, in, ArH), 7.18 (2H, dm, J= 9.1 Hz, ArH), 
6.86 (2H, dm, J= 9.1 Hz, ArH), 4.11 (2H, q, J= 7.1 Hz, OCH2CH3), 4.11 (1 H, d, J 
= 13.7 Hz, CH2N), 3.79 (3H, s, OCH3), 3.63 (1 H, d, J= 13.7 Hz, CH2N), 3.59 (1 H, 
dd, J= 14.4, 8.1 Hz, CH2CH), 3.51 (1H, s,011), 2.96 (lH, dd, J' 14.4, 2.8 Hz, 
CH2CH), 2.78 (1H, dd, J= 8.1, 2.8 Hz, CH2CH), 2.40-2.23 (2H, in, CH2CH2CH), 
2.05-1.91 (2H, in, CH2CH2CH2), 1.73-1.62 (2H, m, CH2CH2CH2), 1.08 (3H, t, J= 
7.1 Hz, OCH2CH3); '3C NMR (62.9 MHz, CDC13) 6 174.7 (C), 170.3 (C), 157.3 (C), 
142.1 (C), 135.6 (C), 129.3 (2 x CH), 128.2 (2 x CH), 126.2 (2 x CH), 125.8 (CH), 
113.8 (2 x CH), 86.4 (C), 61.5 (CH2), 58.0 (C), 55.4 (CH3), 54.4 (CH2), 53.6 (CH), 
41.8 (CH2), 36.4 (CH2), 31.0 (CH2), 23.4 (CH2), 13.8 (CH3); HRMS (FAB) Exact 
mass calcd for C25H30N05 [M+H]: 424.2119. found: 424.2129. 
° 	 (±)-(3R,48)-4-Hydroxy-1-(4-methoxyphenyl)-3,4- 
Me 
dimethyLpyrrolidin-2-one (114a). The title compound was prepared 
Me" 
HO 	according to General Procedure K from 113a (47 mg, 0.20 mmol) for 
----a—reaction—time—of-2  h followed by- 	 - 
chromatography (30% EtOAc/CHC13) to give a white solid (22 mg, 47%). m.p. 155-
156 °C;IR (CHC13) 3410, 2934, 1675 (C0), 1614, 1513, 1468, 1401, 1248, 1181, 
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1033 cm-1 ; 1 H NMR (360 MHz, CDC13) 6 7.49 (2H, dm, J= 9.0 Hz, ArH), 6.88 (2H, 
dm, J= 9.0 Hz, ArH), 3.80 (3H, s, OCH3), 3.78 (1H, d, J= 10.4 Hz, CH2N), 3.69 
(1H, d, J= 10.4 Hz, CH2N), 2.51 (1H, q, J= 7.3 Hz, CH3CH), 1.98 (1H, bs, OH), 
1.47 (3H, s, CH3COH), 1.24 (3H, d, J = 7.3 Hz, CH3CH); '3C NMR (62.9 MHz, 
CDC13) 6 174.2 (C), 156.4 (C), 132.6 (C), 121.4(2 x CH), 114.0(2 x CH), 73.0 (C), 
60.7 (CH2), 55.4 (CH3), 48.6 (CH), 24.7 (CH3), 7.5 (CH3); HRMS (FAB) Exact mass 
calcd for C13H18NO3 [M+H]: 236.1282, found: 236.1293. 
(±)-(3R,4S)-3-Benzyl-4-hyd roxy- 1-.(4-methoxyphenyl)-4- 
'P 
MP 
Ph 	N 	methylpyrrolidin-2-one (114c). The title compound was prepared 
Me" 
	
HO 	according to General Procedure K from 113c (62 mg, 0.20 mmol) 
for a reaction time of 4 h followed by Workup A and purification by column 
chromatography (30% EtOAc/CHC13) to give a white solid (35 mg, 56%). Slow 
evaporation of a CDC13 solution of 109c was found to give colourless crystals 
suitable for X-ray diffraction. m.p. 158-160 °C; JR (CHC13) 3346, 2928, 1661 (C=O), 
1514, 1439, 1391, 1250, 1216, 1173, 1028 cm; 'H NMR (36O MHz, CDC13)67.50 
(21-1, dm, J = 9.2 Hz, ArH), 7.37-7.20 (5H, in, ArH), 6.90 (2H, dm, J = 9.2 Hz, 
ArH), 3.81 (3H, s, OCH3), 3.70 (1 H, d, J = 10.4 Hz, CH2N), 3.60 (2H, d, J = 10.4 
Hz, CH2N), 3.37 (1H, dd, J = 14.3, 4.5 Hz, CH2CH), 2.97 (1H, dd, J= 14.3, 9.7 Hz, 
CH2CH), 2.81 (1H, dd, J = 9.7, 4.5 Hz, CH2CH), 1.94 (lH, br s, OH), 1.14 (3H, s, 
CH3COH); '3C NMR (62.9 MHz, CDC13) 6 173.2 (C), 156.5 (C), 140.1 (C), 132.4 
(C), 129.1 (2 x CH), 128.5 (2 x CH), 126.3 (CH), 121.5 (2 x CH), 114.0 (2 x CH), 
73.3 (C), 61.1 (CH2), 55.4 (CH3), 55.1 (CH), 30.8 (CH2), 25,8 (CH3); HRMS (FAB) 
Exact mass calcd for C20H22NO4 [M+H]: 312.1594, found: 312.1594. 
OMe 	0 	 (±)-(3R,45)-4Hydroxy-3-(2-methoxybenzyl) 1-(4- 
_PMP 
N 	methoxyphenyl)-4-methylpyrrolidin-2-one (1321). The title 6-M':~ 
•• 
HO 	compound was prepared according to General Procedure L 
from 1311 (68 mg, 0.20 mmol) for a reaction time of 24 h followed by Workup B and 
purification bcolumn chromathTaiih7 (30% EtOAdCHC1tgive a whsolid 
(50 mg, 74%). m.p. 136-137 °C; JR (film) 3451, 2935, 1687 (C=O), 1587, 1495, 
1466, 1246, 1031, 829, 755, 733 cm'; 1H NMR (360 MHz, CDC13) 6 7.51 (2H, dm, 
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J= 9.2 Hz, ArH), 7.28-7.24 (1 H, in, ArH), 7.36 (1H, dd, J= 7.5, 1.7 Hz, ArH), 6.99 
(1H, td, J= 7.5, 1.1 H, ArH), 6.94-6.91 (1H, m, ArH), 6.90 (2H, dm, J= 9.2 Hz, 
ArH), 3.92 (3H, s, OCH3), 3.80 (3H, s, OCH3), 3.65 (1H, br s, OH), 3.62 (2H, s, 
CH2N), 3.24 (1H, dd, J = 14.3, 4.2 Hz, CH2CH), 3.12 (1 H, dd, J= 14.3, 11.2 Hz, 
CH2CH), 2.75 (1H, dd,J = 11.2, 4.2 Hz, CH2CH), 1.01 (3H, s, CH3COH); '3C NMR 
(62.9 MHz, CDC13) 6 173.0 (C), 156.4 (2 x C), 132.5 (C), 131.0 (CH), 128.0 (C), 
127.9 (CH), 121.9 (CH), 121.6 (2 x CH), 114.0 (2 x CH), 110.9 (CH), 72.6 (C), 60.4 
55.7 (CH3), 55.4 (CH3), 55.3 (CH), 26.0 (CH3), 24.6 (CH2); HRMS (FAB) 
Exact mass calcd for C20H24N04 [M+H]: 342.1700, found: 342.1700. 
(3R,4S)-3-((furan-2-yI)methyl)-4-hydroxy- 1-(4- 
PMP 
methoxyphenyl)-4-methylpyrrolidin-2-one (132m). The title 
HO 	 compound was prepared according to General Procedure K from 
131m (68 mg, 0.20 mmol) for a reaction time of 24 h followed by Workup B and 
purification by column chromatography (30% EtOAc/CHC13) to give a white solid 
(33 mg, 55%). m.p. 155 °C; JR (film) 3419, 2925, 1675 (C=O), 1513, 1467, 1403, 
1249, 1033, 933, 830 cm'; 'H NMR (360 MHz, CDC13) 6 7.49 (2H, d, J= 9.1 Hz, 
ArH), 7.49 (1H, d,J= 1.3 Hz, ArH), 6.89 (2H, d,J= 9.1 Hz, ArH), 6.34 (1H, dd,J 
= 3.1, 2.0 Hz, ArH), 6.17 (1H, d, J= 3.1 Hz, ArH), 3.80 (3H, s, OCH3), 3.72 (1H, d, 
J= 10.4 Hz, CH2N), 3.63 (1H, d, J = 10.4 Hz, CH2N), 3.33 (1 H, dd, J= 15.4, 4.3 
Hz, ArCH2), 3.05 (1 H, dd, J= 15.4, 10.6 Hz, ArCH2), 2.84 (1H, dd, J= 10.6, 4.3 Hz, 
ArCH2CH), 2.28 (1 H, s, OH), 1.19 (3H, s, CH3COH); '3C NMR (62.9 MHz, CDC13) 
6 172.5 (C), 156.5 (C), 153.2 (C), 141.0 (CH), 132.3 (C), 121.6 (2 x CH), 114.0 (2 x 
CH), 110.8 (CH), 106.8 (CH), 72.7 (C), 60.9 (CH2), 55.8 (CH3), 52.9 (CH), 25.7 
23.3 (CH2) 
o 	 (±)..(3R,4S)-3-(4-chlorobenzyl)-4-hydroxy- 1-(4- 
PMP 
N 	methoxyphenyl)-4-methylpyrrolidin-2-one (132n). The 
Me' 
HO 	 title compound was prepared according to General Procedure 
	
L1rom 131iF(69g0Thnrmoi)for a reaction-time of 241rfblIDwedbyWurkup B 	-- 
and purification by column chromatography (30% EtOAc/CHC13) to give a white 
solid (28 mg, 41%). m.p. 171 °C; JR (film) 3374, 2923, 1661 (C=O), 1512, 1368, 
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1247, 1170, 1028, 824 cm-1; 'H NMR (360 MHz, CDC13)  6 7.49 (2H, dm, J = 9.1 
Hz, ArH), 7.36 (111, d, J= 1.3 Hz, ArH), 6.89 (2H, d, J= 9.1 Hz, ArH), 6.34 (1H, 
dd, J= 3.1, 2.0 Hz, ArH), 6.17 (1 H, d, J= 3.1 Hz, ArH), 3.80 (3H, s, OCH3), 3.72 
(1H, d, J= 10.4 Hz, CH2N), 3.63 (1 H, d, J= 10.4 Hz, CH2N), 3.05 (1H, dd, J = 15.4, 
10.6 Hz, ArCH2), 2.84 (1H, dd, J= 10. 6, 4.3 Hz, ArCH2CH), 2.28 (1H, s, OH), 1.19 
(3H, s, CH3COH); '3C NMR (62.9 MHz, CDC13) 6 172.9 (C), 156.6 (C), 138.7 (C), 
132.3 (CH), 132.0 (C), 130.5(2 x CH), 128.6(2 x CH), 121.6(2 x CH), 114.1 (2 x 
CH), 73.3 (C), 61.2 (CH2), 55.5 (CH), 55.1 (CH3), 30.1 (CH2), 25.8 (CH3); HRMS 
(FAB) Exact mass calcd for C19H20C1NO3 [M+H]: 345.1700, found: 345.1701. 
0 IMP 	 (±)-(3R,4R)-4-Hydroxy-1-(4-methoxyphenyl)-3-methyl-4- 
M.  Ph)-' 	phenylpyrrolidin-2-one (134a). The title compound was prepared 
HO according to General Procedure M from 133a (60 mg, 0.20 mmol) for 
a reaction time of 8 h and purified by column chromatography (50% EtOAc/petrol) 
to give a white solid (34 mg, 57%). m.p. 123-125 °C; JR (CHCI3) 3403 (OH), 2936, 
1677 (C=O), 1511 (C=C), 1461, 1400, 1247, 1032, 829 cm-'; 'H NMR (360 MHz, 
CDC13) 6 7.57-7.55 (2H, in, ArH), 7.51 (2H, dm, J= 9.2 Hz, ArH), 7.46-7.41 (2H, 
in, ArH), 7.38-7.33 (1H, in, ArH), 6.89 (2H, dm, J= 9.2 Hz, ArH), 4.06 (1H, d, J= 
10.6 Hz, CH2N), 3.87 (1H, d, J= 10.6 Hz, CH2N), 3.79 (3H, s, OCH3), 3.11 (IH, q, 
J= 7.2 Hz, CH3CH), 2.50 (1H, s, OH), 1.22 (3H, d, J= 7.2 Hz, CH3CH); '3C NMR 
(62.9 MHz, CDC13) 6 173.2 (C), 156.5 (C), 141.5 (C), 132.5 (C), 128.8 (2 x CH), 
128.1 (CH), 125.2(2 x CH), 121.4(2 x CH), 114.1 (2 x CH), 77.2 (C), 61.6 (CH2), 
55.5 (CH3), 48.5 (CH2), 7.5 (CH3); HRMS (ES) Exact mass calcd for C18H20NO3 
[M+H]: 298.1438, found: 298.1439. 
0 
Me 	 (±)-(3R,4R)-4-Hyd roxy-1-(4-methoxybenzy)-3-methy1-4- 
Ph' 	phenylpyrrolidin-2-one (134b). The title compound was prepared 
HO 
according to General Procedure M from 133b (62 mg, 0.20 mmol) for 
a reaction time of 8 h and purified by column chromatography (50% EtOAc/petrol) 
to give a whit 	lit(33 mg, 513%)tTqi. 133435 °C;IR(CHC135(O12932, 	 - 
1671 (C=O), 1512 (C=C), 1445, 1245, 1032, 700 cm-'; 'H NMR (360 MHz, CDC13) 
8 7.46-7.28 (5H, m, Am), 7.20 (2H, dm, J= 8.7 Hz, ArH), 6.85 (2H, dm, J= 8.7 
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Hz, ArH), 4.50 (2H, s, CH2Ar), 3.76 (3H, s, OCH3), 3.51 (1H, d, J = 10.8 Hz, 
HOCCH2N), 3.35 (1H, d, J = 10.8 Hz, HOCCH2N), 2.97 (1H, q, J = 7.2 Hz, 
CH3CH), 2.10 (1 H, br s, 011), 1.20 (3H, d, J= 7.2 Hz, CH3CH); '3C NMR (62.9 
MHz, CDCI3) 5  174.1 (C), 159.1 (C), 141.9 (C), 129.4 (2 x CH), 128.6 (2 x CH), 
128.2 (C), 127.9 (CH), 125.1 (2 x CH), 114.1 (2 x CH), 75.5 (C), 59.6 (CH2), 55.2 
(CH3), 47.7 (CH), 45.9 (CH2), 7.3 (CH3); HRMS (FAB) Exact mass calcd for 
C19H22NO3 [M+H]+: 312.1595, found: 312.1600. 
Conjugate Reduction of a,13-Unsaturated  Amide 158 
a 	Et2Zn 	 o 
	
Ph" THF/hexane 	Ph NBn2 
NBn2 Co(acac)22H20 
158 	 0CtoRT 159 
A solution of the known cinnamic amide 158 (66 mg, 0.20 mmol) and 
Co(acac)2 2H20 (2.6 mg, 0.01 mmol) in THF (1.5 mL) was stirred at room 
temperature for 15 mm. The mixture was cooled to 0 °C and Et2Zn (1 M solution in 
hexane, 0.40 mL, 0.40 mmol) was then added dropwise over 1 mm. The reaction was 
stirred at 0 °C for 1 h and then at room temperature for 2h. The reaction mixture was 
filtered through a short plug of Si02 (Ca. 4 cm high x 2 cm diameter) using EtOAc as 
eluent (Ca. 50 mL) and the filtrate was concentrated in vacuo. Purification of the 
residue by column chromatography (20% EtOAc/hexane) afforded the amide 159 (48 
mg, 73%) that displayed identical spectroscopic data to those reported previously. 
(±)-(3R,4R)-1-Benzyl-3- [(RS)-deuteriophenylmethylj-4-hydroxy-4- 
methylpiperidin-2-one (163). 
0 	0 	 0 	 Et2Zn (2 equiv) 
Co(acac)2 2H20(5 mot %) 
I 	 THF/hexane 
an OCtort 
160 
+ Ph" 	N'  
HO 163a 	 HO 163b 
2.6:1 mixture before purification 
-- -- (Retativestereochfmixtdesof_rnajor - 
and minor isomers not assigned) 
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General Procedure K was followed using substrate 160 (62 mg, 0.20 mmol) for a 
reaction time of 16 h followed by Work-Lip A to give 163 as a 2.6:1 inseparable 
mixture of diastereomers. Purification of the residue by column chromatography 
(70% EtOAc/petrol) gave 163 as a white solid (52 mg, 84%) as a 2.6:1 inseparable 
mixture of diastereomers. m.p. 114-116 °C; IR (CHCI3) 3399 (OH), 2928, 1617 
(C=O), 1495, 1451, 1269, 1146, 918, 732, 700 cm- 1 ; 1 HNMR (3 60 MHz, CDC13) 
7.43-7.41 (2H, m, ArH), 7.39-7.29 (7H, in, ArH), 7.26-7.21 (1H, in, ArH), 4.75 (1H, 
d, J= 14.7 Hz, CH2Ph), 4.58 (1H, d, J= 14.7 Hz, CH2Ph), 3.47 (1H, ddd, J= 12.2, 
9.0, 5.6 Hz, CH2CH2N), 3.35 (0.7H, d, J= 5.3 Hz, CHD), 3.22 (0.3H, d, J= 5.4 Hz, 
CHD), 3.13 (1H, ddd, J= 12.2, 5.9, 5.1 Hz, CH2CH2N), 2.72 (1H, d, .J= 5.4 Hz, 
CHCHO), 1.92-1.80 (211, in, CH2CH2N), 1.76 (111, br s, OH), 1.31 (3H, s, 
CH3COH); '3C NMR (62.9 MHz, CDC13) 8  171.1 (C), 141.9 (C), 137.1 (C), 129.2(2 
x CH), 128.5 (2 x CH), 128.4 (2 x CH), 127.9 (2 x CH), 127.2 (CH), 126.0 (CH), 
71.0 (C), 54.2 (CH), 50.4 (CH2), 43.0 (CH2), 35.2 (CH2), 32.5 (CHD, t, .JD = 19.5 
Hz), 28.9 (CH3); HRMS (ES) Exact mass calcd for C20H23DN02 [M+H]: 311.1864, 
found: 311.1862. 
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5. Nickel-Catalysed Reductive Aldol Cyclisations 
The cobalt-mediated cyclisation of a,/3-unsaturated carbonyl components tethered to 
a variety of ketones through an amide linkage allows the efficient synthesis of 4-
hydroxypiperidine-2-ones and pyrrolidin-2-ones in moderate yields. Although the 
products were obtained with generally high levels of diastereoselectivity the process 
suffered from a number of limitations. Firstly, the substrate scope was limited to a,/3-
unsaturated amides as the corresponding esters proved to be unreactive under these 
conditions. Secondly, the process could not be rendered asymmetric through the use 
of chiral non-racemic ligands. Finally, the lack of literature president for cobalt-
mediated coupling reactions in presence of diethyizinc reduced the possibilities of 
developing the reaction further. In order to overcome the limitations of the 
previously described cobalt-mediated methodology, our attention turned to the 
possibility of developing a nickel-catalysed reductive aldol reaction using diethylzinc 
as the stoichiometric reductant. 
5.1. Results and Discussion" 
Initial investigations into nickel-catalysed reductive aldol cyclisations began with 
reactions that provided six-membered /3-hydroxylactams as products (Table 5.1). 
Using 5 mol% of Ni(acac)2 in combination with two equivalents of Et2Zn, a range of 
substrates underwent efficient cyclisation to give the corresponding 4-
hydroxypiperidin-2-ones. 
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0 	0 	 Et2Zn (2 equiv) 	
0 





R2 R3 	 0°Ctort 
HO I 
R2 
Entry Substrate Product dra %Yield 
R=Ph 891 901 '19:1 62 
2 0 	0 R=2-furyll3la 
0 
132a '19:1 75 
Me N R 
R 	tPr 131b 
PMP 
N 132b '19:1 70 
4 I R=Me 170a Me 171a '19:1 75  
PMP 
HO 
5 R'Mel7Ob 0 
171b '19:1 97" 







Me 	N R R 	CH2CH2Ph inc = 
8 Bn 
R=Phl3le Me 132e '19:1 
9 R'2-furyll3lf 











EI1 N Ph 







12 0 	0 R=Mei3lg 
0 
132g 9:1 84" 
13 Ph N R 
R ''Eu 131h 
- 	_Bn 
132h 12:1 84" 
14 I 
En 






15 N R 'Me 131J 132J '19:1 62' 
PMP RPhl3lk 132k '19:1 50' 
CO2E1 
'Determined by 'H NMR analysis of the unpurified reaction mixtures; "Results taken from Pekka Joensuu; 'Results taken from Euan Fordyce 
Table 51 
A variety of substituents at the ct,/3-unsaturated amide, including alkyl (entries 3-7, 
10, 12, 13 and 15), aromatic (entries 1, 8 and 16) and heteroaromatic (entries 2, 9 and 
14) groups were tolerated to give the corresponding cyclised products in good to 
excellent yields and with generally high diastereoselectivies. Furthermore, variations 
of the ketone component are accommodated, with alkyl (entries 1-9 and 11), 
cycloa11 (entries 1 and t6 —and onati (ntries 10an124)ketmesaIt 
proving effective acceptor electrophiles. A variety of nitrogen protecting groups can 
also be used, with benzyl (entries 5-9 and 11-14), para-methoxyphenyl (entries 1-4 
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and 15-16) and ortho-methyiphenyl (entry 10) all being tolerated. In addition, the 
pre-existing stereocentre in substrates 131j and 131k, allows the cyclisation to occur 
with high levels of internal asymmetric induction to furnish the bicyclic 4-
hydroxypiperidin-2-ones 132j and 132k respectively. Generally, the results presented 
for the nickel-catalysed reductive aldol cyclisation (Table 5.1) are comparable to 
those previously reported using Co(acac)2 2H20 as the precatalyst (Table 4.2). 
On the other hand simple acrylamides were observed to be less competent substrates 
under these conditions, due to their tendency to favour alkylative aldol cyclisation 
over reductive aldol cyclisation. For example, acrylamide 131c provided the desired 
reductive aldol product 132c in only 17% yield, with the major product 172 
occurring due to the conjugate addition of an ethyl group followed by cyclisation (eq 
44). Conversely, when Co(acac)2-2H20 is used as the precatalyst in place of 
Ni(acac)2 the desired reductive aldol product 132c is obtained in 88% yield with no 
formation of the alkylated product 172 being detected. Substitution at the U'-position 
of the acrylamide allowed the reductive aldol cyclisation to re-establish itself as the 
dominant reaction pathway. This was illustrated by the efficient cyclisation of the 
methacrylamide substrate 137a to provide lactam 138a containing two contiguous 
quaternary centres in 82% yield (eq 45). Subsequent extension of this methodology 
to the reductive aldol cyclisation of trisubstituted a,/3-unsaturated amides has met 
with only limited success. Tighe acid derivate 137b did not undergo cyclisation, 
providing the elimination product 138b instead (eq 46). However, a,,B-unsaturated 
amide 173 provided the desired lactam product 174 in moderate yield (eq 47). Most 
notably attempted cyclisations of substrates 137a,b and 173 using Co(acac)2 2H20 as 
the precatalyst failed. 
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0 	 0 
Ni(acac)2 (5 rnol%) 	
N 	+ 	 N 	 (44) 
	
Bn 	 0°Cto rt 
0 	0 	 Et2Zn (2 equiv) 
Me.% tl. _Bn 	Me.—.. -1 '- _Bn 
THF/hexane Me" 	 Me" 
131c HO 132c 	 HO 172 
>19:1 dr '19:1 dr 
17% yield 	 61%yield 
0 
o 	Et2Zn (2 equiv) 
Ni(acac) (5 mol%) 	 Bn 
Me 	N 	 (45) 
THE! hexane 
PMP Me 	0°C to rt 	
Me'" 
137a 	 HO 138a 
82% yield 
o 	 EtZn (2 equiv) 	 o 
Ni(acac)2 (5 nlol%) 
PMP'  _lL(—..Me 	 (46) THF/hexane 	 H 
PMP Me 	 0°Ctort Me 
137b 	 138b 
82% yield 
0 	0 	Me 	EtZn (2 equiv) 	
Me 0 
Me N 	
Ni(acac)2 (5 mol%) 
MeMe" 
0 °C to rt 	
(47) Me THF/hexane 
173 	 HO 174 
'19:1 dr 
54% yield 
Substrates 175a and 175b incorporating a pendant ester group on the a,/3-unsaturated 
amide component, cyclised efficiently affording bicyclic products 177a and 177b 
respectively. Seemingly this occurs as a consequence of the tertiary zinc alkoxides 
176a and 176b, produced from the initial reductive cyclisation, undergoing 
lactonisation with the pendant ester groups (eq 48; results from Pekka Joensuu). 
0 
Ni(acac)2 (5 mo)%) EtO 
	 N_ 
Et2Zn (2 equiv( 	
p2 
R' N CO2Et THE/hexane  
0°C to rt 	
EtZnO 
175a R' = Ph, R' = PMP 
	
176a 
175b R1  = Me, R2 = Bn 176b  
0 
HO 
177a '19:1 dr, 79% yield 	178a 
177b '19:1 dr, 89% yield 178b 
Not observed 
Remarkably, alternative regioisomeric products 178a and 178b, resulting from 
cyclisation a- to the ester as apposed to the amide were not detected in the 
mixtures. This effectively demonstrates the high levels of chemoselectivity that are 
attainable via this methodology. Equally, attempted cyclisations of 175a and 175b 
using Co(acac)2 2H20 in place of Ni(acac)2 failed to give any product. 
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The application of this methodology to the synthesis of pyrrolidin-2-ones proved 
moderately successful (Table 5.2). Substrates with a diverse array of substitution at 
the /3-position of the cL,/3-unsaturated amide component, including alkyl (entries 1 
and 2), aromatic (entries 4 and 5) and ester groups (entry 3) undergo efficient 
cyclisation. In comparison to the cyclisation of substrates 175a and 175b (eq 48), the 
cyclisation of 179c resulted in <10% lactonisation. 
Et1Zn (2 equiv) 




N 	 R 
I THF/hexane 
0 	PMP 0 °C tort Me'j 
HO 
Entry 	 R Product dr' 	%Yield 
I 	R=Me 179a 180a 5:1 	 42 
2 	R='Pr 179b 180b 5:1 	 70 
3 	R=CO2Etl79c 180c >19:1 	7615 
4 	R=2-MeOPh 1311 1321 '19:1 	58 
5 	R'2-furyll3lm 132m >19:1 	32 
6 	R 'Ph 113c 114c '19:1 	23 
7 	R4-C1Ph 131n 132n - >5 
"Determined by 1 H NMR analysis of the unpurified reaction mixtures 
'Results token from Pekka Jocnsuu 
Table 5.2 
Although these results are comparable to those obtained when Co(acac)2-2H20 is 
used as the precatalyst (Table 4.2), a number of subtle differences are worthy of note. 
Firstly, substrates containing electron-deficient groups such as 131n (entry 7) are not 
competent substrates under the nickel-catalysed conditions. However, under the 
cobalt-catalysed conditions, substrate 131n underwent cyclisation to give the 
corresponding pyrrolidin-2-one 132n in 41% yield with a diastereomeric ratio of 5:1 
(Table 4.2, entry 18). Consequently, by increasing the electron-donating ability of the 
pendant aromatic group the products can be obtained in enhanced yields (entries 4, 5 
and 6). Even so, under the cobalt-catalysed conditions the corresponding cyclisations 
react with greater efficiency and with generally superior yields (Table 4.2, entries 14- 
or estersubstituted- "unsaturated amide 
components 179a, 179b and 179c cyclise more readily under the nickel-catalysed 
methodology, giving the corresponding products in moderate to good yields (entries 
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1, 2 and 3). In contrast, substrates 179a, 179b and 179c react poorly under the cobalt-
catalysed conditions (Chapter 4). 
The synthetic utility of this methodology was further enhanced by the application to 
the cyclisation of oxygen-linked substrates. In contrast to the use of Co(acac)2 2H20 
as the pre-catalyst, where productive cyclisations could not be achieved for ester-
linked precursors, the combination of Ni(acac)2/Et2Zn was found to give efficient 
cyclisations to furnish a range of 18-hydroxylactones in high yield and with high 
diastereoselectivities (Table 5.3; results taken from Pekka Joensuu). 
0 	 EtZn (2 equiv( 
Ni(acac)2 (5 mol%( 	R3 
R3 R1 	 0 	 THF/hexane 







Entry Substrate Product or' %YieLd 
1 R='Bu 181a 0 182a '19:1 77 






Me O R 
R' 4-MeOPh 181c Me 
4 R = 2-furyl 181d HO 182d '19:1 81 
0 
5 R='Bu 181e 182e 5.5:1 99 
0 	 0 
6 R = CH2CH2Ph 181f 1 182f >10:1 76 




8 CO2Et R=Me 181h 18Th >19:1 88 
9 R='Pr 	1811 1821 >19:1 74 
10 R 	Ph 181j 182J '19:1 73 
CO2EI 
'Determined by 1 H NMR analysis of the unpurified reaction mixtures 
Table 5.3 
Subtle electronic effects were revealed in the cyclisation of oxygen-linked cinnamic 
substrates. The cyclisation of the 4-methoxy-substituted precursor 181c gave only the 
expected reductive aldol product in 76% yield (Table 5.3, entry 3), whereas 
substrates 	 t'ovi-dedtgnIfianrquantitie 
of alkylative aldol products 184a and 184b respectively as inseparable 1:1 mixtures 
of diastereomers (eq 49; results taken from Pekka Joensuu). From these results it 
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would appear that as the aromatic substituent becomes more electron-withdrawing, 
the extent of alkylative aldol cyclisation becomes more prevalent. 
	
Et 0 	 0 
0 	 0 	 Et2Zn (2 equiv) 	 + 
N4(acac 2 (5 mot%)  
(49) 
THF/hexaneMe Me 
RJD 	 R 
 
R 	
0°Ctort 	 HO 	 HO 
183a R = H 	 184a 1:1 dr, 18% 	 185a >19:1 dr, 80% 
183b R = CL 	 184b 1:1 dr, 25% 	 185b >19:1 dr, 63% 
5.1.1. Proposed Mechanism 
As previously illustrated (Chapter 2) there are a number of mechanistic possibilities 
that have been proposed to account for the observed products in nickel-catalysed 
reductive couplings and cyclisations. It is generally accepted that the treatment of 
Ni(acac)2 with Et2Zn results in the reduction of Ni(II) to Ni(0) and we believe that 
the same process is operative in our methodology. From the mechanistic possibilities 
proposed for nickel-catalysed reductive couplings and cyclisations, two appeared 
applicable to our methodology. 
Firstly, the involvement of metallacyclic intermediates has been proposed for a large 
number of nickel-catalysed reductive couplings and cyclisations. The formation of 
metallacyclic intermediates has been attributed to the oxidative cyclisation of Ni(0) 
with two it-components. Through the analysis of oxidative cyclisation products by 
X-ray crystallography, the participation of metallacyclic intermediates could be 
inferred .48'89  Although our nickel-catalysed methodology is formally a reductive 
aldol process, it is possible that the mechanistic pathway involves a metallacyclic 
intermediate as illustrated (Scheme 5.1). 
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I Mechanism A 
0 
153 Et2Zn 
R3 N_ R 
ElZnO 	
Ni(acac)2 
Ni (0) 	 0 	R2 	148 
elimination 	
186 • Et2Zn reductive  
oxidative 
cyclisation 
R3 H ° 
	
H// 
H N? N_R2 	 El- 
\' o-+-4 
ElZn 
189 	 El 187 
hydride 	








This mechanism is analogous to that previously described for the cobalt-catalysed 
reductive aldol cyclisation (Chapter 4; Scheme 4.2). In the case of nickel-catalysis 
detailed studies conducted by Montgomery and co-workers38 suggest that diethylzinc 
facilitates the oxidative cyclisation through initial Lewis acid activation of the ketone 
by co-ordination with zinc, followed by subsequent Lewis base activation of Ni(0) 
through a three-centre-two-electron bridging of a zinc-ethyl bond. This type of Lewis 
acid promoted rate acceleration has been previously reported for a variety of nickel-
catalysed oxidative cyclisations. 89c,dAs  observed under our cobalt-catalysed 
methodology, the relative stereochemistry of the cyclised products is related to the 
formation of the bicyclic intermediate preferring to adopt an energetically more 
favourable cis-ring junction as opposed to the higher energy trans-ring junction. 
In addition, a second plausible mechanism - which involves the intervention of 





















CH=CH2 	 0 Ni 
0 R2 
191 
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described for the cobalt-catalysed reductive aldol cyclisation (Chapter 4; Scheme 
4.1). 
Scheme 5.2 
If mechanism B (Scheme 5.2) is the dominant process then one could suggest that the 
proportion of alkylative aldol cyclisation products from precursors 183a and 183b 
(eq 49), is dependant on the particular steric/electronic properties of the substrate 
enabling conjugate addition from 191 to compete with /3-hydride elimination to 192. 
On the other hand the formation of 184a and 184b can be rationalised by invoking 
mechanism A (Scheme 5.1) if reductive elimination from 188 competes with /3-
hydride elimination to 189. However, the isolation of products 184a and 184b as a 
1:1 mixture of diastereomers cannot be explained using mechanism A, assuming all 
steps in mechanism A are stereospecific. 
Furthermore, we examined the reaction of a,/3-unsaturated amide 158 in the absence 
of the pendant ketone t-system to our standard conditions (Scheme 5,3; results 
from Pekka Joensuu) in an effort to identify which mechanism is in operation. 
Principally, mechanism B (Scheme 5.2) does not require the presence of a second 
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electrophilic it-component until after the zinc enolate is formed; however, in 
mechanism A the ketone it-component is an essential prerequisite for oxidative 
cyclisation to form the proposed oxanickellacycle (Scheme 5.1). Consequently, if 
mechanism B is in operation one would expect to observe the product of conjugate 
reduction 159. In the event, exposure of 158 to our standard conditions provided only 
a complex mixture of products which appeared to be composed of oligomeric 
products, with none of the desired amide 159 being observed. The failure to detect 
159 does not exclude mechanism B as a possibility, since the zinc enolate 195 that 
would be formed from conjugate addition of 158 could react with another molecule 
of 158 in a Michael addition, generating another zinc enolate 196 which could then 
participate in ftirther reactions resulting in oligomeric products. This type of 
behaviour has been previously noted for poorly chemoselective 1,4-addition 
reactions of organometallic reagents. The outcome of this reaction differs from that 
previously obtained using Co(acac)2 2H20 in place of Ni(acac)2, where amide 159 
was formed in 73% yield (Chapter 4; eq 42). 
o 
BnN)Lc..Ph 
Et2Zn (2 equiv) 
Ni(acach (5 mot%) oligomeric 
0  
Bfl N J ph  
I THF/hexane 
products 
Bn 0°C to rt 
Bn 











As in (Chapter 4; eq 43) we next conducted the cyclisation of deuterium labelled 
substrate 160 (Scheme 5.4). If mechanism A is operative, the concerted nature of the 
oxidative cyclisation would be expected to provide metallacycle 197 with the relative 
stereochemistry shown. An eventual reductive elimination of nickel hydride 198 that 
proceeds with retention of configuration would be expected to produce a single 
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diastereomer of cyclised product 163a. However, if mechanism B is operative via the 
proposed zinc enolate 161, we should expect to observe the cyclised product as a Ca. 
1:1 mixture of diastereomers 163a and 163b, due to the diastereomeric Zimmerman-




















D 	 0 




0 	N" via zinc enolote 	0 	N 
Me 	 Me 60  
161 
El 	 Et 
Zn Zn 
0' 
°Bn 	HD  l En 
or 
Ph  Ph Me 	 Me 
162a 16Th 
II! 







HO 	163a 	HO 	163b 
Scheme 5.4 
In the event, the nickel-catalysed reductive cyclisation of 160 afforded a 1:1.3 
inseparable mixtures of diastereomers 163a and 163b as determined of NMR 
spectroscopy of the unpurified reaction mixture (eq 50; results taken from Pekka 
Joensuu). 
DH 0 	 H0 0 
, H 
0 	0 	o 	Et2Zn (2 equiv) 	
H 
Bn 
Ni(acac)2 (5 moiX) Ph N 	+ 	Ph N 
(50) 
Me 	N 	Ph 
I 
) TH F/hexane 	Me" 
Bn 	 0°Ctort HO 	 HO 
160 163a 	 163b 
1:1,3 mixture 	 Relative stereochemistroes of major 
nLdiastereamers_ - —and minor isomers notasvigne_ 
As a result several possible explanations could be used to rationalise the observed 
diastereomeric ratio. Firstly, both mechanism A and B are operative as competing 
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reaction pathways. Secondly, mechanism A is operative, but one or more steps in the 
pathway are not stereospecific. This may in part be due to the conformational lability 
of a carbon—nickel bond allowing epimerisation. Thirdly, if mechanism B is 
operative, initial precoordination of either nickel or zinc with both carbonyl groups 
could facilitate a degree of facial selectivity during the reduction of the a,,8-
unsaturated system. This is probable as the chelate effect will favour the substrate 
acting as a bidenate ligand and the coordination of oxygen will activate the a,/3-
unsaturated system to reduction. Even so it is possible that mechanism A and B are 
over simplifications of a more complex mechanistic system. Although on the 
available evidence, mechanism A cannot be completely discounted at this stage, we 
presently favour a variation of mechanism B as the probable reaction pathway based 
on the results from the deuterium-labelling studies. Further aspects of the mechanism 
not discussed within the context of mechanism B which could be responsible for a 
non-equimolar distribution of diastereomers 163a/163b include the 
conformationlhapticity of zinc enolate intermediates (oxa-it-allyl species, C-bound 
versus 0-bound enolates) and fluctuations in the hapticity in the course of the 
reaction. A definitive determination of the reaction mechanism will therefore require 
additional studies. 
On comparison with the results obtained using Co(acac)2 2H20 as the precatalyst (eq 
43), the degree of diastereoselection was increased, and most interestingly the sense 
of diastereoselection was reversed (eq 50). In general the disparity between the 
cobalt-catalysed and the nickel-catalysed methodology is demonstrated through the 
broader substrate scope of the nickel system and their divergent behaviour with 
simple acrylamides 137a and with substrates lacking a pendant ketone 158, the end 
result of this isotopic labelling study also indicates variations in their mechanisms. 
5.2. Conclusions and Future Work 
It-has-been-demonstrated that -in- the-presence-of diethylzinc,Nacac)actsas_an 
effective pre-catalyst in the reductive aldol cyclisation of substrates containing a,8-
unsaturated carbonyl moieties tethered to a variety of ketones through either an 
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amide or an ester linkage. In these reactions diethyizinc serves as a stoichiometric 
reducing agent, delivering a hydride to the /3-position of the (L,/3-unsaturated carbonyl 
component, leading to the formation of several /3-hydroxylactams and /3-
hydroxylactones with generally high levels of diastereoselection. Comparison with 
the previously discussed cobalt-catalysed methodology demonstrates that the nickel-
catalysed methodology is superior in both substrate scope and general reactivity. 
Through the use of deuterium labeling studies, the disparity between the cobalt- and 
nickel-catalysted methodology was further re-enforced indicating that both processes 
proceed through different complex mechanisms. 
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5.3. Experimental 
All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-
dried apparatus. CH202 and THF were dried and purified by passage through 
activated alumina columns using a solvent purification system from 
www.glasscontour.com 'Petrol' refers to that fraction of light petroleum ether boiling 
in the range 40-60 °C. Non-commercially available a,f3-unsaturated carboxylic acids 
used in the preparation of the cyclization substrates were obtained as follows: (E)-5-
methylhex-2-enoic acid was prepared from a Wadsworth-Emmons reaction of 
isovaleraldehyde with triethyl phosphonoacetate, followed by hydrolysis of the 
resulting ethyl ester, according to literature procedures; (E)-5-phenylpent-2-enoic 
acid was prepared analogously using hydrocinnamaldehyde (distilled before use) in 
place of isovaleraldehyde. All other commercially available reagents were used as 
received. Thin layer chromatography (TLC) was performed on Merck DF-Alufoilien 
60F254 0.2 mm precoated plates. Product spots were visualized by UV light at 254 
nrn, and subsequently developed using potassium permanganate or ceric ammonium 
molybdate solution as appropriate. Flash column chromatography was carried out 
using silica gel (Fisher Scientific 60A particle size 35-70 micron) employing the 
method of Still and co-workers.80 Melting points were recorded on a Gallenkamp 
melting point apparatus and are uncorrected. Infra-red spectra were recorded on a 
Jasco FT/IR-460 Plus instrument as a thin film on sodium chloride plates or as a 
dilute solution in CHC13. 1 H NMR spectra were recorded on a Bruker DPX360 (360 
MHz) spectrometer or a Bruker ARX250 (250 MHz) spectrometer. Chemical shifts 
() are quoted in parts per million (ppm) downfield of tetramethylsilane, using 
residual protonated solvent as internal standard (CDC13 at 7.27 ppm). Abbreviations 
used in the description of resonances are: s (singlet), d (doublet), t (triplet), q, 
(quartet), app (apparent), br (broad). Coupling constants (.1) are quoted to the nearest 
0.1 Hz. Proton-decoupled 13C NMR spectra were recorded on a Bruker DPX360 
(90.6 MHz) spectrometer or a Bruker ARX250 (62.9 MHz) spectrometer. Chemical 
-shifts-&)-arequoted-in-part&-per-million (pp m)downüeldftetrametliyIneusing 
deuterated solvent as internal standard (CDC13 at 77.0 ppm). Assignments were made 
using the DEPT sequence with secondary pulses at 90° and 135°. High resolution 
mass spectra were recorded on a Finnigan MAT 900 XLT spectrometer or a Finnigan 
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MAT 95XP spectrometer at the EPSRC National Mass Spectrometry Service Centre, 
University of Wales Swansea. Stated calculated mass values refer to that of the ion 
(i.e. the actual species being detected), not that of the neutral parent compound. 
Preparation of Aminoketones 
4-(4-Methoxyphenylamino)butan-2-one 	(118). 	Prepared 
PMPHN 	 Me 
according to a previously reported procedure (Chapter 3.3). 
PMPHNf( 	1-(4-Methoxyphenyl)aminopropanone (126). Prepared according to 
a previously reported procedure (Chapter 3.3) 
3-(4-Methoxyphenylamino)-1-phenylpropan-1-one(121). 
PMPHN 	 Ph  Prepared according to a previously reported procedure (Chapter 
3.3) 
Preparation of a,/3-Unsaturated Acid Chlorides: Prepared according to the 
previously described General Procedure H. 
	




OH CH2C,rt R 
Preparation of Amide-Tethered Cyclization Precursors: Prepared according to 
the previously described General Procedure D. 
0 
R R2 	 0 
R CI 	 R1  
N 
PMPHN ( 	Na2CO3(aq) 	 IIr 
MP 0 
C H2 Cl2 rt 
Preparation of Amide-Tethered Cyclization Precursors: Prepared according to 
the previously_described Generaifrocedure I. 
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0 	 0 
BrNH2 	
BnHN'-Me CH2Cl2, rt 
0 
R-CI 	
0 	 0 
N 	 Me I. Na2CO3 (oq) 	 I 
CH2Cl2 ,rt Be 
Preparation of Amide-Tethered Cyclization Precursors: Prepared according to 
the previously described General Procedure K. 
0 	 0 
CI
Ph BnNH2, Et3N 	
BnHN 	 Ph CHZCIZ, rt  
163 
0 
0 	 0 
RCI R
1 N 	 Ph Na2CO3 (eq) 	 I 
CH2CL2, rt tin 
° 	N-Benzyl-N-(3-oxobutyl)-(E)-but-2-enamide (170b). The 
Me 	 N 	 M title compound was prepared according to General Procedure 
Bn 
I from methyl vinyl ketone (0.94 mL, 11.0 mmol), benzylamine (1.09 mL, 10.0 
mmol), and crotonoyl chloride (1.29 mL, 12.1 mmol) for a reaction time of 4 h. The 
product was purified by column chromatography (40% EtOAc/petrol) to give a 
colourless oil as a 2:1 mixture of rotamers. JR (film) 2914, 1713 (C0), 1660 (C=C), 
1449, 1369, 1160, 963, 815, 732, 698 cm-1; 'HNMR (360 MHz, CDC13) (Major 
rotamer) 6 7.36-7.25 (4H, m, ArH), 7.17-7.15 (1H, m, ArH), 7.07-6.91 (111, m, 
CH3CH), 6.20 (1H, dq, J= 14.9, 1.5 Hz, CHCO), 4.64 (2H, s, CH2Ph), 3.59 (2H, 
t, .1 = 6.7 Hz, CH2CH2N), 2.79 (2H, t, J = 6.7 Hz, CH2CH2N), 2.10 (3H, s, 
CH3C=O), 1.82 (3H, dd, J = 6.9, 1.5 Hz, CH3CH=); (Minor rotamer) 6 7.36-7.25 
(4H, m, ArH), 7.17-7.15 (1H, m, ArH), 7.07-6.91 (1H, m, CH3CH), 6.29 (1H, d, .J 
= 14.9 Hz, CHCO), 4.64 (2H, s, CH2Ph), 3.59 (2H, t, J= 7.2 Hz, CH2CH2N), 2.63 
(2H, t, J = 7.2 Hz, CH2CH2N), 2.07 (3H, s, CH3C=O), 1.90 (3H, d, J = 6.5 Hz, 
CH3CH=); 13C NMR (62.9 MHz, CDCI3) (Mixture of rotamers - not fully assigned) 
5,207.0 (C), 205.7 (C), 166.7 (C), 166.1 (C), 142.2 (CH), 141.9 (CH), 137.4 (C), 
136.8 (C), 128.4 (CH), 128.1 (CH), 127.6 (CH), 127.1 (CH), 126.9 (CH), 126.0 
(CH), 121.3 (CH), 121.0 (CH), 51.6 (CH2), 48.8 (CH2), 42.4 (CH2), 41.8 (CH2), 41.4 
(CH298c29.6JCH3I, 17.7 (CH3); - HRMS (ES) Exact mass calcd for 
C15H19NO2  [M+H]: 246.1489, found: 246.1489. 
Chapter 5—Nickel-Catalysed Reductive Aldol Cyclisations 	 157 
N-Benzyl-N-(3-oxobutyl)-(E)-5-phenylpent-2-enamide 
Ph 	. 	rJ 	Me  (170c). The title compound was prepared according to 
Bn 
General Procedure I from methyl vinyl ketone (0.56 mL, 6.60 mmol), benzylamine 
(0.65 mL, 6.00 mmol), and the acid chloride (prepared according to General 
Procedure A) derived from (E)-5-phenylpent-2-enoic acid (1.34 g, 7.26 mmol) for a 
reaction time of 16 h. The product was purified by column chromatography (40% 
EtOAc/petrol) to give a pale yellow oil (1.27 g, 63%) as a 2:1 mixture of rotamers. 
IR (CHC13) 2924, 1712 (C=O), 1657 (C=C), 1495, 1425, 1390, 1206, 970, 735, 699 
cm'; 1 H NMR (360 MHz, CDC13) (Major rotamer) 6 7.37-7.13 (lOH, in, ArH), 7.10-
6.94 (111, in, CH), 6.18 (1H, d, J= 15.1 Hz, =CH), 4.59 (2H, s, NCH2Ph), 3.60 
(2H, t, J= 6.7 Hz, CH2CH2N), 2.84-2.46 (6H, in, CH2CH2N and PhCH2CH2), 2.12 
(3H, s, CH3C=O); (Minor rotamer) 7.37-7.13 (10H, in, ArH), 7.10-6.94 (1H, in, 
=CH), 6.23 (1 H, d, J= 17.1 Hz, =CH), 4.63 (2H, s, NCH2Ph), 3.53 (2H, t, J= 7.2 
Hz, CH2N), 2.84-2.46 (6H, in, CH2CH2N and PhCH2CH2), 2.06 (3H, s, CH3C=O); 
'3C NMR (62.9 MHz, CDC13) (Mixture of rotamers - not fully assigned) 6 207.4 (C), 
206.1 (C), 167.1 (C), 166.4 (C), 146.2 (CH), 145.7 (CH), 140.8 (C), 137.6 (C), 137.1 
(C), 128.8 (CH), 128.5 (CH), 128.3 (CH), 128.0 (CH), 127.5 (CH), 127.3 (CH), 
126.4 (CH), 126.0 (CH), 120.9 (CH), 120.5 (CH), 52.1 (CH2), 49.3 (CH2), 42.7 
(CH2), 42.2 (CH2), 41.8 (CH2), 41.7 (CH2), 34.4 (CH2), 34.0 (CH2), 30.2 (CH3), 30.0 
(CH3); HRMS (ES) Exact mass calcd for C22H26NO2 [M+H]: 336.1958, found: 
3 36. 1959. 
N-Benzyl-N-(3-oxo-3-phenylpropyl)-(E)-3-fUrafl-2- 
y1propenamide (170e). The title compound was prepared 
according to General Procedure K from 3-
chioropropiophenone (1.85 g, 11.0 mmol), benzylamine (1.10 mL, 10.0 mmol) and 
3-(2-furyl)acrylic acid (2.07 g, 15.0 mmol) for a reaction time of 5 h. The product 
was purified by column chromatography (15% EtOAc/CHC13) to give an orange gum 
(2.26 g, 63%) as a 2:1 mixture of rotamers. JR (CHC13) 2942, 1682 (C=O), 1651 
(C=C), 1487, 1324, 1213, 971, 733, 692, 594 cm'; 'HNMR (360 
(Major rotamer) 6 8.01 (2H, d, J = 7.7 Hz, ArH), 7.61-7.28 (9H, in, ArH), 7.58 (1 H, 
d, J = 15.1 Hz, CH), 6.82 (1H, d, J= 15.1 Hz, =CH), 6.58 (1 H, d, J= 3.3 Hz, CH) 
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6.46-6.45 (1H, in, CH), 4.84 (2H, s, NCH2Ph), 3.88 (2H, t, J= 6.8 Hz, CH2N), 3.43 
(211, t, J = 6.8 Hz, CH2CH2N); (Minor rotamer) 6 7.90 (2H, d, J = 7.6 Hz, ArH), 
7.64 (1H, d, J= 15.0 Hz, =CH), 7.61-7.28 (9H, in, ArH), 6.91 (1H, d, J= 15.0 Hz, 
=CH), 6.61 (1H, d, J= 3.2 Hz, CH) 6.49-6.48 (111, in, CH), 4.81 (2H, s, NCH2Ph), 
3.92 (2H, t, 1= 7.4 Hz, CH2N), 3.27 (211, t, J= 7.4 Hz, CH2CH2N); 13C NMR (62.9 
MHz, CDC13) (Mixture of rotamers not fully assigned) 6 198.7 (C), 197.5 (C), 
166.9 (C), 166.2 (C), 151.3 (C), 143.8 (CH), 137.5 (C), 137.0 (C), 136.4 (C), 136.1 
(C), 133.3 (CH), 133.0 (CH), 130.2 (CH), 129.7 (CH), 128.7 (CH), 128.4 (CH), 
127.9 (CH), 127.8 (CH), 127.4 (CH), 127.2 (CH), 126.4 (CH), 114.6 (CH), 114.2 
(CH), 114.0 (CH), 113.9 (CH), 112.0 (CH), 52.2 (CH2), 49.4 (CH2), 43.2 (CH2), 42.5 
(CH2), 38.1 (CH2), 37.0 (CH2); HRMS (ES) Exact mass calcd for C23H22NO3 
[M+H]: 360.1594, found: 360.1590. 
Ph )N -' Me 	
N-(4-Methoxyphenyl)-N-(3-oxobutyl)-(E)-3- 
PMP 	 phenylpropenoate (891). Prepared according to a previously 
reported procedure (Chapter 3.3). 
N-(2-Methoxyphenyl)-N-(3-oxo-3-phenylpropyl)-(E)-bUt-2- 
Me 	IJ 	Ph enamide (89k). Prepared according to a previously reported 
OMP 
procedure (Chapter 3.3). 
0 	 N(4-Methoxyphenyl)-N-(3-oxobuty1)-(E)-3-furafl-2- 
ç ) Me ylpropenamide (131a). Prepared according to a previously 
0 	PMP 	
reported procedure (Chapter 4.3). 
0 	0 	
N-(4-Methoxyphenyl)-N-(3-oxobutyl)-(E)-4-methylpeflt- 
Me i N._JMe  2-enamide (131b). Prepared according to a previously 
Me 	PMP 	 reported procedure (Chapter 4.3). 
0 	 Prepared 
N 	Me according to a previously reported procedure (Chapter 4.3). 
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a 	a 	N-Benzyl-N-(3-oxobutyl)-(E)-4-methylpent-2-enamide 
Me JJNAMe (131d). Prepared according to a previously reported 
Me 	Be 
procedure (Chapter 4.3). 
- 	
N-Benzyl-N-(3-oxobutyl)-(E)-3-phenylpropenamide (131e). 
Ph N 	Me  
Bn 	 Prepared according to a previously reported procedure 
(Chpater 4.3) 
0 	0 	N-Benzyl-N-(3-oxobutyl)-(E)-3-furan-2-ylpropenamide 
(1310. Prepared according to a previously reported 
B  
procedure (Chapter 4.3). 
N-Benzyl-N-(3-oxo-3-phenylpropyl)-(E)-but-2-enamide 
Me 	N 	Ph 
Bn  (131g). Prepared according to a previously reported procedure 
(Chapter 4.3). 
Me 	0 	0 	N-benzyl-N-(3-oxo-3-phenylpropyl)-(E)-5-methylhex- 
Me Ph 2-enamide (131h). Prepared according to a previously 
Bn 
reported procedure (Chapter 4.3). 
0 	




oxocyclopentanecarboxyhc acid ethyl ester (131j). Prepared 
according to a previously reported procedure (Chapter 4.3). 
N\ 	
1- [N-(4-Methoxyphenyl)-N-((1l)-3- 
PMP 	 phenylacryloyl)aminomethyl]-2-oxocyclopentanecarboxylic 
0 
acid ethyl ester (131k). Prepared according to a previously 
reported procedure (Chapter 4.3). 
0 	0 	N-(4-Methoxyphenyl)-N-(3-oxobutyl)-2-methylpropenamide 
(137a). Prepared according to a previously reported procedure  
Me PMP 
(Chapter 4.3). 
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N-(4-Methoxyphenyl)-N-(3-oxobutyl)-(E)-2-methYlbut-2-
Me (N-AMe enamide (137b). Prepared according to a previously reported 
Me 	PMP 	 procedure (Chapter 4.3). 
Me 0 	0 	NBenzy1-N-(3-oxobuty1)-3-methy1but-2-enamide (173). 
Me N Me The title compound was prepared according to General 
	
Bn 	Procedure I from methyl vinyl ketone (1.88 mL, 22.0 
mmol), benzylamine (2.18 mL, 20.0 mmol) and the acid chloride (prepared 
according General Procedure A) derived from 3,3-dimethylacrylic acid (2.87 g, 24.2 
mmol) for a reaction time of 16 h. The product was purified by column 
chromatography (40% EtOAc/petrol) to give yellow oil (2.72 g, 52%) as a 2:1 
mixture of rotamers. JR (film) 2912, 1714 (C=O), 1620 (C=C), 1452, 1371, 1163, 
942, 846, 735, 700 cm'; 1 H NMR (360 MHz, CDC13) (Major rotamer) 6 7.34-7.14 
(5H, in, ArH), 5.83 (1H, s, =CH), 4.58 (2H, s, CH2Ph), 3.54 (2H, t, J = 6.8 Hz, 
CH2N), 2.75 (2H, t, J = 6.8 Hz, CH2CH2N), 2.09 (3H, s, CH3C=O), 1.96 (3H, s, 
(CH3)2C), 1.78 (3H, s, (CH3)2C); (Minor rotamer) 6 7.34-7.14 (5H, in, Ar!!), 5.91 
(1H, s, =CH), 4.60 (2H, s, CH2Ph), 3.54 (2H, t, J= 7.2 Hz, CH2N), 2.59 (2H, t, J 
7.2 Hz, CH2CH2N), 2.03 (3H, s, CH3CO), 1.99 (311, s, (CH3)2C), 1.85 (311, s, 
(CH3)2C); '3C NMR (62.9 MHz, CDC13) (Mixture of rotamers - not fully assigned) 
6 207.2 (C), 206.0 (C), 168.6 (C), 168.0 (C), 147.8 (C), 137.6 (C), 137.0 (C), 128.6 
(CH), 128.3 (CH), 127.7 (CH), 127.3 (CH), 127.1 (CH), 126.5 (CH), 117.5 (CH), 
117.2 (CH), 52.3 (CH2), 48.0 (CH2), 42.2 (CH2), 42.0 (CH2), 41.6 (CH2), 40.9 (CH2), 
30.0 (CH3), 29.8 (CH3), 26.3 (CH3), 26.1 (CH3), 20.0 (CH3); HRMS (ES) Exact mass 
calcd for C16H22NO2  [M+H]: 260.1645, found: 260.1644. 
0 	0 Ethyl 	(E)-3-[N-(4-methoxyphenyl)-N-(3-oxo-3- 
EtOC -. N 	Ph 2 	
PMP 	
phenylpropyl)carbamoyl]acrylate (175a). The title 
compound was prepared according to General Procedure D from the amine 121 (663 
mg, 2.60 mmol) and the acid chloride (prepared according to General Procedure A) 
derived from mono-ethyl fumarate (562 mg, 390 ñnOI)foäfc loll Thof6 h 
and purified by column chromatography (30% EtOAc/petrol—*50% EtOAc/petrol) to 
give a yellow/brown oil that solidified upon standing to a yellow solid (841 mg, 
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85%). m.p. 58-59 °C; JR (CHC13) 2981, 1717 (C=O), 1682 (C=O), 1630 (C=C), 
1510, 1161, 1030, 840, 742, 691 cm'; 'H NMR (360 MHz, CDC13) 6 7.89 (211, d, J 
= 7.9 Hz, ArH), 7.52-7.48 (1H, in, ArH), 7.41-7.37 (2H, in, ArH), 7.06 (2H, d, J= 
8.4 Hz, ArH), 6.88 (2H, d, J= 8.4 Hz, ArH), 6.80-6.79 (2H, in, CH=CH), 4.19-4.09 
(411, in, OCH2 and CH2N), 3.77 (311, s, OCH3), 3.30 (2H, t, J= 7.4 Hz, CH2CH2N), 
1.20 (3H, t, J= 7.1 Hz, OCH2CH3); '3C NMR (62.9 MHz, CDC13) 6 197.9 (C), 165.4 
(C), 164.2 (C), 159.2 (C), 136.4 (C), 134.1 (CH), 133.5 (C), 133.1 (CH), 130.9 (CH), 
128.8(2 x CH), 128.4(2 xCH), 127.9 (2 xCH), 114.9(2 x CH), 60.8 (CH2), 55.3 
(CH3), 46.2 (CH2), 36.2 (CH2), 13.9 (CH3); HRMS (ES) Exact mass calcd for 
C22H24N05 [M+H]+: 382.1649, found: 382.1648. 
0 	0 Ethyl 
EtO2C 	N 	Me (175b). The title compound was prepared according to 
Bn 
General Procedure I from methyl vinyl ketone (1.88 mL, 22.0 mmol), benzylamine 
(2.18 mL, 20.0 mmol) and the acid chloride (prepared according to General 
Procedure A) derived from mono-ethyl fumarate (3.93 g, 24.2 mmol) for a reaction 
time of 16 h. The product was purified by column chromatography (40% 
EtOAc/petrol) to give light yellow solid (2.51g, 55 %) as a 2:1 mixture of rotamers. 
JR (CHC13) 2983, 1716 (C=O), 1651 (C=O), 1625 (C=C), 1447, 1297, 1163, 1031, 
973, 700 cm-1 ; 'H NMR (360 MHz, CDC13) (Major rotamer) 6 7.37-7.15 (611, in, 
ArH and =CH), 6.84 (1H, d, J = 15.3 Hz, =CH), 4.68 (2H, s, CH2Ph), 4.28-4.17 
(211, in, 0C112), 3.61 (2H, t, J = 6.4 Hz, CH2CH2N), 2.79 (2H, t, J = 6.4 Hz, 
CH2CH2N), 2.10 (311, s, CH3C=O), 1.33-1.25 (311, in, OCH2CH3); (Minor rotamer) 
6 7.46 (111, d, J= 15.4 Hz, =CH), 7.37-7.15 (5H, in, ArH and =CH), 6.88 (IH, d, J 
15.4 Hz, =CH), 4.65 (2H, s, CH2Ph), 4.28-4.17 (211, in, OCH2), 3.63 (211, t, J= 
6.8 Hz, CH2CH2N), 2.63 (211, t, J = 6.8 Hz, CH2CH2N), 2.04 (311, s, CH3C=O), 
1.33-1.25 (3H, in, OCH2CH3); '3C NMR (62.9 MHz, CDC13) (Mixture of rotamers - 
not frilly assigned) 6 206.8 (C), 205.3 (C), 165.4 (C), 165.3 (C), 165.1 (C), 164.7 (C), 
136.9 (C), 136.2 (C), 133.4 (CH), 131.9 (CH), 131.7 (CH), 128.8 (CH), 128.6 (CH), 
127.9 (CH), 127.7 (CH), 127.5 (CH), 126.5 (CH), 60.9 (CH2),  52.4 (CH2)1  49.2 
(CH2), 42.5 (CH2), 42.2 (CH2), 41.9 (CH2), 41.4 (CH2), 29.9 (CH3), 29.8 (CH3), 13.9 
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(CH3); HRMS (ES) Exact mass calcd for C17H22N04 [M+H]: 304.1543, found: 
304.1541. 
N-(4-Methoxyphenyl)-N-(2-oxopropyl)-(E)-3-
phenylpropenamide (113c). Prepared according to a previously 
PMP 0 





rMP 0 	methoxyphenyl)propenamide (1311). Prepared according to 
a previously reported procedure (Chapter 4.3). 
° 	 N-(4-Methoxyphenyl)-N-(2-oxopropyl)-(E)-3-furan-2- 
y1propenamide (131m). Prepared according to a previously 
PI MP 0 
reported procedure (Chapter 4.3). 
° 	 N-(4-Methoxyphenyl)-N-(2-oxopropyl)-(E)-3-(4- 
chlorophenyl)propenamide (131n). Prepared according 
PMP 0 	
to a previously reported procedure (Chapter 4.3). 




( 	(179a). The title compound was prepared according to General 
PMP 0 
Procedure D from the amine 126 (1.05 g, 5.80 mmol) and 
crotonoyl chloride (834 giL, 8.70 mmol) for a reaction time of 18 h and purified by 
column chromatography (30% EtOAc/petrol) to give a yellow oil (921 mg, 64%). JR 
(film) 2915, 1731 (C=O), 1665 (C=O), 1628, 1513, 1250, 1030, 967, 842, 686 cm'; 
'H NMR (360 MHz, CDC13) 6 7.18 (2H, d, J= 9.0 Hz, ArH), 6.92 (1 H, app q, J= 
6.9 Hz, CH3CH=), 6.87 (2H, d, J= 9.0 Hz, Am), 5.77 (1 H, dq, J= 15.1, 1.7 Hz, 
CHC=O), 4.43 (2H, s, CH2N), 3.80 (3H, s, OCH3), 2.15 (3H, s, CH3C=O), 1.72 (3H, 
dd, J= 6.9, 1.7 Hz, CH3  CH=); 13C NMR (69.2 MHz, CDC13) 6 202.6 (C), 166.2 (C), 
158 	14204CH,-1353-Q),J29.2 (2xCH), 121 
(CH2), 55.4 (CH3), 27.1 (CH3), 17.9 (CH3); HRMS (ES) Exact mass calcd for 
C14H18NO3 [M+H]: 248.1281, found: 248.1279. 
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N-(4-Methoxyphenyl)-N-(2-oxopropyl)-(E)-4-methylpent-
Me N.._-.yMe  2-enamide (179b). The title compound was prepared 
Me 	PMP 0 	according to General Procedure D from the amine 126 (806 
mg, 4.50 mmol) and the acid chloride (prepared according to General Procedure A) 
derived from 4-methyl-2-pentenoic acid (571 mg, 5.00 mmol) for a reaction time of 
18 h and purified by column chromatography (30% EtOAc/petrol-40% 
EtOAc/petrol) to give a yellow oil (665 mg, 54%). JR (film) 2961, 1731 (C=O), 1660 
(C=O), 1629, 1512, 1380, 1251, 1171, 1031, 841 cm'; 'H NMR (360 MHz, CDC13) 
7.14 (2H, d, J= 8.9 Hz, ArH), 6.83 (2H, d, J= 8.9 Hz, ArH), 6.79 (1H, dd, J = 
15.3, 7.1 Hz, CH=CHC=O), 5.66(111, dd,J= 15.3, 1.3 Hz, CH=CHCO), 4.39 (2H, 
s, CH2N), 3.75 (3H, s, OCH3), 2.24 (1H, septet d, J= 6.8, 1.3 Hz, (CH3)2CH), 2.10 
(3H, s, CH3C=O), 0.87 (6H, d, J = 6.8 Hz, (CH3)2CH); '3C NMR (69.2 MHz, 
CDC13) 5 202.5 (C), 166.4 (C), 158.7 (C), 152.9 (C), 135.1 (C), 129.0 (2 x CH), 
117.7 (CH), 114.3 (2 x CH), 59.5 (CH2), 55.2 (CH3), 30.8 (CH), 27.0 (CH3), 21.2 
(CH3); HRMS (ES) Exact mass calcd for C16H22NO3 [M+H]+: 276.1594, found: 
276.1593. 
( Me Ethyl 	 (E)-3-IN-(4-methoxyphenyl)-N-(3- 
EtO2C 	N  
PMP a 	oxopropyl)carbamoyl]acrylate (179c). The title compound 
was prepared according to General Procedure D from the amine 126 (1.07 g, 6.00 
mmol) and the acid chloride (prepared according to General Procedure A) derived 
from mono-ethyl fumarate (1.37 g, 9.00 mmol) for a reaction time of 16 h and 
purified by column chromatography (50% EtOAc/hexanes) to give a beige solid 
(1.60 g, 86%). m.p. 49-50 °C; JR (CIICI3) 2981, 1726 (C=O), 1656 (C=O), 1636 
(C=C), 1512, 1426, 1030, 842, 735, 603 cm'; 'H NMR (360 MHz, CDC13) 8 7.18 
(2H, d, J= 8.9 Hz, ArH), 6.90-6.78 (211, m, CH=CH), 6.88 (2H, d, J= 8.9 Hz, ArH), 
4.49 (2H, s, CH2N), 4.14 (2H, q, J= 7.1 Hz, OCH2), 3.80 (3H, s, OCH3), 2.15 (3H, 
s, CH3CO), 1.22 (3H, t, J= 7.1 Hz, OCH2CH3); '3C NMR (62.9 MHz, CDC13) 
201.4 (C), 165.3 (C), 164.2 (C), 159.3 (C), 134.1 (C), 133.2 (CH), 131.4 (CH), 128.8 
(2 x CH), 114.8 (2 xCH), 60.8 (CH2), 59.8 (CH2), 55.3 (C113), 27.0 (CH3), 13.9 
(CH3); HRMS (ES) Exact mass calcd for C16H20N05 [M+H]+: 306.1336, found: 
306.1336. 
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Preparation of Hydroxyketones 
3-Hydroxypropiophenone (199). Prepared according to a previously 
reported procedure.27 




R20, H20, -20 C 
200 
To a solution of 2-oxocyclopentanecaboxylate (0.60 mL, 4.00 mmol) and aqueous 
formaldehyde solution (37 % wt in H20, 1.80 mL, 24.0 mmol) in EtOH (20 mL) at - 
20 °C, was added KOH (673 mg, 12.0 mmol) portionwise over 5 mm. The mixture 
was stirred at —20 °C for 0.5 h, and then poured into saturated aqueous NH4C1 
solution (20 mL). The mixture was extracted with CH202 (3 x 20 mL), and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo. Purification 
of the residue by column chromatography (30% EtOAc/petrol) gave the alcohol 200 
(432 mg, 58%) that displayed spectroscopic data consistent with those reported 
previously. 
Preparation of Ester-Tethered Cyclization Precursors: General Procedure L 
0 
0 	0 0 R
1 CI 
HO'~-,', R0 	 R2 	 R1 0R2 pyridine, DMAP 
CH2Cl2 , ri 
The appropriate a,-unsaturated acid chloride (neat in the case of commercially 
available acid chlorides, or as a solution in CH202 prepared according to General 
Procedure A, 1.1 equiv) was added dropwise or portionwise to a vigorously stirred 
mixture of the appropriate hydjyketone (1.0 equiv), DMAP (0.05 equiv) and 
pyridine (4.0 equiv) in CH202 (1.0 M with respect to hydroxyketone) over 5 min via 
cannula, and the reaction was stirred at room temperature until TLC analysis showed 
the reaction to be complete. The reaction was partitioned between saturated aqueous 
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NaHCO3 solution and Et20. The organic layer was separated and washed with 
saturated aqueous NaHCO3 solution (x 3), dried (MgSO4) and concentrated in vacuo. 
Purification of the residue by column chromatography (EtOAc/petrol) afforded the 
cyclization substrate. 
Preparation of Ester-Tethered Cyclization Precursors: General Procedure M 
0 
0 	0 
RCI RILOR2 HOR2 EI3N, DMAP 
CH2Cl2, rt 
This method was identical to General Procedure L, except that Et3N (1.5 equiv) was 
used in place of pyridine. 
Me 	0 	0 	3-Oxobutyl (E)-5-methylhex-2-enoate (181a). Prepared 
Me O &Me according to a previously reported procedure. 
27 
0 
3-Oxobutyl (E)-5-phenylpent-2-enoate (181b). 
Prepared according to a previously reported procedure .27 
0 	0 	3-Oxobutyl 	E)-3-(4-methoxyphenyl)propenoate 
Me (181c). Prepared according to a previously reported 
Me.jc--f 	 procedure. 27 
0 	0 	3-Oxobutyl (E)-3-furan-2-ylpropenoate (181d). Prepared 
0Me 	according to a previously reported procedure.27 
Me 	0 	0 	3-Oxo-3-phenylpropyl 	
(E)-5-methylhex-2-enoate 
(181e). The title compound was prepared according to 
General Procedure L from 3-hydroxypropiophenone 199 (751 mg, 5.00 mmol) and 
- - 
	
	the-aei4-eher4de-(prepared--ac-eor4ing to General- Procedure-A)-derive4--from4E5- 
methylhex-2-enoic acid (705 mg, 5.50 mmol) for a reaction time of 16 h and purified 
by column chromatography (20% EtOAc/petrol) to give a colorless oil (600 g, 46%). 
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JR (film) 2958, 1720 (C=O), 1687 (C0), 1654 (CC), 1449, 1265, 1218, 984, 749, 
690 cm1; 1 H NMR (360 MHz, CDC13) 6 7.93 (2H, d, J= 8.0 Hz, ArH), 7.56-7.52 
(I H, in, ArH), 7.45-7.41 (2H, in, ArH), 6.94-6.83 (1H, in, CH=CHCO), 5.75 (111, 
dd, J= 15.7, 1.3 Hz, CHCO), 4.55 (2H, t, J= 6.4 Hz, CH20), 3.32 (2H, t, J== 6.4 
Hz, CH2CH20), 2.03 (2H, app t, J = 7.1 Hz, CHCH2CH), 1.77-1.63 (lH, in, 
(CH3)2CH), 0.87 (611, d, J = 6.7 Hz, (CH3)2CH); '3C NMR (62.9 MHz, CDC13) 6 
197.0 (C), 166.3 (C), 148.6 (CH), 136.5 (C), 133.2 (CH), 128.5 (2 x CH), 127.9 (2 x 
CH), 121.7 (CH), 59.4 (CH2), 41.3 (CH2), 37.3 (CH2), 27.6 (CH), 22.2 (2 x CH3); 
HRMS (ES) Exact mass calcd for C16H2103 [M+H]: 261.1485, found: 261.1489. 
3-Oxo-3-phenylpropyl 	(E)-5-phenylpent-2-enoate 
Ph- 01Ph 
(181!). The title compound was prepared according to 
h""~O 
 
General Procedure L from 3 -hydroxypropiophenone 199 
(751 mg, 5.00 mmol) and the acid chloride (prepared according to General Procedure 
A) derived from (E)-5-phenylpent-2-enoic acid (969 mg, 5.50 mmol) for a reaction 
time of 16 h and purified by column chromatography (20% EtOAc/petrol) to give a 
colorless oil (926 g, 60%). JR (film) 2925, 1722 (C=O), 1691 (C=O), 1652 (C=C), 
1450, 1178, 1088, 976, 750, 699 cm-1 ; 1 H NMR (360 MHz, CDC13) 6 8.03-8.01 (211, 
in, ArH), 7.65-7.61 (lH, in, ArH), 7.54-7.50 (2H, in, ArH), 7.35-7.31 (2H, in, ArH), 
7.26-7.20 (3H, in, Am), 7.05 (1H, dt, J= 15.7, 6.8 Hz, CH=CHCO), 5.88 (111, dt, 
J= 15.7, 1.6 Hz, CHCO), 4.64 (2H, t, J= 6.4 Hz, CH20), 3.38 (2H, t, J= 6.4 Hz, 
CH2CH20), 2.80 (2H, t, J= 7.8 Hz, PhCH2), 2.58-2.52 (2H, in, CH2CH=); 13C NMR 
(62.9 MHz, CDC13) 6 196.9 (C), 166.2 (C), 148.5 (CH), 140.6 (C), 136.5 (C), 133.2 
(CH), 128.5 (2 x CH), 128.3 (2 x CH), 128.2 (2 x CH), 127.9 (2 x CH), 126.0 (CH), 
121.3 (CH), 59.4 (CH2), 37.3 (CH2), 34.1 (CH2), 33.7 (CH2); HRMS (ES) Exact 
mass calcd for C20H24NO3 [M+NH4]: 326.175 1, found: 326.1749. 
3-Oxo-3-phenylpropyl 	(E)-3-furan-2-ylpropenoate 
0 	0 
(181g). The title compound was prepared according to 
GeneralProcedureM from 3-hydroxypropihënone 199 
(1.52 g, 10.0 mmol) and 3-(2-furyl)aciylic acid (1.52 g, 11.0 mmol) for a reaction 
time of 16 h and purified by column chromatography (20% EtOAc/petrol) to give a 
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white solid (1.70 g, 63%). m.p. 85-87 °C; JR (film) 2959, 1707 (C=O), 1637 (C=C), 
1448, 1210, 1162, 974, 929, 748, 689 cm'; 'H NMR (360 MHz, CDC13) 68.02-8.00 
(2H, in, ArH), 7.64-7.63 (1H, in, ArH), 7.53-7.49 (3H, in, ArH and CH), 7.43 (IH, 
d, J= 15.7 Hz, CH=rCHCO), 6.62 (1 H, d, J= 3.4 Hz, CH), 6.48 (1H, dd, J= 3.4, 
1.8 Hz, CH), 6.32 (2H, d, J= 15.7 Hz, CHCO), 4.67 (2H, t, J = 6.4 Hz, CH20), 
3.41 (2H, t, J= 6.4 Hz, CH2CH20); '3C NMR (62.9 MHz, CDC13) 6 197.0 (C), 166.8 
(C), 150.7 (C), 144.7 (CH), 136.6 (C), 133.3 (CH), 131.3 (CH), 128.6 (2 x CH), 
128.0 (2 x CH), 115.3 (CH), 114.8 (CH), 112.2 (CH), 59.7 (CH2), 37.4 (CH2); 





acid ethyl ester (181h). The title compound was prepared 
o 	according to General Procedure M from the hydroxyketone 200 
(152 mg, 0.80 mmol) and trans-crotonoyl chloride (0.12 mL, 1.20 mmol) for a 
reaction time of 22 h and purified by column chromatography (15% EtOAc/petrol) to 
give a colorless oil (96 mg, 46%). JR (film) 2979, 1755 (C=O), 1727 (C=O), 1657, 
1446, 1294, 1261, 1234, 1175, 1029 cm'; 'H NMR (250 MHz, CDC13) 66.93 (1H, 
dq, J= 15.5, 6.9 Hz, =CH), 5.79 (1H, dq, J= 15.5, 1.7 Hz, =CH), 4.49 (1 H, d, J 
=11.1 Hz, CCH20), 4.40 (1H, d, J= 11.1 Hz, CCH20), 4.17 (2H, q, J= 7.1 Hz, 
OCH2CH3), 2.55-1.93 (6H, in, CH2CH2CH2), 1.86 (3II, dd, J = 6.9, 1.7 Hz, 
CH3CII=), 1.24 (3H, t, J = 7.1 Hz, OCII2CH3); '3C NMR (62.9 MHz, CDC13) 6 
212.4 (C), 169.4 (C), 165.8 (C), 145.5 (CH), 122.0 (CH), 64.2 (CH2), 61.7 (CH2), 
59.6 (C), 38.3 (CH2), 31.1 (CH2), 19.7 (CH2), 18.0 (CH3), 14.0 (CH3); HRMS (ES) 
Exact mass calcd for C13H,905 [M+H]+: 255.1227, found: 255.1224. 
1- (E)4MethyIpent-2-enoyloxymethylJ-2- 
Me.1. 	Jt.0 112 	oxocyclopentanecarboxylic acid ethyl ester (181i). The title 
Me 	 compound was prepared according to General procedure M 
from the hydroxyketone 200 (500 mg, 2.70 mmol) and the acid chloride (prepared 
according to General Procedure A) derived from 4-methylpent-2-enoic acid (462ii 
4.10 mmol) for a reaction time of 43 h and purified by column chromatography (15% 
EtOAc/petrol) to give a colorless oil (306 mg, 40%). JR (film) 2968, 1754 (C=O), 
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1727 (C=O), 1653, 1458, 1366, 1262, 1155, 1022, 860 cm-'; 'H NMR (360 MHz, 
CDC13) 6 6.94 (1H, dd, J = 15.7, 6.6 Hz, =CH), 5.73 (1H, dd, .J = 15.7, 1.5 Hz, 
=CH), 4.52 (1 H, d, J= 11.2 Hz, CCH20), 4.44 (1H, d, J= 11.2 Hz, CCH20), 4.20 
(211, q, J= 7.1 Hz, OCH2CH3), 2.56-2.41 (3H, m), 2.38-2.28 (1H, m) and 2.20-1.98 
(3H, m, CH2CH2CH2 and (CH3)2CH), 1.27 (3H, t, J= 7.1 Hz, OCH2CH3), 1.06 (6H, 
d, J = 6.8 Hz, (CH3)2CH); '3C NMR (62.9 MHz, CDC13) 8 212.5 (C), 169.3 (C), 
166.4 (C), 156.6 (CH), 117.8 (CH), 64.3 (CH2), 61.8 (CH2), 59.7 (C), 38.4 (CH2), 
31.1 (CH2), 31.0 (CH), 21.1 (2 xCH3), 19.8 (CH2), 14.0 (CH3). 
COEt 	 2-Oxo-1-I((E)-3- 
phenylacryloyl)oxymethyl]cyclopentanecarboxylic 	acid 
° 	ethyl ester (181j). The title compound was prepared according 
to General Procedure M from the hydroxyketone 200 (488 mg, 2.60 mmol) and 
cinnamoyl chloride (655 mg, 3.90 nimol) for a reaction time of 60 h and purified by 
column chromatography (10% EtOAc/petrol) to give a colorless oil (431 mg, 52%). 
JR (film) 2979, 1754 (C0), 1722 (C=O), 1636, 1450, 1309, 1234, 1202, 1154, 1020 
cm'; 'H NMR (360 MHz, CDC13) 6 7.68 (111, d, J= 16.0 Hz, =CH), 7.54-7.51 (2H, 
in, ArH), 7.42-7.39 (3H, in, ArH), 6.40 (1H, d, J= 16.0 Hz, =CH), 4.62 (1H, d, J= 
11.2 Hz, CCH20), 4.51 (IH, d, J = 11.2 Hz, CCH20), 4.22 (2H, q, J = 7.1 Hz, 
OCH2CH3), 2.59-2.48 (2H, in, CH2CH2CH2), 2.41-2.32 (111, in, CH2CH2CH2), 
2.24-2.01 (3H, m, CH2CH2CH2), 1.28 (3H, t, J= 7.1 Hz, OCH2CH3); '3C NMR 
(62.9 MHz, CDC13) 6 212.4 (C), 169.2 (C), 166.4 (C), 145.6 (CH), 134.1 (C), 130.5 
(CH), 128.9 (2 x CH), 128.1 (2 x CH), 117.2 (CH), 64.5 (CH2), 61.8 (CH2), 59.7 (C), 
38.4 (CH2), 31.1 (CH2), 19.7 (CH2), 14.0 (CH3); HRMS (ES) Exact mass calcd for 
C,8H24N05 [M+NH4]: 334.1649, found: 334.1651. 
° 3-Oxobutyl (E)-3-phenylpropenoate (183a). Prepared 
Ph' 	0 	Me 
according to a previously reported procedure. 27  
3Oxobutyl - 	(E)3-(4h1oiphnyl)pôpenoate 
(183b). Prepared according to a previously reported 
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procedure. 27 
Nickel-Catalyzed Reductive Aldol Cyclizations: General Procedure N 
R2 
R1) X(R 









A solution of the substrate (0.20 mmol) and Ni(acac)2 (2.7 mg, 0.01 mmol) in THF 
(1.5 mL) was stirred at room temperature for 15 mm. The mixture was cooled to 0 °C 
and Et2Zn (1 M solution in hexane, 0.40 mL, 0.40 mmol) was then added over I mm. 
The reaction was stirred at 0 °C for 1 h and then at room temperature until complete 
consumption of starting material as observed by TLC analysis. Workup was carried 
out according to one of the procedures described below. 
Nickel-Catalyzed Reductive Aldol Cyclizations: General Procedure 0 
A solution of the substrate (1.00 mmol) and Ni(acac)2 (13.5 mg, 0.01 mmol) in THF 
(7.5 mL) was stirred at room temperature for 15 mm. The mixture was cooled to 0 °C 
and Et2Zn (1 M solution in hexane, 2.0 mL, 2.0 mmol) was then added over I mm. 
The reaction was stirred at 0 °C for 1 h and then at room temperature until complete 
consumption of starting material as observed by TLC analysis. Workup was carried 
out according to one of the procedures described below. 
Workup A 
The reaction mixture was filtered through a short plug of Si02 (Ca. 4 cm high x 2 cm 
diameter) using EtOAc as eluent (Ca. 50 mL) and the filtrate was concentrated in 
vacuo. Purification of the residue by column chromatography afforded the cyclized 
product. 
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WorkupB 
The reaction was quenched carefully by the addition of 1 M HC1 (1 mL), and the 
mixture was stirred for 1 h before being diluted with saturated aqueous NH4C1 
solution (20 mL). The mixture was extracted with CH202 (3 x 15 mL) and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification of the residue by column chromatography afforded the cyclized product. 
Workup C 
The reaction was quenched carefully by the addition saturated aqueous NH4C1 
solution (20 mL). The mixture was extracted with CH2Cl2 (3 x 15 mL) and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification of the residue by column chromatography afforded the cyclized product. 
Ph
PMP 
Me 	methylpiperidin-2-one (901). The title compound was prepared 
HO according to General Procedure N from 891 (65 mg, 0.20 mmol) for 
a reaction time of 6 h followed by Workup A and purification by column 
chromatography (30% EtOAc/CHCI3) to give a white solid (41 mg, 62%) that 
displayed identical spectroscopic data to those reported previously (Chapter 4.3). 
BtOMP 	
(±)-(3R,4R)-3-Ethyl-4-hy0xY1(2meth0xYPhY4 
Ph• 	 phenylpiperidin-2-one (90k). The title compound was prepared 
HO 
according to general procedure N from 89k (65 mg, 0.20 mmol) for a 
reaction time of 4 h followed by Workup A and purified by column chromatography 
(30% EtOAc/CHC13) to give an off-white solid (41 mg, 62%) that displayed identical 
spectroscopic data to those reported previously (Chapter 3.3). 
PMP 	
(±)-(3R,4R)-3-Furan-2-y1methy14y0xY1(4 
methoxyphenyi)-4-methylpiperidin-2-one (132a). The title 
HO 	compound was prepared according to General Procedure N from 
131a (63 mg, 0.20 mmol) for a reaction time of 16 h followed by Workup A and 
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purification by column chromatography (30% EtOAc/CHC13) to give a white solid 




Me methoxyphenyl)-4-methylpiperidifl-2-Ofle (132b). The title 
HO 	compound was prepared according to General Procedure N from 
131b (58 mg, 0.20 mmol) for a reaction time of 16 h followed by Workup A and 
purification by column chromatography (20% EtOAc/CHC13) to give a white solid 
(41 mg, 70%) that displayed identical spectroscopic data to those reported previously 
(Chapter 4.3). 
_tL.  Bn (±)(3R,4R)-1-Bzyl-3-is0-b14-hydr0xY4-methylPiPer11- 
IPr)) 	
2-one (132d). The title compound was prepared according to 
HO 	General Procedure K from 131d (55 mg, 0.20 mmol) for a reaction 
time of 8 h using Workup A and purified by column chromatography (50% 
EtOAc/petrol) to give a white solid (54 mg, 98%) that displayed identical 
spectroscopic data to those reported previously (Chapter 4.3). 
(±)(3R,4R)1,3Dibenzy1-4-hydroxy-4-methylpiperidifl-2-Ofle 
Ph 	 N 
Bn  (132e). The title compound was prepared according to General 
Me 
HO 	 Procedure N from 131e (61 mg, 0.20 mmol) for a reaction time of 8 h 
followed by Workup A and purification by column chromatography (60% 
EtOAc/petrol) to give a white solid (60 mg, 97%) that displayed identical 




Me 	 methylpiperidin-2-one (132!). The title compound was prepared 
HO 
according to General Procedure N from 131f(59 mg, 0.20 mmol) 
for a reaction time of8hfollowed by Workup A and purification by column 
chromatography (50% EtOAc/petrol) to give a white solid (59 mg, >99%) that 
displayed identical spectroscopic data to those reported previously (Chapter 4.3). 
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0 	 (±)-(3R,4R)-1-Benzyl-3-ethyl-4-hydroxy-4-phenylpiperidin-2-one 
Et _Bn 
N 	(132g). The title compound was prepared according to General 
Ph.... 
HO 	 Procedure N from 131g (61 mg, 0.20 mmol) for a reaction time of 8 h 
followed by Workup A and purification by column chromatography (50% 
EtOAc/petrol) to give a white solid (52 mg, 84%) that displayed identical 
spectroscopic data to those reported previously (Chapter 4.3). 
J... Be 	
(±)-(3R,4R)-1-Benzyl-4-hydroxy-3-(3-methylbutyl)-4- 
Me 	 N 
Ph 	 phenylpiperidin-2-one (132h). The title compound was 
HO prepared according to General Procedure N from 131h (70 mg, 
0.20 mmol) for a reaction time of 8 h followed by Workup A and purification by 
column chromatography (50% EtOAc/petrol) to give a white solid (59 mg, 84%) that 





methoxyphenyl)-3-azabicyclo [4.3.0] nonan-4-one (132j). The title 
CO2Et compound was prepared according to General Procedure N from 131j 
(72 mg, 0.20 mrnol) for a reaction time of 1 h followed by Workup B and 
purification by column chromatography (40% EtOAc/petrol-50% EtOAc/petrol) to 
give a colourless oil (45 mg, 62%) that displayed identical spectroscopic data to 
those reported previously (Chapter 4.3). 
0 




methoxyphenyl)-3-azabicyclo [4.3.0] nonan-4-one (132k). The 
CO2Et 
title compound was prepared by General Procedure N from 131k 
(84 mg, 0.20 mmol) for a reaction time of 1 h followed by Workup B and 
purification by column chromatography (40% EtOAc/petrol) to give a colourless oil 
(43 mg, 50%) that displayed identical spectroscopic data to those reported previously 
(Chapter 4.3). 





	 , (171a). The title compound was prepared according to General 
N 
Me" Procedure N from 170a (49 mg, 0.20 mmol) for a reaction time of 14 h 
HO 
followed by Workup A and purification by column chromatography 
(70% EtOAc/petrol) to give a white solid (48 mg, 97%). m.p. 94-96 °C; JR (CHC13) 
3408 (OH), 2964, 1621 (C=O), 1496, 1453, 1269, 1149, 929, 732, 702 cm-1; 
1 H NMR (360 MHz, CDC13) 6 7.33-7.23 (5H, in, ArH), 4.64 (1H, d, J = 14.7 Hz, 
NCH2Ph), 4.51 (1H, d, J= 14.7 Hz, NCH2Ph), 3.39-3.32 (1 H, In, CH2N), 3.10-3.03 
(1H, in, CH2N), 2.19 (111, dd, J= 7.3, 3.8 Hz, CH2CH), 1.96-1.81 (3H, m) and 1.79-
1.69(211, in, CH2CH2N, CH3CH2, and OH), 1.30 (3H, s, CH3COH), 1.21 (3H, t, J 
7.3 Hz, CH3CH2); '3C NMR (62.9 MHz, CDC13) 6 171.9 (C), 137.3 (C), 128.5 (2 x 
CH), 127.9 (2 x CH), 127.2 (CH), 70.6 (C), 54.2 (CH), 50.0 (CH2), 43.1 (CH2), 34.1 
(CH2), 28.3 (CH3), 20.6 (CH2), 14.6 (CH3); HRMS (ES) Exact mass calcd for 
C15H21NO2 [M+H]: 248.1645, found: 248.1645. 
0 	 (±)-(3R,4R)- 1-Benzyl-4-hydroxy-4-methyl-3-(3- 
Ph YJN 	phenylpropyl)piperidin-2-one (171c). The title compound was 
HO 	 prepared according to General Procedure N from 170c (67 mg, 
0.20 mmol) for a reaction time of 16 h followed by Workup A and purification by 
column chromatography (50% EtOAc/petrol) to give a white solid (64 mg, 95%). 
m.p. 120-122 °C; JR (CHC13) 3410 (OH), 2928, 1620 (C0), 1496, 1452, 1269, 
1142, 931, 734, 700 cm-1; III  NMR (360 MHz, CDC13) 67.34-7.16(1011, in, ArH), 
4.66 (1H, d, J= 14.7 Hz, NCH2Ph), 4.50 (111, d, J= 14.7 Hz, NCH2Ar), 3.39-3.31 
(111, in, CH2N), 3.10-3.03 (1 H, in, CH2N), 2.72-2.68 (2H, in, PhCH2CH2), 2.29-2.26 
(111, in, CH2CH), 2.18-2.04 (lH, m) and 1.94-1.67 (611, in, PhCH2CH2CH2, 
CH2CH2N and OH), 1.27 (311, s, CH3COH); 13C NMR (62.9 MHz, CDC13) 6 171.8 
(C), 142.4 (C), 137.2 (C), 128.5 (2 x CI), 128.4 (2 x CH), 128.2 (2 x CH), 127.9 (2 x 
CH), 127.2 (CH), 125.6 (CH), 70.5 (C), 52.5 (CH), 50.0 (CH2), 43.0 (CH2), 36.2 
(CH2), 34.1 (CH2), 31.5 (CH2), 28.3 (CH3), 27.1  (CH2)- 
-
0 	 (±)-(3R,4R)-3-Benzyl-4-ethyl-4-hydroxy-1-(4- 
Ph 	
N Bn 
methoxypheny)piperidin-2-one (171d). The title compound was 
EU" 
HO 
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prepared according to General Procedure N from 170d (67 mg, 0.20 mmol) for a 
reaction time of 16 h followed by Workup A and purification by column 
chromatography (40% EtOAc/petrol) to give a white solid (56 mg, 82%) that 
displayed identical spectroscopic data to those reported previously. 85 
(±)-(3R,4R)-1-Benzyl-3-furan-2-ylmethyl-4-hydroxy-4-
phenylpiperidin-2-one (171e). The title compound was prepared 
° ''"" 	according to General Procedure N from 170e (72 mg, 0.20 mmol) 
HO 
for a reaction time of 16 h followed by Workup A and purification by column 
chromatography (50% EtOAc/petrol) to give a white solid (59 mg, 79%). nip. 120-
122 °C; IR (CHC13) 3398 (OH), 2925, 1624 (C0), 1495, 1447, 1354, 1073, 911, 
758, 701 cm'; 11-1 NMR (360 MHz, CDC13) 6 7.44-7.25 (10H, in, ArH), 7.23 (1H, 
dd, J = 1.9, 0.8 Hz, CH), 6.21 (1 H, dd, .J = 3.1, 1.9 Hz, CH), 5.97 (1 H, d, J = 3.1 Hz, 
CH), 4.68 (2H, s, NCH2Ph), 3.58 (1H, ddd,J = 11. 6, 11.6, 4.8 Hz, CH2N), 3.32 (1H, 
t, J= 5.2 Hz, CH2CH), 3.21 (1H, dd, J= 15.3, 5.2 Hz, CH2CH), 3.16-3.10 (1H, in, 
CH2N), 3.01 (1 H, dd, J = 15.3, 5.2 Hz, CH2CH), 2.59 (1H, br s, OH), 2.20 (1H, ddd, 
J = 13.9, 11.3, 6.1 Hz, CH2CH2N), 1.91 (1H, ddd, J = 13.9, 4.8, 2.7 Hz, CH2CH2N); 
'3C NMR (62.9 MHz, CDC13) 6 170.0 (C), 153.7 (C), 145.4 (C), 140.8 (CH), 137.1 
(C), 128.5 (4 x CH), 127.9 (2 x CH), 127.2 (CH), 127.1 (CH), 124.4 (2 x CH), 110.7 
(CH), 107.4 (CH), 74.9 (C), 50.6 (CH), 50.5 (CH2), 43.4 (CH2), 37.1 (CH2), 24.7 
(CH2); HRMS (ES) Mass calcd for C23H24NO3 [M+H]': 362.1751, found: 362.1753. 
(±)-(3R,4R)-1-Benzyl-4-hydroxy-3,4-dimethylpiperidin-2-one (132c) and (±)-




Me Bn + n-Pr  
I THF/hexane 	Me, 	 MeJ) 
Bn 	 OCtoRT 
131c 	 HO 132c 	 HO 172 
>19:1 dr >19:1 dr 
17% 	 61% 
General Procedure N was followed using substrate 131c (46 mg, 0.20 mmol) for a 
reaction time of 14 h and the reaction mixture was subjected to Workup A followed 
by purification by column chromatography (50% EtOAc/petrol) to give the lactam 
Chapter 5—Nickel-Catalysed Reductive Aldol Cyclisations 	 175 
132c (32 mg, 61%) as a white solid, followed by the lactam 172 (8 mg, 17%) as a 
white solid that displayed identical spectroscopic data to those reported previously. 
Data for 172: m.p. 72-74 °C; JR (CHC13) 3399 (OH), 2959, 1619 (C0), 1496, 1453, 
1266, 1149, 935, 731, 701 cm'; 1 H NMR (360 MHz, CDC13) 67.38-7.27 (5H, in, 
ArH), 4.71 (1H, d, J= 14.6 Hz, NCH2Ph), 4.52 (1H, d, J= 14.6 Hz, NCH2Ph), 3.41 
(I H, ddd, J = 12.3, 7.5, 5.9 Hz, CH2CH2N), 3.12 (1H, ddd, J= 12.3, 6.2, 6.2 Hz, 
CH2CH2N), 2.29 (1 H, dd, J= 6.1, 4.3 Hz, CH2CH), 2.00-1.94 (1H, in, CH2CH2N), 
1.86-1.69 (4H, in, CH2CH2N, CH3CH2 and OH), 1.63-1.52 (2H, In,  CH2CH), 1.34 
(3H, s, CH3COH), 1.01 (3H, t, J = 7.1 Hz, CH3CH2); '3C NMR (62.9 MHz, CDC13) 
6 172.0 (C), 137.3 (C), 128.5 (2 x CH), 128.0 (2 x CH), 127.3 (CH), 70.7 (C), 52.4 
(CH), 50.1 (CH2), 43.1 (CH2), 34.2 (CH2), 29.6 (CH2), 28.3 (CH3), 23.2 (CH2), 14.3 





N 	trimethylpiperidin-2-one (138a). The title compound was prepared 
HO 	 according to General Procedure G from 137a (52 mg, 0.20 mmol) for 
a reaction time of 4 h followed by Workup A and purification by column 
chromatography (20% EtOAc/petrol-30% EtOAc/petrol) to give a white solid (43 
mg, 82%).m.p. 104-105°C;IR(CHC13)2978, 1630 (C0), 1605, 1511, 1329, 1243, 
1100, 1035, 827, 668 cm'; 'H NMR (360 MHz, CDC13) 6 7.12 (2H, d, J= 9.0 Hz, 
ArH), 6.89 (2H, d, J = 9.0 Hz, ArH), 3.83 (lH, ddd, J = 15.3, 9.2, 5.8 Hz, 
CH2CH2N), 3.80 (3H, s, OCH3), 3.44 (1 H, ddd, J = 12.9, 6.4, 4.6 Hz, CH2CH2N), 
2.16 (111, ddd, J= 15.3, 9.2, 6.4 Hz, CH2CH2N), 1.96 (1 H, ddd, J= 12.9, 5,8, 4.6 
Hz, CH2CH2N), 1.78 (1H, br s, OH), 1.34 (3H, s, CH3), 1.33 (3H, s, CH3), 1.30 (3H, 
s, CH3); '3C NMR (69.2 MHz, CDC13) 6 175.8 (C), 157.9 (C), 136.6 (C), 127.4 (2 x 
CH), 114.3 (2 x CH), 72.6 (C), 55.4 (CH3), 47.3 (C), 47.0 (CH2), 32.2 (CH2), 24.9 
(CH3), 24.1 (CH3), 19.9 (CH3); HRMS (ES) Exact mass calcd for C15H22NO3 
- 	 [M+H]: 264.1598, foundE264J1594. 









Procedure G from 173 (52 mg, 0.20 mmol) for a reaction time of 14 
HO 	h followed by Workup A and purification by column 
chromatography (50% EtOAc/petrol) to give a white solid (28 mg, 54%). m.p. 108-
110 °C; JR (CHC13) 3408 (OH), 2964, 1621 (C=O), 1496, 1453, 1265, 1147, 926, 
737, 702 cm'; 'H NMR (360 MHz, CDC13) 6 7.36-7.27 (5H, in, ArH), 4.62 (211, s, 
CH2Ph), 3.41 (1 H, ddd, J= 12.5, 6.6, 5.9 Hz, CH2CH2N), 3.05 (1 H, ddd, J = 12.5, 
7.1, 5.9 Hz, CH2CH2N), 2.37-2.29 (211, m, (CH3)2CH and CHC=O), 1.96 (1H, ddd, J 
= 13.4, 7.1, 5.9 Hz, CH2CH2N), 1.86 (1 H, br s, OH), 1.72 (1H, ddd, J= 13.4, 6.6, 5.9 
Hz, CH2CH2N), 1.32 (311, s, CH3COH), 1.32 (311, d, J= 6.9 Hz, (CH3)2CH), 1.07 
(3H, d, J= 6.8 Hz, (CH3)2CH); '3C NMR (62.9 MHz, CDC13) 6 170.5 (C), 137.2 (C), 
128.4 (2 x CH), 128.2 (2 x CH), 127.2 (CH), 70.9 (C), 57.9 (CH), 49.9 (CH2), 43.0 
34.1 (CH2), 29.0 (CH3), 26.8 (CH), 25.7 (CH3), 19.8 (CH3); HRMS (ES) 
Exact mass calcd for C16H24NO2 [M+H]: 262.1802, found: 262.1802. 
(±)-(3aR,7aR)-5-(4-Methoxyphenyl)-7a- 
- PMP phenyihexahyd rofuro[3,2-cJ pyridine-2,4-dione (176a). The title 
	
o 	 compound was prepared according to General Procedure G from 
Ph 
174a (76 mg, 0.20 mmol) for a reaction time of 18 h followed by 
Workup A and purification by column chromatography (25% EtOAc/CHC13—*35% 
EtOAc/CHC13) to give a white solid (53 mg, 79%). JR (CHC13) 2930, 1783 (C=O), 
1650 (C=O), 1511, 1248, 1031 cm'; 'H NMR (360 MHz, CDC13) 67.47-7.38 (511, 
in, ArH), 7.21 (211, dm, J=r 8.7 Hz, ArH), 6.95 (211, dm, J= 8.7 Hz, ArH), 4.02 (1H, 
ddd, J= 13.0, 9.3, 5.4 Hz, CH2N), 3.83 (311, s, OCH3), 3.63-3.57 (211, in, CH2N and 
CH2CH), 2.99-2.87 (211, in, CH2CII), 2.52-2.41 (2H, in, CH2CH2N); '3C NMR (62.9 
MHz, CDC13) 6 174.6 (C), 168.8 (C), 158.5 (C), 141.3 (C), 135.0 (C), 129.1 (2 x 
CH), 128.6 (CH), 126.9 (2 x CH), 124.3 (2 x CH), 114.6 (2 x CH), 86.4 (C), 55.5 
47.8 (CH), 47.0 (CH2), 34.9 (CH2), 33.6 (CH2); LRMS (ES) Mass calcd for 
C2oH2oNO4M±H]: 338.1, found: 338.1. 
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(±)-(3aR,7aR)-5-Benzyl-7a-methylhexahydrofuro 13,2-cl pyridine-2,4-dione 
Bn 
 (176b). The title compound was prepared according to General 
N 	
Procedure G from 174b (61 mg, 0.20 mmol) for a reaction time of 8 
Me 	 h followed by Workup A and purification by column 
chromatography (50% EtOAc/petrol) to give a white solid (46 mg, 89%). m.p. 114-
115 °C; JR (CHC13) 3510 (OH), 2976, 1778 (C=O), 1643 (C=O), 1496, 1292, 1147, 
948, 735, 708 cm; 'H NMR (360 MHz, CDC13) 6 7.36-7.27 (3H, in, ArH), 7.24-
7.22 (2H, in, ArH), 4.76 (1H, d, J = 14.6 Hz, CH2Ph), 4.46 (1 H, d, J = 14.6 Hz, 
CH2Ph), 3.42-3.35 (1H, in, CH2CH2N), 3.21-3.14 (2H, in, CH2CH2N and CH2CH), 
3.04 (1H, dd, J= 10.4, 3.1 Hz, CH2CH), 2.92 (1H, dd, J= 18.1, 3.1 Hz, CH2CH), 
2.16-2.10 (1H, in, CH2CH2N), 1.90 (IH, ddd,J= 14.4, 9.9, 4.6 Hz, CH2CH2N), 1.50 
(3H, s, CH3COH); '3C NMR (62.9 MHz, CDC13) 6 174.2 (C), 168.3 (C), 136.0 (C), 
128.5 (2 x CH), 127.6 (2 x CH), 127.4 (CH), 83.3 (C), 50.1 (CH), 46.2 (CH), 41.9 
(CH2), 33.8 (CH2), 32.6 (CH2), 26.0 (Cl3); HRMS (ES) Exact mass calcd for 
C15H18NO3 [M+H]: 260.1281, found: 260.1281. 
° 	 (±)-(3R,48)-3-Benzyl-4-hydroxy- 1-(4-methoxyphenyl)-4- 
P MP 
Ph 	 N methylpyrrolidin-2-one (114c). The title compound was prepared 
Me' 
HO 	 according to General Procedure N from 113c (62 mg, 0.20 mmol) 
for a reaction time of 24 h followed by Workup A and purification by column 
chromatography (30% EtOAc/CHC13) to give a white solid (14 mg, 56%) that 
displayed identical spectroscopic data to those reported previously (Chapter 4.3). 
(±)-(3R,48)-4-Hydroxy-3-(2-methoxybenzyl)- 1-(4- 
OMe 	0 
6 PMP methoxyphenyl)-4-methylpyrrolidin-2-one 
(1321). The title - 
Me '° 
N 	
compound was prepared according to General Procedure G from 
HO 	
1311 (68 mg, 0.20 mmol) for a reaction time of 4 h followed by 
Workup A and purification by column chromatography (30% EtOAc/CHC13) to give 
a white solid (34 mg, 58%) that displayed identical spectroscopic data to those 
epol ted pi  eviously(€ihapter 4T3  
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(3R,4S)-3-((furan-2-yl)methyl)-4-hydroxy-1-(4- 
IMP methoxyphenyl)-4-methylpyrrolidin-2-one (132m). The title 
Me 
HO 	 compound was prepared according to General Procedure K from 
131m (68 mg, 0.20 mmol) for a reaction time of 24 h followed by Workup B and 
purification by column chromatography (30% EtOAc/CHC13) to give a white solid 
(22 mg, 32%) that displayed identical spectroscopic data to those reported previously 
(Chapter 4.3). 
o 	 (±)-(3R,48)-3-Ethyl-4-hyd roxy-1-(4-methoxyphenyl)-4- 
Et....Jt., IMP N 	methvinvrrohdin-2-one (180a. The title comnound was orenared 
HO 	 according to General Procedure G from 179a (49 mg, 0.20 mmol) for 
a reaction time of 30 min followed by Workup A and purification by column 
chromatography (30% EtOAc/petrol) to give a white solid (21 mg, 42%). m.p. 120-
122 °C; IR (CHC13) 3427 (OH), 2964, 1675 (C=O), 1513, 1401, 1248, 1181, 1033, 
944, 830 cm; 1 H NMR (360 MHz, CDC13) 8 7.49 (2H, d, J= 9.2 Hz, ArH), 6.89 
(2H, d, J= 9.2 Hz, ArH), 3.80 (3H, s, OCH3), 3.73 (1H, d, J= 10.3 Hz, CH2N), 3.65 
(1H, d, J= 10.3 Hz, CH2N), 2.31 (1H, t, J= 7.3 Hz, CHC=O), 1.98-1.86 (1 H, m, 
CH3CH2), 1.77-1.67 (1H, in, CH3CH2), 1.65 (111, br s, OH), 1.53 (3H, s, CH3COH), 
1.19 (311, t, J=r 7.3 Hz, CH3CH2); '3C NMR (69.2 MHz, CDC13) 8  174.0 (C), 156.5 
(C), 132.5 (C), 121.5 (2 x CH), 114.0 (2 x CH), 73.3 (C), 60.9 (CH2), 55.5 (CH), 
55.0 (CH3), 26.0 (CH3), 17,9 (CH2), 13.1 (CH3); HRMS (El) Exact mass calcd for 
C14H19NO3 [M]: 249.1359, found: 249.1358. 
0 	 (±)-(3R,48)-3-iso-Butyl-4-hydroxy-1-(4-methoxyphenyl)-4- 
Me 	 PMP 
N 	methylpyrrolidin-2-one (180b). The title compound was 
MeMe" 
 HO 	 prepared according to General Procedure G from 179b (55 mg, 
0.20 mmol) for a reaction time of 30 min followed by Workup A and purification by 
column chromatography (30% EtOAc/petrol) to give a white solid (39 mg, 70%). 
m.p. 124-126 °C; JR (CHCI3) 3426 (OH), 2956, 1674 (C=O), 1513, 1401, 1248, 
- 	 if 3495fi829cmW 	 C NMR(36OMHz, DC16749(2H, d, J— 9.2 IIL, 
ArH), 6.89 (2H, d, J = 9.2 Hz, Aril), 3.80 (3H, s, OCH3), 3.75 (1H, d, J= 10.3 Hz, 
CH2N), 3.65 (111, d, J= 10.3 Hz, CH2N), 3.47 (1H, t, J= 6.8 Hz, CHC=O), 2.07- 
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1.96 (111, in, CH2CHC=O), 1.87 (IH, br s, OH), 1.78-1.70 (1H, m, CH2CHC=O), 
1.51-1.43 (IH, m, (CH3)2CH), 1.50 (3H, s, CH3COH), 1.00 (3H, d, J= 6.6 Hz, 
(CH3)2CH), 0.97 (3H, d, J = 6.6 Hz, (CH3)2CH); '3C NMR (69.2 MHz, CDC13) 6 
174.3 (C), 156.4 (C), 132.6 (C), 121.4 (2 x CH), 114.0 (2 x CH), 73.4 (C), 60.8 
(CH2), 55.4 (CH3), 50.9 (CH), 33.4 (CH2), 25.9 (CH), 25.3 (CH3), 22.6 (CH3), 
22.5(CH3); HRMS (ES) Exact mass calcd for C16H24NO3 [M+H]: 278.1751, found: 
278.1751. 
Ethyl [(3R,4S)-4-Hyd roxy-1-(4-methoxyphenyl)-4-methyl-2- 
0 
PMP oxopyrrolidin-3-yl]acetate (180c). The title compound was 
EtO2C 	 N 
prepared according to General Procedure G from 179c (61 mg, 
HO 
0.20 mmol) for a reaction time of 14 h followed by Workup A 
and purification by column chromatography (40% EtOAc/petrol) to give a white 
solid (47 mg, 76%). m.p. 79-81 °C. JR (CHC13) 3399 (OH), 2928, 1617 (C=O), 1495, 
1451, 1269, 1146, 918, 732, 700 cm-1 ; 1H NMR (360 MHz, CDC13) 6 7.45 (2H, d, J 
= 9.1 Hz, ArH), 6.89 (2H, d, J= 9.1 Hz, ArH), 4.48 (111, br s, OH), 4.25-4.17 (2H, 
in, OCH2), 3.88 (IH, d, J= 9.4 Hz, CH2N), 3.79 (3H, s, OCH3), 3.57 (1 H, d, J= 9.4 
Hz, CH2N), 3.14 (1 H, dd, J= 12.1, 3.7 Hz, CH2CH), 3.13 (IH, dd, J= 18.7, 3.7 Hz, 
CH2CH), 2.60 (1H, dd, J = 18.7, 12.1 Hz, CH2CH), 1.35 (3H, s, CH3COH), 1.31 
(3H, t, J= 7.1 Hz, OCH2CH3); '3C NMR (62.9 MHz, CDC13)  6 174.1 (C), 170.9 (C), 
156.7 (C), 132.0 (C), 121.7 (2 x CH), 114.0 (2 x CH), 72.9 (C), 61.4 (CH2), 60.2 
(CH2), 55.4 (CH3), 50.6 (CH), 30.8 (CH2), 23.3 (CH3), 14.0 (CH3); HRMS (ES) 
Exact mass calcd for C16H22NO5 [M+H]: 308.1492, found: 308.1494. 
Me 	o 	 (±)-(3R,4R)-4-Hyd roxy-4-methyl-3-(3- 
Me 	 O methylbutyl)tetrahydropyran-2-one (182a). The title compound 
HO 	 was prepared according to General Procedure N from 181a (40 mg, 
0.20 mmol) for a reaction time of 16 h followed by Workup B and purification by 
column chromatography (30% EtOAc/petrol) to give a colourless oil (31 mg, 77%) 
- 	 thadip1ayed-identica4-pectroscopicdatato those reported-previously.)" 
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(±)-(3R,4R)-4-Hydroxy-4-methyl-3-(3- 
phenylpropyl)tetrahydropyran-2-one (182b). The title compound 
Ph  
Me 	J was prepared according to General Procedure N from 181b (49 mg, 
HO 
0.20 mmol) for a reaction time of 16 h followed by Workup B and 
purification by column chromatography (30% EtOAc/petrol) to give a white solid 
(42 mg, 85%) that displayed identical spectroscopic data to those reported 
previously. 27 
0 	 (±)-(3R,4R)-4-Hydroxy-3-(4-methoxybenzyl)-4- 
MeO0t 
methyitetrahydropyran-2-one (182c). The title compound was 
HO 	prepared according to General Procedure N from 181c (50 mg, 
0.20 mmol) for a reaction time of 16 h followed by Workup B and purification by 
column chromatography (40% EtOAc/petrol) to give a white solid (38 mg, 76%) that 
displayed identical spectroscopic data to those reported previously.27 
o 	 (±)-(3R,4R)-3-Furan-2-ylmethyl-4-hydroxy-4- 
methyitetrahydropyran-2-one (182d). The title compound was 
HO 	prepared according to General Procedure N from 181d (42 mg, 0.20 
mmol) for a reaction time of 16 h followed by Workup B and purification by column 
chromatography (30% EtOAc/petrol) to give a white solid (34 mg, 81%) that 
displayed identical spectroscopic data to those reported previously.27 
Me 	0 	 (±)-(3R,4R)-4-Hyd roxy-3-(3-methylbutyl)-4- 
MeJ5O phenyltetrahydropyran-2-one (181e). General Procedure N was 
HO 	followed using 182e (52 mg, 0.20 mmol) for a reaction time of 8 h 
followed by Workup B and purification by column chromatography (30% 
EtOAc/petrol) to give the title compound and its diastereomer as a 5.5:1 inseparable 
mixture as a white solid (44 mg, 99%). m.p. 116-118 °C; JR (CHC13) 3366 (OH), 
2953, 1703 (C=O), 1447, 1210, 1110, 1065, 934, 755, 703 cm 1; 1HNMR (360 
MH7,CllCh)_7.43-7.39 (4}{,mArH),7.35-7.29 (tH,m,ArH), 46' (1H, ddd, .J= 
11.4, 8.4, 4.9 Hz, CH20), 4.41 (11-1, ddd, J= 11.4, 5.7, 5.3 Hz, CH20), 2.80 (1H, dd, 
J= 8.5, 2.6 Hz, CHCO), 2.43 (1H, ddd, J= 14.7, 8.4, 5.3 Hz, CH2CH20), 2.28 (1H, 
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br s, OH), 2.13 (1H, ddd, J = 14.7, 5.7, 4.9 Hz, CH2CH20), 1.83-1.73 (1H, in, 
CH2CH2CHC=O), 1.52-1.41 (IH, in, CH2CH2CHC=O), 1.39-1.30 (1H, in, 
CH2CHC=O), 1.27-1.18 (1H, in, CH2CHC=O), 1.06-0.94 (IH, in, (CH3)2CH), 0.72 
(3H, d, J= 6.5 Hz, (CH3)2CH), 0.70 (3H, d, J= 6.5 Hz, (CH3)2CH); '3C NMR (62.9 
MHz, CDC13) 6 173.3 (C), 145.2 (C), 128.7 (2 x CH), 127.5 (CH), 124.3 (2 x CH), 
75.6 (C), 65.1 (CH2), 51.2 (CH), 39.2 (CH2), 38.3 (CH2), 27.8 (CH), 22.9 (CH2), 22.4 
(CH3), 22.0 (CH3); HRMS (ES) Exact mass calcd for C16H26NO3 [M+NH4]: 
280.1907, found: 280.1903. 
(±)-(3R,4R)-4-Hyd roxy-4-phenyl-3-(3- 
Ph 	 o phenylpropyl)tetrahydropyran-2-one (1821). General Procedure Ph 
HO 	N was followed using 181f(62 mg, 0.20 mmol) for a reaction time 
of 8 h followed by Workup B and purification by column chromatography (30% 
EtOAc/petrol) to give the title compound and the corresponding alkylative aldol 
cyclization product as a >95:5 inseparable mixture as a white solid (50 mg, 76% 
(adjusted yield of 1761)). m.p. 100-102 °C; JR (CHCI3) 3366 (OH), 2953, 1703 
(C=O), 1447, 1210, 1110, 1065, 934, 755, 703 cm'; 1 H NMR (360 MHz, CDC13)  6 
7.41-7.38 (4H, in, ArH), 7.35-7.31 (1H, in, ArH), 7.23-7.18 (2H, in, ArH), 7.15-7.11 
(I H, m, ArH), 7.03-7.01 (2H, in, ArH), 4.62 (IH, ddd, J= 11. 5, 8.7, 4.8 Hz, CH20), 
4.40 (1 H, ddd, J= 11. 5, 5.5, 5.5 Hz, CH20), 2.84 (1H, dd,J= 8.3, 2.7 Hz, CHC=O), 
2.46 (2H, t, J = 7.7 Hz, PhCH2), 2.43 (1 H, ddd, J= 14.2, 8.7, 5.5 Hz, CH2CH20), 
2.31 (1H, br s, OH), 2.10 (1H, ddd, J= 14.2, 5.5, 4.8 Hz, CH2CH20), 2.00-1.79 (2H, 
in, CH2CH2CHC=O), 1.50-1.42 (IH, m, CH2CHC=O), 1.34-1.25 (IH, in, 
CH2CHC=O); '3C NMR (62.9 MHz, CDC13) 6 173.3 (C), 145.0 (C), 141.9 (C), 128.7 
(2 x CH), 128.2 (2 x CH), 128,1 (2 x CH), 127.5 (CH), 125.6 (CH), 124.3 (2 x CH), 
75.4 (C), 65.1 (CH2), 51.0 (CH), 39.1 (CH2), 35.5 (CH2), 30.5 (CH2), 24.9 (CH2); 
HRMS (ES) Exact mass calcd for C20H26NO3 [M+NH4]: 328.1907, found: 
328.1906. 
- - 	 0 	- 	- 	- 	- 
0 
0 p 	phenyltetrahydropyran-2-one (182g). General Procedure N was 
follwed using 181g (54 mg, 0.20 mmol) for a reaction time of 8 h 
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followed by Workup B and purification by column chromatography (70% 
EtOAc/petrol) to give the title compound and the corresponding alkylative aldol 
cyclization product as a 9:1 inseparable mixture as white solid (46 mg, 75% 
(adjusted yield of 182g)). m.p. 108-110 °C; JR (CHC13) 3436 (OH), 2972, 1727 
(C=O), 1447, 1408, 1266, 1198, 1011, 754, 701 cni'; 'H NMR (360 MHz, CDC13) 6 
7,45-7.38 (4H, in, ArH), 7.33-7.27 (1H, in, ArH), 7.20 (1H, dd, J = 1.9, 0.8 Hz, 
CH), 6.19 (1H, dd, J= 3.2, 1.9 Hz, CH), 5.96 (1 H, dd, J= 3.2, 0.8 Hz, CH), 4.67 
(1H, ddd, J= 11.4, 9.6, 4.6 Hz, CH20), 4.42 (1H, ddd, J = 11.4, 5.5, 4.6 Hz, CH20), 
3.39 (1H, dd, J= 6.5, 4.5 Hz, CHC=O), 3.07 (1 H, dd, J= 15.5, 6.5 Hz, CH2CH), 
2.93 (1 H, dd, 1= 15.5, 4.5 Hz, CH2CH), 2.72 (1 H, br s, OH), 2.43 (1H, ddd, J 
14.7, 9.6, 5.5 Hz, CH2CH20), 2.08 (1H, ddd, J= 14.7, 9.6, 5.5 Hz, CH2CH20); 13C 
NMR (62.9 MHz, CDC13) 6 171.9 (C), 152.7 (C), 144.4 (C), 141.0 (CH), 128.7 (2 x 
CH), 127.5 (CH), 124.3 (2 x CH), 110.7 (CH), 107.4 (CH), 75.0 (C), 65.3 (CH2), 
50.2 (CH), 39.5 (CH2), 23.9 (CH2); HRMS (ES) Exact mass calcd for C16H,704 
[M+H]: 273.1121, found: 273.1120. 
Et 
HO 	_J 	oxabicyclo[4.3.0]nonan-4-one (182h). The title compound was 
prepared according to General Procedure N from 181h (51 mg, 0.20 
mmol) for a reaction time of 3.5 h followed by Workup C and purification by column 
chromatography (30% EtOAc/petrol) to give a colorless oil (45 mg, 88%). JR (film) 
3489 (OH), 2972, 1734 (C0), 1467, 1329, 1305, 1270, 1186, 1134, 1061 cm 1 ; 'H 
NMR (250 MHz, CDC13) 6 4.68 (1H, d, J= 12.1 Hz, CCH20), 4.22 (2H, q, J= 7.2 
Hz, OCH2CH3), 3.97 (1H, d, J= 12.1 Hz, CCH20), 3.62 (1 H, s, OH), 2.37 (1 H, dd, J 
= 9.3, 2.7 Hz, CH2CH), 2.33-2.21 (1 H, m), 2.16-1.88 (4H, m), and 1.73-1.58 (3H, in, 
CH2CH2CH2 and CH2CH), 1.28 (3H, t, J= 7.2 Hz, OCH2CH3), 1.05 (3H, t, J= 7.4 
Hz, CH3CH2CH); 13C NMR (62.9 MHz, CDC13) 6 174.1 (C), 172.5 (C), 85.0 (C), 
69.2 (CH2), 61.9 (CH2), 56.5 (C), 50.4 (CH), 41.5 (CH2), 35.0 (CH2), 23.4 (CH2), 
18.1 (CH2), 14.0 (CH3), 13.6 (CH3); HRMS (ES) Exact mass calcd for C13H24N05 
[M+NH4]: 274.1649, found: 274.1647. 	 - 	 - 
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0 	 (±)-(1R,5R,65)-5-Iso-butyl-1-carbethoxy-6-hydroxy-3- 
Me 
HO 	
° oxabicyclo[4.3.0]nonan-4-one (1821). The title compound was 
Me 
CO2Et prepared according to General Procedure N from 181i (56 mg, 
0.20 mmol) for a reaction time of 21 h followed by Workup C and purification by 
column chromatography (10% EtOAc/petrol-30% EtOAc/petrol) to give a colorless 
oil (42 mg, 74%). JR (film) 3489 (OH), 2957, 2871, 1740 (C=O), 1469, 1369, 1302, 
1249, 1175, 1118 cm'; 1 H NMR (360 MHz, CDC13)  64.72 (1H, d, J= 12.1 Hz, 
CCH20), 4.24 (2H, q, J= 7.1 Hz, OCH2CH3), 4.00 (1 H, d, J= 12.1 Hz, CCH20), 
3.58 (1H, d,J= 1.0 Hz, OH), 2.52 (1 H, dd, J=9.2, 1.6 Hz, CHC=O), 2.33-2.24 (1 H, 
m), 2.13-2.04 (2H, m), 1.99-1.90 (2H, m), 1.77-1.61 (3H, m) and 1.37-1.30 (lH, in, 
CH2CH2CH2 and (CH3)2CHCH2), 1.30 (3H, t, J= 7.1 Hz, OCH2CH3), 0.98 (3H, d, J 
= 6.6 Hz, (CH3)2CH), 0.88 (3H, d, J= 6.6 Hz, (CH3)2CH); '3C NMR (62.9 MHz, 
CDC13) 6174.1 (C), 172.7 (C), 85.2 (C), 69.2 (CH2), 62.0 (CH2), 56.4 (C), 46.1 (CH), 
41.5 (CH2), 35.1 (CH2), 33.7 (CH2), 26.5 (CH), 23.4 (CH3), 23.3 (CH2), 21.6 (CH3), 
14.0 (CH3). 
1R,5R,651ui1 1 -carbethoxy-6-hyd roxy-3- 
Ph 
HO 	oxabicyclo[4.3.01nonan-4-one (182j). The title compound was 
c02 	prepared according to General Procedure N from 181j( 63 mg, 0.20 
mmol) for a reaction time of 2 h followed by Workup C and purification by column 
chromatography (30% EtOAc/petrol) to give a colorless oil (47 mg, 73%). JR (film) 
3481 (OH), 2967, 1739 (C=O), 1454, 1394, 1368, 1305, 1240, 1126, 1043 cm 1 ; 1 H 
NMR (360 MHz, CDC13) 6 7.34-7.26 (4H, m, ArH), 7.22-7.18 (lH, m, ArH), 4.69 
(1H, d, J= 12.1 Hz, CCH20), 4.26 (2H, q, J= 7.1 Hz, OCH2CH3), 3.95 (1 H, d, J= 
12.1 Hz, CCH20), 3.90 (1H, d, J= 0.9 Hz, 011), 3.41 (1H, dd, J= 14.6, 8.0 Hz, 
CH2CH), 2.98 (1H, dd, J = 14.6, 3.4 Hz, CH2CH), 2.79 (111, dd, J = 8.0, 3.4 Hz, 
CH2CII), 2.32-2.12 (2H, m, CH2CH2CH2), 1.98-1.89 (2H, m, CH2CH2CH2), 1.69-
1.58 (2H, m, CH2CH2CH2), 1.32 (3H, t, J= 7.1 Hz, OCH2CH3); 13C NMR (62.9 
MHz, CDC13)  6 174.2 (C), 172.1 (C), 140.8 (C), 129.2 (2 x CH), 128.4 (2 x CH), 
126.2 (CH), 85.2(C), 69.2 (CH2), 62.2 (CH2)3  56.6 (C), 51.1 (CH), 41.8 (CH2), 35.0 
(CH2), 30.9 (CH2), 23.4 (CH2), 14.0 (CH3); HRMS (El) Exact mass calcd for 
C18H2205 [M]: 318.1462, found: 318.1463. 
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(±)-(3R,4R)-4-Hydroxy-4-methyl-3-[(RS)-1-phenylpropyljtetrahydropyran-2-
one (184a) and (±)-(3R,4R)-3-benzyl-4-hydroxy-4-methyltetrahyd ropyran-2-one 
(185a) 
Et 0 	 0 
0 	 0 	 H 
Me O
Ph Ni(acac), (5 mot 5) 	Ph JO 	+ Ph O 
Et2Zn (2 equiv) 	Me'' Me) 
THF, 0 C tort 
183a 	 HO 184a 	 HO 185a 
	
1:1 dr 19:1 dr 
18% 	 79% 
General Procedure N was followed using substrate 183a (218 mg, 1.00 mmol) for a 
reaction time of 16 h and the reaction mixture was subjected to Workup B followed 
by purification by column chromatography (20% EtOAc/petrol) to give the lactone 
184a (45 mg, 18%) as a 1:1 mixture of diastereomers as a colourless gum, followed 
by the lactone 185a (174 mg, 79%) as a white solid that displayed identical 
spectroscopic data to those reported previously. 
Data for 184a (1:1 mixture of diastereomers): JR (CHC13) 3436 (OH), 2967, 1709 
(C=O), 1454, 1262, 1149, 1120, 1073, 766, 703 cm'; 1 H NMR (360 MHz, CDC13) 
7.47-7.24 (5H, in, ArH), 4.60 (0.5H, ddd, J = 11.4, 8.0, 4.8 Hz, CH20), 4.32-4.13 
(1.5H, in, CH20), 3.29-3.23 (0.5H, in, CH2CH), 3.18-3.12 (0.5H, in, CH2CH), 2.90 
(1H, d, J= 4.0 Hz, CHC=O), 2.32-2.17 (0.5H, m, CH2CH20), 2.08-1.71 (4.5H, m, 
CH2CH20, CH3CH2 and OH), 1.43 (1.5H, s, CH3COH), 1.39 (1.5H, s, CH3COH), 
0.86 (1.5H, t, J= 7.3 Hz, CH3CH2), 0.77 (1.5H, t, J= 7.3 Hz, CH3CH2); '3C NMR 
(62.9 MHz, CDC13) 5  171.6 (C), 171.4 (C), 144.4 (C), 142.2 (C), 129.5 (CH), 128.8 
(CH), 128.7 (CH), 128.6 (CH), 127.1 (CH), 126.6 (CH), 71.1 (C), 70.9 (C), 65.1 
(CH2), 65.0 (CH2), 58.6 (CH), 57.0 (CH), 46.2 (CH), 45.3 (CH), 36.4 (CH2), 35.7 
(CH2), 29.7 (CH3), 29.5 (CH3), 29.3 (CH2), 26.9 (CH2), 12.8 (CH3), 12.5 (CH3); 
HRMS (ES) Exact mass calcd for C1 5H24NO3 [M+NH]+: 266.175 1, found: 266.1750. 
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(±)-(3R,4R)-4-Hyd roxy-4-methyl-3- I(RS)-1-(4- 
chlorophenyl)propylltetrahydropyran-2-one (184b) and (±)-(3R,4R)-3-(4-
chlorobenzyl)-4-hydroxy-4-methyltetrahyd ropyran-2-one (185b) 
Et 0 	 0 




Ni(acac)2 (5 mot %) 
Et2Zn (2 equiv) 
183b 	
THF,O'C tort 	 HO 184b 	 HO 185b 
1:1 dr '19:1 dr 
25% 	 63% 
General Procedure N was followed using substrate 183b (253 mg, 1.00 mmol) for a 
reaction time of 8 h and the reaction mixture was subjected to Workup B followed by 
purification by column chromatography (20% EtOAc/petrol) to give the lactone 
184b (71 mg, 25%) as a 1:1 mixture of diastereomers as a white solid, followed by 
the lactone 185b (160 mg, 63%) as a white solid that displayed identical 
spectroscopic data to those reported previously. 
Data for 184b (1:1 mixture of diastereomers): m.p. 77-79 °C; IR (CHCI3) 3430 (OH), 
2931, 1708 (C=O), 1492, 1408, 1262, 1210, 1093, 1014, 830 cm 1 ; 'H NMR (360 
MHz, CDC13) 6 7.43-7.40 (1H, in, ArH), 7.37-7.29 (311, in, ArH), 4.60 (0.5H, ddd, J 
= 11.4, 8.5, 4.7 Hz, CH20), 4.31-4.12 (1.5H, in, CH20), 3.29-3.24 (0.5H, in, 
CH2CH), 3.14-3.09 (0.511, in, CH2CH), 2.87 (0.511, d, J= 3.3 Hz, CHC=O), 2.77 
(0.5H, d, J= 3.4 Hz, CHCrO), 2.24-2.11 (0.5H, in, CH2CH20), 2.06-1.69 (4.5H, m, 
CH2CH20, CH3CH2 and OH), 1.43 (1.5H, s, CH3COH), 1.42 (1.511, s, CH3COH), 
0.83 (1.5H, t, J= 7.3 Hz, CH3CH2), 0.77 (1.5H, t, J= 7.3 Hz, CH3CH2); '3C NMR 
(62.9 MHz, CDC13) 6 171.4 (C), 171.3 (C), 143.4 (C), 140.7 (C), 132.7 (C), 132.0 
(C), 130.9 (2 x CH), 130.1 (C), 128.7 (2 x CH), 128.6 (2 x CH), 70.9 (C), 70.0 (C), 
65.2 (CH2), 64.9 (CH2), 58.3 (CH), 57.1 (CH), 45.4 (CH), 44.6 (CH), 36.4 (CH2), 
35.6 (CH2), 29.6 (CH3), 29.5 (CH3), 29.3 (CH2), 26.4 (CH2), 12.7 (CH3), 12.6 (CH3); 
HRIVIS (ES) Exact mass calcd for C15H23C1NO3 [M+NH4]: 300.1361, found: 
300.1362.  
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Preparation and Cyclization of Deuterium-Labeled Substrate 154 
0 o 	o 	 N-Benzyl-N-(3-oxobutyl)-(E)-3-deuterio-3- 
Ph Me phenylpropenamide (160). The title compound was prepared 
Bn 
according to General Procedure I from methyl vinyl ketone 
(361 iL, 4.00 mmol), benzylamine (393 iL, 3.60 mmol) and the acid chloride 
(prepared according General Procedure A) derived from (E)-3-deuteriocinnamic acid 
(603 mg, 3.60 mmol) for a reaction time of 16 h and purified by column 
chromatography (40% EtOAc/petrol) to give light yellow solid (518 mg, 47%) as a 
2:1 mixture of rotamers. m.p. 54-56 °C; IR (CHC13) 2923, 1713 (C0), 1638 (C=O), 
1600 (C=C), 1496, 1370, 1206, 1162, 871, 734, 700 cm'; 'HNMR (360 MHz, 
CDCI3) (Major rotamer) 6 7.47 (2H, d, J= 5.6 Hz, ArH), 7.42-7.26 (8H, in, ArH), 
6.86 (1 H, s, =CH), 4.79 (211, s, CH2Ph), 3.72 (2H, t, J= 6.7 Hz, CH2CH2N), 2.89 
(2H, t, J= 6.7 Hz, CH2CH2N), 2.16 (3H, s, CH3C=O); (Minor rotamer) 6 7.59 (2H, 
d, J = 6.3 Hz, ArH), 7.42-7.26 (8H, in, ArH), 7.01 (111, s, =CH), 4.75 (2H, s, 
CH2Ph), 3.76 (2H, t, J = 6.7 Hz, CH2CH2N), 2.73 (2H, t, J = 6.7 Hz, CH2CH2N), 
2.11 (3H, s, CH3C=O); '3C NMR (90.6 MHz, CDC13) (Mixture of rotamers - not 
fully assigned) 6 207.2 (C), 205.9 (C), 166.9 (C), 166.3 (C), 137.5 (CH, t, Jj) = 20.4 
Hz), 137.0 (CH, t, J1) = 23.7 Hz), 134.9 (C), 134.8 (C), 129.5 (CH), 128.7 (CH), 
128.6 (CH), 128.5 (CH), 128.4 (CH), 127.9 (CH), 127.7 (CH), 127.6 (CH), 127.5 
(CH), 127.2 (CH), 126.3 (CH), 117.0 (CH), 116.7 (CH), 52.1 (CH2), 49.3 (CH2), 
42.7 (CH2), 42.4 (CH2), 41.7 (2 x CH2), 30.1 (CH3), 29.9 (CH3); HRMS (ES) Exact 
mass calcd for C20H21DN02 [M+H]: 309.1708, found: 309.1707. 
(±)-(3R,4R)-1-Benzyl-3-[(RS)-deuteriophenylmethyll -4-hydroxy-4-
methylpiperidin-2-one (163). 
DH 0 	 HO 0 










) I F/hexane 	Me' 	 Me 
_________ _____ - 	 - _______ 1 HO 163a  
1:1.3 mixture before purification 
(Relative stereochemistries of major 
and minor isomers not assigned) 
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General Procedure N was followed using substrate 160 (62 mg, 0.20 mmol) for a 
reaction time of 16 h followed by Workup A to give 163 as a 1:1.3 inseparable 
mixture of diastereomers. Purification of the residue by column chromatography 
(70% EtOAc/petrol) gave 163 as a white solid (52 mg, 84%) as a 1:1.5 inseparable 
mixture of diastereomers. m.p. 114-116 °C; JR (CHC13) 3399 (OH), 2928, 1617 
(C=O), 1495, 1451, 1269, 1146, 918, 732, 700 cm'; 1 HNMR (360 MHz, CDC13) 
7.43-7.41 (2H, in, ArH), 7.39-7.29 (7H, m, ArH), 7.26-7.21 (1H, in, ArH), 4.75 (III, 
d, J= 14.7 Hz, CH2Ph), 4.58 (1H, d, .1= 14.7 Hz, CH2Ph), 3.47 (111, ddd, J= 12.2, 
9.0, 5.6 Hz, CH2CH2N), 3.35 (0.4H, d, J= 5.3 Hz, CHD), 3.22 (0.6H, d, J= 5.4 Hz, 
CHD), 3.13 (1H, ddd, J= 12.2, 5.9, 5.1 Hz, CH2CH2N), 2.72 (1 H, d, J= 5.4 Hz, 
CHCH=O), 1.92-1.80 (2H, in, CH2CH2N), 1.76 (1H, br s, OH), 1.31 (3H, s, 
CH3COH); '3C NMR (62.9 MHz, CDC13) 6  171.1 (C), 141.9 (C), 137.1 (C), 129.2 (2 
x CH), 128.5 (2 x CH), 128.4 (2 x CH), 127.9 (2 x CH), 127.2 (CH), 126.0 (CH), 
71.0 (C), 54.2 (CH), 50.4 (CH2), 43.0 (CH2), 35.2 (CH2), 32.5 (CHD, t, JD = 19,5 
Hz), 28.9 (CH3); HRMS (ES) Exact mass calcd for C20H23DN02 [M+H]: 311.1864, 
found: 311.1862. 
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6. Enantioselective Synthesis of Pyrrolidin-2-ones 
As mentioned previously (Chapter 3), the stereoselective synthesis of heterocyclic 
ring systems present a particular challenge to synthetic chemists. These structural 
motifs often appear at the core of important biologically active natural products and 
pharmaceutical agents, such as salinosporamide A (87)70 and morphine (88)( Figure 
3.1). 
In recent years our group has been interested in developing a novel and efficient 
synthesis of the marine natural product salinosporamide A (87).70 The main focus of 
our research has centred on the development of a reductive aldol methodology which 
will allow the construction of the y-lactam core in a highly stereocontrolled manner 
(Scheme 6.1). 
C'~'-M.' . VNH 
(87) 
R2O___...)l_PMP R1 R' 
> R
20 	 Me 
Reductive aldol 
cyclisation 	 PMP 0 
Scheme 6.1 
We envisioned that through the development of appropriate conditions, a variety of 
a,/3-unsaturated carbonyl compounds tethered to ketones through an amide linkage 
would cyclise to provide a number of pyrrolidin-2-one products, which are 




Conditions 	R NPMP 	(51) 
MP Mef 
HO 
rider our previously described copper-catalysed conditions the reductive aldol 
cyclisation of substrates 113 was extremely inefficient (eq. 24-26). On the other 
hand, the application of our cobalt- (Table 4.2, entries 13-17) and nickel-catalysed 
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(Table 5.2) conditions allowed the construction of a number of pyrrolidin-2-one 
products 132 and 180 to be accomplished in moderate yield and with generally good 
levels of diastereoselectivity; however, all efforts to develop an enantioselective 
variant of these processes failed. 
As a consequence, we considered an alternative strategy for the stereoselective 
synthesis of y-lactams involving the cyclisation of a substituted malonate unit on to a 
tethered methyl ketone acceptor 201 (Scheme 6.2). 
0 	 0 
/ 	 R2 	 (do[ CI 	O2C N MP  cycLisation 	
Me





In a similar vein, Pattenden and co-workers elegantly demonstrated that the core 
lactarn of (87) could be constructed in 71% yield via tandem ketone deprotection 
followed by sequential aldol cyclisation to give the product as a single diastereorner 




















Although this type of intramolecular aldol addition of a substituted malonate unit to a 
- 
	
	 tethered ketoncha&rcceivediittl ttentioninjhe literature, wurn ised that through 
the development of appropriate conditions the cyclisation of malonates 201 could be 
accomplished stereoselectively (Scheme 6.2). 
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6.1. Results and Discussion 
6.1.1. Lewis-acid Mediated Cyclisations 
We initially considered the synthesis of pyrrolidin-2-ones via a Lewis acid-catalysed 
cyclisation of substituted malonate derivative 201a (eq 52). 
0 
0 0 	
Me - PMP Me 	
OP 	
Les acid 	EtO2C 	N 
0 	PMP Me 	 Me" 	
(52) 
HO 
201a 	 203a 
Such transformations have not been reported in the literature to the best of our 
knowledge; however, the related conjugate addition of malonates to U,,13-unsaturated 
ketones involving a number of Lewis-acidic catalyst species is well documented 




COBn (204) (10 mot%) 





COBn =5 CO2  8nCO2Bn 	
Me02C 	 Et02C 
93% yield 	 83% yield 	 75% yield 





1-1 ff"DI- 0-  
 (R,R)-La-M-0-Linked-BINOL complex 
(204) 
Scheme 6.4 
Therefore, we began by assessing the suitability of several potential Lewis acid 
promoters in the presence of additional base (Table 6.1). 
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0 	0 
Me ( sat 
0 
Me 
EtOxC N _ PMP  
OEt 
 0	PMPMe Mej 
HO 
201a 203a 
Entry 	Metal Salt 	moiX Base 	mol% Time (h) Conversion%°  
1 	La(OTf)3 -xH2O 	10 K2CO3 133 1 100 
2 	La(OTf)3 xH20 	10 - - 48 0 
3 	Yb(OTf)3 xH20 	10 K2CO3 133 1 50 
4 	Yb(OTf)3-xH2O 	10 - - 48 0 
5 	Mg(ClO)2 	 10 K2CO, 133 1 100 
6 	Mg(C104)2 	 10 K2CO3 10 3 100 
7 	Mg(C104)2 	 10 - - 48 0 
8 	Zn(OTf)2 	 10 K2CO3 133 48 0 
9 	Zn(OTf)2 	 10 - - 48 0 
10 	Ni(acac)2 	 10 K2CO3 133 48 0 
11 	Sn(OTf)5 	 10 K2C05 133 48 0 
"Dcteniiined by 'H NMR analysis of the unpurified reaction mixtures 
Table 6.1 
It was observed that in the absence of additional base the reaction failed to initiate 
and no product 203a was formed when substoichiometric quantities of 
La(OTf)3 xH20 and Yb(OTf)3 xH20 were used (entries 2 and 4). Nevertheless, the 
addition of 1.33 eq of K2CO3  resulted in the formation of the aldol product 203a as a 
1:1 mixture of diastereomers (entries I and 3); with La(OTf)3 xH20 proving to be the 
more effective catalyst, giving the product 203a in 100% conversion after 1 hour 
(entry 1). Similarly, the use of substoichiometric quantities of Mg(C104)2 is only 
effective in the presence of K2CO3 (entries 5 and 6); however, in this case the 
amount of K2CO3  can be lowered to 10 mol% with no loss in conversion (entry 6). 
Alternative Lewis acid promoters such as, Zn(OTf)2, Ni(acac)2 and Sn(OTf)2 proved 
to be ineffective even in combination with the additional base (entries 8, 10 and 11). 
Replacing K2CO3  with organibãés such aEt3NPf2EtN or 2,6-lutidlfferesulted in 	 - - 
negligible substrate conversion, while alternative solvents such as THF, DCM or 
toluene proved inferior to EtOH in terms of reaction turn-over. 
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Following the development of an effective Mg(C104)2/K2CO3 catalyst combination 
the scope of the reaction was next investigated (Table 6.2). 
0 	0 
R1-it.J.3 
0 	PMP R2 
201a-e 
K2CO3 (10 mol%) 



















0 	P, MP R R=Bn2Olc 	










203d 	5:1 100 




0 EtO2C._ N.MP 
5 Ph ( &y). 201  203e 	- <5 
Ph'j 
PMPMe HO 
'Determined by 'H NMR analysis of the unpurified reaction mixtures 
Table 6.2 
Substrates containing methyl ketones tethered to the malonate unit underwent the 
most productive cyclisations (entries 1, 2 and 4), giving the corresponding 3-
hydroxylactams 203a, 203b and 203d in 100% conversion and with 
diastereoselectivities of 1:1, 3:1 and 5:1 respectively. However, under these 
conditions, the attempted cyclisation of substrate 203c resulted in a mixture of 
unidentified side-products. Furthermore, replacement of the methyl ketone with a 
phenyl ketone 203eled to negligible cyclisation under these conditions (entry 5). 
This is most likely due to the decreased electrophilicity of aryl ketones compared 
with alkyl ketones. 
Subsequently, the scope of this process was further explored by applying our 
magnesium catalyst system to the cyclisation of substituted malonate units tethered 
to ketones via an ester linkage (Table 6.3). One would except that due to the 
decreased electron-donation from the ester tether in substrates 205 compared with 
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that of the amide tether in substrates 201, that the deprotonation of the malonate unit 
and thus cyclisation should occur more readily for those substrates incorporating an 
ester linkage. 
o 	0 K2CO3 (10 moIX) R2 
Mg(CL0)2 (10 mot%( RO2C 0  
0 
EtOH, it R" 
HO 
205a-c 206a-c 
Entry 	 Substrate Product d.r %Conversion< 
0 
O 	0 R'1  
Ph  R<Me205a 206a 15 
2 	
O OEI R = Bn 205a 206b 	- <5 
O 	 R Phd 
HO 







206c 	- <5 
O 	 Bn Me'i 
HO 
<Determined by H NMR analysis of the unpurified reaction mixtures 
Table 6.3 
In the event, ester tethered substrates failed to undergo any observable cyclisation 
and only starting material was recovered from the reaction mixture (entries 1-3). It 
could be reasoned that the increased electron-donation from the amide linkage is in 
fact facilitating the coordination of the Lewis acid catalyst, therefore, allowing more 
efficient activation of the malonate proton towards deprotonation. 
At this stage, lacking any literature president, only a speculative mechanistic 
rationale can be suggested (Scheme 6.5). 




MP R2  
201 Mg(CIO)2 	
0 	P 
Mg2 2(C104 )2 
p2 
R1  
L,,MgO 	 2(Ct0 207 
0 	IMP R2 





Initial coordination of Mg(Cl04)2 with substrate 201 is followed by deprotonation by 
potassium ethoxide (formed by the deprotonation of ethanol by K2CO3)  to produce 
magnesium enolate intermediate 207. Rapid aldol cyclisation of 207 will provide the 
product as a magnesium alkoxide 209 which would then be rapidly protonated by 
ethanol. If this mechanism is indeed operative then the participation of magnesium 
enolate 209 in the bond forming event would seem to indicate that a careful choice of 
chiral non-racemic ligand may lead to an asymmetric variant of this process. 
In this regard the cyclisation of substrate 201a was evaluated in the presence of a 
variety of chiral non-racemic ligands (Table 6.4). 
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0 
0 	0 	 K2CO3(10mo%) 	 Me 
PMP 
OEt 	Mg(CO4 )2 (10 moL%) 	
EtO2C Me...__._lL.1..._tL. Ligand (12 mot%( 
0 	PMP Me 	 EtOH, 	
Me'j 
HO 







PPh2 	 PPh2 
(S)-BNAP (103) 	(S)-SEGPHOS (104) 	(R(-BINOL (210) 	 Indane-box (211) 
0% ee 	 0% ee 	 0% ee 	 0% ee 
Et ,-01,1 — 11 " 	 Q 





/—Me 	 PPh2 Ph2 
C 3 
(R,k(-Et-OuPhOs (111) 	 Pybox-ip (1) 	 Trost tigand (112) 
0% ee 	 0% ee 0% ee 
Me Me 	 CN Me 	 Me. 
0 	
NH 
- 	 N 	 NH N 	 Me 	 Me 
	
Bn OH 	 OH R 	 R 
Box-Bn (142) 	 Semicorrin (143) 	 Ephedrine (144) 	PseudoephedflTle (145) 
0% ee 	 0% ee 	 0% ee 	 0% ee 
Table 6.4 
Unfortunately, in the presence of substoichiometric quantities of a variety of chiral 
ligands only racemic products were obtained. Alternative magnesium salts such as 
Mg(OTf)2 also gave racemic products. From these results it would appear that either 
magnesium is not involved in the stereochemical-determining step or that there is 
inefficient magnesium- ligand complexation. A this stage we elected to investigate 
the use of a chiral non-racemic Ni(II) complex as a potential catalyst in the 
transformation. As previously illustrated, Ni(acac)2 proved to be ineffective as a 
catalyst in the cyclisation, even in the presence of K2CO3 (Table 6.1, entry 10). 
Nevertheless, such Ni(II) complexes have been shown to promote the 
enantioselective intermolecular Michael addition of a variety of malonates to several 
nitro-olefins (Table 6.5).' 
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EO) 2 EtO OEt 212 (2 mol%) 
toluene 	 CO2Et 
R %Yietd %ee 
4-MeOPh 99 95 
2,3-(MeO)Ph 99 93 
2-furyl 98 95 
4-MePh 99 95 
4-CIPh 98 92 
CH(Me)5 82 90 
Table 6.5 
In the event, no cyclisation was observed in the presence of the nickel salt, even at 
elevated temperatures (eq 53 and 54). The use of alternative solvents such as toluene, 
CH2CC12  and THF also resulted in negligible reactivity. 
0 
Me N) OR' 	212 (lOmol%) 	
R20C 	 PMP 
0 	PMP R' 	 rt to50°C 	
Me 
EtOH HO 
= Me, R2 = Et 201a 	 203a 0% conversion 	(53) 
= Ph, R2 = 'Bu 201d 203d 0% conversion (54) 
In conclusion, it has been shown that the use of Lewis acid-catalysis results in 
minimal substrate scope and to date no asymmetric induction has been observed. As 
a consequence it was necessary to consider alternative catalyst systems that would 
allow the cyclisation of a broader range of substrates with observable enantiomeric 
excesses. 
6.1.2. Organocatalyst mediated cyclisations 
The development of organocatalysts has become a significant area of interest that has 
provoked enormous amounts of research into the discovery of new organic molecules 
that catalyse reactions only previously mediated by metal-ligand combinations. In 
this respect, we considered the use of known organocatalysts as potential mediators 
in the atdoftyclisati-on of mlonate substrates 201.- Must-notably—,(L)zprolin has  
proven to be a potent and highly stereoselective promoter for the aldol cyclisation of 
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trione 213 in the Hajos-Parrish-Eder-Sauer-Wiechert reaction, to produce bicyclic 
product 214 in excellent yield (eq 55)92 
me 	







Despite this isolated example other aldol cyclisations are rare in the chemical 
literature. However, in related areas the development of efficient catalyst systems has 
continued to advance and break new ground. For example, the conjugate addition of 
diethylmalonate into a variety of nitroolefins catalysed by the bifunctional 




F3C-. N YN 
CF3 
215 
0 R 0 0 	 NO2 EtO
2 EtO OEt 215 (10 mol%) 
toluene 	 CO2Et 
R %Yietd %ee 
Ph 86 93 
2,6-(MeO)2Ph 87 93 
4-FPh 87 92 
2-thienyL 74 90 
pentyt 78 81 
'Bu 88 81 
Table 6.6 
Therefore, we focused on screening several bifunctional organic molecules as 
potential catalysts in our aldol cyclisation. From the outset cinchona alkaloids were 
considered as their use as organo-catalytic reagents has been well documented. 
94, 95 
These catalysts are likely to operate via duel activation of the substrate molecule 
(Figure 6.1). Firstly, the tertiary amine moiety serves to activate the nucleophile by 
thedeprotonatioirof the 1na1onateunitTesuitingi1ratighonPairtheffiCienCyof 
which will greatly depend on the pKa of the malonate proton. Secondly, the pendant 
alcohol substituent acts as a hydrogen-bond donor, coordinating with the acceptor 
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ketone and increasing its inherent electrophilicity. The degree of ketone activation by 
the hydroxy-group will depend upon its hydrogen-bond-donating ability; a stronger 
donating-ability will result in greater activation 
Activates the electrophite 	 Activates the nucleophile 
via hydrogen-bonding via deprotonation 
CHIL SCAFOLD 	1 





Initially, cinchonidine (216) was tested for catalytic activity against a number of 
substrates (Table 6.7). 
0 0 
R 	
N " 0 R 3 (216) (15 mol%) 
0 	PMP R2 	 Toluene, rt 
201a-e  
H 
R II _PMP cI;O R3 O2C7'N 	 H
ftJ 
R"i 
HO 	 Cinchonidine 
203a-e 	 (216) 
Entry Substrate Product ee% %Conversion< 
0 
1 0 	0 R=Me2Ola R 203a 	- <5 
2 Me )* R 	Ph 201b 
_PMP 
EI02CIN  203b 	23 60 









203d 	33 60 




S 	 PMP 0 0 	 Et02C N 
5 	Ph ) 	 201e 	
Ph' 	
203e 	- 	 <5 
Cr_ PMPMe 	 - 	- - -HO 
'Determined by 'H NMR analysis of the unpurified reaction mixtures 
Table 6.7 
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Similarly to the results described for the magnesium-catalysed cyclisation of 
substrates 201 (Table 6.2), the incorporation an aryl ketone results in negligible 
reactivity (entry 5). Additionally, substrates containing an alkyl substituted malonate 
unit (entries 1 and 3) are also poor substrates. This is most likely due to insufficient 
substrate activation and deprotonation by the weakly basic catalyst. It should be 
noted that ester tethered substrates; such as those described previously (Table 6.3) 
are also unreactive under these conditions. The only substrates that result in product 
formation are 201b and 201d giving the desired /3-hydroxylactams 203b and 203d 
respectively in 60% conversion and with diastereoselectivities of >19:1 (entries 2 and 
4). The apparent reactivity of these substrates is almost certainly due to the sp2-
hydridised phenyl substituent on the malonate component increasing the acidity of 
the malonate proton, hence, allowing its deprotonation by the weakly basic 
cinchonidine catalyst. Gratifyingly, the analysis of the reaction mixtures by chiral 
HPLC indicated that products 203b and 203d had formed with an enantiomeric 
excess of 23% and 33% respectively. As a consequence, alternative amino-alcohol 
derivatives were screened for reactivity and asymmetric induction in the cyclisation 
of substrate 203d (Table 6.8). 
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0 0 	 0 Ph 	II 
Me 	 Catalyst (15 mot%) 	tBuO2cç_ N_ PMP 
Toluene, rt 
0 	PMP Ph 	 days 	 Mel 
HO 
201d 	 203d 
HJ 
H 	 H 





Quinine (217) 	 218 	 219 
60% conversion 80% conversion 	 <50% conversion 
33% ee 	 68% ee 	 19% ee 
OH 
Me 
NMe2 ~' 	 - 
:~6 
Mef 	 Ph 
OH H TL 	 jJ 
N-methytephedrine (220) 	 OH 221 
40% conversion 	 220 	 50% conversion 
39% ee 	 nr -23% ee 
Table 6.8 
The majority of amino-alcohol derivates tested result in poor reactivity and/or poor 
selectivity. However, use of modified quinine derivative 218 resulted in 80% 
conversion of starting material, producing the aldol product 201d in an impressive 
68% enantiomeric excess and with a diastereomeric ratio of >19:1. 
Additionally, it was perceived that the pendant ester substituent would have an effect 
on the selectivity of the process. Therefore, a variety of ester substituents were 
examined (Table 6.9). 
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0 	R' 	Ph Me'' 
HO 
Entry R' It2 Product %Cor,version°  %ee" 
I PMP Et 201b 203b 95 47 
2 PMP 'Pr 222a 223a 95 63 
3 PMP 'Bu 201d 203d 95 68 
4 PMP 'Amy( 222b 223b 95 63 
5 Br 'Bu 222c 223c 100 65 
"Determined by 'H NMR analysis of the unpurified reaction mixtures 
'Determined by chiral HPLC analysis of the unparifucd reaction mixtures 
Table 6.9 
In all cases the reactions proceed well giving the desired products in >95% 
conversion and with diastereoselectivities of >19:1. As suggested the ester 
substituent does indeed influence the stereochemical outcome of the reaction. 
Substrate 201b incorporating an ethyl ester provides the product in an unimpressive 
47% ee (entry 1). Increasing the steric bulk of the ester also results in an increase in 
the enantiomeric excess with substrates 222a and 201d incorporating iso-propyl and 
tert-butyl substituents respectively, providing the products with the highest levels of 
stereoselection (entries 2 and 3). By increasing the steric bulk of the ester group 
further 222b, results in a decrease in the selectivity (entry 4). The replacement of the 
electron-rich PMP protecting group with the more electron-neutral benzyl group 
222c results in an augmented reaction rate with little effect on the diastereo- or 
enantioselectivity (entry 5). 
Furthermore, the relative stereochemistry of the major diastereomer of lactam 223a 
was confirmed by X-ray crystallography (Figure 6.2). 
Chapter 6—Enantioselective Synthesis of Pyrrolidin-2-ones 	 202 
Ph D 
CO 







As previously stated the catalysts operate through a duel activation of the substrate 
molecule, with the tertiary amine functionality activating the nucleophule through 
deprotonation (Figure 6.1). In order to increase substrate activation by the catalyst it 
is necessary to augment its hydrogen-bond-donating ability. In this regard, 
Jacobsen, 96  Takemot093 and Connon97 have pioneered the use of chiral thiourea 
derivatives as powerful hydrogen-bond-donor catalysts that promote a diverse range 
of reactions with excellent enantioselectivity. Therefore, the replacement of the 
donor-hydroxy group with a thiourea moiety should, in principle result in greater 
catalyst activity. To explore these effects two thiourea catalysts 224 and 225 were 
evaluated for efficacy (eq 56). 
Chapter 6—Enantioselective Synthesis of Pyrrolidin-2-ones 	 203 
0 0 Ph 
Catalyst (15 moL%) 	BuO2C._._,N_1MP 	
(56) 
Toluene, rt 
0 	PMP Ph 	 2 days 	 Me""  
HO 
20k! 	 203d 
CF3 
















Although the use of the thiourea catalysts 224 and 225 gave increased conversion of 
starting material, the enantioselectivities were inferior to that obtained for quinine 
derivative 218. 
In an effort to increase the selectivity of the process a number of relatively non-polar, 
aprotic solvents were investigated and in the presence of a variety of catalysts, the 
conversion and selectivities were evaluated with the most promising results detailed 
below (Table 6.10). 
0 	0 
Me_-...)I_*,.1 	
Cat (15 mot%) 
0 
Ph 




PMP 	Ph 	 2 days Me" 
HO 
201d 03d  2 
Entry Sotevnt Catalyst %Conversion° 	-- - 
Toluene 218 Ca. 90 68 
2 EtOAc 218 Co. 90 70 
3 Et20 218 Ca. 40 71 
4 THE 218 Ca. 95 70 
5 Dioxane 218 ca. 95 71 
6 EtOAc 224 CU. 90 63 
7 Et20 224 Ca. 40 77 
£Dotm-issinc4by -H-NM-R analysis of the unpuiifie4re-aossxs-aiissuros----- 
5Dctemined by chiral HPLC analysis of the unpurified reacnon mixtures 
Table 6.10 
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The choice of solvent was observed to effect both the conversion and the 
enantioselectivity in the formation of 201d. In the presence of 218 as the catalyst, the 
use of Et20 as solvent gives the aldol product in 71% ee; however, due to the poor 
solubility of 218 in Et20 the conversion was limited to 40% (entry 3). This could be 
overcome by replacing Et20 with 1 ,4-dioxane as the solvent, giving the aldol product 
in 95% conversion and with 71% enantiomeric excess (entry 3). Likewise, the use of 
EtOAc and THF gives high levels of conversion with similar levels of selection 
(entries 4 and 5). In the presence of 224 as the catalyst, the use of toluene was noted 
to offer high conversion levels but with poor enantioselectivities (eq 56). However, 
the replacement of toluene with Et20 allowed the aldol product to be generated in 
77% ee, albeit with a greatly reduced conversion of 40% (entry 7) due to the poor 
solubility of the catalyst in Et20. By using EtOAc as the solvent the conversion 
levels could be increased; however, this resulted in a reduction in the 
enantioselectivity compared that obtained when Et20 is used as solvent (entry 6). 
Alternative solvents such as CH2C12, CHC13, EtOH and DMSO were inferior to those 
described (Table 6.10). Notably, the diastereoselectivity of the process was not 
affected by the change in solvent. 
6.2. Conclusions and Further Work 
It has been demonstrated that a combination of substoichiometric quantities of 
Mg(C104)2 and K2CO3 effects the aldol cyclisation of substituted malonate moieties 
tethered to a methyl ketone via an amide linkage. However, the substrate scope is 
limited to a select group of amide tethered substrates such as 201b and 201d. 
Furthermore, ester linked substrates are not reactive under these conditions (Table 
6.3). Subsquent attempts to render the magnesium-catalysed process enantioselective 
through the addition of chiral non-racemic ligands failed to yield any observable 
levels of selection. Further to this it has been illustrated that in the presence of 
modified cinchona alkaloids such as, 218 the aldol products could be obtained in 
4~-/o-~~ion-and-w-ith-enantioselectivities-of-up to 680LLlhmugLlnadificati ons 
to the catalyst structure and a survey of reaction solvent conditions the levels of 
enantioselection could be further enhanced to a maximum of 77%. Nevertheless, the 
substrate scope in this area remains limited to the cyclisation of amide tethered 
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substrates bearing an sp2-substituted malonate unit. Potential future work in this area 
would aim to identify more effective catalyst systems that will enable the cyclisation 
of a variety of substrates to occur with enantioselectivities of >90%. These may 
include other modified alkaloid derivatives or other bifunctional organocatalysts 
reported in the literature. 
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6.3. Experimental 
All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-
dried apparatus. CH202 was distilled from CaH2. THF was distilled from sodium 
benzophenone ketyl. 'Petrol' refers to that fraction of light petroleum ether boiling in 
the range 40-60 °C. All other commercially available reagents were used as received. 
Thin layer chromatography (TLC) was performed on Merck DF-Alufoilien 60F254 
0.2 mm precoated plates. Product spots were visualised by UV light at 254 rim, and 
subsequently developed using potassium permanganate, ceric ammonium molybdate 
solution or vanillin solution as appropriate. Flash column chromatography was 
carried out using silica gel (Fisher Scientific 60A particle size 35-70 micron) 
employing the method of Still and co-workers 
.
80 Melting points were recorded on a 
Gallenkamp melting point apparatus and are uncorrected. Infra-red spectra were 
recorded on a Jasco FT/IR-460 Plus instrument as a thin film on sodium chloride 
plates or as a dilute solution in CHC13. 'H NMR spectra were recorded on a Bruker 
DPX360 (360 MHz) spectrometer or a Bruker ARX250 (250 MHz) spectrometer. 
Chemical shifts (6) are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using residual protonated solvent as internal standard (CDC13 at 
7.27 ppm, C2D2CL4 at 5.94 ppm, CD30D at 3.35 ppm). Abbreviations used in the 
description of resonances are: s (singlet), d (doublet), t (triplet), q, (quartet), app 
(apparent), br (broad). Coupling constants (J) are quoted to the nearest 0.1 Hz. 
Proton-decoupled '3C NMR spectra were recorded on a Bruker DPX360 (90.6 MHz) 
spectrometer or a Bruker ARX250 (62.9 MHz) spectrometer. Chemical shifts (6) are 
quoted in parts per million (ppm) downfield of tetramethylsilane, using deuterated 
solvent as internal standard (CDC13 at 77.0 ppm, C2D2CL at 74.2 ppm, CD30D at 
49.0 ppm). Assignments were made using the DEPT sequence with secondary pulses 
at 90° and 135°. High resolution mass spectra were recorded on a Finnigan MAT 900 
XLT spectrometer using the electrospray (ES) positive ion mode at the EPSRC 
National Mass Spectrometry Service Centre, University of Wales Swansea, or on a 
Katos-M&5OT-C-speetFometer using-the-fäsL atom- bOmbardmeflt_(EAB) technique in 
the mass spectrometry laboratory at the School of Chemistry, University of 
Edinburgh. Stated calculated mass values refer to that of the ion (i.e. the actual 
species being detected), not that of the neutral parent compound. Chiral HPLC 
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analysis was performed on an Agilent 1100 instrument. Optical rotations were 
performed on an Optical Activity POLAAR 20 polarimeter. 
PMPHN 	
Me 1-(4-Methoxyphenyl)aminopropanone (126). Prepared according to 
a previously reported procedure (Chapter 3.3). 
Preparation of mono-esters from phenyl malonic acid: General Procedure P 
CO2H 	 CO2H 
DCC, CH2CL1  
CO2H  
ROH, 0 °C 
A DCC (1 equiv) solution in CH202 (50 mL) was added dropwise over 1 hour to a 
stirred solution of phenylmalonic acid (1 equiv) and the appropriate alcohol (1 equiv) 
in CH202 (150 mL) at 0 T. The mixture was stirred at 0 °C for 1 hand then allowed 
to warm to room temperature and the precipitated dicyclohexylurea was removed by 
filtration. The filtrate was concentrated under reduced pressure and partitioned 
between Et20 (100 mL) and NaHCO3(aq) (100 mL). The aqueous layer was removed 
and washed with Et20 (2 x 50 mL) then acidified to pH 3 by the addition of 2M 
HC aq). The aqueous layer was then extracted with EtOAc(3 x 50 mL), the combined 
organic layers were dried over MgSO4 and concentrated under reduced pressure to 
yield the corresponding mono-ester substituted phenylmalonic acid. 
CO2H 	 2-(isopropoxycarbonyl)-2-phenylacetic acid (226). The title 
C (OMe compound was prepared according to general procedure P from 
phenylmalonic acid (11 g, 60 mmol), isopropanol (4.6 mL, 60 
mmol) and DCC (12.4 g, 60 mmol) for a reaction time of 2 hrs. The product was 
obtained as a white solid (10.6 g, 80%). m.p. 68-70 °C; JR (CHC13) 3034 (OH), 
2984, 1716 (C=O), 1498, 1304, 1167, 1033, 991, 815, 700 cm-1; 1HNMR (360 
MHz, CDC13) 3 11.5 (111, bs, CO2H), 7.45-7.30 (5H, m, ArH), 5.11 (lH, heptet, J= 
- 	 6.3 Hz, OCH(CH3)2), 4.b5 (IH 	hCH(CO2H)(CO2R))3t29-(3-H,_d,_J - 6.3F1z, 	 -- 
OCH(CH3)2), 1.24 (3H, d, J= 6.3 Hz, OCH(CH3)2); '3C NMR 178.3 (C), 174.0 (C), 
167.6 (C), 129.1 (2 x CH), 128.7 (2 x CH), 128.7 (CH), 70.0 (CH), 57.7 (CH), 21.4 
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(CH3), 21.4 (CH3); HRMS (ES) Exact mass calcd for C12H,404 [M+NH4]: 
222.0887, found: 222.0886. 
	
CO2H 	 2-(tert-butoxycarbonyl)-2-phenylacetic acid (227). The title 
0 M a--,  o 	compound was prepared according to general procedure P from 
phenylmalonic acid (11 g, 60 mmol), tert-butanol (5.8 mL, 60 
mmol) and DCC (12.4 g, 60 mmol) for a reaction time of 2 hrs. The product was 
isolated as a white solid (9.9 g, 70%). m.p. 72-73 °C; JR (dc13) 2978 (OH), 1714 
(C0), 1498, 1370, 1145, 1032, 838, 750, 699, 668 cm'; 1 H NMR (360 MHz, 
CDC13) ö 11.80 (1H, s, OH), 7.44-7.30 (5H, in, AnT), 4.60 (1H, s, PhCH(CO2R)2), 
1.49 (9H, s, C(CH3)3); '3C NMR 178. 2 (C), 174.1 (C), 167.3 (C), 129.1 (2 x CH), 
128.6 (2 x CH), 128.3 (CH), 83.0 (C), 58.5 (CH), 27.7 (3 x CH3); HRMS (ES) Exact 
mass calcd for C13H,604 [M+NH4]': 236.1044, found: 236.1043. 
CO2H 	 2-((tert-pentyloxy)carbonyl)-2-pheflYlaCetiC acid (228). The 
0(0 Me Me 
 title compound was prepared according to general procedure P 
Me 	
from phenylmalonic acid (11 g, 60 mmol), amylalcohol (60 
mmol) and DCC (12.4 g, 60 mmol) for a reaction time of 2 hrs. The product was 
isolated as a white oil (8.7 g, 58%). JR (CHC13) 3033 (OH), 2978, 1713 (C=O), 1456, 
1387, 1289, 1145, 1032, 830, 699 cm'; 'H NMR (360 MHz, CDCI3) 6 11.73 (1H, bs, 
OH), 7.47-7.34 (5H, in, ArT!), 4.64 (1H, s, PhCH(CO2R)2), 1.80 (2H, q, J= 7.5 Hz, 
CH2CH3), 1.48 (6H, d, J = 2.9 Hz, C(CH3)2CH2CH3), 0.87 (3H, t, J = 7.5 Hz, 
CH2CH3); '3C NMR 178.1 (C), 174.1 (C), 167.1 (C), 129.1 (2 x CH), 128.7 (2 x CH), 
128.5 (CH), 85.4 (C), 58.6 (CH), 33.4 (CH2), 25.1 (CR3), 25.1 (CH3), 7.8 (CH3); 
HRMS (ES) Exact mass calcd for C14H1804 [M+NH4]: 250.1198, found: 250.1200. 
Preparation of mono-ethyl-phenylmalonic acid: General Procedure Q 
CO2Et 	 KOH 	 CO2H 
CO2Et 	EtOH, 0 °C 	RCO2Et 
A potassium hydroxide (1 equiv) solution in ethanol (50 mL) was added dropwise 
over 1 hour to a stirred solution of the appropriate diethylmalonate (1 equiv) in 
Chapter 6—Enantioselective Synthesis of Pyrrolidin-2-ones 	 209 
ethanol (90 mL) at 0 oC. The mixture was allowed to warm to room temperature and 
stirred until TLC analysis showed the reaction to be complete (Ca. 2 days). The 
slightly turbid solution was heated to reflux and filtered through a glass sinter. After 
cooling to room temperature the solvent was removed under reduced pressure and 
the resultant white solid dissolved in H20 (100 mL) and washed with Et20 (3 x 30 
mL). The aqueous layer was acidified with cone. HC1, extracted with EtOAc (3 x 30 
mL), dried over MgSO4  and concentrated under reduced pressure to yield the 
corresponding mono-ester substituted malonic acid. 
2H 	2-(ethoxycarbonyl)-2-methylacetiC acid (229). The title compound was 
Me ill CO2Et prepared according to general procedure Q from diethylmethylmalonate 
(17.2 mL, 100 mmol), potassium hydroxide (5.6 g, 100 mmol) for a reaction time of 
2 days. The product was isolated as a colourless liquid (11.9 g, 82%). Analytical data 
corresponds to that reported.98  
c02i 	2-(ethoxycarbonyl)-3-phenytpropaflOiC acid (230). The title 
CO2Et compound was prepared according to general procedure Q from 
diethylbenzylmalonate (12 mL, 50 mmol), potassium hydroxide (2.8 g, 50 mmol) for 
a reaction time of 2 days. The product was isolated as a colourless liquid (9.5 g, 
86%). Analytical data corresponds to that reported.99 
2-(ethoxycarbonyl)-2-phenylacetiC acid (231). 






A solution of diethylphenylmalonate (11 mL, 50 mmol) in THF (100 mL) was added 
portionwise 0.25M NaOH(aq) (1.2 L) at 0 °C until TLC analysis showed the reaction 
to be complete (Ca. 4 hrs). The mixture was washed with EtOAc (3 x 40 mL) and the 
oInbine&orgacsweredriedtrverMgSO4  and concentrated under-reduee4-pressure. 
The residue was triturated with hot petro]JCH2C12 (50 mL) to give the product as a 
white solid (10.2 g, 98%). Analytical data corresponds to that reported.'°° 
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Preparation of Acid Chlorides: General Procedure R 
CO2H 	(COCL)2, DMF 	CO2CI 
RlCO2R2 	CH2C 2, rt 	R1CO2R2 
Oxalyl chloride (1-10 equiv) was added dropwise over 2 mill to a solution of the 
appropriate mono-ester acid (1.00 equiv) and DMF (0.25 equiv) in CH2Cl2 (0.55 M 
with respect to carboxylic acid) at 0'C. The mixture was stirred at 0 °C until no 
more effervescence was observed (Ca. 1 h) to give a solution of mono-ester acid 
chloride which was used directly in the next step. 
Preparation of Amide-Tethered Cyclisation Precursors: General Procedure S 
c02c1 	 0 0 
Me 
NHPMP R1CO
2R2 Me ) QR2 
0 	 DCM, NaCO3(aq) 	0 	PMP R' 
The appropriate mono-ester acid chloride (as a solution in CH2Cl2 prepared 
according to General Procedure R, 1.5 equiv) was added dropwise or portionwise to 
a vigorously stirred mixture of the appropriate aminoketone (1.0 equiv) in CH2Cl2 (1 
mL/mmol of aminoketone) and saturated aqueous Na2CO3  solution (1 mL/mmol of 
aminoketone). The mixture was stirred at room temperature until TLC analysis 
showed the reaction to be complete. The reaction was partitioned between saturated 
aqueous NaHCO3 solution and CH202. The aqueous layer was separated and 
extracted with CH202  (x 3), and the combined organic layers were dried (MgSO
4) 
and concentrated in vacuo. Purification of the residue by column chromatography 
afforded the cyclization substrate. 
o o 	 Ethyl2(N(4-methoxYPheflYD-N(2 
Mey_ N)LvlLoEt  oxopropyl)carbamyl)PrOPafloate (201a). The title compound 
0 	PMPMe 	
was prepared according to General Procedure S from the amine 
126 (890 mg, 5.00 mmol) and the acid chloride (prepared according to General 
Procedure R) derived from 2(ethoxycarbofly1)-2-methYlacetic acid 229 (1.10 g, 7.50 
mmol) for a reaction time of 30 mins and purified by column chromatography (30% 
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EtOAc/petrol) to give an orange oil (760 mg, 50%). IR (CHC13) 2984, 1739 (C0), 
1661, 1512, 1418, 1250, 1170, 1053, 1031, 845 cm-1 ; 'H NMR (360 MHz, CDC13) 6 
7.04 (2H,d, J = 8.9 Hz, ArH), 6.64 (2H, d, J = 8.9 Hz, ArH), 4.27 (1H, d, J = 17.5 
Hz, CH2N), 4.01 (1 H, d, J = 17.5 Hz, CH2N), 3.78 (2H, q, J = 7.1 Hz, OCH2CH3), 
3.52 (3H, s, OCH3), 3.21 (1 H, q, J= 7.1 Hz, CH3CH(CO2R)2), 1.86 (3H, s, CH3=0), 
0.98 (3H, d, J = 7.1 Hz, CH3CH(CO2R)2), 0.94 (3H, t, J = 7.1 Hz, OCH2CH3); 13C 
NMR (69.2 MHz, CDC13) 6 201.4 (C), 169.6 (C), 158.6 (C), 134.5 (C), 128.6 (2 x 
CH), 114.0 (2 x CH), 60.1 (CH2), 58.8 (CH3), 54.6 (CH), 42.3 (CH2), 26.2 (CH3), 
13.2 (CH3), 13.1 (CH3) ; HRMS (ES) Exact mass calcd for C16H21N05 [M+H: 
307.1417, found: 307.1414. 
° ° 
Me )t)L0t 
3-phenyipropanoate (201c). The title compound was prepared 
according to General Procedure S from the amine 126 (890 mg, 5.00 mmol) and the 
acid chloride (prepared according to General Procedure R) derived from 2-
(ethoxycarbonyl)-3-PheflYlProPafloic acid 230 (1.60 g, 7.50 mmol) for a reaction 
time of 2 hrs and purified by column chromatography (30% Et20/Petrol) to give a 
caramel oil (1.68 g, 90%). IR (CHC13) 2980, 1739 (C=O), 1660, 1512, 1251, 1170, 
1030, 843, 755, 702 cm'; 'H NMR (360 MHz, CDC13) 6 7.19-7.13 (3H, in, ArH), 
6.96 (2H, d, J = 7.6 Hz, ArH), 6.76-6.67 (2H,m, ArH), 4.27 (1H, d, J= 17.3 Hz, 
CH2N), 4.12 (1H, d, J = 17.3 Hz, CH2N), 4.02 (2H, q, J= 7.1 Hz, OCH2CH3), 3.67 
(3H, s, OCH3), 3.56 (1H, dd, J= 9.5, 5.5 Hz, CH(CO2R)2), 3.10 (1H, dd, J= 
13.5, 
9.5 Hz, PhCH2CH), 3.00 (1H, dd, J = 13.5, 5.5 Hz, PhCH2CH), 2.00 (3H, s, 
CH3=0), 1.16 (3H, t, J= 7.1 Hz, OCH2CH3); '3C NMR (69.2 MHz, CDC13
) 6 201.7 
(C), 168.7 (C), 168.6 (C), 158.8 (C), 137.9 (C), 134.3 (C), 129.1 (2 x CH), 128.8 (3 x 
CH), 127.9 (2 x CH), 126.1 (C), 114.1(2 x CH), 60.8 (CH2), 59.2 (CH2), 55.0 (CH3), 
50.1 (CH), 34.6 (CH2), 26.6 (CH3), 13.6 (CH3); HRMS (ES) Exact mass calcd for 
C22H25N05 [M+H]1 : 383.1727, found: 383.1723. 
° ° 
Me )LOEt 
2-phenylacetate (201b). The title compound was prepared 
0 	PMP Ph 
according to General Procedure S from the amine 126 (890 mg, 5.00 mmol) and the 
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acid chloride (prepared according to General Procedure R) derived from 2-
(ethoxycarbonyl)-2-pheflYlacetic acid 231 (1.56 g, 7.50 mmol) for a reaction time of 
2 hrs and purified by column chromatography (30% Et20/Petrol) to give a light 
yellow solid (1.52 g, 83%). m.p. 67-69 T. JR (CHC13) 2979, 1734 (C0), 1659 
(C=O), 1512, 1385, 1250, 1170, 1028, 841, 698 cm'; 'H NMR (3 60 MHz, CDC13) 6 
7.37-7.26 (4H, in, ArH), 7.17 (3H, in, ArH), 6.86 (2H, bd, J= 8.1 Hz, ArH), 4.68 
(IH, s, CH(CO2R)2), 4.45 (lH, d, J = 17.4 Hz, CH2N), 4.37 (1H, d, J = 17.4 Hz, 
CH2N), 4.17 (2H, q, J = 7.1 Hz OCH2CH3), 3.83 (3H, s, OCH3), 2.14 (3H, s, 
CH3=0), 1.26 (3H, t, J = 7.1 Hz, OCH2CH3); 13C NMR (69.2 MHz, CDC13) 6 201.9 
(C), 168.6 (C), 168.3 (C), 159.4 (C), 134.8 (C), 133.3 (C), 129.6 (2 x CH), 129.4 (2 x 
CH), 128.2 (2 x CH), 127.7 (CH), 114.7 (2 x CH), 61.5 (CH2), 59.7 (CH2), 55.4 
(CH3), 27.0 (CH3), 13.9 (CH3); HRMS (ES) Exact mass calcd for C21H23N05 
[M+H]: 369.1572, found: 396.1571. 
	
° ° 	 tertbutyI2-(N-(4-methOXYPheflYl)N(2 
oxopropyl)carbamyl)-2-PheflYlacetate (201d). The title 
compound was prepared according to General Procedure S from the amine 126 (890 
mg, 5.00 mmol) and the acid chloride (prepared according to General Procedure R) 
derived from 2(tertbutoxycarbonyl)-2-PhenYlacetic acid 227 (1.77 g, 7.50 mmol) 
for a reaction time of 4 brs and purified by column chromatography (30% 
EtOAc/Petrol) to give a beige solid (1.05 g, 53%). m.p. 109 °C. JR (CHCI3) 2977, 
1738 (C=O), 1659, 1512, 1368, 1251, 1146, 1066, 1030, 840 cm 1 ; 1 H NMR (360 
MHz, CDC13) 6 7.32-7.26 (4H, in, ArH), 7.21-7.19 (3H, in, ArH), 6.90 (2H, bd, J= 
8.2 Hz, ArH), 4.62 (1H, s, PhCH(CO2R)2), 4.45 (1H, d, J—= 17.5 Hz, CH2N), 4.31 
(1H, d, J= 17.5 Hz, CH2N), 3.84 (3H, s, OCH3), 2.14 (3H, s, CH3 0), 1.49 (9H, s, 
O(CH3)3); '3C NMR (69.2 MHz, CDC13) 6 201.7 (C), 168.4 (C), 167.5 (C), 159.2 
(C), 134.9 (C), 133.5 (C), 129.5 (2 x CH), 129.3 (2 x CH), 127.9 (2 x CH), 127.4 (2 x 
CH), 81.6 (C), 59.5 (CH), 55.7 (CH2), 55.3 (CH3), 27.6 (3 x CH3), 26.9 (CH3); 
HRMS (ES) Exact mass calcd for C23H27N05 [M+H]: 388.1962, found: 398.1961. 
o o 	 isopropy12-(N-(4-methOXYPheflYI)N(2 
Me 	
OPr oxopropyI)carbamyI)2-PheflYtaCetate (222a). The title 
0 	PMP Ph 
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compound was prepared according to General Procedure S from the amine 126 (890 
mg, 5.00 mmol) and the acid chloride (prepared according to General Procedure R) 
derived from 2(isopropoxycarbonY1)-2-PheflYlacetic acid 226 (1.67 g, 7.50 mmol) 
for a reaction time of 4 hrs and purified by column chromatography (50% 
EtOAc/Petrol) to give a beige crystalline solid (1.08 g, 51%). m.p. 126-127 T. IR 
(CHC13) 2980, 1737 (C=O), 1660, 1512, 1385, 1251, 1170, 1106, 1030, 843 cm
1 ; 'H 
NMR (360 MHz, CDC13) 6 7.30-7.26 (4H, in, ArH), 7.19-7.16 (3H, in, ArH), 6.88 
(2H, bd, J = 8.5 Hz, ArH), 5.02 (1H, septet, J = 6.1 Hz, CH(CH3)2), 
4.65 (1H, s, 
PhCH(CO2R)2), 4.39 (2H, s, CH2N), 3.84 (3H, s, OCH3), 2.15 (3H, s, CH3=0), 1.25 
(6H, appt, J = 6.1 Hz, OCH(CH3)2); '3C NMR (69.2 MHz, CDC13) 6; HRMS (ES) 
Exact mass calcd for C22H25N05  [M+H]+: 384.1805, found: 384.1806. 
0 0 Me 
T
Me 	N O)< Me 
	
tertpenty12(N-(4-mCthOXYPheflYD1(2 
oxopropyI)carbamyI)2-PhCflY1aCetate (222b). The title 
PMP Ph  
compound was prepared according to General Procedure S from the amine 126 (890 
mg, 5.00 mmol) and the acid chloride (prepared according to General Procedure R) 
derived from 2(/ertpentoxycarbOnyl)2PheflY cetic acid 228 (1.88 g, 7.50 mmol) 
for a reaction time of 4 hrs and purified by column chromatography (50% 
EtOAc/Petrol) to give a beige crystalline solid (1.21 g, 59%). m.p. 87-88 °C. JR 
(CHC13) 2975, 1739 (C=O), 1660, 1512, 1384, 1251, 1145, 1065, 1030, 841 cm; 111 
NMR (360 MHz, CDC13) 6 7.29-7.26 (4H, in, ArH), 7.20-7.18 (3H, in, ArH), 6.89 
(2H, bd, J= 8.4 Hz, ArH), 4.61 (1 H, s, PhCH(CO2R)2), 4.43 (1H, d, J= 
17.4 Hz, 
CH2N), 4.35 (IH, d, J = 17.4 Hz, CH2N), 3.85 (3H, s, OCH3), 2.15 (3H, s, CH
3 0), 
1.78 (2H, q, J= 7.5 Hz, O(CH3)2CH2CH3), 1.45 (6H, s, O(dH3)2CH2
CH3), 0.86 (3H, 
t, J= 7.5 Hz, O(CH3)2CH2CH3); 13C NMR (69.2 MHz, CDC13
) 6201.9(C), 168.6 
(C), 167.6 (C), 159.3 (C), 135.0 (C), 133.6 (C), 129.6 (2 x CH), 129.4 (2 x CH), 
128.0 (2 x CH), 127.5 (CH), 114.6 (2 x CH), 84.3 (C), 59.6 (CH2), 55.9 (CH3), 55.4 
(CH), 33.5 (CH2), 27.0 (CH3), 25.2 (CH3), 25.1 (CH3) 8.0 (CH3); HRMS (ES) Exact 
mass calcd for C24H29N05  [M+H]: 412.2118, found: 412.2116. 
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(222c). 
0 0 
1. Acid chloride 
Me 	 cH2C12, N3CO3aq) 	
Me ) OB 
NHBn 
OH 	
2. (COd)2, DM50, Et3N 	0 	Bn 	Ph 
CH2CL21  -78 °C 
The title compound was prepared according to General Procedure S from 1-
(benzylamino)propan-2-ol (890 mg, 5.00 mmol) and the acid chloride (prepared 
according to General Procedure R) derived from 2-(tert-butoxycarbonyl)-2- 
phenylacetic acid 227 (1.10 g, 7.50 mmol) for a reaction time of 8 hrs. The crude 
product was taken forward without further purification. A solution of oxalyl chloride 
(486 1tL, 5.46 mrnol) in CH202  (20 mL) was cooled to —78 °C then DMSO (776 iL, 
10.92 mmol) was added and the mixture allowed to stir for 20 mins. A solution of the 
crude amide in CH2C12 (20 mL) was added via cannula and the mixture allowed to 
stir for 1 hour at —78 °C before Et3N was added dropwise over 10 mins. The mixture 
was allowed to slowly warm to room temperature over 3 hrs then quenched by the 
addition of saturated aqueous NH4C1 (5 mL). The aqueous layer was extracted with 
CH2C12  (2 x 10 mL) and the combined organics dried over MgSO4  and concentrated 
under reduced pressure. The residue was purified by column chromatograophy (30% 
Et20/Petrol) to give a white solid. m.p. 95-97 °C; IR (CHCI3) 2978, 1740 (C=O), 
1653, 1497, 1431, 1367, 1150, 1031, 920, 699 cm-1 ; 1 H NMR (360 MHz, CDCI3) 6 
7.38-7.31 (9H, in, ArH), 7.14-7.11 (lH, in, ArH), 5.30 (1H, s, PhCH(CO2R)2), 4.64 
(1H, d, J= 16.8 Hz, CH2N), 4.45 (1H, d, J= 16.8 Hz, CH2N), 4.25 (111, d, J = 17.5 
Hz, NCH2Ph), 3.92 (1H, d, J = 17.5 Hz, NCH2Ph), 2.09 (3H, s, CH3=0), 1.49 (9H, s, 
C(CH3)3); 13C NMR (69.2 MHz, CDC13) 6 202.7 (C), 169.0 (C), 167.4 (C), 135.5 
(C), 133.2 (C), 129.4 (CH), 128.9 (CH), 128.6 (CH), 128.0 (CH), 126.8 (CH), 82.2 
(C), 56.6 (CH), 55.2 (CH3), 52.4 (CH2), 27.9 (3 x CH3); HRMS (ES) Exact mass 
calcd for C23H27N04 [M+H]: 381.1935, found: 381.1931. 
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0 	 0 
A DCC (1 equiv) solution in CH2C12 (5 mL) was added dropwise over 1 hour to a 
stirred solution of phenylmalonic acid (1 equiv) and the appropriate alcohol (1 equiv) 
in CH202 (5 mL) at 0 T. The mixture was stirred at 0 °C for 1 h and then allowed to 
warm to room temperature and the precipitated dicyclohexylurea was removed by 
filtration. The filtrate was concentrated under reduced pressure and partitioned 
between Et20 (10 mL) and NaHCO3(aq) (10 mL). The aqueous layer was removed 
and washed with Et20 (2 x 20 mL) then acidified to pH 3 by the addition of 
concentrated HC1. The aqueous layer was then extracted with EtOAc(3 x 10 mL), the 
combined organic layers were dried over MgSO4 and concentrated under reduced 
pressure to yield the corresponding ester-tethered cyclisation substrate. 
° 	° 	1-ethyl-3-(2-oxopropyl)-2-benzylmalonate (205c). The title 
MeO LQE, 
compound was prepared according to General Procedure T 
from hydroxyacetone (381 iL, 5.00 mmol) and the malonic acid 230 (prepared 
according to General Procedure R) (1.39 g, 5.00 mmol) and DCC (1.03 g, 5.00 
mmol) for a reaction time of 4 hrs and purified by column chromatography (50% 
EtOAc/Petrol) to give a colourless oil (904 mg, x%). IR (CHC13) 2983, 1734 (C=O), 
1455, 1370, 1279, 1226, 1147, 1064, 753, 701 cm 1 ; 'H NMR (360 MHz, CDC13) 6 
7.30-7.27 (2H, in, Ar!!), 7.24-7.21 (311, in, ArH), 5.19 (2H, s, CH20), 4.87 (2H, q, J 
= 5.6 Hz, CH3CH20), 4.53 (1H, t, J= 6.2 Hz, CH(CO2R)2), 4.12 (2H, d, J= 6.2 Hz, 
ArCH2), 3.18 (3H, s, CH3=0), 2.49 (3H, t, J = 5.6 Hz, CH3CH20); '3C NMR 
(69.2 MHz, CDC13) 6 201.1 (C), 168.3 (C), 168.2 (C), 137.5 (C), 128.8 (2 x CH), 
128.5 (2 x CH), 126.8 (CH), 68.9 (CH2), 61.7 (CH2), 53.4 (CH), 34.6 (CH2), 25.9 
	
(GH1)H-39-(-Cff --HRMS-(-ES)-E-xact--mass caled-for- C 5H1 -±H}--2-78--1-F491 	 - 
found: 278.1152. 
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1ethyI-3-(2-oxo-1-pheny1ethanone)-2-methY1IflaIOnate 
(205a). The title compound was prepared according to General 
Me 	
Procedure T from 2-hydroxyacetophenone (680 mg, 5,00 
mmol) and the malonic acid 229 (prepared according to General Procedure R) (1.04 
g, 5.00 mmol) and DCC (1.03 g, 5.00 mmol) for a reaction time of 6 hrs and purified 
by column chromatography (20% EtOAc/Petrol) to give a yellow oil (995 mg, 75%). 
IR (CHC13) 2988, 1755 (C=O), 1733 (C=O), 1705 (C=O), 1450, 1371, 1332, 1224, 
1096, 863 cm'; 'H NMR (360 MHz, CDC13)  6 7.91-7.88 (2H, in, ArH), 7.63-7.58 
(I H, in, Aril), 7.51-7.46 (2H, in, ArH), 5.44 (1H, d, J= 16.3 Hz, CH20), 5.33 (1H, 
d, J= 16.3 Hz, CH20), 4.23 (2H, q, J= 7.1 Hz, OCH2CH3), 3.64 (1 H, q, J= 7.3 Hz, 
CH3CH(CO2R)2), 1.52 (3H, d, J= 7.3 Hz, CH3CH(CO2R)2); 1.29 (3H, t, J= 7.1 Hz, 
OCH2CH3); '3C NMR (69.2 MHz, CDC13) 6 191.4 (C), 169.7 (C), 169.6 (C), 134.0 
(C), 133.9 (2 x CH), 128.8 (4 x CH), 127.7 (4 x CH), 66.5 (CH2), 61.5 (CH2), 45.9 
(CH), 14.0 (CH3), 13.6 (CH3); HRMS (ES) Exact mass calcd for C14H,605 [M+H]: 
264.0992, found: 264.0992. 
° ° 	1ethy13-(2-oxo-1-pheny1ethanone)-2-beflLY1ma1Oflate 
Ph O) OEt 
(205b). The title compound was prepared according to General 
Procedure T from 2-hydroxyacetophenone (680 mg, 5.00 mmol) and the malonic 
acid 231 (prepared according to General Procedure R) (1.06 g, 5.00 mmol) and DCC 
(1.03 g, 5.00 mmol) for a reaction time of 6 hrs and purified by column 
chromatography (20% EtOAc/Petrol) to give a yellow oil (1.03 g, 62%). JR (CHCI3) 
2982, 1755 (C=O), 1735 (C=O), 1705 (C=O), 1450, 1370, 1284, 1223, 1148, 754 
cm'; 'H NMR (360 MHz, CDC13) 6 7.88 (2H, d, J= 8.5 Hz, ArH), 7.60 (1H, tt, J= 
7.5, 7.5, 1.3, 1.3 Hz, ArH),7.48 (2H, tq, J= 7.5 Hz, ArH), 7.32-7.20 (5H, in, ArH), 
5.36 (2H, d, J= 3.6 Hz, CH200.18 (2H, q, J= 7.1 Hz, OCH2CH3), 3.87 (1H, t, J= 
7.8 Hz, CH(CO2R)2), 3.34 (211, dd, J = 7.8, 2.1 Hz, ArCH2), 1.21 (3H, t, J= 7.1 Hz, 
OCH2CH3); '3C NMR (69.2 MHz, CDC13) 6 191.2 (C), 168.4 (C), 168.3 (C), 137.7 
(C), 133.9 (C), 128.8 (6 x CH), 128.5 (2 x CH),127.7(2 x CH), 126.7 (C), 66.6 
(CH2), 61.6 (CH2), 53.5 (CH), 34.6 (CH2) 13.9 (CH3); HRMS (ES) Exact mass calcd 
for C20H2005 [M+H]: 340.1305, found: 340.1308. 
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Transition-Metal Catalysed Cyclisations: General Procedure U 
Me 
0 	(3S,4R)-ethyl-4-hydroxy- 1-(4-methoxyphenyl)-3,4-dimethyl-2- 
EtO2C 
oxopyrrolidine-3-carboxylate (203a). The title compound was 
Me' 
HO 	prepared according to general procedure U from precursor 201a 
and isolated as a 2:1 mixture of diastereomers yellow oil. JR (CHC13) 3441, 2959, 
1742 (C0), 1697, 1510, 1395, 1287, 1250, 1031, 833, 699 cm-1 ; 1 H NMR (360 
MHz, CDC13) 6 7.48 (2H, d, J= 9.2 Hz, ArH), 6.92 (2H, D, J= 9.2 Hz, ArH), 4.32-
4.11(211, m, CH2CH3), 4.00 (1 H, d, J = 10.0 Hz, CH2N, major), 3.90 (1H, d, J' 9.7 
Hz, CH2N, minor), 3.81 (311, s, 0CH3), 3.68 (1H, d, J = 10.0 Hz, CH2N, major), 
3.64 (1H, d, J= 9.7 Hz, CH2N, minor), 1.47 (311, s, CH3, major), 1.43 (311, s, CH3, 
minor), 1.38 (311, s, CH3), 1.31 (3H, t, J= 7.1 Hz, CH2CH3, minor), 1.26 (3H, t, J= 
7.1 Hz, CH2CH3, major); '3C NMR (69.2 MHz, CDC13) 6 ; HRMS (ES) Exact mass 
calcd for C 6H21NO5  [M+H]: 307.1414, found: 307.1420. 
(3S,4R)-ethyl-4-hydroxy-1-(4-methoxyphenyl)-4-methYl-2-OXO- 
EtO2C 	N IPMP 
f3-phenylpyrrolidine-3-carboxylate (201b). The title compound 
Me' 
HO 	was prepared according to general procedure U from precursor 203b 
and isolated as a yellowish oil. JR (CHC13) 3445, 2963, 1747 (C=O), 1697,1513, 
1398, 1290, 1252, 1035, 831, 700 cm 1 ; 1 H NMR (360 MHz, CDC13) 6 7.59 (211, d, J 
= 9.2 Hz, ArH), 7.37-7.32 (5H, m, Aril), 6.95 (2H, D, J= 9.2 Hz, Aril), 5.15 (111, 
bs, OH), 4.30 (211, qq, J= 10.6, 7.1 Hz, OCH2CH3), 3.91 (1H, d, J= 9.6 Hz, CH2N), 
3.82 (3H, s, OCH3), 3.59 (1H, d, J= 9.6 Hz, CH2N), 1.28 (311, t, J = 7.1 Hz, 
OCH2CH3), 1.11 (3H, s, CH3); '3C NMR (69.2 MHz, CDC13) 6 171.5 (C), 167.0 (C), 
157.0 (C), 134.8 (C), 132.0 (C), 128.5 (2 x CH), 127.9 (3 x CH), 122.1 (2 x CH), 
114.1 (2 x CH), 76.4 (C), 67.8 (C), 62.5 (CH2), 58.8 (CH2), 55.4 (CH3), 24.1 (CH3), 
13.7 (CH), 0.95 (CH3); HRMS (ES) Exact mass calcd for C21H23N05 [M+H]: 
369.1571, found: 369.1569. Enantiomeric excess was determined by HPLC with a 
Chiralpak OD-H column (85:15 hexanes:isopropanol, 0.8 mL/min, 210 nm, 25 °C); tr 
(minor) = 14.0 min,tr  (major) = 18.4 mm. 
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Ph 
o 	(3S,4R)-isopropyl-4-hydroxy-1-(4-methoxyphenyl)-4-methyl-2- 
PrO2C 	N PMP oxo-3-phenylpyrrolidine-3-carboxylate 	(223a). 	The 	title 
Me0 	 compound was prepared according to general procedure U from 
precursor 222a and isolated as a white solid. m.p. 118-120 °C; JR (CHC13) 3444, 
2980, 1743 (C=O), 1693, 1513, 1375, 1288, 1250, 1035, 831, 700 cm-1; 'H NMR 
(360 MHz, CDC13) 6 7.59 (2H, d, J= 9.2 Hz, ArH), 7.37-7.31 (5H, m, ArH), 6.95 
(2H, D, J = 9.2 Hz, ArH), 5.23 (1 H, bs, OH), 5.18 (1 H, septet, J = 6.3 Hz, 
OCH(CH3)2), 3.90 (1H, d, J= 9.6 Hz, CH2N), 3.82 (3H, s, OCH3), 3.58 (1H, d, J= 
9.6 Hz, CH2N), 1.25 (3H, d, J = 6.3 Hz, OCH(CH3)2), 1.19 (3H, d, J = 6.3 Hz, 
OCH(CH3)2), 1.10 (3H, s, CH3); '3C NMR (69.2 MHz, CDC13) 6 171.1 (C), 167.1 
(C), 157.0 (C), 135.0 (C), 132.1 (C), 128.4 (2 x CH), 128.0 (2 x CH), 127.7 (CH), 
122.2 (2 x CH), 114.2 (2 x CH), 70.5 (CH), 67.8 (C), 58.9 (CH2), 55.5 (CH3), 24.2 
(CH3), 21.4 (CH3), 21.0 (CH3); HRMS (ES) Exact mass calcd for C22H25NO5 
[M+H]: 383.1727, found: 383.1726. Enantiomeric excess was determined by HPLC 
with a Chiralpak AD-H column (80:20 hexanes:isopropanol, 0.8 mL/min, 210 nm, 25 
°C); tr  (minor) = 19.9 mm, t,. (major) = 17.6 mm. 
Ph
(3S,4R)-tert-butyl-4-hydroxy-1-(4-methoxyphenyl)-4-methyl-2- 
BOC 	_PMP 2 N oxo-3-phenylpyrrolidine-3-carboxylate (223d). The title 
Me 
HO 	 compound was prepared according to general procedure U from 
precursor 222d and isolated as a white solid. m.p. 169-170 °C; JR (CHC13) 3435, 
2976, 1744 (C=O), 1691, 1513, 1368, 1291, 1251, 1034, 831, 700 cm 1; 'H NMR 
(360 MHz, CDC13) 6 7.58 (2H, d, J= 9.2 Hz, ArH), 7.42-7.31 (5H, m, ArH), 6.95 
(2H, d, J= 9.2 Hz, ArH), 5.28 (1H, bs, OH), 3.89 (1 H, d, J= 9.5 Hz, CH2N), 3.83 
(3H, s, OCH3), 3.57 (1H, d, J= 9.5 Hz, CH2N), 1.44 (9H, s, OC(CH3)3), 1.10 (3H, s, 
CH3); '3C NMR (69.2 MHz, CDC13) ö 170.6 (C), 167.4 (C), 157.0 (C), 135.3 (C), 
128.3 (2 x CH), 128.0(2 x CH), 127.6 (CH), 122.2 (2 x CH), 114.2(2 x CH), 84.1 
(C), 68.0 (C), 59.0 (CH2), 55.5 (CH3), 27.7 (3 x CH3), 24.3 (CH3); HRMS (ES) Exact 
mass calcd for C23H27N05  [M+H]: 397.1884, found: 397.1883. Enantiomeric excess 
was determined by HPLC with a Chiralpak AD-H column (80:20 
hexanes:isopropanol, 0.8 mL/min, 210 nm, 25 °C); tr (minor) = 17.1 min,tr (major) = 
15.7 mm. 
Chapter 6—Enantioselective Synthesis of Pyrrolidin-2-ones 	 219 
PMP 
(3S,4R)-tert-pentyl-4-hydroxy-1-(4-methoxyphenyl)-4-methyl- 
MiyI 2 	 N 	2-oxo-3-phenylpyrrolidine-3-carboxylate (223b). The title 
Me0 	
compound was prepared according to general procedure U from 
precursor 222b and isolated as a white solid. m.p. 149-151 °C; IR (CHC13) 3435, 
2975, 1742 (C=O), 1692, 1513, 1369, 1288, 1251, 1035, 830, 700 cm; 1 H NMR 
(360 MHz, CDC13) 6 7.57 (2H, d, J = 9.2 Hz, ArH), 7.45-7.31 (5H, m, ArH), 6.95 
(2H, d, J= 9.2 Hz, ArH), 5.37 (1H, bs, OH), 4.00 (1H, d, J= 9.5 Hz, CH2N), 3.82 
(3H, s, OCH3), 3.56 (1H, d, J= 9.5 Hz, CH2N), 1.76 (1 H, app dq, J= 14.0, 7.5, 7.5, 
7.5 Hz, CH2CH3), 1.44 (3H, s, OC(CH3)2), 1.40 (3H, s, OC(C113)2), 1.10 (3H, s, 
CH3), 0.72 (3H, t, J= 7.5 Hz, CH2CH3); 13  NMR (69.2 MHz, CDC13) 6 170.6 (C), 
167.3 (C), 157.0 (C), 135.3 (C), 132.2 (C), 128.2 (2 x CH), 128.0 (2 x CH), 127.5 
(CH), 122.2 (2 x CH), 114.2 (2 x CH), 86.6 (C), 67.8 (C), 59.0 (CH2), 55.5 (CH3), 
33.8 (CH2), 25.3 (CH3), 24.9 (CH3), 24.3 (CH3), 7.8 (CH3); HRMS (ES) Exact mass 
calcd for C24H29NO5  [M+H]: 411.2040, found: 411.2041. Enantiomeric excess was 
determined by HPLC with a Chiralpak AD-H column (80:20 hexanes:isopropanol, 
0.8 mL/min, 210 nm, 25 °C); t (minor) = 13.9 mm, tr (major) = 16.2 mm. 
0 (3S,4R)-tert-butyl-1-benzyl-4-hyd roxy-4-methyl-2-oxo-3- 
BuO2C 
phenylpyrrolidine-3-carboxylate (223c). The title compound was 
Me 
HO 	prepared according to general procedure U from precursor 222c and 
isolated as a white solid. m.p. 162-163 °C; JR (CHC13) 3434 (OH), 1743 (C=O), 
1684, 1457, 1368, 1267, 1158, 841, 748, 699 cm; 1 H NMR (360 MHz, CDC13) 6 
7.39-7.28 (10H, m, ArH), 5.16 (1H, bs, OH), 4.78 (1H, d, J= 14.6 Hz, CH2Ph), 4.47 
(I H, d, J= 14.6 Hz, CH2Ph), 3.42 (1 H, d, J = 9.6 Hz, CH2N), 3.04 (1H, d, J = 9.6 
Hz, CH2N), 1.42 (9H, s, OC(CH3)3), 0.91 (3H, s, CH3); 13C NMR (69.2 MHz, 
CDC13) 6 170.7 (C), 168.4 (C), 135.9 (C), 135.0 (C), 128.7 (2 x CH), 128.3 (2 x CH), 
128.2 (2 x CH), 128.0 (2 x CH), 127.8 (2 x CH), 127.4 (C), 83.9 (C), 66.9 (C), 57.3 
(CH3), 47.1 (CH2), 27.7 (3 x CH3), 24.6 (CH2); HRMS (ES) Exact mass calcd for 
C23H27N04 [M+H]+: 381.1935, found: 381.1935. Enantiomeric excess was 
determined by HPLC with a Chiralpak OD-H column (85:15 hexanes:isopropanol, 
0.8 mL/min, 210 nm, 25 °C); tr (minor) = 7.3 mm, t,. (major) = 7.7 mm. 
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Appendix 1 
Felkin Control 
The attack of an enolate to an aldehyde bearing an a-stereocentre often leads to 
excellent stereocontrol.' 
Transition states for Z(0)-Enolate Aldol Reactions 
Felkin TS 
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'Roush, W. R. J. Org, Chem. 1991, 56, 4151. 
Appendix 2 
Publications in support of thesis. 
Diastereoselective Synthesis Of 4-hydroxypiperidin-2-ones via Cu(I)-
Catalysed Reductive Aldol Cyclisation, Lam, H. W.; Murray, G. J.; Firth, J. 
D. Org. Lett. 2005, 7, 5743. 
Diastereoselective Cobalt-Catalysed Reductive Aldol Cyclisations Using 
Diethyizinc As The Stoichiometric Reductant, Lam, H. W.; Joensuu, P. M.; 
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4-Hydroxypiperidin-2-ones may be prepared in highly diastereoselective fashion using a Cu(I)-catalyzed reductive aldol cyclization of a,fl-
unsaturated amides with ketones. Used in combination with proline-catalyzed asymmetric Mannich reactions, this methodology enables the 
en anti oselective synthesis of more highly functionalized piperidin-2-ones and hydroxylated piperidines. 
Metal-mediated cyclization reactions provide the basis for 
many powerful methods of carbocyclic and heterocyclic ring 
construction.' Within this field, intramolecular reductive 
atdol2 and Michael2 '3 reactions have proven to be of high 
utility. These processes are initiated by the hydrometalation 
Dedicated to Prof. David A. Evans on the occasion of his 65th birthday. 
(I) For representative examples, see: (a) Montgomery, J. Angew. Chem., 
ml. Ed. 2004, 43, 3890-3908. (b) Dounay, A. B.; Overman, L. E. Chem. 
Rev. 2003, 103, 2945-2964. (c) Negishi, E.; Copérct, C.; Ma, S.; Liou, 
S.-Y.; Liu, F. Chem. Rev. 1996, 96,365-393. (d) Ojima, I.; Tzamarioudaki, 
M.; Li, Z,: Donovan, R. J. Chem. Rev. 1996, 96, 635-662. 
(a) Kocch, P. K.; Krische, M. J. Org. Leo. 2004, 6, 691-694. (b) 
Huddleston, R. R.; Krische, M. J. Org. Left. 2003, 5,1143-1146. (c) Wang, 
L.-C.; Jang, H.-Y.; Roh, Y.; Lynch, V.; Schultz, A. J.; Wang, X.; Krische, 
M. J. J. Am. Chem. Soc. 2002, 124, 9448-9453. (d) Jang, H.-Y.; 
Huddleston, R. R.; Krische, M. J. J. Am. Chem. Soc. 2002, 124, 15156-
15157. (c) Chiu, P.; Leung, S. K. Chem. Commun. 2004, 2308-2309. (f) 
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of an a,/3-unsaturated carbonyl compound, allowing the 
regioselective generation of a metal enolate under mild 
reaction conditions. Subsequent intramolecular trapping of 
the enolate with an appropriate electrophile leads to the cyclic 
product, often with high levels of diastereo selectivity. The 
majority of such processes reported thus far have been 
concerned with the preparation of carbocycles; however, we 
recently reported a copper(J)-bisphosphine catalyzed reduc-
tive aldol cyclization (eq 1) that affords a variety of five- 
	
R2 0 	 R2 0 
R 
bisphosphina 
0 	Cu(OAc)2H20 	R (1) 
R 	
TMDS, THF, RT 
3
n= 	 R3' t2 
0 	 HO 
and six-membered /3-hydroxylactones in moderate to good 
yields and with moderate enantioselectivites when suitable 
chiral bisphosphines are employed.4 Herein we describe the 
extension of this process to the synthesis of 4-hydroxy-
piperidin-2-ones through the use of the corresponding 
substrates containing an amide linkage in place of an ester. 
Lam, H. W.; Joensuu, P. M. Org. Let!. 2005, 7, 4225-4228. 
Table 1. Catalytic Reductive Aldol Cyclizations To Form 4Hydroxypiperidin2onesu 
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11 Reactions were conducted using 1.0 mmol of substrate, 5 mol % Cu, 5 mol % DPPF, and 1.0 mniol of TMDS in 5 niL of THE I Isolated yield. 
Conducted using 0.2 mL of substrate, 5 mol % Cu, 5 mol % DPPF, and 0,2 rnmol of TMDS in 2 mL of THE "(EtO)iMcSiH (2.0 mmol) was employed 
in place of TMDS. PMP = p-methoxyphcnyl, OMP = o-mcthoxyphenyl. 
To increase the synthetic versatility of the products, we 
elected to examine the reactions of substrates 1 containing 
a removal nitrogen substituent, and PMP (p-methoxyphenyl) 
and OMP (o-methoxyphenyl) groups were chosen for this 
study .5 N-Alkyl-N-arylamides such as I are known to exist 
predominantly as the E-arnide rotamer, with the aryl group 
twisted such that the plane of the aromatic ring is ap-
proximately perpendicular to that of the amide group 
(Scheme 1).6 At the outset of these investigations, it was 
not clear whether this rotamer distribution would have any 
impact on the ability of these substrates to undergo cycliza-
tion. 
Scheme 1. Rotational Isomers of Cyclizatton Precursors I 
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In the event, using the conditions described previously for 
the corresponding ester substrates' (5 mol % Cu(OAc)2 H20, 
5744 
5 mol % 1,1'-bis(diphenylphosphino)-ferrocene (DPPF), and 
1 equiv of 1,1,3,3-tetramethyihydrosiloxane (TMDS) in THF 
at room temperature), a range of substrates la— k under-
went cyclization to form 4-hydroxypiperidin-2-ones 2a—k 
(Table 1). The reaction proved to be tolerant to wide variation 
in the ketone component, with alkyl (entries 1-3 and 7-10), 
aromatic (entries 4, 5, and 11), and heteroaromatic (entry 6) 
ketones reacting readily. However, the reaction was less 
tolerant of substitution in the a,/3-unsaturated carbonyl 
component. Acryloyl amides were found to be the best 
substrates, giving the desired piperidin-2-one products for 
all cases examined (entries 1-6 and 9). Although crotonoyl 
amides also underwent cyclization (entries 7, 8, 10, and 11), 
reaction rates and conversions were generally lower.' In 
the case of substrate 1k, use of (EtO)2MeSiH in place of 
TMDS proved to be beneficial (entry 11). The reactions 
(5) PMP and OMP groups may be removed oxidatively, for example, 
using eerie ammonium nitrate (CAN). See: (a) Kronenthal, D. R.; Han, C. 
Y.; Taylor, M. K. J. Org. Chem. 1982, 47, 2765-2768. (b) Ishitani, H.; 
Ucno, M.; Kobayashi, S. J. Am. Chem. Soc. 1997, 119, 7153-7154. For 
the removal of OMP groups using Phl(OAc)s, see: (c) Porter. J. R.; 
Traverse, J. F.; Floveyda, A. H.; Snapper, M. L. I Am. Chem. Soc. 2001, 
123, 10409-10410. 
(6) (a) Pederson, B. F.; Pederson, B. Tetrahedron Let:. 1965, 6, 2995-
3001. (b) ltai, A.; Toriumi, Y.; Tomioka, N.; Kagechika, H.; Azumaya, I.; 
Shudo, K. Tetrahedron Let!. 1989,30,6177-6180. (c) Curran, D. P.; Hale, 
G. R.; Geib, S. J.; Balog, A.; Cass, Q. B.; Degani, A. L. G.; Hernandes, M. 
Z.; Freitas, L. C. G. Tetrahedron: Asymmet,y 1997, 8, 39553975. 
(7) As the size of the substituent on the a,-unsaturated amide is 
increased further, the fomiation of uncyclized side products resulting 
from both ketone reduction and conjugate reduction also becomes prob-
lematic. 
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Table 2. Formation of C5- and C6—Substituted 
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11 Reactions were conducted using 0.2 mmcl of substrate, 5 mol % Cu, 
5 mol % DPPF, and 0.2 mmcl of TMDS in 2 mL of THF for 2-24 h. 
Determined by 'H NMR analysis of the unpurified reaction mixtures 
Minor diastcreomers (not shown) are assumed to possess inverted configura-
tions at 0 and C4. 'Isolated yield of major diastereomer. 
proceeded with high diastereoselectivities (>95:5 by IH 
NMR analysis), and the relative configurations of the 
products8 were found to match those of the lactone products 
described previously.' 
We next examined the effect of preexisting stereocenters 
in the tether linking the amide and the ketone on the 
diastereoselectivity of the process (Table 2). Acrylamide 3a, 
containing a methyl substituent a to the ketone, cyclized to 
give a mixture of two diastereomers in a ratio of 8:1, from 
which piperidinone 4a was isolated in 78% yield (entryl). 
By employing L-proline-catalyzed direct asymmetric Man-
nich reactions to prepare the requisite fi_aminoketones,9 we 
were able to access acrylamides 3b-3d in enantiomerically 
enriched form, and these cyclized to give piperidinones 4b-
4d, respectively, as the major products (entries 24)) The 
The relative configurations of the piperidinones 2a, 2d, and 2g were 
confirmed by X-ray crystallography. See Supporting Information for details. 
The stcreoehemistries of the remaining products were assigned by analogy. 
(a) Nota, W.; Watanabe, SA.; Chowdari, N. S.; Zhong, G.; Betancort, 
J. M.; Tanaka, J.; Barbas, C. F., HI. Adv. Synth. C'atal. 2004, 346, 1131-
1140. Sec also: (b) List, B.; Pojarliev, P.; Biller, W. T.; Martin, H. J. J. 
Am. Chem. Soc. 2002, /24, 827-833. (c) List, B. .1. Am. Chem. Soc. 2000, 
122, 9336-9337. 
The stereochemistrics of the piperidinones 4a, 4c, and 4d were 
determined by X-ray crystallography. Analysis of 'H NMR coupling 
constants was used to establish the stereochemistry of 4b. See Supporting 
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Figure 1. Possible reactive conformations for the cyclization of 
substrates 3a—d. 
The synthetic utility of the piperidinone products was 
illustrated by a number of transformations. Reductive 
removal of the carbonyl group allows entry to the piperidine 
ring system, a ubiquitous structural feature of many natural 
products and biologically important compounds.l2  For ex-
ample, treatment of id with borane at reflux provided 
piperidine 5 in good yield, which could be converted into 6 
by oxidative removal of the PMP group5c  followed by in 
situ treatment of the resulting amine with Boc20 (Scheme 
2). The amide reduction of piperidin-2-ones 4c and 4d with 
Scheme 2. Conversion of Piperidinone Products into 
Piperidines 
0 
Me N_PMP BH3 THF Me 
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(96% ee) (>99% ee) 
borane was accompanied by reduction of the ethyl esters to 
give piperidines 7 and 8, respectively. Polyhydroxylated 
piperidines are of considerable biological interest due to their 
potential to act as glycosidase inhibitors)3 
(II) For related cyclizations involving the Sm12-promoted intramolecular 
Reformatsky reactions of/3-haloacetoxyketones and an excellent discussion 
of the factors determining the stereochetnical outcomes, see: Molander, 
G. A.; Etter, J. B.; Harring, L. S.; Thorel, P.-J. J. Am. Chem. Soc. 1991, 
113, 8036-8045. 
(12) For reviews of piperidine synthesis, see: (a) Weintraub, P.M.; Sabo], 
J. S.; Kane, J. M.; Borchcrding, D. R. Tetrahedron 2003, 59, 2953-2989. 
(b) Laachat, S.; Dickncr, T. Synthesis 2000, 1781-1813. 
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moderate to excellent levels of 1,2- and 1,3-asymmetric 
induction in these reactions may be rationalized by invoking 
the chelated chairlike conformations A—fl shown in Figure 
>19:1 	65 	 1, with substituents in the tether linking the amide enolate 
and the ketone preferring to adopt pseudoequatorial posi-
tions. II  
Org. Let!., Vol. 7, No. 25, 2005 	 5745 
In summary, we have applied copper(I)-catalyzed reductive 
aldol cyclizations to the highly diastereoselective synthesis 
of 4-hydroxypiperidin-2-ones. L-Proline-catalyzed Mannich 
reactions may be used to prepare more highly substituted 
cyclization precursors in enantiomerically enriched form, 
enabling the enantioselective synthesis of piperidin-2-ones 
and piperidines. Current work is focused on identifying 
catalyst systems that allow a greater range of substituted a,fi-
unsaturated amides to become viable substrates, developing 
enantioselective variants of this process, and applying this 
methodology to other substrate classes. The results from these 
studies will be reported in due course. 
(13) For a recent review, see: Pearson, M. S. W.; Mathó-Allainrnat, M.; 
Fargeas, V.; Lebreton, J. Eu,. J. Org. Chem. 2005, 2159-2191. 
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Cobalt catalysis enables a new method for the generation of zinc enolates using diethyizinc to reduce tx/I-unsaturated amides. This method 
has been applied to a high-yielding diastereoselective reductive aldol cyclization. 
The trapping of aldehydes and ketones with enolates gener-
ated in situ via metal-catalyzed conjugate reduction of cij3-
unsaturated carbonyl compounds has emerged as a powerful 
method for accessing aldol products.' Despite the tremendous 
progress that has been made in this area,' the continued 
development of new methods that exhibit high stereocontrol 
for an increased range of substrates remains an important 
goal. Recent contributions to this field from our laboratory 
have detailed copper(T)-bisphosphine-catalyzed reductive 
aldol cyclizations using TMDS (1,1 ,3,3-tetramethylhydrosi-
loxane) as the stoichiometric reductant that could be applied 
to the synthesis of j3-hydroxylactones and fihydroxylactams2b 
(eq 1). 
University of Edinburgh. 
Hoffman-La Roche. 
(I) For a seminal reference, see: (a) Revis, A.; Hilty, T. K. Tetrahedron 
Lett, 1987, 28,4809-4812. For an extensive collection of reports of catalytic 
reductive aldol reactions, see references cited within: (b) Jung, C.-K.; 
Gamer, S. A.; Krische, M. J. Org. Let!. 2006, 8, 519-522. For relevant 
reviews, see: (c) Jang, H.-Y.; Krische, M. J. Eur. .1. Org. Chem. 2004, 
3953-3958. (d) Jang, H.-Y.; Krische, M. J. Ace. Chem. Res. 2004, 37, 
653-661. (e) Huddleston, R. R.; Krische, M. J. Syn/et! 2003, 12-21. (1) 
Chin, P. Synthesis 2004, 2210-2215. (g) Motherwell, W. B. Pure App!. 
Chem. 2002, 74, 135-142. 
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R2 0 
R2 	0 	 bisphosphine (cat.) 
...*-L.....R3 Cu(OAc)2 H20 (cat.) 	R1 	 (1) 
TMDS, THE, rt 
XO:n=1.2 0 
X = NAr: n 2 	 HO 
Although the products were obtained with generally high 
levels of diastereoselectivity (and with moderate enantiose-
lectivitiest in the case of 3-hydroxylactones when suitable 
chiral bisphosphines were employed2a),  the process suffered 
from a number of limitations. First, the yields of these 
reactions were moderate at best (typically in the range 60-
70%) due to competing side reactions.2 Second, the attenu-
ated electrophilicity of a,/3-unsaturated amides compared 
with the corresponding esters meant that productive cycliza-
tions were limited to those amide substrates where R' = H 
(a) Lam, H. W.; Joensuu, P. M. Org. Let!. 2005, 7, 4225-4228. (b) 
Lam, H. W.; Murray, G. J.; Firth, J. D. Org. Left. 2005, 7, 5743-5746. 
For enantiosclectivc copper-catalyzed intermolecular reductive aldol 
reactions with ketones, see: (a) Deschamp, J.; Chuzel, 0.; Hannedouche, 
J.; Riant, 0. Angew. Chem., In!. Ed. 2006, 45, 1292-1597. (b) Zhao, 0.; 
Oisaki, K.; Kanai, M.; Shibasaki, M. Tetrahedron Let!. 2006, 46, 1403-
1407. 
or Me (with R2 = H).2b Therefore, a search for improved 
reaction conditions was initiated, and we describe herein a 
new cobalt-based catalyst system that exhibits broader scope 
for amide-tethered substrates and allows products to be 
isolated with higher yields. 
Initial investigations began with the cyclization of cin-
namic amide la (Table 1). Application of our previously 
Table 1. Survey of Reaction Conditions 
0 
Ph N_PMP 
hg and (5 mol %) 
metal Salt (5 mol %) 	HO 2a 
O 	 OH 







entry 	reagents 	solvent (°C) (%)° 2a13" 
1 Cu(OAc)2 H20, DPPF, THF rt 77 34:66 
TMDS (1 equiv) 
2 Cu(OAc)2 H20, rae- THF rt 87 39:61 
BINAP, TMDS (1 equiv) 
3 Cu(OAc)2 H20, DPPF, THF rt <5 na 
PhSiH3 (1 equiv) 
4 Co(dpm), CH2C12 rt Ca. 90 nab 
PhSiH3 (1 equiv) 
5 Co(dpm)2, DCE rt to 50 ca 80 nab 
PhSiH3 (1 equiv) 
6 Co(acac)22H20, THF/ 0 tort <5 na 
Et3B (2 equiv) hexane 
7 Co(acac)2 2H20, THF/ 0 to rt >95 >95:5r 
Et2Zn (2 equiv) hexane 
"Determined by 'H NMR analysis of the unpurified reaction mixture. 
A complex mixture containing unidentified side products was obtained, 
with only a trace (<10%) of 2a present. I Product 2a was isolated in 89% 
yield. PMP =para-methoxyphenyl, DPPF = l,l'-bis(diphcnylphosphino)-
fenocenc, TMDS = 1,1,3,3-tetramcthylhydrosiloxanc, BINAP = 2,2'-
bis(diphcnylphosphino)-1,l'-binaphthyl, dpm = dipivaloylinethane, acac = 
acetonylacetonate. 
reported copper conditions2 proved ineffective, providing the 
desired product 2a but contaminated with significant quanti-
ties of the uncyclized side product 3 along with the starting 
material (entry 1). The formation of 3 may be attributed to 
conjugate reduction of the a,j3-unsaturated amide being slow, 
allowing prior reduction of the ketone to become competitive. 
Replacement of DPPF with rac-BINAP led to a similar result 
(entry 2), whereas use of PhSiH3 in place of TMDS led to 
minimal reaction (entry 3). Having obtained no success with 
copper-based catalyst systems, our attention turned to the 
use of other metals. In conjunction with an appropriate chiral 
ligand, the combination of CoC12 and NaBH4 has proven 
useful for the asymmetric conjugate reduction of a,/3-
unsaturated amides.4 Unsurprisingly, conditions employing 
NaBH4 led to rapid reduction of the ketone of Ia. Conditions 
employing cobalt salts that were developed for intermolecular 
reductive aldol reactionssa and later extended to aldol 
cyclizations 5b,c  also proved ineffective, providing complex 
mixtures (entries 4 and 5). In light of recent reports of 
organometallic reagents with /3-hydrogen-containing alkyl 
groups being utilized as stoichiornetric reductants for a 
variety of transition-metal-catalyzed reductive couplings,' we 
examined Et3B 6b-  and Et2Zn6a,b in our reaction. In the 
presence of 5 mol % of Co(acac)2 hydrate (degree of 
hydration - 2), Et3B resulted in no reaction (entry 6), but 
we were delighted to observe that the more reactive Et2Zn 
led to the formation of 2a in 89% yield with none of the 
side product 3 being observed (entry 7). No reaction occurs 
in the absence of Co(aeac)2 2H20. 
With effective conditions identified, the scope of the 
process was next explored (Table 2). Substrates containing 
a wide range of substitution at both the a,j3-unsaturated 
amide and the ketone7 underwent cyclization to give 4-hy-
droxypiperidin-2-one products in generally excellent yields 
and high diastereoselectivities' (entries I - 12). It should be 
noted that the copper conditions (as in Table 1, entry 1) 
proved ineffective in the majority of these examples. In a 
number of reactions, incomplete conversions were observed 
using Co(acac)2 2H20 (method A), but the combination of 
CoCl2 and the electron-rich phosphine Cy2PPh (method B) 
was found to provide good results in these cases (entries 
10-12). The reaction could also be applied to the formation 
of pyrrolidin-2-ones (entries 13-15), though with somewhat 
lower yields and diastereoselectivities. Although 5 mol % 
of the cobalt source was employed for convenience in these 
experiments, the reaction is tolerant of lower catalyst 
loadings. For example, on a 5 mmol scale, substrate I a 
underwent cyclization using 0.5 mol % of Co(acac)2 2H20 
to provide 2a in 79% yield (entry 2). 
Difficulties were encountered when substrates 4a,b con-
taining phenyl ketones were employed; in contrast to methyl 
ketones il — n (Table 2, entries 13-15), the desired pyrro-
lidin-2-ones were obtained in <20% yield along with 
numerous other side products. However, replacement of Et2- 
(4)(a) v. Matt, P.; Pfaltz, A. Tetrahedron: Asynnnetrv 1991, 2, 691-
700. (b) Gieger, C.; Kreitmeicr, P.; Reiscr, 0. Adv. Synth. Catal. 2005, 
347, 249-254. (c) Yamada, T.; Ohtsuka, V.; lkcno, T. Chem. Let!. 1998, 
1129-1130. (d) Ohtsuka, V.; Ikeno, T.; Yamada, T. Tetrahedron: Asym-
metry 2003, 14, 967-970. 
(a) lsayama, S.; Mukaiyama, T. Chem. Left. 1989, 2005-2008. (b) 
Baik, T.-G.; Luis, A.-L. Wang, L.-C.; Krische, M. J. .1. Am. Chem, Soc. 
2001, 123, 5112-5113. (c) Wang, L.-C.; Jang, H.-Y.; Roh, Y.; Lynch, V.; 
Schultz, A. J.; Wang, X.; Krischc, M. J. I Am. Chem. Soc. 2002, 124, 
9448-9453. 
For selected examples, see: (a) Kimura, M.; Miyachi, A.; Kojima, 
K.; Tanaka, S.; Tamaru, Y. J. Am. Chem. Soc. 2004, 126, 14360-14361. 
(b) Kimura, M.; Ezoe, A.; Shibata, K.; Tamaru, V. I. Am. Chem. Soc. 1998, 
/20, 4033-4034. (c) Molinaro, C.; Jamison, T. F. Angew. Chem., In!. Ed. 
2004, 44, 129-132. (d) Molinaro, C.; Jamison, T. F. J. Am. Chem. Soc. 
2003, 125, 8076-8077. (e) Miller, K. M.; Huang, W.-S.; Jamison, T. F. J. 
Am. Client. Soc. 2003, /25,3442-3443. For a review, see: (f) Montgomery, 
J. Angew. Chem., In!. Ed. 2004, 43, 3890-3908. 
Aldehydes do not serve as competent electrophiles under these 
conditions, as they undergo reduction and ethylation instead. 
The relative stereochcnsistries of 2f, 21, and 2m were confirmed by 
X-ray crystallography and matched those of products obtained previously 
using copper catalysis (see ref 2). The stereochemistrics of the remaining 
products were assigned by analogy. See Supporting Information for further 
details. 
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Table 2. Cobalt-Catalyzed Reductive Aldol Cyclizations" 
Co (cat.) 	 o 
0 	 Ugand (cat.)  
Et2Zn (2 equlv) 	Rl-;' 	N_ R  
t1 	' 	THF, hexane 
R2 0 	O Ctort HO 
la-n 	 2a-n 
Method A: Co(acac)221120 mol %) 
Method B: CoCl2 (5 mol %). Cy2PPh (5.5 mol %) 
entry substrate method product dr' yield 
(%)C 
2 
o R = Me la 
R = Me la 
A 
0 









I R=EtIb A 
R 2b 9:1 88 
PMP HO 
4 0 	0 R"HIc 












R 	NMe I R=Ph le A Me"  2e >19:1 97 
Ba R = 2-furyl If A HO 21 >19:1 >99 
AN 
R= Me Ig A 
0 
R')5(fl 2g >19:1 
94 





CO2E1 	R = H 	1 B 	 21 9:1°  56 
11 R'N 	 R=Me Ij B 
N 	 2j >19:1°  80 
12 	 PMP 	R= Ph 1k 	B 	 2k >19:1°  88 
13 	 ° 	 R=H II 	 A 	 21 9:1 47 PMP 
R = Ph Im A R 	N 	 2m 14 R''11t(
PMP 74
'f( 
8:1 56  
15 	 0 	R 	OMP In 	B 	 2n 14:1 
HO 
"Unless otherwise stated, reactions were conducted using 0.2 mrnol of substrate in THF (1.5 niL) and hcxane (0.4 niL) for I —24 h. h Determined by 'H 
NMR analysis of the unpurified reaction mixtures. 	Isolated yield of the major diasterconicr. d Reaction conducted using 5 mrnol of la using 0.5 mol % of 
Co(acac)2 2H20 in THF (10 mL) and hexanc (10 niL). I Here, dr = (major isomer):( 	other isomers). OMP = ortho-mcthoxyphenyl. 
Zn with Et3AI allowed isolation of 5a,b in modest yield (eq 
2).1  Analogues of 4a,b containing substituted ,/3-unsaturated 
0 




Co(acac)2-2H20 (5 mol %) 
THF, hexane 
R' 	0 	o°Ctort HO 
4a R = PMP 	 5a (57% yield, >19:1 dr) 
4b R = PMB 5b (53% yield, 5:1 dr) 
amides did not cyclize under any conditions examined. 
In the absence of detailed studies, discussion of the 
mechanism of the reaction can only be speculative at this 
stage. We believe that a zinc enolate is the species that 
undergoes aldol cyclization, but the precise details leading 
to the formation of this enolate are not known. One possible 
catalytic cycle is presented in Scheme 1. Treatment of Co-
(acac)2-2H20 (or CoCl2) with Et2Zn results in the formation 
of a cobalt hydride species 6,10  presumably via a transmeta-
lationl,8-hydride elimination sequence. Hydrometalation of 
(9) Pyrrolidin-2-ones 5a,b were accompanied by Ca. 15% of the 
corresponding products resulting from conjugate addition of an ethyl group 
from Et3AI followed by aldol cyclization. 
Org. Lett., Vol. 8, No. 17, 2006 




1  L 	R3 
7 
\, R 0 
Et2Zn 
Et2Zn 	 OZnEI 
C0L2 	LCo-H 
R1 	10 1 
6 	
j\.... 4.3 R3 
LC0Et 	 2 0 
	
CH2=CH2 	 0 
p1 	N R2 
EtZnO 11 
the substrate 7 with 6 generates a cobalt enolate 811 that reacts 
with Et2Zn to give an ethyizinc enolate 10 1,12 and an 
ethylcobalt species 9. Enolate 10 then undergoes cyclization 
to give the zinc alkoxide 11, whereas the ethylcobalt species 
9 undergoes /3-hydride elimination to regenerate 6 along with 
ethylene. This mechanism bears similarities to those proposed 
for catalytic variants of the Reformatsky reaction employing 
3731 
a-bromocarbonyl compounds and dialkylzinc reagents medi-
ated by rhodium",  and nicke1.13 
Another scenario that we do not rule out involves the 
participation of Et2Zn at an earlier stage of the mechanism. 
Binding of Et2Zn to the a/-unsaturated carbonyl in Lewis 
acidic fashion, along with Lewis basic interaction with the 
cobalt hydride via three-center, two-electron bridging of a 
zinc-ethyl bond (as in 12, eq 3), would lead to zinc enolate 





H-C'L 0 	 OZnEt 
R1 	 R' "''" 
12 R 	 0 2 
 flg 	
1k2 o 
to our knowledge this type of bridging interaction has not 
been invoked for a cobalt-catalyzed reaction, it has been 
proposed for a number of related Ni(0)-catalyzed alkylative 
couplings to explain the accelerating effect of organozinc 
reagents. 4at) Furthermore, it has been observed crystallo-
graphically for cobalt 141  and nickel 4d,e complexes involving 
Grignard 14el  and organoaluminum t 4e reagents. 
Yet another possibility that was initially considered 
involves the Et2Zn-assisted oxidative cyclization 14a  of a low-
valent cobalt species with substrate 7 to form the cobaltacycle 
13 (eq 4). 
0 
R3 LCo, Et2Zn 
oxidative - Et : 	
• 	(4) 
R2 0 cyclization Zn 
Et 	13 
Metallacycles have been implicated as intermediates in a 
number of cobalt-15 and nickel-catalyzed6 reductive coup- 
(10) The oxidation State of cobalt species 8 is not known, though we 
assume a reduction occurs to generate a low-valent cobalt hydride. For the 
presumed generation of cobalt hydride by treatment of Co(acac)3 with Et2-
AId, see: Takacs, J. M.; Mehrman, S. J. Tetrahedron Let!. 1996, 37, 2749-
2752. 
 
(II) Although we have arbitrarily depicted enolates as being 0-bound, 
high C-bound character is possible. 
(12) For a discussion of the preparation, characterization, and reactivity 
of an cthylzine enolate, see: Hansen, M. M.; Bartlett, P. A.; Heathcock, C. 
H. Organornetallics 1987, 6, 2069-2074. 
(13) (a) Kanai, K.; Wakabayashi, H.; Honda, T. Org. Let!. 2000,2,2549-
2551. (b) Adrian, J. C., Jr.; Snapper, M. L. .1. Org. C/tern, 2003, 68, 2143-
2150. (c) Cozzi, P. G.; Rivalta, E. ..lngew. Client., In!. Ed. 2005, 44, 3600-
3603. 
(14) (a) Hratchian, H. P.; Chowdhury, S. K.; Gutiérrez-Garcia, V. M.; 
Amarasinghe, K. K. D.; Heeg, M. J.; Schlegel, H. B.; Montgomery, J. 
Organorneta//ics 2004, 23, 4636-4646. (b) Subbaraj, K.; Montgomery, J. 
J. Am. C'hem. Soc. 2003, 125, 11210-11211. (c) Jonas, K.; Koepe, 0.; 
Krueger, C. Angew. C/sent., mt. Ed. Engl. 1986, 25, 923-925. (d) Kaschube, 
W.; Pdrsehke, K.-R.; Angermund, K.; Kruger, C.; Wilke, G. Chem. Ber. 
1988, 121, 1921-1929. (e) Ogoshi, S.; Ueta, M.; Arai, T.; Kurosawa, H. 
I. Am. Chem. Soc. 2005, 127, 12810-12811. 
lings; in the present case, the final product would be formed 
from 13 by a sequence involving transmetalation, 13-hydride 
elimination, and reductive elimination. However, a number 
of observations led us to conclude that this pathway is not 
operative. First, reaction in the presence of catalytic quantities 
of a variety of chiral ligands'6 led to racemic products in all 
cases, providing circumstantial evidence that cobalt is not 
involved in the stereo chemical-determining step. Second, the 
simple ti,/3-unsaturated amide 14 underwent conjugate 
reduction to give 15 in 73% yield under these conditions 
(eq 5), demonstrating that a second electrophilic ic-compo-
nent is not required for the reaction to proceed. 
0 	 Et2Zn 	 0 
Co(acac)2 21`120 
Ph NBn2 	(5) 2 	THF, hexane 
14 	 O°Ctort 	 15 
73% yield 
In conclusion, we have developed an efficient and highly 
diastereoselective cobalt-catalyzed reductive aldo I cyclization 
that utilizes Et2Zn as the stoichiometric reductant. This study 
has highlighted two important features: (i) conjugate reduc-
tion of a,8-unsaturated amides using Et2Zn, which to our 
knowledge has not been developed as a general synthetic 
method,'7 and (ii) a mild new approach to access zinc 
enolates that does not require the prior formation of an alkali 
metal enolate (for transmetalation with a zinc halide) or the 
use of x-halocarbonyl compounds (which can be difficult 
to prepare for complex substrates). We anticipate this method 
of zinc enolate generation will find application in a range of 
other reactions. Further studies in this area will be reported 
in due course. 
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